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RESUMO 
 
 
 
 
A menopausa tem sido genericamente definida como um fenómeno bio-médico, tendo 
como consequência a emergência de sintomas físicos e psicológicos decorrentes da 
diminuição de estrogénios endógenos. O presente trabalho pretende alargar esta 
conceptualização da menopausa, contextualizando-a no modelo bio-psico-sócio-
cultural, explorando se variáveis pessoais (como a espiritualidade) e contextuais (por 
exemplo, acontecimentos de vida) podem predizer sintomas reconhecidos como de 
menopausa. 
É ainda objectivo deste estudo explorar que variáveis estão associadas ao aumento de 
peso na transição para a menopausa e na pós-menopausa, e se uma intervenção breve 
cognitivo-comportamental pode promover a diminuição de peso em mulheres com 
obesidade e excesso de peso. 
Finalmente, pretende-se construir um modelo causal de bem-estar subjectivo na meia-
idade. 
Uma amostra comunitária constituída por 1.003 mulheres com idades compreendidas 
entre os 42 e os 60 anos, recolhida maioritariamente através de estabelecimentos de 
ensino na área de Lisboa, preencheu um questionário para recolha de informação sócio-
demográfica, relacionada com saúde, menopausa e estilo de vida. As participantes 
responderam ainda a instrumentos validados para averiguar o bem-estar subjectivo, 
depressão, ansiedade e stress, sintomas de menopausa, percepção de controlo sobre os 
afrontamentos, espiritualidade, acontecimento de vida e preocupações com a forma 
corporal. 
Desta amostra, 17 mulheres com excesso de peso ou obesidade participaram numa 
intervenção cognitivo-comportamental individual para a perda de peso. Antes da 
intervenção, imediatamente após e quatro meses depois do seu término, as participantes 
foram avaliadas em relação a medidas antropométricas, psicológicas e de 
comportamento alimentar. 
Os resultados mostram que, tanto os acontecimentos de vida, como a espiritualidade, 
predizem de forma significativa a gravidade dos sintomas de menopausa. Além destes, 
também variáveis de estilo de vida, sócio-demográficas e relacionadas com o estado de 
saúde associam-se de forma significativa a estes sintomas.  
Dos doze grupos de sintomas de menopausa averiguados (psicológicos e físicos), 
apenas três são preditos pelo estado de menopausa. Assim, sintomas vasomotores, 
sexuais e alterações na pele e nos pêlos faciais são os únicos sintomas que parecem 
decorrer das alterações hormonais.  
Observou-se ainda que mulheres com uma escolaridade mais baixa, com uma prática de 
exercício físico mais reduzida, com um problema psicológico auto-relatado, mais 
preocupadas com a forma corporal e em pós-menopausa apresentavam um ganho de 
peso maior. A perda de peso após a intervenção mostrou-se estatisticamente 
significativa, comparando o peso antes da intervenção e quatro meses após a mesma, 
ficando contudo abaixo dos 5% do peso corporal. 
Verificou-se ainda que o bem-estar subjectivo na meia-idade é predito pelo humor 
deprimido, presença de um problema psicológico, espiritualidade, stress, 
acontecimentos de vida e ainda consumo de café. 
Esta investigação permite concluir que a maior parte dos sintomas identificados como 
decorrentes da menopausa são, nesta amostra, determinados por factores não hormonais, 
VI 
 
sendo a única sintomatologia consequente do estado de menopausa os sintomas sexuais, 
vasomotores e alterações na pele/pêlos faciais. Tal contribui para uma compreensão da 
menopausa para além da abordagem medicalizada que tem vigorado na literatura. 
Adicionalmente, são identificados factores de vulnerabilidade em relação ao aumento de 
peso e bem-estar na meia-idade, que permitem potenciar mudanças neste âmbito. 
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ABSTRACT 
 
 
 
 
Menopause has been generically defined as a bio-medical phenomenon, having as 
consequence the emergence of physical and psychological symptoms, subsequent to the 
decrease of endogenous estrogens. The present research intends to broaden this 
conceptualization of menopause, contextualizing it in the bio-psycho-socio-cultural 
model. Therefore, we will explore if personal (such as spirituality) and contextual 
variables (for example, life events) can predict symptoms recognized as menopausal 
ones. 
It is also the aim of this study to investigate which variables are associated with weight 
gain in the menopausal transition and post-menopause. Also, it is our objective to 
explore if a brief cognitive-behavioural intervention can promote a weight decrease in 
obese and overweight women. 
Finally, we intend to build a causal model of subjective well-being in midlife.   
A community sample of 1,003 women, aged between 42 and 60 years, mainly collected 
in schools and universities in Lisbon, answered a questionnaire to gather socio-
demographic, health and menopause-related, and lifestyle information. Moreover, 
participants filled in validated instruments to assess subjective well-being, depression, 
anxiety and stress, menopausal symptoms, perceived control over hot flashes, 
spirituality, life events and body shape concerns. 
From this sample, 17 overweight and obese women participated in an individual 
cognitive-behavioural intervention for weight loss. Before the intervention, immediately 
after and at a 4-month follow-up, participants were assessed regarding anthropometric, 
psychological and eating behaviour variables. 
Results show that both life events and spirituality significantly predicted menopausal 
symptoms’ severity. Besides these two, also lifestyle, socio-demographic and health-
related variables were significantly associated with menopausal symptoms.   
From the twelve sets of menopausal symptoms assessed (psychological and physical), 
only three were predicted by the menopausal status. Therefore, vasomotor and sexual 
symptoms, and skin and facial hair changes are the only ones which appear to be a 
consequence of hormonal changes. 
Women with less schooling years, less physical activity, the presence of a self-reported 
psychological problem, more concerned with body shape and in post-menopause, 
manifested higher weight gain. The weight loss consequent to the cognitive-behavioural 
intervention was statistically significant, when comparing body weight prior to the 
intervention and weight at the follow-up; however, the loss was lower than 5% of body 
weight. 
Subjective well-being in midlife was predicted by depressive mood, presence of a 
psychological problem, spirituality, stress, life events and coffee intake. 
This research allows the conclusion that the majority of symptoms identified as 
menopausal are, in this sample, determined by non-hormonal factors; the only 
symptoms consequent to menopausal status are sexual, vasomotor and skin/facial hair 
changes. This outcome contributes to an understating of menopause beyond the 
medicalized approach that is common in the literature. Additionally, vulnerability 
factors for weight modifications and well-being in midlife, which allow the 
development of changes in this field, were identified. 
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GENERAL INTRODUCTION 
 
 
 
 
1. Menopause 
 
 
It is estimated that at least 2% of the world‘s female population is going to start 
having menstrual changes (that is, entering peri-menopause) or will have the final 
menstrual period (post-menopause) in the decade of 2010-2020 (Skouby, 2004).  
The improvement of life conditions, and the development and advances in public 
health and medicine, has enabled an increase of life expectancy trend in the past two 
centuries (having as exceptions the periods during which infectious diseases epidemics 
and pandemics, war and famine emerged) (Olshansky et al., 2005). As a consequence, 
nowadays women spend a third of their life in the post-menopausal stage.  
Obermeyer, Ghorayeb and Reynolds (1999) emphasize the importance of the research 
developed on menopause given the aging of the world population, and also the loss of 
the cardio-vascular protection that endogenous estrogens provide to women, which ends 
at the time of menopause. Additionally, this protection of women‘s health, provided by 
estrogens, is also demonstrated in another research, which suggests that a later 
menopause is linked with a longer overall survival and a lower risk of death due to 
ischemic heart disease (Ossewaarde et al., 2005). 
 
 
1.1 Menopause-related Concepts 
 
Women are born with a finite number of oocytes and throughout the reproductive 
aging process (which starts prior to birth and develops in a continuum), the progressive 
loss of these oocytes (during atresia or ovulation) is observed, which does not 
necessarily happen at a constant rate. The reproductive failure is what signals 
menopause (Hansen et al., 2008).  
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Since age is a weak indicator of menopause, a staging system was developed to 
identify the different menopausal statuses. Therefore, pre-menopausal women are the 
ones who will present an absence of menstrual cycles‘ alterations. Women in 
menopausal transition (also designated as peri-menopause) will evidence menstrual 
cycle changes, i.e., the cycle length will vary (in more than seven days than usual) 
and/or intervals of amenorrhea (superior to two months) will be observed. The post-
menopause phase starts with menopause and endures until the end of life. Menopause 
per se is defined as the last menstrual period, confirmed after a 12-month amenorrhea 
(Soules et al., 2001).  Speroff and Fritz (2005) clarify that the term climacteric, usually 
found in literature, traduces the phase of peri- and post-menopause, during which 
vasomotor symptoms, psycho-physiological and atrophic changes occur.  
 
 
1.2 Menopausal Symptoms 
 
During peri-menopause, several symptoms may arise and can prevail until post-
menopause. Among others, the literature has documented hot flashes, joint pain, sleep 
disorder, depressive mood, irritability, fatigue and decrease of libido as the most 
common (Genazzani, Schneider, Panay, & Nijland, 2006; Obermeyer, Schulein, Hajji, 
& Azelmat, 2002; Obermeyer, Reynolds, Price, & Abraham, 2004; Obermeyer, Reher, 
Alcala, & Price, 2005; Pinkerton & Zion, 2006).  
Symptoms exacerbation has been identified as a robust predictor of the search for 
medical help behaviour, especially regarding vasomotor symptoms (Avis, Crawford, & 
McKinlay, 1997; Guthrie, Dennerstein, Taffe, & Donnelly, 2003; Whitcomb, 
Whiteman, Langenberg, Flaws, & Romani, 2007). However, literature has evidenced 
that, although physical changes happen throughout the climacteric period, the 
menopausal transition experience is also influenced by cultural, social and political 
factors (Berger & Forster, 2001; Hunter, O‘Dea, & Britten, 1997). 
 
 
1.3 Medicalization 
 
The use of medical language to assert a concern, apply a medical theoretical 
approach to conceptualize an issue and treat it with medical interventions consists in 
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medicalization; therefore, medicalization resides in the management of non-medical 
problems as if they were illness or disorders. More than a neutral term, this concept 
emphasizes a critique regarding the (over)medical approach to non-medical issues 
(Conrad, 1992).  
It is known that the iatrogenic cause of ill-health is mediated not only by 
pharmacological and surgical interventions, but also by environmental and cultural 
transformations. Hence, it is suggested that medicalization disables personal-care, leads 
to the decline of the ability to cope (supported by the cultural context) and promotes a 
dependence on health services and professionals for one‘s health management (Illich, 
1982). 
Nowadays, medicalization is more driven by pharmaceutical industry and genetics, 
consumers, managed care, commercial and market interests than by professional claims-
makers (Conrad, 2005).  Also, the advertising of prescription drugs directly to the 
consumer, as well as the appearance of private medical markets, play a relevant role in 
this medical approach to conditions that are not medical or not in need of medical 
management (Conrad & Leiter, 2004).  
It has been observed that, in the occidental societies, the depreciation of aging, as 
opposed to youth, strength and extended ability to implement actions, led to the 
medicalization of age progression as if it was a disease (Paúl & Fonseca, 2001). 
Menopause has been mentioned as a paradigmatic case of medicalization (Sievert et 
al., 2008). It was defined as a deficiency disease at a time when synthetic estrogens 
started being commercialized; hormonal therapy, promoted both by physicians and 
pharmaceuticals, appeared as a way to delay aging and preserve valuable attributes, 
such as youth and beauty (McCrea, 1983). 
Meyer (2003) states that the conceptualization of menopause as an estrogens‘ 
deficiency state and its medicalization, which started in the United States and spread 
afterwards to Europe, is causing harm to women around the world.  
Women who see menopause as a hormonal deficiency condition or perceive 
menopausal transition as a synonym of aging, are more prone to use hormonal therapy 
and recognize its benefits in relation, for example, to skin appearance (Liu & Gass, 
2007).  
However, opting for a treatment for menopausal symptoms (hormone therapy), 
specifically in women who do not have a favourable attitude towards the use of 
medication in general, is influenced by fear of ill-health; this apprehension might be 
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boosted by prior experiences of health absence in family members or by medical advice. 
Moreover, the main information sources regarding the treatment of menopausal 
symptoms are social peers and the media (Griffiths, 1999).  
The promotion and use of hormone therapy, seen in the last decades, has been 
regarded by the sociological literature as a strong sign of menopause‘s representation as 
a medical condition (Griffiths, 1999). Hormone replacement therapy gained its highest 
notoriety in the 1990‘s as a preventive medical approach of coronary heart disease, 
dementia, osteoporosis and vasomotor symptoms (Sievert et al., 2008).  
However, in 2002, the outcomes of the randomized controlled trial Women‘s 
Health Initiative (WHI), evidenced that participants doing estrogens and progestin had 
an increased risk for breast cancer, and higher incidence of tromboembolic episodes, 
coronary heart disease, stroke and pulmonary embolism when compared with 
counterparts doing a placebo. For this reason, this arm of the study was terminated at 
the fifth year of the study (Naftolin, Schneider, Sturdee, & Executive Committee of the 
International Menopause Society, 2005). And although many researchers and clinicians 
continue to deliberate about WHI‘s results and methodological issues, many women 
have stopped using hormone therapy since then (Sievert et al., 2008). 
The medicalization degree varies according to cultures and might even present 
differences inside the same country. A Spanish research has evidenced that the 
conceptualization of menopause in the context of a medical theoretical approach (given 
by rates of surgical menopause and hormone therapy use) is significantly higher in 
urban areas than in rural regions (Bernis & Reher, 2007). 
Therefore, as it appears that, socially, menopause has been conceptualized as an 
illness in need of medical care (Ferguson & Parry, 1998), Meyer (2003) states that 
biases regarding the female gender, particular cultural assumptions and certain policies 
have led to the medicalization of this female developmental process. And, contrary to 
what might be expected, this will function as an obstacle to health awareness and this 
conceptualization of the menopausal transition will increment a focus on women‘s own 
bodies transformations and age progression, making the experience of menopause‘s 
acceptance more difficult (Ferguson & Parry, 1998). Exemplary of the generalized 
medicalization, regarding the menopausal transition, are the publications‘ trends, which 
have been predominantly based on the biomedical conceptualization of menopause 
(Rostosky & Travis, 1996).  
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1.4 Bio-medical Model of Menopause 
 
The bio-medical paradigm focuses on menopause from a physiological point of 
view. According to Hansen and colleagues (2008), the main mechanism influencing 
reproductive aging is the depletion of the ovarian pool of non-growing follicles. From 
the biological model‘s point of view, the age variability of natural menopause (average 
51±8 years) is explained in terms of disparities in the initial determination of non-
growing follicles or the rate of non-growing follicles depletion (Hansen et al., 2008). 
However, the authors conclude that age by itself cannot account for a great percentage 
of variability in non-growing follicles between different individuals. 
As mentioned before, during the last decades of the XX century menopause was 
defined as an estrogens deficiency disease (Liu & Gass, 2007). The recommendation of 
the American Association of Clinical Endocrinologists, in 1999, was that menopause 
was a condition that should be treated given that it was caused by hormones‘ deficiency 
(Cobin et al., 1999). 
The medicalization of menopause was originated from its physiological 
understanding that started in the decades of 1930 and 1940, and also from the 
concomitant emergence and availability of pharmacological therapies responsive to the 
physiological characteristics of the menopausal transition process (Liu & Gass, 2007). 
The emergence of diverse symptoms during climacteric is frequently explained by 
the bio-medical model. According to this framework, depressive symptoms, fatigue, 
concentration and memory problems are associated with endogenous estrogens‘ 
decrease (Collins & Landgren, 2002). Additionally, Saletu et al. (1996) and Brace and 
McCauley (1997) sustain that well-being is equally influenced by endogenous 
estrogens: low levels of estradiol lead to the decrease of neurophysiological vigilance, 
which in turn is associated with the increase of depressive mood and other menopausal 
symptoms emergence. Sarrel (1999) also endorses a biological explanation, specifying 
that hormonal changes around menopausal transition play an important role in the 
psychological symptoms and sexual difficulties‘ manifestation. 
Several authors associate a depressive mood and anxiety to hormonal fluctuations 
observed in specific phases of the reproductive cycle, namely during the days prior to 
the menstrual period, after giving birth and along the menopausal transition (Becker, 
Orr, Weizman, Kotler, & Pines, 2007; Birkhäuser, 2002; Soares, Poitras, & Prouty, 
2003). 
6 
 
However, research has evidenced that women using hormonal therapy might not 
present lower frequency of menopausal symptoms (namely, hot flashes). Therefore, it is 
recommended, particularly to specialists developing research in reproductive aging from 
a biological perspective, that cultural influences are accounted for, given their possible 
influence in biomedicine (Sievert, 2003). 
In addition, recent research efforts have been made in order to assess which 
menopausal symptoms are due to hormonal changes and which ones are caused by 
aging, changing health status, lifestyle and psychosocial factors (Dennerstein, Dudley, 
Hopper, Guthrie, & Burger, 2000). Like climacteric symptomatology, also the age at the 
natural menopause is influenced by socio-demographic factors (Sievert, 2003).  In this 
context, and despite the evidences, the alternative frameworks regarding menopausal 
transition and middle-age, specifically integrating psychological dimensions, are still 
scarce (Rostosky & Travis, 1996).   
 
 
1.5 Bio-psycho-socio-cultural Model of Menopause 
 
Although the biological contribution for menopause conceptualization is 
indisputable, the integration of psychological and social variables in the individual 
understanding of aging accounts for a more complete understanding of the aging 
process (Paúl & Fonseca, 2001). Moreover, only the bio-psycho-social model can 
explain the evidence that, in around 50% of the cases, the climacteric‘s psychosomatic 
and emotional symptoms (including depressive mood) go into remission with placebos 
(Wasilewski, 2004). In this context, the literature evidences conclusions contrary to the 
ones being drawn according to the biological model, that is, symptoms like mood 
fluctuations and depression during midlife do not occur exclusively due to the 
menopausal status, specifically, due to the hormonal changes (Coope, 1996; Deeks, 
2003). 
Lowenberg and Davis (1994) propose the concept of holistic health, which 
emphasizes the personal responsibility regarding one‘s health status and well-being 
through the implementation of specific strategies (for example, search for health-related 
relevant information), risk behaviours‘ modification, adoption of a healthier lifestyle, 
stress reduction and management, among others. The holistic health intends to broaden 
the comprehensive framework of symptomatology, incorporating psychological, 
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relational, lifestyle-related and environmental aspects in the symptoms‘ understanding. 
In this context, an integrative model were the climacteric is perceived as a personal 
growth period is proposed, emphasizing the importance of bio-psycho-social factors, 
which account for the differences regarding health status and quality of life in middle-
aged women, and the improvement of health policies so that they can lead to a global 
health promotion (Ulacia et al., 1999). 
Contrasting with the hormonal deficiency representation, the climacteric period can 
be conceptualized as a developmental and normative process, with a minimal or null 
impact in women‘s life; therefore, psycho-social and cultural variables are going to 
modulate the way women experience the menopausal symptoms (Collins & Landgren, 
2002). This paradigm supports that the difficulties associated to the menopausal 
transition and post-menopausal phase are culturally built and have their origins in the 
attitudes regarding aging, women‘s role in society and negative stereotypes (Kaufert, 
1982).  
Several authors emphasize that psychosocial and cultural factors might influence 
menopausal symptoms‘ reporting during peri- and post-menopause (Beyene, 1986; 
Deeks, 2003, 2004; Lock, 1994; Obermeyer et al., 2002). Vasomotor symptoms are 
paradigmatic of a physiological process which is influenced by psychological variables 
(Hunter & Mann, 2010). Particularly, it has been evidenced that the prevalence of hot 
flashes varies according to ethnicity (Tan, Haines, Limpaphayom, Holinka, & 
Ausmanas, 2005) and lower cultural level, as well as life events, are linked to 
depressive symptoms in post-menopausal women (Amore et al., 2004). 
Contrasting with Hansen and colleagues (2008), other authors indentify the 
reproductive aging as process which is permeable to the influence of non-hormonal 
variables. Hence, differences in reproductive aging can also be determined by age, body 
mass index and environmental context (Bernis & Reher, 2007). 
The representation of menopause itself also varies. In a study comparing 
Portuguese with British women, significant differences emerged: the latter linked 
menopause to the loss of womanliness, whereas Portuguese participants perceived 
menopause as a set of physical and psychological changes (Figueiras & Marteu, 1995). 
Hunter (1992) highlights that women who have negative expectations about menopause 
(that is, the belief that this period implies psychological and physical symptomatology) 
are more likely to endure a negative experience of the menopausal transition, namely, 
feeling depressed. Similarly, Rotem, Kushnir, Levine and Ehrenfeld (2005), concluded 
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that the more negative the attitudes concerning menopause, the more exacerbated the 
symptoms will be during climacteric phase. This conclusion has been equally 
documented by Liao and Hunter (1998) regarding the depressed mood and vasomotor 
symptoms. 
It has been suggested that, to accurately analyze reproductive aging and 
menopause‘s characteristic symptoms (like hot flashes), variables of women‘s context 
should be considered, specifically, the modernization associated with urban 
environments (which can influence the symptoms‘ risk), or protective behaviours during 
the menopausal transition phase, the ecological attributes regarding social support and 
lifestyle (such as nutritional and physical exercise habits) and also the development of 
women‘s identity as middle-aged human beings (Bernis & Reher, 2007). 
Hence, the integration of biological, psychological, social and cultural factors 
allows a broader comprehensive approach of menopause. Consequently, the impact that 
menopause appears to have on women‘s sexual life (Deeks, 2002; Graziottin & Basson, 
2004; Mansfield, Voda, & Koch, 1995; Mishra & Kuh, 2006; Nappi, Verde, Polatti, 
Genazzani, & Zara, 2002) can be explained through multi-nature factors. Mishra and 
Kuh (2006) report that peri- and post-menopausal women, compared with their pre-
menopausal counterparts, manifest a decline in sexual life (which is associated with 
psychological symptomatology, a life perceived as stressful and smoking behaviour), 
and report more frequently difficulties in sexual intercourse (linked to the presence of 
somatic and vasomotor symptoms); vaginal dryness was a relevant risk factor for both 
negative occurrences. Besides vaginal dryness, marital status (namely, being married) 
can also be a significant predictor of the decrease in sexual pleasure and desire in pre- 
and peri-menopausal women (Mansfield, Voda, & Koch, 1995). 
It has also been proven that a negative self-image, weight gain, depressive and uro-
genital symptoms are more frequently observed in women with sexual complaints 
(Nappi et al., 2002). Avis, Stellato, Crawford, Johannes and Longcope (2000) support 
the conclusion that, although menopausal status might have an influence in some sexual 
issues, its impact is weaker than the health status‘, which can significantly impact 
women‘s sexual functioning. Additionally, the changes in sexual response might be 
explained by developmental alterations and socio-cultural factors related with aging, or 
even with the partner‘s circumstances (such as becoming less interesting, less interested 
or sick) (Mansfield, Koch, & Voda, 2000). 
9 
 
Deeks (2002) emphasizes that, although there are numerous studies exploring the 
impact that physiological modifications have on the sexual life during the climacteric, 
there is still a poor understanding regarding the influence of psychological factors in 
menopausal women‘s sexual experience.  
Binfa et al. (2004) have observed that life events can predict the occurrence of 
menopausal symptoms, and Hardy and Kuh (2002) have mentioned that certain 
symptoms observed in middle-age women are not linked to the menopausal transition 
but rather to life events or difficult situations of current life (namely, related with family 
issues). 
Having the offspring leaving home, daily-life stress, health problems and death of a 
loved one are risk factors for the development of a depressed mood during the 
climacteric (Kaufert, Gilbert, & Tate, 1992). Moreover, feelings of loss and self-
uselessness can also emerge during midlife (Betti et al., 2001), which might interfere 
with the euthymic mood. 
Overload of responsibilities and demands has also been identified as a frequent 
experience between the forties and fifties, which can be a source of significant stress: 
women often divide their time and availability between adolescent children and aged or 
diseased parents (Mansfield & Voda, 1997).  
Furthermore, the deterioration of one‘s health (or partner‘s health) during middle-
age and financial problems can also be identified as events that will have a negative 
impact on during midlife, and which can overlap the climacteric phase (Mansfield & 
Voda, 1997).  
Besides midlife events, factors related with lifestyle and interpersonal relationships 
might again play an important role in depressive mood and anxiety symptoms‘ 
manifestation during climacteric (Deeks, 2003). Moreover, the socio-demographic 
status, like the marital and professional statuses, can influence the emergence of 
psychological ill-being in this stage of women‘s development (Liao & Hunter, 1998). 
Furthermore, Deeks (2003) reports that body image can be one of the factors associated 
with depressive mood and anxiety during the menopausal transition. 
The vast majority of menopause-related literature has focused on the negative 
outcomes and associations. Nevertheless, some authors document that many women 
link the phase of their lives, when menopause happens, with positive experiences. 
Deeks and McCabe (2004) emphasize several studies which report that women feel 
relief with the cessation of the menstrual period, the end of pre-menstrual syndrome, 
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and also evidence a valorisation of the freedom from contraception and non-planned 
pregnancy; it is also reported that women feel calmer, wiser and perceive a higher status 
in the community subsequent to menopause.  
An increased state of calm and concentration, as well as feeling energized, have 
also been documented by menopausal women elsewhere; in addition, women can also 
asses their emotional and physical health, during this reproductive aging stage, in a very 
positive way (Mansfield & Voda, 1997). The matureness of midlife can also promote 
the development of a higher assertiveness in women with ages around 50 (Mansfield & 
Voda, 1997).  
Moreover, women can associate this change in the menopausal status with an 
increased well-being (Berger & Forster, 2001) and, during the menopausal transition, 
they can describe a modification in personal interests and the discovery of new ones 
(Betti et al., 2001). Additionally, a higher spirituality, in this phase of women‘s life, has 
been linked with less menopausal symptoms‘ reporting (Kim, 1998; Steffen, 2009).   
Despite the identification of depressive mood, anxiety, sleep disorders and sexual 
problems along the climacteric period, the literature evidences that the presence of these 
symptoms might be due to socio-demographic and psychosocial negative factors 
(Wiklund, 1998). Moreover, research in the field of menopause is strongly focused on 
the negative experience of menopausal transition and post-menopause; nonetheless, the 
relation between depression and anxiety symptoms, and menopausal status is still 
inconclusive and inconsistent (Mansfield & Voda, 1997). Collins and Landgren (2002) 
highlight that most studies about menopause are conducted with women who search for 
medical help to manage the symptoms, therefore excluding the exploration of the 
climacteric‘s experience of the overall female population who do not seek medical care 
to deal with menopause and do not evidence high symptoms‘ severity. 
Regarding the menopausal symptoms, Coope (1996), and Hardy and Kuh (2002), 
report that there is an absence of unanimity regarding which ones are in fact a 
consequence of the menopausal status (specifically, the symptoms which occur during 
the climacteric period more frequently than in other life‘s phases and are subsequent to 
the estrogens‘ decrease). Hunter and O‘Dea (2001) mention evidences from several 
studies which point to menstrual irregularities and vasomotor symptoms as the only 
consistent indicators of menopausal transition.    
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2. Body Weight 
 
 
Although the tendency of the life expectancy has been of an increase for the past 
thousand years, this trend has been predicted to come to an end, given the impact of 
obesity in life expectancy (Olshansky et al., 2005). 
Obesity was acknowledged as an epidemic and as an objective public health‘s 
threat more than a decade ago, by the World Health Organization (World Health 
Organization, 1998). In addition, the increasing incidence of obesity has been linked to 
a growing morbidity and mortality, bearing a significant economic, personal and social 
burden (Nawaz & Katz, 2001).  
Since the increase in the prevalence of obesity has been observed in genetically 
stable populations, it is plausible to consider contextual and lifestyles changes as strong 
contributors for it (Duvigneaud et al., 2007). 
Carmo et al. (2007) reported that the prevalence of overweight and obesity, among 
the Portuguese adult population, is equal to 39.4% and 14.2%, respectively. The authors 
document an increased trend, comparing data from 2003-2005 with results from 1995-
1998. 
Cognitive-behavioural approaches provide the basis to understand the excessive 
food intake mechanisms, which usually lead to overweight and obesity. Concerning the 
aliments intake, the literature evidences that the excessive food ingestion presents 
cognitive and neuronal similarities with addictive behaviours (Kelley, Schiltz, & 
Landry, 2005). Therefore, through a learning process, certain food-related stimuli are 
going to provoke an anticipatory hyper-activation; the strong desire for food will lead to 
a behaviour of excessive food intake (Jansen, 1998; Rodin, Schank, & Striegel-Moore, 
1989). Hence, the emotional component (that is, perceiving the food stimulus as 
positive, which in turn is going to influence the person‘s motivation) and the internal 
pressure to act (which is dependent on the hyper-arousal level when the person is 
exposed – physically or mentally - to the food cue) are going to explain the 
(maintenance) of excessive ingestion of food (Drobes et al., 2001). 
Craeynest, Crombez, Koster, Haerens and Bourdeaudhuij (2008) have 
demonstrated that people manifest a higher hyper-arousal when facing fat-enriched food 
than when before light aliments; and this association it is not mediated by the 
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individuals weight category (that is, both normal weight and overweight people 
evidence this differentiation in terms of food-related arousal). 
During midlife and menopausal transition, women frequently report an increase in 
body weight (Campbell & Samaras, 2000; Dubnov, Brzezinski, & Berry, 2003; 
Heymsfield et al., 1994). 
Research with adult women has demonstrated that alcohol intake and more years of 
education are related with a decreased risk of overweight (Duvigneaud et al., 2007). 
Carmo et al. (2007) support this establishing that, besides less schooling years, a lower 
socio-economic status is linked with a higher prevalence of obesity. Furthermore, the 
presence of binge eating is associated with a higher calorie intake and more 
psychological disorders in obese people (Allison, Grilo, Masheb, & Stunkard, 2005). 
Given the impact of overweight and obesity on women‘s health, it is urgent to find 
interventions which can lead to an effective weight loss. In this context, cognitive-
behavioural therapies, both individual and in group format, have proven to be effective 
in the promotion of weight loss (Agras, Telch, Arnow, Eldredge, & Marnell, 1997; 
Brennan, Walkley, Fraser, Greenway, & Wilks, 2008; Calleja, Germán, Trincado, & 
Lucas, 2007; Eichler, Zoller, Steurer, & Bachmann, 2007; Gallagher, Jakicic, 
Napolitano, & Marcus, 2006; Grilo & Masheb, 2005, 2007; Jelalian, Mehlenbeck, 
Lloyd-Richardson, Birmaher, & Wing, 2006; Kalodner & DeLucia, 1991; Mefferd, 
Nichols, Pakiz, & Rock, 2007; Tsiros et al., 2008; van den Akker et al., 2007; Weber & 
Wyne, 2006; Wilfley et al., 2002; Wilfley, Welch, & Stein, 2003). 
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3. Well-being during Midlife 
 
 
It has been proven before that, rather than the endocrine changes, it is the health 
status, psychosocial variables and lifestyle that determine well-being in women during 
midlife (Dennerstein, Smith, & Morse, 1994). 
The study of aging as a healthy process and the exploration of which life 
trajectories are related with well-being and a good health is barely explored (Franco et 
al., 2009). Some authors emphasize the need to investigate the broader context of 
women‘s lives during midlife, beyond the menopausal status (Woods & Mitchell, 1997) 
and very few studies have explored well-being during menopausal years (Dennerstein, 
Smith, & Morse, 1994). 
Subjective well-being encompasses the subjective evaluation (positive or negative) 
of people‘s lives, including positive and negative affects in relation to life events, 
appraisals and feelings about satisfaction with life (including important domains like 
work, health, relationships, among other), interest and commitment (Diener & Ryan, 
2009).  
This construct integrates the concept of life satisfaction (general appraisals of the 
person‘s life and satisfaction with important domains such as work and relationships) 
and both positive and negative affects (that is, the presence of enjoyable emotions and 
mood and low levels of unpleasant mood or emotions) (Diener, 2000). 
According to Diener (2000) the variability of subjective well-being is explained by 
several factors. The bottom-up theories of subjective well-being conceptualize this 
internal experience as permeable to the influence of external variables, such as socio-
demographic characteristics (namely, age, marital and professional status, income and 
education), perceived health status, life events, among others (Galinha, 2008). Top-
down theories represent well-being as a result of individual variables (like emotional 
dimensions) which, interacting with the person‘s reality, will lead to a positive or 
negative well-being state. Research has confirmed the causal models of well-being as 
bidirectional and (being neither of them better and both explaining the data adequately), 
therefore, the subjective well-being can simultaneously be established as the cause and 
the consequence of contextual (specifically, life events) and personal factors (for 
example, personality determinants) (Feist, Bodner, Jacobs, Miles, & Tan, 1995). 
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Currently, an integrative approach of both theories, regarding the subjective well-being 
concept, is used (Galinha, 2008).  
Therefore, the research has been confirming the subjective well-being theories, 
demonstrating that this can be influenced by life events (Alati et al., 2007; Dennerstein, 
Lehert, & Guthrie, 2002; Smith-DiJulio, Woods, & Mitchell, 2008). Diener (2000) 
postulates that positive life events will correlate with positive emotions, whereas 
negative life events will be linked to negative mood. However the impact of life events 
on well-being can be overcome in the short run given the adaptation mechanisms: 
individuals tend to adapted very quickly and there is evidence that only recent events 
are correlated with subjective well-being (Suh, Diener, & Fujita, 1996).  
During midlife, women usually play several concomitant roles, among them the 
roles of partner, mother, paid worker and caregiver of aged parents. It has been 
concluded that, even though the number of roles might influence the presence of 
negative emotions, this effect will be neutralized with the satisfaction conveyed by the 
roles and when the demand associated with the different tasks is managed (Reid & 
Hardy, 1999). 
 It has been demonstrated that life satisfaction does not decrease with age 
progression; however, positive affect decreases from one age cohort to the following 
one. Also, some resources that are associated with well-being (such as marriage and 
income), might change across the life-span (Diener & Suh, 1998) and this might have 
an impact on the subjective experience of well-being, especially during midlife. Biswas-
Diener, Vittersø and Diener (2010) and Kaczmarek (2004) support this conclusion, 
documenting that, characteristics such as income, marital status and education can 
influence well-being. 
In addition, a healthier lifestyle can as well contribute to well-being improvement 
(Franco et al., 2009; Lee, 1999). 
Health-related factors (Dennerstein et al., 1994) and menopausal status 
(Dennerstein et al., 2002) can also impact the well-being, as can spirituality (Cohen & 
Koenig, 2003; Sadler & Biggs, 2006) and weight increase (Allison, Mackell, & 
McDonnell, 2003). Regarding menopausal symptoms, there is evidence that these can 
disrupt well-being during the climacteric (Oldenhave, Jaszmann, Haspels, & Everaerd, 
1993) although this is not a unanimous conclusion (Smith-DiJulio et al., 2008). 
Besides socio-demographic, menopause and health-related factors, life events and 
personal characteristics, it is important to account for cultural variability when exploring 
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the subjective well-being, since cross-cultural differences exist (Biswas-Diener et al., 
2010; Daukantaitė & Zukauskiene, 2011).  
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4. Aims of the Present Research 
 
 
Therefore, given the evidences presented in the literature, this research intends to 
address eleven main questions. 
First, it is our objective to explore the particular representations of menopause and 
its perceived consequences (both positive and negative), in a sample of peri- and post-
menopausal Portuguese women, since they can vary across different populations. To 
accomplish this, several interviews with open-ended questions are going to be done, in 
order to collect data to build theoretical models which explain the structure of the three 
concepts (representations, perceived positive and negative consequences of menopause). 
Thereafter, and also subsequent to the exploration of menopause‘s perceived 
negative consequences (and also supported in pre-existing scales), it is our aim to 
develop and validate an inventory to measure both frequency and intensity of 
menopausal symptoms (and, hence, build an instrument that accurately assesses the 
severity of symptoms), since the available measures for climacteric symptoms assert 
either frequency or bothersomeness. Additionally, we intend to investigate if there are 
significant differences between measuring symptoms in terms of frequency and 
intensity. Furthermore, it is our goal to characterize a community sample of Portuguese 
peri- and post-menopausal women in terms of menopausal symptoms distribution. 
Subsequently, and using the inventory previously developed in the context of this 
study, it is our objective to explore different types of predictors of vasomotor 
symptoms‘ severity, in a symptomatic sample of middle-age women, namely socio-
demographic, health and menopause-related variables, lifestyle and perceived control. 
And because vasomotor symptoms are the menopausal clinical manifestations 
which lead women to search for medical help more frequently, it is also our objective to 
explore if psychological variables, such as stress and depression, can be significant 
predictors of hot flashes and night sweats‘ occurrence (using a sample of pre-, peri- and 
post-menopausal participants who have, and do not have, hot flashes and night sweats).  
Moreover, our fifth objective is to assert, in a sample of peri- and post-menopausal 
women, which socio-demographic, health and menopause-related, and lifestyle 
variables significantly predict the severity of both physical and psychological 
menopausal symptoms. 
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In the context of a broad approach to menopause, it is additionally our aim to 
evaluate if spirituality can be a predictor of less severe menopausal symptoms, 
independently of socio-demographic, health and menopause-related and lifestyle, in 
peri- and post-menopausal women. 
Similarly, our seventh goal is to explore if life events can determine menopausal 
symptoms‘ severity, by building a causal model, which controls for confounding 
variables. Also an aim in the research is to compare women in pre-, peri- and post-
menopause, regarding menopausal symptoms‘ severity. 
Because of the evidences that, during the menopausal transition, women usually 
gain weight, our next objective is to explore which variables determine weight variation 
and, specifically, weight gain in menopausal women. Furthermore, we intend to 
characterize a sample of peri- and post-menopausal participants in relation to weight 
variation from pre- to current menopausal status (in terms of loss, maintenance or gain) 
and also to identify in which phase of their life-span the overweight started.  
Given the evidences of weight gain around peri-menopause, our ninth goal is to 
explore if a brief and individual 8-week cognitive-behavioural therapy (CBT) can 
promote changes in anthropometric (weight and abdominal perimeter), psychological 
(sexual and health-related quality of life, anxiety, stress and depression) and behavioural 
variables (restrain, emotional and external eating, as well as in binge eating disorder 
status). With this purpose, a quasi-experimental design will be used, including an 
assessment before the intervention (and control condition), after the intervention (and 
control condition equivalent time) and a 4-month follow-up; overweight and obese 
participants will be randomly assigned to the CBT or to the control group (waiting list).  
As mentioned before, the literature also evidences high body mass index (BMI) as a 
health and well-being risk factor. Therefore, our tenth aim is to assess what determines 
the different BMI categories in midlife women. Consequently, a causal model 
comparing normal weight, overweight and obese participants regarding socio-
demographic, health and menopause-related variables, lifestyle and psychological 
variables (such as body shape concerns, depression and stress), will be built. 
Finally, and because the variables influencing well-being are numerous and often 
studied apart from each other, our last aim is to build a global causal model of well-
being in midlife women, encompassing socio-demographic, health and menopause-
related variables, lifestyle, body shape concerns, life events, stress, spirituality and 
menopausal symptoms. 
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Abstract 
 
Our aim in conducting this study is to describe the representations and perceived 
consequences of menopause, elicited through a semi-structured interview with 36 
Portuguese women, in peri- and post-menopause. The most prevalent response of the 
interviewed women was to see menopause as a normal/neutral phase of their life cycle 
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(28.3%). Menses‘ cessation (58.7%) was identified as the most prevalent positive 
consequence of menopause, and a range of psychological changes (18.3%) was the most 
mentioned negative consequence. Health care provider‘s awareness of women‘s 
attitudes will allow them to communicate more effectively and to reinforce women‘s 
positive attitudes.   
 
Keywords: menopause; representation; consequences; positive; negative. 
 
 
1. Introduction 
 
Women‘s representation of menopause and their response to this period of life reflects 
both medical and nonmedical perceptions. Given the importance of the support that is 
rendered by health care providers to menopausal women, in terms of both information 
and meaning (Jones, 1997), and also of the psychosocial and cultural contexts in 
determining the meaning and impact of menopause (Hunter, 1994), the investigation of 
how peri- (i.e., when women start having a variable cycle length or at least two skipped 
cycles and an interval of amenorrhea of at least 60 days) and post-menopausal women 
(that is, who manifest amenorrhea for at least 12 months) (Soules et al., 2001) represent 
this process and its consequences, is clinically relevant. 
Currently 10% of the women population worldwide is going through menopause or has 
already gone through this process (Skouby, 2004).  
The biomedical model, which represents menopause as a cluster of physical and 
emotional difficulties caused by hormone deficiency, contrasts with the socio-cultural 
model, which conceptualizes menopause as a natural, developmental process, with little 
or no consequences for women (Hunter, & O‘Dea, 2001). It is evident, in a large 
amount of studies, that menopause‘s perception and symptoms are influenced by several 
factors, not only physiological but also of psychosocial and cultural nature (Collins, & 
Landgren, 2002; Hall, Callister, Berry, & Matsumura, 2007; Keefer, & Blanchard, 
2005; Kowalcek, Rotte, Banz, & Diedrich, 2005; Singh, & Arora, 2005; Uncu, Alper, 
Ozdemir, Bilgel, & Uncu, 2007). Although physiological processes are well conserved 
in the human species, and overall communications have reduced the cultural gaps in 
developed countries, qualitative studies can explore with detail cultural contents 
relevant for successful interventions (Strickland, 1999).  
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Therefore, it is relevant to explore how different cultures, namely the Portuguese one, 
perceive the menopause process, in order to adequate interventions to their beliefs about 
menopause, in future clinical and research settings.  
Women may have ambivalence towards menopause, welcoming it on one hand, and 
fearing it on the other (Im, & Meleis, 2000). Thus, women can perceive menopause has 
a process which has both positive and negative features.  
Although the vast majority of the research around menopause has focused on the 
negative experiences and adverse symptoms, other studies have evidenced that women 
can recognize positive experiences associated with menopause (Berger, & Forster, 
2001; Betti, Orsini, Sciaky, Cristini, Cesa-Bianchi, & Zandonini, 2001; Deeks, & 
McCabe, 2004). However, as Winterich (2003) infers, very little research explores the 
positive sexual changes during the climacteric period. 
Our aim, in performing this research, was to explore women‘s menopause 
representations and its perceived consequences (both negative and positive), in a group 
of women in menopausal transition and post-menopause. 
 
 
2. Materials and Methods 
 
The sampling of participants was based on the availability of respondents, and they 
were recruited
 
by a non-probabilistic sampling procedure. Participants had to be in 
menopausal transition (i.e., have a variable cycle length or at least two skipped cycles 
and an interval of amenorrhea of at least 60 days) or in post-menopause (that is, 
manifest amenorrhea for at least 12 months) (Soules et al., 2001). 36 women gave their 
informed consent after a presentation of the study. 
A qualitative approach, employing content analysis, was used to analyze the data 
collected by means of a semi-structured individual interview, with 36 women in the 
menopausal transition and post-menopausal. 
The content analysis was done using the following procedure: 1) develop and define 
major emergent categories, mutually exclusive, that were reflective of the 36 interviews 
for each one of the three pre-existing categories (menopause representations, positive 
consequences and negative consequences of menopause); 2) generate a list of coding 
cues; 3) analyze the statements and characterizations for best fit and which substantiate 
a given emergent category, for each interview; 5) identify sub-categories, within and 
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across the interviews, while preserving the principle of homogeneity of the category, 
whenever the categories did not express per se the multiplicity of elements that it 
integrated, and 6) derive major emergent categories of the study (Bardin, 2007). 
The pre-existing categories explored in the 36 interviews were: menopause 
representations (―what is menopause for you?‖), positive consequences of menopause 
(―does menopause have any positive consequences? If so, which ones?‖), and negative 
consequences of menopause (―does menopause have any negative consequences? If so, 
which ones?‖). The same participant could express more than one representation or 
identify more than one consequence. All representations and consequences evidenced 
were taken into account and subjected to analysis. At the end of the content analysis, 
only emergent categories which were mentioned by at least 10% of the sample were 
considered.    
A jury of two psychologists (both faculty) made an independent analysis of the 36 
interviews and, afterwards, made a co-resolution regarding the categories. 
A Multiple Correspondence Analysis (MCA) was used to thoroughly represent the 
associations between the emergent categories obtained from the text analysis, and to 
find latent constructs that can work as major determinants in women‘s conceptualization 
of menopause. A descriptive analysis and the associations between observed categories 
were analyzed with MCA using SPSS (v. 16, SPSS Inc, Chicago, IL).  
 
 
3. Results  
 
3.1 Participants 
Thirty-six women were interviewed and questioned about their menopause 
representations and perceived (positive and negative) consequences. The mean age of 
participants was 56 (SD=5.369; Min.=39; Max.=64). Regarding the menopausal status, 
there were 6 women in menopausal transition and 30 women in post-menopause. 36% 
of participants had a college degree and 22% had completed high school. Concerning 
the marital status, 58% of participants were married or living with a partner and 17% 
were divorced. 
 
3.2 Content analysis: emergent categories of representations of menopause and its 
perceived consequences (positive and negative) 
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Regarding menopause representations, the jury found 7 emergent categories of answers, 
namely,  1) a normal/neutral phase of life cycle (which had four sub-categories, 
specifically, normal/natural phase of life, phase that you accept, another/a new phase of 
life and a neutral phase of life cycle), 2) cessation of menses (which has five sub-
categories, the end of the objective experience of menstruation, improvement in 
hygiene, ovarian failure/reduction of estrogens, freedom to go to the beach/pool and the 
end of the reproductive capacity),  3) aging, 4) a positive experience (which had two 
sub-categories – a subjective positive experience and an objective gain), 5) a negative 
experience (which also had two sub-categories – a subjective negative experience and 
an objective loss), 6) negative physical consequences, and finally, 7) depreciation of the 
menopause. 
 A normal/neutral phase of life was the most mentioned representation of menopause, as 
seen in Table 1 
 
Table 1 – Emergent categories and sub-categories resulting from content analysis of the 
pre-category of menopause representations  
Categories Sub-categories 
Sub-category 
frequency 
Category 
frequency 
Category 
percentage 
Normal/neutral 
phase of life 
cycle 
Normal/natural phase of life 12 
26 28.3 
Phase that you accept 3 
Another/a new phase of life 9 
A neutral phase of life cycle 2 
Cessation of 
menses 
End of the objective experience 
of menstruation 
6 
16 17.4 
Improvement in hygiene 2 
Ovarian failure/reduction of 
estrogens 
4 
Freedom to go to the beach/pool 1 
The end of the reproductive 
capacity 
3 
Aging --- 15 16.3 
Negative Subjective negative experience 7 14 15.2 
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experience Objective loss 7 
Positive 
experience 
Subjective positive experience 6 
8 8.7 
Objective gain 2 
Negative 
physical 
consequences 
--- 8 8.7 
Depreciation of 
the menopause  
--- 5 5.4 
Total of 
representations 
mentioned 
--- 92 100 
 
 
Regarding the positive consequences of menopause, the jury identified three emergent 
categories: 1) cessation of menses (in which were identified seven sub-categories, 
namely, end of the objective experience of menstruation, improvement in hygiene, 
ability to stop contraception, terminus of pre-menstrual syndrome, greater sexual 
freedom, stop buying and using tampons/pads and freedom to plan vacations), 2) 
psychological changes (divided in nine categories: feeling calmer, feeling less concern, 
feeling more confidence, increased assertiveness, increase in the ability to accept life‘s 
aspects, increased maturity, desire to invest in pleasurable things, give more value to 
positive experiences and increased sensitivity), and 3) absence of positive 
consequences. 
Cessation of menses (58.7%) and positive psychological changes (27%) were the most 
mentioned positive consequences of menopause, as evidenced in Table 2. 
 
Table 2 – Emergent categories and sub-categories resulting from the content analysis of 
the pre-category of positive consequences of menopause 
Categories Sub-categories 
Sub-
category 
frequency 
Category 
frequency 
Category 
percentage 
Cessation of 
menses 
End of the objective experience of 
menstruation 
14 37 58.7 
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Improvement in hygiene 3 
Terminus of contraception 8 
Terminus of pre-menstrual 
syndrome 
1 
Greater sexual freedom 3 
Stop buying and using 
tampons/pads 
5 
Freedom to plan vacations 3 
Psychological 
changes 
Feeling more calm 4 
17 27 
Feeling less concern 1 
Felling more confidence 1 
Increased assertiveness 1 
Increased ability to accept life‘s 
aspects 
2 
Increased maturity 1 
Desire to invest in pleasurable 
things 
5 
Give more value to positive 
experiences 
1 
Increased sensitivity 1 
Absence of 
positive 
consequences 
--- 9 14.3 
Total  63 100 
 
 
Regarding the negative consequences of menopause, there were found  eight emergent 
categories: 1) psychological changes (which had eight sub-categories, namely, 
depressed mood/mood swings, hopelessness regarding the future, irritability/lack of 
patience, feelings of self-depreciation, anxiety, aggravation of pre-existing vulnerability, 
memory loss, general psychological change),  2) physical changes (which had six sub-
categories, specifically, flaccidity in body parts, perception of changes in the body in 
general, physical constraints in doing certain things, dry skin, hair loss and 
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tiredness/decrease of energy), 3) concern with disease appearance or aggravation 
(divided in five sub-categories, osteoporosis/osteopenia, high blood pressure, cardio-
vascular disease, high cholesterol and worry with health deterioration in general), 4) 
changes in sexual life (which had five sub-categories, specifically, decreased libido, 
vaginal dryness, general difficulties in sex life, estrangement from partner due to sex-
related difficulties and guilt and insecurity related with her own sexual performance), 5) 
vasomotor symptoms (which had two sub-categories, presence of vasomotor symptoms 
and feelings of shame related with the presence of vasomotor symptoms), 6) absence of 
negative consequences, 7) weight gain, and 8) perception of loss (which has four sub-
categories, namely, loss of femininity, loss of the reproductive capacity, quit doing 
some pleasurable things and concern with the possibility of losing an attractive figure). 
 Negative psychological changes (18.3%), physical changes (17.2%) and concern with 
disease appearance or aggravation (15%) were the most mentioned negative 
consequences of menopause (Table 3). 
 
Table 3 – Emergent categories and sub-categories resulting from the content analysis of 
the pre-category of negative consequences of menopause 
Categories Sub-categories 
Sub-category 
frequency 
Category 
frequency 
Category 
percentage 
Psychological 
changes 
Depressed mood/mood 
swings 
2 
17 18.3 
Hopelessness regarding 
the future 
2 
Irritability/lack of patience 4 
Feelings of self-
depreciation 
2 
Anxiety 2 
Aggravation of pre-
existing vulnerability 
1 
Memory loss 2 
General psychological 
change 
2 
Physical Flaccidity in body parts 3 16 17.2 
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changes Perception of changes in 
the body in general 
4 
Physical constrains in 
doing certain things 
3 
Dry skin 1 
Hair loss 1 
Tiredness/decrease of 
energy 
4 
Concern with 
disease 
appearance or 
aggravation 
Osteoporosis/osteopenia 7 
14 15 
High blood pressure 2 
Cardio-vascular disease 1 
High cholesterol 1 
Worry with health 
deterioration in general 
3 
Changes in 
sexual life 
Decreased libido 7 
11 11.8 
Vaginal dryness 1 
General difficulties in 
sexual life 
1 
Estrangement from partner 
due to sex-related 
difficulties 
1 
Guilt and insecurity 
related with own sexual 
performance 
1 
Vasomotor 
symptoms 
Presence of vasomotor 
symptoms 
8 
10 10.8 Feelings of shame related 
with the presence of 
vasomotor symptoms 
2 
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Absence of 
negative 
consequences 
--- 9 9.7 
Weight gain --- 8 8.6 
Perception of 
loss 
Loss of femininity 2 
8 8.6 
Loss of the reproductive 
capacity 
3 
Quit doing some 
pleasurable things 
2 
Concern with the 
possibility of losing an 
attractive figure 
1 
Total  93 100 
 
 
As mentioned earlier, the same participant could identify more than one representation 
or consequence (hence, the total of answers – for example, the total of category‘s 
frequency for negative consequences is 93 - exceeds the number of participants, that is, 
36). In order to have an overview of how many participants mentioned a certain 
category, the frequency of the categories mentioned by each participant was explored. 
Therefore, regarding to the categories of the theme ―representation of menopause‖, a 
normal/neutral phase of life cycle was mentioned by 19 participants, cessation of 
menses by 11, aging was identified 15 times, negative experience was mentioned by 11 
women, a positive experience was evidenced by 6 people, negative physical 
consequences by 8 and 5 people undervalued the topic (depreciation of the menopause). 
Positive consequences of menopause were demonstrated by three emergent categories 
that were mentioned as follows: cessation of menses was mentioned by 23 participants, 
absence of positive consequences by 9 and positive psychological changes by 8. 
Regarding the negative consequences of menopause, we found eight emergent 
categories that were mentioned as follows: concern with disease appearance or 
aggravation was mentioned by 12 participants, negative physical changes by 11, 
negative psychological changes by 10, negative changes in sex life was evidenced by 10 
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women, vasomotor symptoms by 8 participants, weight gain by 8, absence of negative 
consequences was identified by 7 and perception of loss by 5 participants. 
 
3.3 Multiple Correspondence Analysis (MCA) of the emergent categories of 
representations of menopause and its perceived consequences (positive and negative) 
The MCA explores the correlational structure of the three pre-categories, i.e., 
representations of menopause, positive and negative consequences, organized in three 
models (one for each pre-category) with several factors and factor loadings (which give 
the relation between each emergent category and a factor).  
The results evidenced that the representations of menopause are better explained by a 
three-dimension model. The three factors account for 66% of total inertia (variance) 
observed (Table 4). 
 
Table 4 –Three-dimensional representations of menopause: factor loadings for each 
dimension, mean loadings and % inertia (variance) explained 
 Dimensions 
Categories 
Negative 
features 
Positive or 
neutral 
features 
Phase of 
life cycle 
Mean 
Menses cessation .027 .722 .010 .253 
Normal/neutral phase 
of life cycle 
.250 .022 .522 . 265 
Aging .566 .033 .106 .235 
Depreciation of the 
menopause 
.199 .290 .089 .193 
Negative physical 
consequences 
.503 .029 .082 .205 
Positive experience .062 .344 .090 .166 
Negative experience .411 .005 .262 .226 
Eigenvalues 2.017 1.445 1.162 1.542 
% of Variance 28.821 20.648 16.601 22. 023 
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Regarding to positive consequences of menopause, a two-dimension model was 
evidenced by MCA as a best-fit solution and explained 96% of total inertia (variance) 
(Table 5). 
 
Table 5 – Two-dimensional representation of positive consequences of menopause: 
factor loadings for each dimension, mean loadings and % inertia (variance) explained 
 
 Dimensions 
Categories 
Menses 
cessation 
Psychological 
changes 
Mean 
Absence of positive 
consequences 
. 928 .021 . 475 
Menses cessation .816 .138 .477 
Positive psychological 
changes 
.040 .946 .493 
Eigenvalue 1.785 1.105 1.445 
% of Variance 59.484 36.833 48.159 
 
 
Perceived negative consequences of menopause are best explained in a four-dimension 
model (accounting for 74% of total variance), as evidence in Table 6. 
 
Table 6 – Four-dimensional representation of the negative consequences of menopause: 
factor loadings for each dimension, mean loadings and % inertia (variance) explained 
 
 Dimensions 
Categories 
Sexual and 
Psychologic
al changes 
Disease and 
physical 
changes 
Vasomotor 
symptoms 
Perception 
of loss 
Mean 
Absence of negative 
consequences 
.692 .050 .069 .001 .203 
Vasomotor symptoms .000 .258 . 431 .033 .180 
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Negative sexual 
changes 
.419 .000 .295 .001 .179 
Concern with disease .090 .412 .016 .351 .217 
Weight Gain .194 .161 .064 .270 .172 
Negative 
psychological 
changes 
.193 .000 .190 .165 .137 
Negative physical 
changes 
.253 .480 .000 .047 .195 
Perception of loss .088 .178 .220 .290 .194 
Eigenvalue 1.929 1.540 1.286 1.156 1.478 
% of Variance 24.107 19.247 16.081 14.451 18.471 
 
 
4. Discussion 
 
This research evidenced in this sample of peri- and post-menopausal women, the 
positive consequences of menopause were mentioned 63 times (and were organized in 
16 sub-categories) whereas the negative were evidenced 93 times (and 31 
categories/sub-categories were identified). This demonstrates that in this sample there is 
a higher number of perceived negative consequences regarding menopause, comparing 
with the positive consequences. 
Previous studies have shown that attitudes towards menopause are positive or neutral 
(Avis, & McKinlay, 1995; Chirawatkul, & Manderson; 1994; Padonu, Holmes-Rovner, 
Rothert, Schmitt, & Kroll, 1996). These findings are supported by the data collected in 
the present study: 28.3% of the total of representations indicate menopause as a 
normal/neutral phase of life cycle and 8.7% identified it as a positive experience. 
Similarly, other studies emphasize that women perceive menopause as a natural 
transition in the life cycle (Lock, 1986).  
However, some women have defined menopause as a negative experience (15.2% of all 
representations alluded); in the same way, Shore (1999) and Delanoë (1997) concluded 
that majority of women in their studies have negative representations of menopause. 
45 
 
Several authors also evidence that women perceive menopause has a process related to 
aging (Jones, 1997; Lock, 1991; Padonu, Holmes-Rovner, Rothert, Schmitt, & Kroll, 
1996). This relation is also obvious in the present study. 
Concerning the positive consequences of menopause, the results point out that the most 
positive consequence mentioned is the cessation of menses. Several studies have 
emphasized that women see the cessation of menses as a positive experience (Avis, & 
McKinlay, 1991; Deeks, & McCabe, 2004) and consider menopause as socially good 
for women (Singh, & Arora, 2005) 
In this research women evidenced positive psychological changes as an advantageous 
consequence of menopause; other studies have concluded that an increase of the feeling 
of calmness is mentioned by women during the years of menopause (Deeks, & McCabe, 
2004; Mansfield, & Voda, 1997).  
Regarding the negative consequences of menopause, women have designated negative 
psychological changes (18.3%) and vasomotor symptoms (10.8%) as two negative 
consequences of menopause. These results agree with the observations of Padonu, 
Holmes-Rovner, Rothert, Schmitt and Kroll (1996) which have concluded that 
psychological symptoms are viewed more negatively than vasomotor symptoms. 
Deeks, Zoungas and Teede (2008) evidence that both in peri- and post-menopause, but 
more significantly in pre-menopause, women feared loss experiences. This goes in the 
same direction as our results that show the perception of loss (8.6% of all negative 
consequences elicited) as one of the negative consequences of menopause. 
Although in Crawford, Casey, Avis and McKinlay‘s (2000) research the menopause 
transition was not associated with weight gain, the present study emphasizes that 8.6% 
of participants have identified weight gain as one of the negative consequences of 
menopause. Similarly, in an Australian study, women perceived menopause as a process 
that has an impact on weight gain (Deeks, Zoungas, & Teede, 2008). In addition, the 
perception of midlife weight gain has recently been confirmed by a population-based 
sample of women and men from across Canada. The body mass index gain of 1.2 units 
for women over the decade between ages 45 and 54 was significantly more than for men 
in the same decade (Hopman, Leroux, Berger et al., 2007).  
Another perceived negative consequence of menopause is the concern with disease 
appearance or aggravation (15%). Likewise, other researchers have concluded that peri- 
and post-menopausal women fear that menopause affects adversely their physical health 
(Deeks, Zoungas, & Teede, 2008; Singh, & Arora, 2005).  
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According to psychodynamic psychiatrists, the end of fertility is associated with 
symbolic losses (Lock, 1991). In the present research 8.6% of the sample highlights the 
perception of loss as a negative consequence of menopause. 
Menopausal process can facilitate the manifestation of depressed mood and sexual 
changes, which can have an impact on the participants‘ personal life (Nappi, & Nijland, 
2008). In the present study, negative psychological and sexual changes were also 
reported as two negative consequences of menopause. 
 
MCA suggests that the representation of menopause can be explained by three factors. 
The first factor is represented by negative experience, negative physical consequences 
and aging; therefore age progression can be viewed as a negative experience by these 
menopausal women, given the strong relation with two other negative representations. 
The second factor, that supports the representations of the menopause model, is 
composed by three independent aspects: the termination of menses, a depreciation (or 
minimization) of the menopause of the participant, and the menopause as a positive 
experience. This association could suggest that the termination of menses is associated 
with neutral or positive representations, which would be congruent with the findings of 
previous studies (Avis, & McKinlay, 1995; Chirawatkul, & Manderson; 1994; Padonu, 
Holmes-Rovner, Rothert, Schmitt, & Kroll, 1996), although both positive experience 
and absence of positive consequences have low loadings in this factor (that is, inferior 
to .40). 
The third factor evidences menopause‘s representation as a phase of life cycle; this 
means that menopause is seen as a normal or expected transition that is clearly distinct 
from negative and positive representations.  
In conclusion, women might represent menopause as being a negative or positive 
experience or as a life cycle transition. 
The perceived positive consequences of menopause are explained by two major factors, 
one clearly psychological (positive psychological changes) and the other of a more 
physical nature (termination of menses and absence of positive consequences). The 
strong association between the emergent categories of cessation of menses and absence 
of positive consequences may mean that the termination of menses is not always 
perceived as a positive consequence, although it accounts for 58.7% of all positive 
consequences mentioned. Other researches reached the same conclusions: women feel 
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relief or neutral feelings towards the menses cessation, or refer to the end of 
menstruation as having little significance (Lock, 1991; Avis, & McKinlay, 1991). 
The MCA regarding the model of negative consequences of menopause highlights that 
this pre-category is largely explained by a four-factor structure. Hence, negative 
psychological changes, negative sexual changes and the absence of negative 
consequences constitute the first factor; the second one gathers negative physical 
changes and concern with development or aggravation of disease; the third is vasomotor 
symptoms and the fourth factor is defined by weight gain and perception of loss. In this 
model of negative consequences of menopause, negative psychological changes (as well 
as negative sexual changes) are strongly associated with the absence of negative 
consequences. Since positive psychological changes were not related with the absence 
of positive consequences in the model analyzed previously (i.e., the model of positive 
consequences), it can be hypothesized that changes at a psychological level might be 
more significant when they are positive than when they are negative, since in the model 
of negative consequences, the psychological changes are associated with the absence of 
negative consequences. Moreover, psychological changes have a low loading in this 
factor (.193). The association between the absence of negative consequences and sexual 
changes might also mean that the later are not very significant.  
The second (negative physical changes and concern with disease) and third (vasomotor 
symptoms) factors, although of physical nature, are distinct dimensions. A similar result 
has been found in other studies regarding factor analysis of menopausal symptoms: 
somatic experiences and vasomotor symptoms are usually identified as being different 
factors (Green, 1998).  
The fourth factor aggregates weight gain and perception of loss. These two negative 
consequences of menopause, although bearing low loadings (.270 and .290, 
respectively), have similarities: weight gain may reflect the lost of a known body shape 
which may be perceived as changed due to menopause. Therefore, the model of 
negative consequences of menopause has four main factors, one of psychological/sexual 
nature, other of physical nature, a third one which represents vasomotor symptoms and 
a last factor which reflects the subject of lost. 
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5. Conclusion  
 
Despite the associations that women establish between menopause and a series of 
consequences (positive or negative), the menopause process might not be the only 
variable influencing the representations and perceived consequences, since psychosocial 
and cultural factors can have an impact in the reporting of menopause symptoms and in 
the way women perceive menopause.  
Our results emphasize that, in a group of Portuguese women, representation of 
menopause may be of a negative, a positive or a neutral experience, or as a life cycle 
transition. The perceived positive consequences are cessation of menses or absence of 
positive consequences on one hand, and positive psychological changes on the other 
hand. Negative consequences of menopause are of psychological/sexual nature, physical 
nature, vasomotor symptoms or weight gain and lost perception. 
The non-probabilistic nature of this study cannot lead to generalizations. However, and 
contrary to studies using closed-end questionnaires, this approach allows for insightful 
gains into the overall nature of representations of menopause and the perceived 
consequences of this transition. There is evidence that women can internalize the 
biological model and perceive menopause in terms of deficiency, attributing to the 
menopausal process several psychological difficulties (Ballinger, 1990).  
Given that the psychosocial and cultural context can determine the meaning and impact 
of menopause (Hunter, 1994) and that health care professionals may reinforce these 
representations or modify them (Moscovici, 1990), it should be clear what the cognitive 
constructions women have about menopause are, with qualitative studies making an 
important contribution to this understanding.   
In future research, it would be useful to explore whether these conclusions are 
confirmed in larger samples. It would also be pertinent to study if certain types of 
representations of menopause and associated consequences, identified in the present 
research, are correlated with other psychological variables, given the high frequency of 
psychological phenomena being identified by the participants as negative consequences 
of menopause. 
There may be some socio-cultural biases in our results that also limit generalizations.  
Yet, the conservation of physiological processes within the human species and the 
proximity between developed societies, due to global communications, has reduced the 
cultural gap. Thus, women‘s representations of menopause may well be similar across 
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different countries and socio-economic groups. Therefore, the present research is an 
important examination of how a group of Portuguese women see menopause and its 
consequences which can affect the way they live this phase and relate with family and 
social context. 
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ABSTRACT 
Objectives Menopausal instruments usually assess frequency or intensity of symptoms. 
The present study develops and validates an inventory to assess menopausal symptoms‘ 
severity through the measurement of their frequency and intensity, and explores the 
differences between women with different menopausal status.  
Methods A community sample of 1,003 Portuguese women in pre-, peri- and post-
menopause filled the proposed inventory with 47-items. Factor exploratory and 
confirmatory analyses, and comparative statistics for paired and independent samples, 
were applied using PASW Statistics v.19 and AMOS v.18 software.  
Results The final structure with 38-items organized in twelve factors showed overall 
good psychometric properties (in terms of factor analysis, convergent, discriminant and 
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criterion validity, as well as regarding reliability, sensitivity, and measure invariance in 
two different and independent samples). Wilcoxon test confirmed significant differences 
between frequency and intensity of symptoms. Moreover, peri- and post-menopausal 
women in this community sample presented low symptoms severity (ranging from 0.6 
to 1.4 in a scale from 0 to 4) and, although post-menopausal participants present higher 
levels (when compared with their peri-menopausal counterparts), the two groups only 
diverge significantly in some physical symptoms (namely, aches and pain, vasomotor 
symptoms, numbness, skin and facial hair changes, urinary and sexual symptoms). 
Conclusion This research emphasizes that symptoms‘ severity measurement should 
account for both frequency and intensity. Moreover, it contributes with a dully validated 
12-dimenson inventory for menopausal symptoms. Regarding to differences between 
peri- and post-menopausal women, the symptoms‘ increment only happens in physical 
symptoms, although the severity levels are not exacerbated.   
 
 
INTRODUCTION 
As the aging of the world‘s population becomes more pronounced, valid and reliable 
measures to assess situation-specific symptoms become an important research direction 
in order to identify the necessity of interventions, evaluate the impact of therapies and 
map a specific population on a particular set of problematic occurrences.   
Both genders manifest, during the aging process, physical and psychological 
deterioration with several associated symptoms (including episodic sweating, memory 
and concentration impairment, anxiety, depressive mood, joint complaints, among 
others) [1].  
According to the bio-medical model, menopause refers to the last menses that occurs 
after a continuous loss of ovarian follicles throughout the reproductive lifespan, and 
gradual reduction of hormones‘ production by the ovaries, which lead to changes in the 
length of the menstrual cycle and ultimately to its cessation. This circumscribed 
occurrence will take place during the menopause transition period [2]. This period 
encompasses the transition from a reproductive to a non-reproductive life phase, during 
which the emergence of particular symptoms will occur, being their severity associated 
to bio-psycho-social factors [3-5]. As a result, menopausal symptoms vary greatly 
across cultures [6-8]. 
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Usually women do not experienced all menopausal symptoms; it is known that about 
75% of post-menopausal women manifest some symptoms, experiencing them in an 
acute way. Moreover, different symptoms will have a dissimilar impact, ranging from 
mild discomfort to extreme distress [9].  
To evaluate these changes that emerge in midlife, several instruments have been 
designed to assess symptoms that occur during the climacteric period [1,10,11], 
including some that were developed from previous scales [11]. 
Menopause‘s symptoms measurement usually includes the evaluation of the presence of 
the symptoms, but should also include a self-rating assessment of their intensity or 
severity [12]. However, most of the available measures do not assess simultaneously the 
frequency and the intensity of each symptom which would result in a more exact 
assessment of their severity level.  
In order to identify an accurate severity of menopausal symptoms in peri- and post-
menopausal women an inventory was developed, to assess the frequency (how many 
times) and the intensity (how strong/intense) of each symptom. 
Some of the items, included in this inventory, are evidenced in the literature as changes 
that occur during menopausal transition, but have been absent in previous menopausal 
scales and checklists. Some examples are the increment of facial hair, weight gain, 
breast tenderness, loss of head hair, changes in the skin (dryness or texture and tone 
alterations), as they can be identified as hormone therapy secondary effects [13]. 
 
 
METHODS 
Participants 
After having given their informed consent and agreed to participate in the research, a 
community sample of 1,003 Portuguese women between 42 and 60 years of age filled in 
all the instruments adequately (45 were excluded due to incorrect filling in). 
The instruments included the Menopause Symptoms‘ Severity Inventory (MSSI-38), the 
Portuguese adaptation of the Depression, Anxiety and Stress Scales [14] the Utian 
Quality of Life Scale [15], and the Body Shape Questionnaire [16], as well as a 
questionnaire to identify the menopausal status [17] and to explore socio-demographic, 
health and menopause-related characteristics. Participants form a community sample 
recruited through basic, middle and high schools, universities and corporate settings. 
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The menopausal status was defined according to Soules et al. [17]. Pre-menopausal 
women were identified for not having any changes in their menstrual cycle. Peri-
menopausal women would report variable cycle length (more than seven days different 
than usual), or had skipped two or more cycles and had an amenorrhea interval superior 
to sixty days. Post-menopausal women were confirmed for having at least a twelve-
month period of amenorrhea. 
To improve the accuracy of menopausal status‘ determination, in addition to the actual 
age, the age of the individual when the last menstrual period occurred was also asked. 
Table 1 describes the peri- and post-menopausal participants. 
 
Table 1 - Distribution of the study‘s participants according to socio-demographic and 
health-related characteristics 
 Pre- Peri- Post- 
Characteristics n % n % n % 
N 282 28.4 298 30.1 412 41.5 
Age (M; SD) 45.7(3.230)  47.6(3.787)  53.9(4.207)  
Marital status       
Married or in a 
relationship 
202 71.9 218 73.2 277 67.4 
Not married or in 
a relationship 
79 28.1 80 26.8 134 32.6 
Education       
Primary school  19 6.9 28 9.5 62 15.4 
Middle school 51 18.5 68 23.1 98 24.4 
High school  79 28.6 91 31.0 109 27.1 
University degree 127 46.0 107 36.4 133 33.0 
Professional status       
Active 259 92.5 262 89.7 317 78.7 
Inactive 21 7.5 30 10.3 86 21.3 
HT, herbal/soy 
therapy or Nothing 
      
HT 4 1.5 13 4.5 49 13.5 
Herbal/soy 0 0 16 5.5 48 13.3 
57 
 
therapy 
Nothing 273 98.5 262 90.0 265 73.2 
Body mass index 
(kg/m
2
) 
      
≤ 24,9 166 59.1 157 53.0 205 50.6 
> 24,9 115 40.9 139 47.0 200 49.4 
 
Item generation 
A list of symptoms, which could be manifested by peri- and post-menopausal women, 
was compiled from different sources including menopause literature and pre-existing 
menopause-related instruments [1,10,11], researchers‘ clinical experience and 
menopause-specific knowledge of three consultants (two gynaecologists and one 
psychologist). Thirty-two semi-structured interviews were also conducted on the subject 
of menopause experience, which were later reviewed by two researchers to determine, 
amongst other things, additional symptoms or problematic occurrences.  
 
Question format 
For each symptom participants were asked how frequent (how many times) and how 
intense (how strong) the symptom had been during the last month.  
Responses were organized in a five-point Likert-type scale (ranging from 0 to 4) for 
both frequency (that is, ―never‖, ―yes, less than once a week‖, ―yes, once or twice a 
week‖, ―yes, several times a week‖ and ―yes, daily or almost every day‖) and intensity 
(namely, ―not intense‖, ―minimum intensity‖, ―moderate intensity‖, ―high intensity‖ or 
―extreme intensity‖). 
 
Item Reduction 
After exploratory factor analysis, nine items from the initial forty-seven were 
eliminated: i) strong or fast heartbeat; ii) difficulty in sleeping; iii) mood swings; iv) 
feeling impatient towards others; v) flatulence (gas) or pain caused by gas; vi) dry skin; 
vii) breast tenderness; viii) difficulty in urinating and ix) very strong and/or irregular 
vaginal bleeding. These items were excluded because they presented poor association 
with the factor to which they were predictably associated in the exploratory factor 
analysis, were absent in at least 50% of the sample, presented a kurtosis higher than 7 
and a skewness higher than 3, or did not have an adequate internal consistency (this was 
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the case of a thirteenth factor that compiled two items – breast tenderness and strong 
and/or irregular vaginal bleeding - which had a Cronbach‘s alpha of .40; composite 
reliability was also calculated for this factor but again it was very low, .51. 
The final structure included thirty-eight symptoms, evaluated both in terms of frequency 
and intensity, and organized in twelve factors (anxiety; depressive mood; cognitive 
impairment; vasomotor symptoms; numbness; mouth, nails and hair changes; perceived 
loss of control; sexual symptoms; aches and pain; body shape; skin and facial hair 
changes and urinary symptoms).  
 
Statistical and Psychometric Analysis 
To identify if frequency scores were significantly different from intensity scores, the 
data distributions of each symptom were compared using the Wilcoxon test for paired 
samples. 
Construct validity was asserted by factor analysis (exploratory and confirmatory), 
convergent and discriminant validity. 
To explore the factor structure of the inventory, an exploratory factor analysis was made 
with PASW Statistics (v. 19.0, SPSS Inc., Chicago, IL), using the principal components 
method and a varimax rotation. This analysis was made in 60% of the peri- and post-
menopausal sample, randomly selected. To demonstrate the invariance of the 
measurement model, a confirmatory factor analysis was conducted using AMOS 
software (v. 18.0, SPSS Inc., Chicago, IL).  
The convergent validity of the inventory was analysed through the average variance 
extracted (AVE). An adequate value should be higher than .50 [18]. 
This discriminant validity was explored comparing the inter-factors‘ squared correlation 
with the AVE of each individual factor. In order to have discriminant validity the 
association between factors should be smaller than the individual AVE [18].  
Criterion validity was explored through concurrent-oriented validity of some scales, 
using Pearson‘s correlation with similar constructs. To test this, three other subscales 
were used, namely, the Depression, Anxiety and Stress Scales – DASS [14], the Utian 
Quality of Life Scale for sexual quality of life [15] and the Body Shape Questionnaire – 
BSQ [16].  
In addition, to demonstrate that the measure was adequate in assessing symptoms that 
occur during menopause (that is, during the menopausal transition and post-
menopause), the invariance of the measurement model was tested integrating, in the 
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analysis, women who were not in the menopause phase (pre-menopausal participants), 
and therefore were not expected to have menopausal symptoms. This analysis had the 
purpose of proving that the measurement model would be variant when using a group of 
women who were not in menopause. 
Reliability was studied applying the Cronbach‘s alpha, and sensitivity was explored 
through the analysis of minimum and maximum values, skewness and kurtosis. Values 
are expected to range from 0 to 4 and skewness and kurtosis are expected to have values 
below 3 and 7 respectively, while reliability scores should be above .70 [18]. 
To evaluate if age could function as a moderator for the impact of menopausal status 
over the symptoms, a structural model was built to evaluate a possible interaction effect 
will be evaluated to the twelve symptoms.   
Finally, to explore if there are significant differences between women in peri- and post-
menopause, regarding the twelve sets of symptoms, a one-way ANOVA was applied.   
 
 
RESULTS 
Frequency and intensity 
To assert if the frequency was significantly different from the intensity measurement, 
every item‘s (symptoms) frequency and intensity were compared with Wilcoxon test for 
paired samples. As evidenced in the table 2, there are significant differences between 
the measurement of frequency and intensity, for most symptoms.  
 
Table 2 – Mean and standard deviation of each symptom for the sample of peri- and 
post-menopausal women and comparison of the two menopausal status groups 
(Wilcoxon test) for each symptom 
Items 
Frequency 
M(SD) 
Intensity 
M(SD) 
Wilcoxon test 
(peri- vs. post-) 
Z sig.
†
 
1 – Feeling tense or nervous 1.59(1.065) 1.49(1.000) -3.825*** 
2 - Getting easily excited (that is, 
agitated, excited or startled) 
1.30(1.170) 1.21(1.094) -3.900*** 
3 – Panic attacks .27(.720) .29(.726) -1.278 n.s. 
4 – Difficulty in concentrating 1.27(1.144) 1.19(1.056) -3.277*** 
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5 – Feeling tired or with lack of 
energy 
1.78(1.215) 1.59(1.101) -6.792*** 
6 – Loss of interest in most things .87(1.100) .84(1.076) -1.363 n.s. 
7 – Crying spells .63(1.015) .63(.990) -.175 n.s. 
8 – Irritability 1.31(1.051) 1.28(1.059) -1.228 n.s. 
9 – Being unhappy with your personal 
life 
1.09(1.157) 1.01(1.113) -3.119** 
10 – Feeling anxious or nervous 1.50(1.099) 1.36(1.042) -5.568*** 
11 – Felling a loss or lack of memory 1.39(1.194) 1.22(1.094) -6.407*** 
12 – Overall decrease in the 
performance capacity (for example, 
doing less things than you are used to 
do) 
1.27(1.177) 1.15(1.089) -5.058*** 
13 – Feeling depressed, down or sad 1.27(1.165) 1.21(1.096) -2.142* 
14 – Wanting to be alone 1.37(1.273) 1.28(1.224) -3.821*** 
15 – Feeling dizzy or fainting .44(.815) .42(.822) -1.426 n.s. 
16 –Sense of tension and pressure on 
the head or body 
1.10(1.103) 1.02(1.042) -3.564*** 
17 –Numbness or tingling in some 
body parts  
1.21(1.271) 1.09(1.167) -5.112*** 
18 – Headache 1.22(1.143) 1.22(1.130) -.212 n.s. 
19 – Pain in the muscles and joints 1.69(1.297) 1.53(1.203) -5.757*** 
20 – Loss of sensation on the hands or 
feet  
.74(1.137) .67(1.050) -2.683** 
21 – Difficulty in breathing or 
breathlessness  
.56(.989) .51(.896) -2.812** 
22 – Pain on the back of the neck or 
head  
1.53(1.306) 1.42(1.185) -4.581*** 
23 – Decrease in physical strength 1.32(1.210) 1.20(1.099) -4.447*** 
24 – Weight gain 1.06(1.223) 1.00(1.174) -2.387* 
25 – Increased facial hair .62(1.029) .56(.956) -3.295*** 
26 – Changes in the appearance, 
texture or tone of your skin 
.67(1.003) .62(.951) -2.969** 
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27 – Feeling bloated 1.39(1.239) 1.27(1.190) -4.654*** 
28 – Lower back pain 1.82(1.330) 1.68(1.235) -4.719*** 
29 – Urine loss when laughing or 
coughing 
.98(1.254) .82(1.108) -6.302*** 
30 – Hot flashes 1.17(1.411) 1.06(1.296) -4.831*** 
31 – Night sweats 1.15(1.383) 1.03(1.276) -5.663*** 
32 – Excessive sweating .74(1.123) .71(1.081) -1.959* 
33 – Loss of sexual interest 1.50(1.364) 1.41(1.287) -3.868*** 
34 – Excessive wish to urinate .77(1.124) .67(1.033) -4.594*** 
35 – Vaginal dryness (feeling of 
dryness, burning and problems during 
sexual intercourse) 
1.03(1.269) .97(1.206) -3.279*** 
36 – Hair problems (for example, 
insufficient or excessive hair)  
.73(1.101) .71(1.042) -1.583 n.s. 
37 – Nail changes (changes in colour, 
thickness, appearance of the nail, etc.) 
.72(1.119) .70(1.081) -1.781 n.s. 
38 – Mouth and teeth problems (pain 
and burning feeling in the gums, 
altered taste, increased sensitivity to 
hot and cold, dry mouth, etc.) 
.80(1.092) .75(1.054) -2.204* 
†
2-tailed; n.s. not significant; * p≤.05; ** p≤.01; *** p≤.001 
 
To assess the psychometric qualities of the measures assessed by the inventory, 
construct-related and criterion validity were evaluated for each factor. Moreover, 
reliability, sensitivity and measurement invariance, in two independent samples, were 
also explored. 
The severity of each symptom is given by the frequency and intensity‘s mean for that 
symptom. 
 
Construct Validity 
Factorial Validity 
The exploratory factor analysis was done, using PASW Statistics (v. 19.0), on 60% of 
randomly selected data, from the total sample of peri- and post-menopausal women. 
Factors extracted were those with eigenvalue greater than one and theory-supported. 
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The best-fit solution was a twelve factor structure, excluding nine items from the 
original inventory. The sampling adequacy was confirmed by the Kaiser-Meyer-Olkin 
test (KMO=0.938) and the total variance explained by this twelve-factor structure is 
73.0% 
Table 3 evidences the range of all symptoms‘ loadings that compose each one of the 
twelve factors. 
 
Table 3 – Range of symptoms‘ loadings for each factor 
Factors 
Nr. of 
items 
Range of symptoms 
loadings 
Variance explained 
by factor (%) 
Anxiety 5 0.495 - 0.754 9.407 
Depressive mood 5 0.643 – 0.743 9.112 
Aches and pain 6 0.478 –0.754 8.769 
Cognitive impairment 3 0.619 – 0.726 7.247 
Vasomotor symptoms 3 0.705 – 0.899 6.555 
Mouth, nails and hair changes 3 0.577 – 0.785 5.502 
Perceived loss of control 3 0.586 – 0.680 4.859 
Numbness 2 0.762 – 0.767 4.763 
Urinary symptoms 2 0.748 – 0.783 4.462 
Sexual symptoms 2 0.705 – 0.823 4.302 
Skin and facial hair changes 2 0.670 – 0.800 4.065 
Body shape 2 0.677 – 0.688 3.963 
Total variance explained (%) 38 --- 73.006 
 
 
Convergent validity 
All subscales present good AVE scores (i.e., equal or above .50) except for the mouth, 
nails and hair changes (.41) and perceived loss of control (.38) subscales. 
   
Discriminant validity  
Of the sixty-six paired-factors possible comparisons, for the existent twelve factors, 
fifty-seven presented good discriminant validity. The nine exceptions with low 
discriminant validity were the following pairs: depressive mood and cognitive 
impairment; cognitive impairment and aches/pain; depressive mood and anxiety; 
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aches/pain and numbness; skin, facial hair changes and body shape; depressive mood 
and perceived loss of control; aches/pain and perceived loss of control; mouth, nails and 
hair changes and perceived loss of control; and anxiety and perceived loss of control.   
 
 
Criterion validity 
MSSI-38‘s anxiety subscale was highly related with DASS‘s anxiety factor (rp=.617; 
p<.001). 
In addition, MSSQ-38‘s depressive mood was also strongly associated with DASS‘s 
depression subscale (rp=.736; p<.001). 
The association between sexual quality of life and sexual symptoms was both negative 
and significant (rp=-.221; p<.001) as expected.  
Finally, MSSQ-38‘s body shape was also correlated with the total of BSQ (rp=.557; 
p<.001). 
 
 
Multi-group Analysis  
Invariance Analysis 
The model presents a good adjustment (X
2
/df=2.055; CFI=.895; GFI=.830; 
RMSEA=.039, p=1.000, C.I. 90% ].037; .041[) in both groups (60% and 40% of the 
sample of peri- and post-menopausal women). 
The unconstrained measurement model does not have a significantly better fit than the 
model with constrained factorial weights (X
2
(26)=27.229; p=0.397), hence confirming 
the invariance of the measurement model. Therefore, there are no significant differences 
in the factorial measurement weights between both groups (60% of the sample versus 
40%) confirming the assessment‘s stability of the twelve constructs comprised in the 
MSSI-38. 
 
Pre- versus peri- versus post-menopausal participants 
This measure also presented a good adjustment to the global sample, that is, 1,003 
women in pre-, peri- and post-menopause (X
2
/df=3.415; CFI=.923; GFI=.901; 
RMSEA=.049, p=.735 C.I. 90% ].047; .051[). As expected, when women in pre-
menopause are included, the measurement weights are significantly different 
(X
2
(52)=82.208; p=.005) supporting the variance of the measure in the groups. 
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However, and again as expected, if only peri- and post-menopausal women are 
considered, the constrained measurement model does not have a significantly better 
adjustment than the unconstrained one (X
2
(26)=30.448; p=.249). These results support 
the inventory‘s stability as a measure for menopausal symptoms that are observed in 
peri- and post-menopausal women (X
2
/df=2.131; CFI=.888; GFI=.827; RMSEA=.040, 
p=1.000 C.I. 90% ].038; .042[). 
 
Reliability 
The internal consistency of these twelve subscales was also explored. All subscales 
presented an acceptable Cronbach‘s alpha as shown in table 4.  
 
Table 4 – Internal consistency of the twelve subscales 
Subscales 
Nr. of 
items 
Cronbach‘s alpha for Severity 
Anxiety 5 0.899 
Depressive mood 5 0.870 
Aches and pain 6 0.859 
Cognitive impairment 3 0.815 
Vasomotor symptoms 3 0.847 
Mouth, nails and hair changes 3 0.701 
Perceived loss of control 3 0.674 
Numbness 2 0.793 
Urinary symptoms 2 0.653 
Sexual symptoms 2 0.716 
Skin and facial hair changes 2 0.613 
Body shape 2 0.737 
 
 
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values for the severity of all symptoms. 
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Table 5 – Minimum and maximum values, skewness and kurtosis for the 38 items 
Item Minimum Maximum Skewness Kurtosis 
1 – Feeling tense or nervous 0 4 .326 -.497 
2 - Getting easily excited (that 
is, agitated, excited or startled) 
0 4 .599 -.572 
3 – Panic attacks 0 4 2.902 8.236 
4 – Difficulty in concentrating 0 4 .696 -.224 
5 – Feeling tired or with lack of 
energy 
0 4 .324 -.762 
6 – Loss of interest in most 
things 
0 4 1.249 .620 
7 – Crying spells 0 4 1.686 2.092 
8 – Irritability 0 4 .625 -.165 
9 – Being unhappy with your 
personal life 
0 4 .976 .009 
10 – Feeling anxious or nervous 0 4 .448 -.472 
11 – Felling a loss or lack of 
memory 
0 4 .575 -.594 
12 – Overall decrease in the 
performance capacity (for 
example, doing less things than 
you are used to do) 
0 4 .732 -.368 
13 – Feeling depressed, down or 
sad 
0 4 .696 -.350 
14 – Wanting to be alone 0 4 .711 -.597 
15 – Feeling dizzy or fainting 0 4 2.194 4.703 
16 –Sense of tension and 
pressure on the head or body 
0 4 ,849 -.160 
17 –Numbness or tingling in 
some body parts  
0 4 .844 -.409 
18 – Headache 0 4 .735 -.282 
19 – Pain in the muscles and 0 4 .338 -.961 
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joints 
20 – Loss of sensation on the 
hands or feet  
0 4 1.464 1.050 
21 – Difficulty in breathing or 
breathlessness  
0 4 1.836 2.643 
22 – Pain on the back of the 
neck or head  
0 4 .455 -.882 
23 – Decrease in physical 
strength 
0 4 .640 -.580 
24 – Weight gain 0 4 1.066 .122 
25 – Increased facial hair 0 4 1.862 2.844 
26 – Changes in the appearance, 
texture or tone of your skin 
0 4 1.713 2.402 
27 – Feeling bloated 0 4 .581 -.772 
28 – Lower back pain 0 4 .189 -1.054 
29 – Urine loss when laughing 
or coughing 
0 4 1.257 .509 
30 – Hot flashes 0 4 .955 -.453 
31 – Night sweats 0 4 1.004 -.338 
32 – Excessive sweating 0 4 1.573 1.516 
33 – Loss of sexual interest 0 4 .580 -.893 
34 – Excessive wish to urinate 0 4 1.610 1.782 
35 – Vaginal dryness (feeling of 
dryness, burning and problems 
during sexual intercourse) 
0 4 1.085 -.034 
36 – Hair problems (for 
example, insufficient or 
excessive hair)  
0 4 1.580 1.640 
37 – Nail changes (changes in 
colour, thickness, appearance of 
the nail, etc.) 
0 4 1.693 1.932 
38 – Mouth and teeth problems 
(pain and burning feeling in the 
0 4 1.475 1.430 
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gums, altered taste, increased 
sensitivity to hot and cold, dry 
mouth, etc.) 
 
A structural model was built to explore if age was a confounding variable. The results 
showed that there is a negative and significant interaction in two sets of symptoms. This 
means that for both skin and facial hair changes (β=-.183; p=.028) and vasomotor 
symptoms (β=-.228; p=.001) age moderates the effect of menopausal status over these 
two sets of symptoms.  
To evaluate the sensitivity of the subscales, minimum and maximum values, as well as 
skewness and kurtosis were explore for the severity of twelve sets of symptoms. 
 
Table 6 - Minimum and maximum values, skewness and kurtosis for the twelve 
subscales 
Subscales Minimum Maximum Skewness Kurtosis 
Anxiety 0 4 .490 -.315 
Depressive mood 0 4 1.050 .487 
Aches and pain 0 4 .571 -.258 
Cognitive impairment 0 4 .664 -.200 
Vasomotor symptoms 0 4 1.134 .278 
Mouth, nails and hair changes 0 4 1.616 2.449 
Perceived loss of control 0 4 2.135 5.073 
Numbness 0 4 1.134 .421 
Urinary symptoms 0 4 1.502 1.851 
Sexual symptoms 0 4 .790 -.411 
Skin and facial hair changes 0 4 1.698 2.807 
Body shape 0 4 .836 -.094 
 
 
Peri- versus Post-menopausal participants regarding symptoms’ severity 
The mean severity was calculated for each subscale, for peri- and post-menopausal 
participants separately, and a t-Student test was used to analyse if both groups diverged 
significantly in the twelve groups of symptoms, as observed in table 7. 
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Table 7 – Mean severity scores and t-Student for peri- and post-menopause comparison 
Symptoms 
Peri- 
M(SD) 
Post- 
M(SD) 
T-test 
t(df) sig
†
 
Depressive mood 1.0 (.909) 1.0 (.952) -1.029(676) n.s. 
Cognitive impairment 1.1 (.952) 1.2 (.962) -1.352(674) n.s. 
Aches and pain 1.2 (.873) 1.4 (.934) -2.395(684) * 
Vasomotor symptoms 0.7 (.979) 1.1 (1.186) -4.456(660.440) *** 
Numbness 0.8 (1.012) 1.0 (1.058) -2.003(665) * 
Mouth, nails and hair 
changes 
0.6 (.846) 0.7 (.833) -.946(655) n.s. 
Anxiety 1.4 (.895) 1.4 (.926) -.287(683) n.s. 
Skin and facial hair changes 0.5 (.758) 0.7 (.830) -3.433(627.359) *** 
Urinary symptoms 0.6 (.876) 0.9 (1.021) -3.133(648.911) ** 
Sexual symptoms 0.9 (1.018) 1.4 (1.208) -5.634(649.321) *** 
Body shape 1.1 (1.042) 1.1 (1.094) -.195(667) n.s. 
Perceived loss of control 0.4 (.624) 0.5 (.695) -1.697(642.851) n.s. 
†
2-tailed; n.s. not significant; * p≤.05; ** p≤.01; *** p≤.001 
 
DISCUSSION 
Patient-reported outcomes are useful not only in the context of research, but also in 
clinical settings, as they allow the identification of psychological and physical 
symptoms that might be unobserved, monitoring symptoms‘ evolution and exploring 
pertinent information regarding the implemented treatment [19]. Specifically for 
menopause, the literature evidences the importance of the availability of indexes that 
cover both menopausal symptoms and the potential side effects of hormone therapy 
[20]. 
Some of the nine excluded items have been receiving some attention in the menopause 
literature. Specifically, difficulty in sleeping has been associated with vasomotor 
symptoms and psychosocial factors [21,22]. This was not found in the present research, 
given that this particular item was never associated with the vasomotor symptoms scale. 
The low severity of vasomotor symptoms in this community sample might partially 
explain the absence of this association.  
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Dysuria (difficulty in urinating) was also excluded, although there was clearly a factor 
compiling urinary symptoms (which was kept due to its good psychometric 
characteristics and theoretical sustainability) with which this item was never related. 
This may evidence that dysuria is not an observed urinary symptom in this sample of 
peri and post-menopausal women.  
The poor discriminant validity between some subscales, namely between perceived loss 
of control and depressive mood; anxiety, aches and pain; mouth, nails and hair changes, 
might evidence that some psychological and physical symptoms may enhance the 
perception of decreased control.  
Breast tenderness and very strong and/or irregular vaginal bleeding, although being 
related with hormonal changes [23] and hormonal therapy side effects [24], and 
therefore important items to include in a menopausal symptoms scale, showed, in this 
study, a very low internal consistency. As a result, this factor was not included in the 
final version of the inventory.  
The Menopause Symptoms‘ Severity Inventory provided data with good psychometric 
properties. Thus, the MSSI-38 may be used to accurately measure the severity of 
menopause symptoms, considering both the frequency and intensity of each symptom. 
The inclusion of these two evaluation elements is important, given that the times a 
symptom occurs (frequency) and the intensity (how intense/strong) of the symptom are 
two significantly different ways of evaluating it, as shown above. As analysed, thirty of 
the thirty-eight symptoms presented statistically significant differences between their 
frequency and intensity measurements.  
In addition, it is also shown that the symptoms‘ frequency assessment presents higher 
means when compared with intensity: except for item three, ―panic attacks‖ (where 
frequency is lower than intensity) and items seven, ―crying spells‖, and eighteen, 
―headache‖ (that present an equal mean frequency and intensity) all symptoms are more 
frequent than intense. Hence, studies considering only intensity may obtain lower levels 
of reported symptoms than those assessing the frequency of each symptom. This 
conclusion is supported by a prior study [25] regarding the vasomotor symptoms: 
although 57% of women in their study reported hot flashes, only 9% considered these to 
be bothersome; likewise, night sweats were manifested by 36% of participants however 
only 6% considered them to be troublesome. 
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This inventory allows the measurement of twelve types of symptoms, of both physical 
and psychological nature. Thus, it allows the calculation of twelve distinct indexes of 
symptoms severity, corresponding to the twelve subscales of this instrument. 
Results show that the mean severity of symptoms is low (ranging from 0.6 to 1.4 in a 
scale from 0 to 4) in both peri- and post-menopausal women. This supports the idea that 
the great majority of women in this community sample do not present a high severity of 
menopausal symptoms. This is congruent with a previous study [26] which concluded 
that, although menopausal symptoms are common in middle-aged women, they are 
usually not perceived as problematic. Also, it has been concluded that a higher 
educational level is associated with less symptoms complaints [21,27]; given that a 
large number of participants has a university degree (specifically, 37% of the total 
sample), this might also explain the low severity of menopausal symptoms reported. 
However, there is also the possibility that the self-report methodology has resulted in an 
underreport of the symptoms; as examined elsewhere [28], highly symptomatic 
participants underreported the number of objective (physiological) hot flashes by 43%. 
Nevertheless, the low severity of symptoms might be due to the fact that this is a 
community and not a clinical sample. That nature of the sample aims to overcome a 
limitation that is usually seen in menopausal research which is the fact that many studies 
use clinical samples, excluding the extrapolation to a non-clinical population [29]. 
Moreover, most women in this research were not taking hormonal therapy nor 
herbal/soy products to decrease menopausal symptoms (90 and 73.2% of peri- and post-
menopausal women respectively did not take any medicine or supplement to manage 
menopausal symptoms), thus, the probability of the symptoms being under-reported due 
to medication is diminished. However, the possibility that the subgroup of women 
taking hormone therapy (or herbal/soy therapy) may have reported lower levels of 
symptoms than they would have if therapy was not being used, cannot be discarded. 
An increase on symptom‘s reporting is usually expected during the menopausal stages‘ 
progression [27]. Melby, Lock and Kaufert [30] evidence that, although symptom 
reporting during pre-menopause is consistently lower, when compared with peri- and 
post-menopause phases, it is still not unanimous in which one of the two latter 
menopausal stages (peri- or post-menopause) higher rates of symptoms are reported. 
Regarding the hot flashes, its prevalence has been evidenced as higher in post than in 
peri-menopausal women: 37% of pre-, 48% of early peri-, 63% in late peri- and 79% in 
post-menopausal women have reported these vasomotor symptoms in a previous 
71 
 
research [31]. Guthrie et al. [32] have also concluded that the presence of higher rates of 
bothersome hot flushes is observed two years after the final menstrual period. However, 
this conclusion it is not unanimous, since some authors have verified a decrease in 
menopausal symptoms from peri- to post-menopause [33], or found peri-menopausal 
women more prone than their counterparts in pre- and post-menopause to experience 
aches and pains (head, back or joint); however, vasomotor symptoms were more 
prevalent in post-menopause, remaining high in this stage [34]. 
In this research, although, no analysis was made in terms of comparing early with late 
peri-menopause; the differences between women in menopausal transition (peri-) and 
post-menopause are not significant in all symptoms. The symptoms that increase 
significantly are eminently physical (aches and pain, vasomotor symptoms, numbness, 
skin and facial hair changes, urinary and sexual symptoms). Psychological symptoms 
like depressive mood, anxiety and perceived loss of control, do not increase 
significantly from menopausal transition to post-menopause. This conclusion is 
congruent with a previous study which found that post-menopausal women do not 
present a higher prevalence of psychological symptoms, reporting only more hot flashes 
and night sweats [4]. 
The same research, when comparing women in pre- and post-menopause, did not find 
significant differences in the occurrence of the vast majority of symptoms (anxiety, 
depression, somatic and sexual symptoms did not diverge between the two groups) [4]. 
However, the present research evidences that when comparing women in pre- with 
participants in menopausal transition and post-menopause, differences in symptoms 
measurement are observed indicating different measurement weights according to the 
menopausal status. 
Memory functioning has also been observed to be decreased in peri-menopausal women 
when compared with post-menopausal counterparts [35].This was not observed in the 
present sample given that there are no significant differences in cognitive impairment 
(which encompasses a memory self-reported assessment) between peri- and post-
menopausal women. 
The results also evidence that age moderates the effect of menopausal status over two 
types of symptoms (vasomotor and skin and facial hair changes). Since the interaction is 
negative, the impact of menopausal status over the symptoms is suppressed by age. 
Therefore, as age progresses, vasomotor symptoms and changes in skin and facial hair 
become less influenced by menopausal status. Similar conclusions have been mentioned 
72 
 
in the literature, namely, that somatic symptoms of menopause are negatively and 
significantly related with age progression [36] and also that skin changes are observed 
in the aging process [37]. 
Although the inventory was applied to women from 42 to 60 years old, it is believed 
that this instrument will also be useful in assessing post-menopausal symptoms in 
women older than 60. Further research with this age group and other ethnicities and 
cultures is recommended, since this is a mostly Caucasian Portuguese sample. 
In conclusion, the Menopausal Symptoms‘ Severity Inventory is an instrument with 
good psychometric properties, which assess menopausal symptoms, both in frequency 
and intensity, in order to obtain an accurate degree of symptoms‘ severity. 
This inventory has been proven to have factorial, convergent and discriminant validity. 
Moreover, criterion validity for some scales as well as a good reliability and sensitivity 
for all scales has been shown. 
More studies are needed to confirm this structure with other samples (for example, 
clinical ones, given that this inventory was generated in a community sample) and 
cultures (since there are evidences that cultural and ethnical differences may influence 
the menopause experience). 
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Abstract 
 
Objective:  To develop a model to predict hot flashes (HF) and night sweats‘ (NS) 
perceived severity in symptomatic women. Methods: Cross-sectional study 
encompassing a vasomotor symptomatic community-based sample, of 243 women. 
Menopausal status was asserted according to the ‗Stages of Reproductive Aging 
Workshop‘ criteria and perceived control was measured by a validated Portuguese 
version of the Perceived Control over Hot Flushes Index. Structural equation modelling 
was used to investigate a causal model of the self-reported severity of both HF and NS 
comprising age, marital status, parity, professional status, educational level, family 
annual income, recent diseases and psychological problems, medical help-seeking 
behaviour to manage menopause, hormone therapy and herbal/soy products use, 
menopause status, alcohol, coffee and hot beverages intake, smoking, physical exercise, 
body mass index and perceived control. Results: Significant predictors are hormone 
therapy for both HF (β=-.245;p=.022) and NS‘ perceived severity (β=-.298;p=.008), 
coffee intake again for HF (β=-.234;p=.039) and NS (β=-.258;p=.029) and perceived 
control for HF (β=-1.0;p<.001) and NS (β=-1.0;p<.001). The variables explain 
respectively 67% and 72% of the variability of HF and NS‘ severity. Moreover, women 
with high perceived control had a significantly low frequency (t(235)=2.022;p=.044) 
and intensity of HF (t(217)=3.582;p<.001); similarly, participants with high perceived 
control presented a low frequency (t(235)=3.267;p<.001) and intensity 
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(t(210)=3.376;p<.001) of NS. Conclusion: Perceived control is the strongest predictor of 
self-reported severity of both HF and NS. Other causal predictors are hormone therapy 
and caffeine intake. All three are associated with a lower severity of the two vasomotor 
symptoms.  
 
Key-words: hot flashes; night sweats; predictors; perceived control; lifestyle; socio-
demographic. 
 
 
1. Introduction 
 
Most women experience vasomotor symptoms during midlife, being common an 
increase in the reporting of these symptoms as women go from one menopausal stage to 
the next [1]. However, and although around 70% of women report vasomotor symptoms 
[2], only a few consider them bothersome. In a prior study just 9% considered hot 
flashes (HF) as bothersome, and 6% described night sweats (NS) as troublesome [3]. 
Moreover, it has been evidenced that these are considered problematic by 12-20% of 
women [2,4]. Regarding the menopausal stages, it has been shown that late peri-
menopause (during which amenorrhea periods of at least two months may occur) and 
post-menopause (which starts after the final menstrual period) [5] are strongly 
associated with bothersome HF reporting [1]. 
Despite its physiological nature, it has been evidenced that socio-demographic, lifestyle, 
health and menopause-related variables have an impact on the vasomotor symptoms‘ 
report. Specifically, using hormonal therapy decreases their bothersomeness [6,7], 
having a good health status diminishes both their frequency and distress [3], less 
medical help-search is associated with less frequent and less severe symptoms [8-10], 
low caffeine intake predicts a lower symptoms‘ severity [11,12], high perceived control 
is related with lower frequency and distress [13], higher educational level predicts lower 
prevalence and severity [4,8,14,15] and not being divorced is associated with lower 
bothersomeness [8] of vasomotor symptoms.  
However, there are some characteristics that are not unanimous regarding their 
association with vasomotor symptoms. Alcohol [3,11,12,14,16], smoking [1,3,8,12,17],  
physical exercise [1,10,11,14,15], body mass index (BMI) [4,12,14,18-20], and 
educational level [3] present no consensus in literature given that they might predict 
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either an increase or a significant decrease in vasomotor symptoms‘ reporting. Some of 
these factors may also have an impact on both (HF and NS) or on only one symptom. 
Moreover, the research developed with multiple health-related conditions has found that 
perceived control over symptoms is a strong predictor of less emotional distress [21], 
lower prevalence and severity of symptoms [22,23], and of health-protective behaviours  
[24]. 
This research has the objective of exploring if socio-demographic, health and 
menopause-related variables, as well as lifestyle and perceived control, are predictors of 
the vasomotor symptoms‘ severity (measured trough frequency and intensity of HF and 
NS separately) in a symptomatic community sample of pre-, peri- and post-menopausal 
women. 
 
 
2. Material and Methods 
 
2.1 Participants 
A community sample of 243 women, who reported hot flashes (HF) and/or night sweats 
(NS) in the previous month, filled in the self-report measures to assess the vasomotor 
symptoms‘ frequency and intensity, perceived control, socio-demographic, health and 
menopause-related variables, and lifestyle characteristics. Table 1 describes this study‘s 
sample. 
 
Table 1 – Characterization of participants in relation to socio-demographic, health, 
menopause-related and lifestyle variables 
 Participants 
Characteristics n % 
Age (M; SD)  51.8±4.501 
Marital status   
Married or in a relationship 171 70.7 
Not married nor in a relationship 71 29.3 
Parity   
0 25 10.6 
1 84 35.6 
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2 99 41.9 
3 21 8.9 
>3 7 2.9 
Education   
Primary school  34 14.3 
Middle school 65 27.4 
High school  60 25.3 
University degree 78 32.9 
Professional status   
Active 197 82.8 
Inactive 41 17.2 
Family annual income   
≤ 10.000 € 56 26.7 
10.001 – 20.000 € 52 24.8 
20.001 – 37.500 € 54 25.7 
37.501– 70.000 € 34 16.2 
≥ 70.001 € 14 6.7 
Recent disease   
Yes 62 26.3 
No 174 73.7 
Recent psychological problem   
Yes 55 23.1 
No 183 76.9 
Search for medical help to deal with 
menopause 
  
Yes 155 70.8 
No 64 29.2 
HT, herbal/soy therapy or Nothing   
HT 23 10.5 
Herbal/soy therapy 31 14.1 
Nothing 166 75.5 
Menopausal status   
Pre- 15 6.3 
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Peri- 75 31.5 
Post- 148 62.2 
Body mass index (kg/m
2
) (M,SD) 26.3±4.826  
≤ 24,9 112 46.9 
> 24,9 127 53.1 
Physical activity   
Yes 105 43.8 
No 135 56.3 
Smoking behaviour   
Current smoker 58 24.2 
Current non-smoker 182 75.8 
Alcohol consumption   
Yes 129 53.5 
No 112 46.5 
Coffee consumption   
Yes 208 86.3 
No 33 13.7 
Hot beverages intake   
Daily 198 87.6 
Occasionally or never 28 12.4 
 
2.2 Procedure 
A community sample was mainly recruited through schools and universities in the city 
of Lisbon. Questionnaires and informed consents were given to students, inside sealed 
envelopes, who would take them to their mothers. The American Psychological 
Association‘s standards on ethical treatment of participants were followed. A written 
informed consent form was delivered to all participants, explaining the aims of the 
study, emphasizing that the participation in this research was voluntary and that 
participants could interrupt their collaboration at any time, without any consequences. 
Each participant kept a copy of the informed consent form, where the contacts of the 
responsible researcher were included (so that women could contact her if any question 
emerged). 
The inclusion criteria in this research were gender (female), age (between 42 and 60 
years old) and having had some vasomotor symptoms in the last month (HF and/or NS). 
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The measures were filled in by 302 women. However, from these, 59 were excluded for 
not providing information regarding the HF and NS‘ frequency and intensity, or 
mentioned that in the previous month they had never experienced vasomotor symptoms. 
Two hundred and forty three women with vasomotor symptoms filled in the self-report 
measures mentioned above. 
 
2.3 Measures 
The instruments included the assessment of HF and NS during the previous month, both 
in frequency and intensity, using a five-point Likert scale (from 1 to 5) that ranged from 
―never‖ to ―daily or almost every day‖, and from ―not intense‖ to ―extreme intensity‖, 
respectively. The perceived severity of HF and NS was given by the mean between the 
frequency and intensity values of each symptom.   
To evaluate perceived control, the Portuguese validated version of the Perceived 
Control over Hot Flushes Index was applied [13]. This version excluded item 15 (―I 
want to learn as much as I can about hot flashes and the menopause‖) given this item 
was not significantly correlated with the construct, presenting a negative standardized 
estimate (λ=-.105; p=.134), and only 1.1% of its variance was explained by the 
construct. Moreover, the modification index (MI=33.785) evidenced this item as the 
strongest negative influence on the quality of fit of the measurement model. 
The 14-item instrument presented good psychometric properties. Confirmatory factor 
analysis of the instrument presented a good fit (X
2
/df=2.239; CFI=.888; GFI=.909; 
RMSEA=.072, I.C. 90% ].057; .086[ p=.009). The reliability (estimated by Cronbach‘s 
alpha) was also good (.78). 
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria [5]. Pre-menopausal women were identified for not having any 
changes in their menstrual cycle. Peri-menopausal participants would report a variable 
cycle length (a difference of more than seven days, than usual) or had skipped two or 
more cycles and had an amenorrhea interval superior to sixty days. Post-menopausal 
women had, at least, a twelve-month period of amenorrhea.  
Socio-demographic characteristics (age, marital status, parity, professional status, 
educational level, family‘s annual income), as well as health and menopause-related 
(recent diseases and psychological problems, medical help-seeking to manage 
menopause, hormone therapy and herbal/soy products), and lifestyle characteristics 
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(alcohol, coffee and hot beverages intake, smoking, physical exercise and body mass 
index) were assessed.  
Lifestyle habits (namely, alcohol, coffee, hot beverages, smoking and physical exercise) 
were assessed in terms of presence/absence, amount and/or frequency. Hence, physical 
exercise was measured in terms of times per week, and during how many minutes, the 
participant exercised; a mean between weekly frequency and duration was used in the 
multivariated model. Coffee and hot beverages intake, when present, was assessed in a 
four-option scale, ranging from occasionally to more than five per day. Alcohol intake, 
when observed, was measured both in terms of frequency (daily, every weekend or 
rarely) and quantity (until I feel drunk, moderately or less than a glass per occasion); a 
mean value of both translates the alcohol consumption variable, in the causal model. 
Finally, for current smokers, smoking was quantified in a six-point Likert-type scale 
that ranged from less than 10 cigarettes per month, until more than 40 cigarettes per 
day; this quantification integrated the structural equation model to assert the influence 
of smoking on the vasomotor symptoms‘ perceived severity. 
 
2.4 Statistical Analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. 
Multicollinearity between the independent variables was explored with the variance 
inflation factor given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables presented a value below 5, indicating the absence of collinearity [25,26]. 
To test the causal model for vasomotor symptoms, a structural equation model was built 
relating the two dependent variables (HF and NS‘ perceived severity) with twenty 
independent variables (namely, perceived control, age, marital status, parity, 
professional status, family‘s annual income, educational level, transition from pre- to 
peri- and from peri- to post-menopause, medical help seeking behaviour, use of 
hormone therapy or herbal/soy products for menopausal symptoms, presence of a recent 
psychological problem or a disease, alcohol, coffee and hot beverages intake, smoking, 
physical exercise and body mass index). The model was evaluated with SPSS AMOS 
software (v. 18, IBM SPSS Inc, Chicago, IL). The quality of the fit of the structural 
model was given by chi-square statistics (X
2
/df), comparative fit index (CFI), goodness 
of fit index (GFI) and root mean square error of approximation (RMSEA), and it were 
used the reference values currently practiced in structural equation modelling [26,27]. 
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A two-step approach was employed to evaluate the causal structural model. First, the 
factor‘s measurement model was evaluated to demonstrate an acceptable fit. Thereafter, 
the structural causal model, encompassing the two dependent and the twenty 
independent variables, was adjusted and the significance of the causal trajectories was 
evaluated. 
Group differences were evaluated with the one-way ANOVA (followed by post-hoc 
Tukey‘s test) and Student-t tests implemented in SPSS Statistics (v. 19, IBM SPSS Inc, 
Chicago, IL). The variances‘ homogeneity was confirmed prior to Student t-tests. To 
compare women with high perceived control (HPC) with participants with low 
perceived control (LPC), a median split was used. 
 
 
3. Results 
 
The measurement model (X
2
/df=2.786; CFI=.891; GFI=.910; RMSEA=.077 C.I. 90% 
].065;.090[ p<.001), as well as the causal model (X
2
/df=1.593; CFI=.888; GFI=.890; 
RMSEA=.049, C.I. 90% ].042; .057[; p=.534), showed a good fit. Significant predictors 
are highlighted in Figure 1.  
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Figure 1 – Causal Model for Vasomotor Symptoms‘ Severity: its relation with socio-
demographics, health and menopause-related variables, lifestyle and perceived control 
 
 
 
As shown, the causal model accounts for 72% and 67% of the variability of night 
sweats (NS) and hot flashes‘ (HF) perceived severity, respectively. Significant 
predictors are hormone therapy for both HF (β=-.245; p=.022) and NS‘ perceived 
severity (β=-.298; p=.008), coffee intake again for HF (β=-.234; p=.039) and NS (β=-
.258; p=.029), and perceived control for HF (β=-1.0; p<.001) and NS‘ perceived 
severity (β=-1.0; p<.001). 
 
The median value of perceived control was 34.1 (SD=5.977). This value was similar to 
the ones found in previous studies [23,25]. Low perceived control (LPC), that is, below 
34.1, was evidenced by 104 women; 139 demonstrated a high perceived control (HPC), 
translated by scores above 34.1. In this symptomatic sample there are significant 
differences between women who have HPC and LPC, regarding both frequency and 
intensity of vasomotor symptoms (table 2).  
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Table 2 – Differences in frequency and intensity of hot flashes (HF) and night sweats 
(NS) between women with high (HPC) and low perceived control (LPC) 
 
 LPC 
 
M(SD) 
HPC 
 
M(SD) 
t-Student 
HPC vs. LPC 
t(df)p
 a
 
Frequency of HF 3.4(1.209) 3.1(1.172) 2.022(235)* 
Intensity of HF 3.4(1.188) 2.8(1.110) 3.582(217)*** 
Frequency of NS 3.3(1.400) 2.7(1.279) 3.267(235)*** 
Intensity of NS 3.2(1.388) 2.6(1.172) 3.376(210)*** 
a
 p (2-tailed); * p≤.05; *** p≤.001 
 
Perceived control was not associated with age, as demonstrated by a low and not 
significant Pearson correlation (rp=-.040; p=.536). 
Regarding perceived control in women who use hormone therapy (HT), herbal/soy 
products or nothing, to manage the menopausal symptoms, there are significant 
differences between groups. Participants who do not take anything for the symptoms 
present a higher perceived control than those who take HT (MD=.275; p=.009). Women 
who use herbal/soy products also demonstrate higher perceived control than those who 
do HT (MD=.297; p=.026). No significant differences were observed between women 
who use herbal/soy therapy and those who do not use anything to manage the symptoms 
(MD=.022; p=.960). 
To explore if these differences could be explained by different perceived severity 
scores, the three groups (women who used HT, who used herbal/soy products and who 
use nothing to manage their symptoms) were compared concerning the vasomotor 
symptoms‘ severity. The results show no differences between the three groups, not in 
relation to HF (F(2)=1.848; p=.160) nor to NS‘ perceived severity (F(2)=1.491; 
p=.227). 
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4. Discussion 
 
Socio-demographic variables (such as age, marital status, professional status, parity, 
educational level, and annual income) and health-related variables were not significant 
predictors of hot flashes (HF) and night sweats‘ (NS) perceived severity. These results 
go against what has been evidenced in other studies [3,4,8-10,14,15] . Nevertheless, this 
absence of relation has been reported elsewhere [28]. 
Although alcohol [3,11,12,14,16], hot beverages [12], physical exercise [1,10,11,14,15], 
body mass index (BMI) [4,12,14,18-20] and smoking [1,3,8,12,17] have been 
considered predictors of vasomotor symptoms, the vast majority of lifestyle factors 
presented no causal associations with the perceived severity of these symptoms, in this 
sample of symptomatic women. 
In a previous research, in which high BMI was associated with HF, participants had a 
higher mean BMI (29.8 kg/m
2
) [28] than the one found in this study (M=26.3; 
SD=4.826), which can partially explain the absence of a causal relation between both 
variables. 
Hormone therapy (HT) significantly predicted a lower perceived severity of both HF 
and NS, which is congruent with prior studies [6,7]. Moreover, and as Reynolds [13] 
also found, perceived control varies significantly between women who use HT, 
herbal/soy products or nothing for menopausal symptoms: participants who have 
vasomotor symptoms, and use no medication or use herbal/soy products, have a higher 
perceived control than those who are taking HT. This result is not due to differences in 
the symptoms‘ severity since there are no significant differences between women who 
are taking HT, herbal/soy products and women who do not use any 
medication/supplements. Additionally, it has been shown that, in this symptomatic 
sample, women who present high perceived control (scores greater than 34) have a 
lower frequency and intensity of both vasomotor symptoms, than women who present a 
low perceived control. Although the construct of perceived control is oriented to HT, 
significant differences are also evidenced in terms of NS. 
Congruently with Reynolds‘ [13,29] results, there was no association between age and 
perceived control. This was also supported by a previous study, which evidences that 
perceived control and health changes are strongly associated in older women (above 65 
years old) but not in middle-aged participants [30]. 
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Caffeine intake has been evidenced as a positive predictor of HF in other researches 
[11,12]. However, in this study, the amount of coffee consumed is a strong negative 
predictor of the vasomotor symptoms‘ perceived severity: women who drink more 
coffee have less severe vasomotor symptoms than the ones who drink less coffee.  
Caffeine is a central nervous system stimulant [31] and produces a more rapid and 
clearer flow of thoughts, limits fatigue and drowsiness, increases concentration and 
allows a more sustained intellectual ability, increases motor activity and diminishes 
reaction‘s time [32]. Therefore, it is possible that these behavioural outcomes, of 
caffeine intake, are partially associated with effective coping strategies, which would 
eventually decrease vasomotor symptoms. Also, certain selective serotonin-reuptake 
inhibitors (SSRIs), which can be used in the treatment of HF [33], have in their 
metabolism the same isoenzyme that is involved in caffeine‘s metabolism [31]. Despite 
this high potential for pharmacokinetic interaction, due to the inhibition of SSRI‘s 
metabolism, coffee intake predicts a decrease in the self-reported severity of vasomotor 
symptoms, in this sample. It can be also hypothesized that this strong predictive effect is 
a reflex of the interaction of caffeine with other substances (other than SSRIs), that were 
not controlled in this research and could promote the reduction of the vasomotor 
symptoms‘ severity. Moreover, decreased estrone levels have been observed in women 
with vasomotor symptoms [34]. In this context, it has been confirmed that caffeine was 
positively associated with estrone levels [35]. These results might explain how coffee 
can be a strong negative predictor of HF and NS‘ severity. This conclusion needs 
further exploration and confirmation in other samples, controlling for other sources of 
caffeine intake (such as tea and soft drinks).  
Perceived control has been reported to have significant associations with fewer 
symptoms‘ reporting in diverse areas [21-23], and also in relation to HF [13,36]. In this 
sample, this association was very strong and significant, after controlling for all the 
socio-demographic, health and menopause-related, and also for the lifestyle 
characteristics mentioned above. In fact, perceived control had the strongest negative 
impact on the vasomotor symptoms‘ perceived severity. It can also be hypothesized 
that, since perceived control has been associated with behavioural changes in other 
areas [24], this evidence might translate some behavioural adjustments (for example, 
dressing in layers, avoiding spicy foods, effective stress management, among others) 
strongly associated with a sense of control that may have led to the reduction of the 
vasomotor symptoms‘ severity. The fact that perceived control had the strongest 
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negative impact in predicting the vasomotor symptoms‘ self-reported severity 
emphasizes the importance of cognitive appraisal. Reynolds [13] also highlighted this 
when concluding that, although the distress associated with HF was higher in women 
who experienced this symptom more frequently, low levels of perceived control were 
even more predictive of the distress caused by these symptoms than frequency itself. 
Furthermore, cognitive appraisals have been identified as accounting for some of the 
individual variation regarding HF [37]. 
These conclusions can have an impact on how cognitive appraisals play an important 
role in the symptoms‘ reporting and experiencing. Additionally, they are supported by 
the fact that around 20 to 40% of the HF‘s frequency can decrease with placebo effects 
alone [38], which accentuates how psychological variables (in this case expectations) 
may play an important role on the vasomotor symptoms‘ severity.  
However, regarding the present study it can also be hypothesized that a higher perceived 
control is a consequence of lower HF and NS‘ severity. Therefore, it is recommended 
that further investigation clarifies this, evidently strong, association. 
The sample size (namely, 243 participants) was adequate for this type of statistical 
analysis given it was applied a rule of thumb of ten subjects per manifest variable, as is 
current practice in structural equation modelling [26,39]. Nevertheless, the fact that this 
research has a cross-sectional design, and uses a sample where a third of the women 
have a college degree, limits the generalization of these results. 
 
 
5. Conclusions 
 
Perceived control is the strongest negative predictor of vasomotor symptoms‘ severity: 
women with high levels of perceived control report lower symptoms‘ severity, than 
women with low perceived control; this result is independent of socio-demographic, 
health, menopause-related and lifestyle factors. The use of hormone therapy and coffee 
intake are also significant negative predictors of vasomotor symptoms‘ severity.  The 
causal model explored in study accounts for 72% and 67% of the variability of night 
sweats and hot flashes‘ perceived severity, respectively. 
This research emphasizes the importance of perceived control on vasomotor symptoms‘ 
management and contributes with new data about the impact of caffeine on these 
symptoms. 
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ABSTRACT 
 
Objective: This study explores what predicts the occurrence of hot flashes (HF) and 
night sweats (NS) in middle-aged women.  
Methods: A community sample of 992 women, aged between 42 and 60 years, 
answered a questionnaire to collect socio-demographic, health and menopause-related, 
and lifestyle information. The menopausal status was determined based on STRAW 
criteria. Anxiety, stress and depression were assessed with a validated instrument; HF 
and NS were evaluated in terms of presence, frequency and intensity. Structural 
96 
 
equation modeling was used to build a causal model to predict the occurrence of both 
symptoms, in a sample of pre-, peri- and post-menopausal women. Additionally, 
ANOVA and t-Student tests were also applied.  
Results: Age was a significant predictor of HF (β=.088;p=.030); being married/in a 
relationship was correlated with HF (β=.111;p<.001) and NS (β=.118;p<.001); parity 
also predicted HF (β=-.075;p=.011) and NS (β=-.081;p=.008) occurrence. The presence 
of a disease predicted only NS (β=.080;p=.010). Contrary to expectations, the use of 
herbal/soy therapy predicted the manifestation of HF (β=.087;p=.004) and NS 
(β=.086;p=.006). Alcohol was associated with NS‘ presence (β=.120;p<.001). Stress 
predicted NS (β=.154;p=.006), whereas depression was linked to HF‘s (β=.149;p=.006) 
occurrence. Being peri-menopausal and post-menopausal, as well as having searched for 
medical help, were also significant predictors of both HF and NS. Higher depression, 
stress and anxiety were observed in women with HF and NS.  
Conclusions: The use of herbal/soy products predicted the presence of vasomotor 
symptoms. It is hypothesized that the differentiated influence of stress and depression in 
vasomotor symptoms is due to the psychological symptoms‘ nature.  
 
Keywords: hot flashes; night sweats; occurrence; stress; depression; structural equation 
modelling. 
 
 
INTRODUCTION 
 
Most women experience hot flashes during midlife
1
 and these tend to increase as 
women pass from one menopausal status to the following one
2
. However, the 
prevalence of vasomotor symptoms does not have a similar distribution between 
menopausal stages and even in a given stage, in the population of menopausal women
3
. 
Vasomotor symptoms prevalence, which vary from 14% to 51% in pre-, from 35% 
to50% in peri- and from 30% to 80% in post-menopause
4
, are frequently identified as 
the menopausal symptoms that lead to the search for medical advice during the 
menopausal transition
5
. 
It has been suggested that vasomotor symptoms are the only ones having 
hypoestrogenism as their origin
6
. Additionally, although these symptoms, which reflect 
an actual increase of the core body temperature, are likely due to the decline in the 
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estradiol levels, there is still some debate around their mechanisms
1,7
. While around 
70% of women experience them, only 15-20% perceive them as problematic due its 
particular consequences (such as, social embarrassment, distress and physical 
discomfort)
8
.  
 
Menopause and health-related variables 
The literature evidences that the menopausal status influences the occurrence of 
vasomotor symptoms
9
. Also, a seeking for medical help behaviour has been predicted 
by a higher frequency, and bothersomeness, of vasomotor symptoms
10-12
. 
In a prior study, health status (namely, an excellent self-rated health) was found to have 
a positive and strong relation with night sweats‘ decrease, but not with hot flashes13.  
The efficacy of treatments for vasomotor symptomatology has also been explored in the 
last decades. Hormone therapy can decrease successfully vasomotor symptoms
14,15
; 
however, isoflavones and other herbal therapies‘ efficacy in decreasing hot flashes, 
remains unconfirmed given the disparity of controlled trials available
15
. There is also 
the evidence that many times women try several herbal extracts to deal with menopausal 
symptoms before searching for medical help
5
. 
 
Stress, Depression and Anxiety 
It has been observed in a small sample that, among several variables that included 
environmental temperature, levels of stress, coffee, alcohol and cigarette consumption, 
stress was the only factor that was strongly correlated with hot flashes
16
. Similarly, 
other studies have documented a positive relation between stress and hot flashes
17
, also 
demonstrating that a stress reduction intervention can decrease their severity
18
.  
Depressed mood has, too, been associated with the presence of vasomotor 
symptoms
19,20
,  and depression is significantly higher in peri- and post-menopausal 
women with hot flashes than in their counterparts without this vasomotor symptom
21
. 
Similarly, anxiety is strongly linked to hot flashes, independently of the menopausal 
status, estradiol levels and smoking
22
. However, it is suggested that this association is 
due to the overlapping of anxiety‘s somatic symptoms and hot flashes‘ physical 
manifestations, given that these vasomotor symptoms are connected with the somatic 
dimension of anxiety, but not with the affective one
23
.  
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Lifestyle 
Lifestyle habits can also contribute to hot flashes‘ manifestation9. Alcohol intake has 
also been identified has a strong predictor of vasomotor symptoms, increasing their 
risk
13,17,24,25
. Nonetheless, another research concludes that alcohol intake is strongly 
associated with a decreased risk for hot flashes‘ occurrence, independently of the age 
and smoking behavior, and with alcohol users and non-users presenting similar 
hormonal profiles
26
. A more frequent occurrence of hot flashes has also been connected 
with cigarette consumption
10,17,27,28
; however, this was not true for night sweats
13
. 
Strategies to decrease body temperature may be helpful in hot flashes‘ control29. Hence, 
the ingestion of cold drinks and avoidance of coffee may be effective to some degree. In 
this context, caffeine intake has been identified as a predictor of hot flashes
17,24
.  
Frequent physical activity in midlife is connected with increased risk for hot 
flushes
12,24,30
. However, in other studies, as physical exercise levels increased, hot 
flashes and night sweats‘ reporting decreased25,28. 
Body weight can also have an important role in the manifestation of vasomotor 
symptoms. The ―thin‖ hypothesis suggests that an increase in adiposity is related with 
higher circulation of estrogens (due to the aromatization of androstenedione to estrone, 
which represents a supplemental source of estrogen promoted by the adipose tissue, 
among other reasons); hence, women with higher body mass index (BMI) would present 
a lower risk for hot flashes. On the contrary, thermoregulatory models – which see hot 
flashes as an attempt to dissipate heat and reduce body core temperature, and 
symptomatic menopausal women has having a narrowed thermoneutral zone – evidence 
that adipose tissue can restrain heat dissipation, therefore increasing hot flashes‘ 
occurrence
31
.  BMI has been presented in studies as having both positive and negative 
correlations with vasomotor symptoms
3
. Specifically, research has evidenced that 
women with lower BMI tend to have more hot flashes than women with higher 
adiposity
17
. Contrary to this conclusion, other studies have documented that a higher 
BMI presents an increased risk for hot flashes occurrence
25,31-33
. Differently from the 
previous conclusions, no association between body weight and hot flashes has also been 
evidenced
34
. 
 
Socio-demographics characteristics  
Literature is not unanimous in the conclusions regarding the relation between socio-
demographic variables and vasomotor symptoms. Socio-economic factors have been 
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associated with menopause-related symptoms
9
. However, the absence of a link was also 
found between hot flashes and socio-demographic factors
34
.   
Having an unskilled or no occupation and smoking where related elsewhere with the 
onset of hot flashes
7
. Frequency and bothersomeness of vasomotor symptoms were also 
linked with a lower education level and marital status (being divorced)
10
. A higher level 
of education has been also found to be associated with a decreased risk of night sweats, 
but not of hot flashes
13
. In a similar way, it was observed that more schooling years was 
strongly related with lower prevalence of hot flashes
25,30,33
. 
 
Many studies about menopause use clinical populations, which represents samples that 
will report more symptoms and complaints
35,36
. 
Because hot flashes may persist in some women, even concomitantly with hormone 
therapy
5
, and because for a minority of women these may endure into the late post-
menopause
33
, it is important to explore which factors are significant predictors of 
vasomotor symptoms‘ incidence.  
Therefore, the aim of this study is to build a causal model for hot flashes and night 
sweats‘ occurrence, using a sample of pre-, peri- and post-menopausal women with and 
without vasomotor symptoms. Specifically, we will explore if psychological variables 
(namely, depression, anxiety and stress), health and menopause-related factors, lifestyle 
and socio-demographic characteristics, can predict the presence of these two vasomotor 
symptoms. Moreover, it is also our objective to demonstrate if there are significant 
differences between participants in different menopausal statuses, regarding hot flashes 
and night sweats‘ severity, and frequency of anxiety, depression and stress symptoms. 
Finally, we will analyze if women with vasomotor symptoms differ significantly from 
women without them in terms of psychological symptoms (anxiety, stress and 
depression). 
  
 
METHODS 
 
Participants 
A community sample of 992 women in pre-, peri- and post-menopause was included in 
the present study. Table 1 describes the participants. 
 
100 
 
Table 1 – Characterization of the participants in relation to socio-demographic, health 
and menopause-related and lifestyle variables 
 Pre-menopausal Peri-menopausal Post-menopausal 
Characteristics n % n % n % 
n 282 28.4 298 30.1 412 41.5 
Age (M; SD) 45.7 
(3.230) 
 47.6 
(3.787) 
 53.9 
(4.207) 
 
Marital status       
Married or in a 
relationship 
202 71.9 218 73.2 277 67.4 
Not married or in a 
relationship 
79 28.1 80 26.8 134 32.6 
Parity       
0 21 7.6 22 7.5 42 10.4 
1 83 30.0 97 33.1 104 25.9 
2 123 44.4 136 46.4 186 46.3 
3 36 13.0 32 10.9 49 12.2 
>3 14 5.1 6 2.0 21 5.1 
Education       
Primary school  19 6.9 28 9.5 62 15.4 
Middle school 51 18.5 68 23.1 98 24.4 
High school  79 28.6 91 31.0 109 27.1 
University degree or 
higher 
127 46.0 107 36.4 133 33.0 
Professional status       
Active 259 92.5 262 89.7 317 78.7 
Inactive 21 7.5 30 10.3 86 21.3 
Family annual income       
≤ 10.000 € 47 19.5 60 23.9 91 26.1 
10.001 – 20.000 € 66 27.4 66 26.3 85 24.4 
20.001 – 37.500 € 63 26.1 65 25.9 79 22.6 
37.501– 70.000 € 44 18.3 42 16.7 68 19.5 
≥ 70.001 € 21 8.7 18 7.2 26 7.4 
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Recent disease       
Yes 35 12.5 51 18.0 95 23.8 
No 245 87.5 233 82.0 304 76.2 
Recent psychological 
problem 
      
Yes 33 12.0 43 14.8 76 18.9 
No 243 88.0 247 85.2 327 81.1 
Search for medical help 
to deal with menopause 
      
Yes 35 13.5 136 46.7 257 71.6 
No 224 86.5 155 53.3 102 28.4 
HT, herbal/soy therapy or 
Nothing 
      
HT 4 1.5 13 4.5 49 13.5 
Herbal/soy therapy 0 0 16 5.5 48 13.3 
Nothing 273 98.5 262 90.0 265 73.2 
Hot flashes       
Yes 31 11.6 102 36.8 206 55.1 
No 237 88.4 175 63.2 168 44.9 
Night sweats       
Yes 57 21.0 115 40.9 200 51.7 
No 214 79.0 166 59.1 182 48.3 
Body mass index (kg/m
2
)       
≤ 24,9 166 59.1 157 53.0 205 50.6 
> 24,9 115 40.9 139 47.0 200 49.4 
Physical activity       
Yes 118 41.8 127 43.1 197 48.8 
No 162 57.9 168 56.9 207 51.2 
Smoking behavior       
Current smoker 73 26.4 87 29.7 82 20.5 
Current non-smoker 204 73.6 206 70.3 318 79.5 
Alcohol consumption       
Yes 137 49.1 157 53.0 192 47.2 
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No 142 50.9 139 47.0 215 52.8 
Coffee consumption       
Yes 242 86.4 266 89.6 344 84.3 
No 38 13.6 31 10.4 64 15.7 
Hot beverages intake       
Daily 244 89.7 260 92.2 333 87.6 
Occasionally or never 28 10.3 22 7.8 47 12.4 
 
Procedure 
This cross-sectional study encompasses a community sample, which was mainly 
recruited through schools and universities in the city of Lisbon. The inclusion criteria in 
this research were gender (women), literacy and age (between 42 and 60 years). The 
American Psychological Association‘s standards on the ethical treatment of participants 
were followed. A written informed consent form was delivered to all participants, 
explaining the aims of the study, emphasizing that the participation in this research was 
voluntary and that participants could interrupt their collaboration at any time, without 
any consequences.  
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1,003 Portuguese women answered to all instruments adequately (45 were 
excluded due to lack of sufficient information). Of these, 992 gave sufficient 
information to be classified in one of the three menopausal statuses and were included 
in the present study. 
 
Measures  
Vasomotor symptoms  
The instruments included the hot flashes and night sweats‘ items from the Menopause 
Symptoms‘ Severity Inventory, MSSI-3837, which evaluates the two symptoms, both in 
terms of frequency and intensity, in a five-point Likert-type scale (from 0 to 4) that 
range from ―never‖ to ―daily or almost every day‖ and from ―not intense‖ to ―extreme 
intensity‖, respectively. Hot flashes and night sweats‘ absence was defined as a ―never‖ 
(0) and ―not intense‖ (0) answer, regarding the assessment of both frequency and 
intensity. Women who reported in frequency scale an answer above 0 (that is, 1, 2, 3 or 
4), independent of intensity, were classified as having hot flashes (or night sweats). 
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Depression, Anxiety and Stress 
To evaluate stress, anxiety and depression a Portuguese adaptation of the Depression, 
Anxiety and Stress Scales
38,39
 was applied. Each subscale encompasses seven items 
which are evaluated in a 4-point Lykert-type scale, ranging from 1 (―did not apply to 
me‖) to 4 (―it applied to me most of the time‖), and the instrument presented good 
psychometric properties
39
. 
 
Menopausal and Health–related variables  
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria40. Women in pre-menopause presented an absence of changes in 
their menstrual cycle. Peri-menopausal participants would report variable cycle length 
(a difference of more than seven days, than usual) or had skipped two or more cycles, 
having an amenorrhea interval superior to sixty days. Post-menopausal women had at 
least a twelve-month period of amenorrhea. 
Besides menopausal status, the use of hormone therapy, herbal/soy products or nothing 
to manage menopause symptoms was also asserted. In addition, the search for medical 
help to manage these symptoms was also controlled. 
Health status (both physical and psychological), as menopausal status, was self-
reported. The participants were inquired about presence of a recent disease and of a 
psychological problem. 
 
Lifestyle 
Alcohol, hot beverages and coffee intake, smoking, physical exercise and BMI were 
assessed.  
Lifestyle habits were explored in terms of presence/absence, amount and/or frequency. 
Hence, physical exercise was measured in terms of times per week, and during how 
many minutes, the participant exercised; a mean value of weekly frequency and 
duration was used in the multivariated model. Coffee intake, when present, was 
assessed in a four-option scale, ranging from ―occasionally‖ to ―more than five per 
day‖. Alcohol intake, when observed, was measured both in terms of frequency 
(―daily‖, ―every weekend‖ or ―rarely‖) and quantity (―until I feel drunk‖, ―moderately‖ 
or ―less than a glass per occasion‖); a mean value of both translates the alcohol 
consumption variable, in the causal model. Finally, for current smokers, smoking was 
quantified in a 6-point Likert-type scale that ranged from ―less than 10 cigarettes per 
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month‖, until ―more than 40 cigarettes per day‖; this quantification integrated the 
structural equation model to assert the influence of smoking on the occurrence of hot 
flashes and night sweats. 
 
Socio-demographic characteristics 
Socio-demographic factors such as age, marital status, parity, professional status, 
educational level and family annual income were explored.  
 
Statistical Analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. 
The distribution of the variables studied was explored with SPSS Statistics (v. 19, IBM 
SPSS Inc, Chicago, IL).  
To explore if there were differences between the three menopausal statuses, regarding 
stress, anxiety and depressive symptoms‘ frequency, as well as hot flashes and night 
sweats‘ severity, a one-way ANOVA followed by post-hoc Tukey‘s test were used. 
Variances‘ homogeneity was confirmed and a Student t-test was implemented to 
evaluate the differences regarding stress, anxiety and depression levels between 
participants with and without vasomotor symptoms (hot flashes and night sweats) using 
SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). 
Multicollinearity between the independent variables was explored with the variance 
inflation factor (VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables should present a value below 5, indicating the absence of collinearity
41,42
. 
Because in the structural model anxiety evidenced a VIF above this value (that is, equal 
to 66), this variable was excluded from the causal model, since it showed 
multicollinearity with other independent variables.  
To test the causal model for the occurrence of hot flashes and night sweats, a structural 
equation model was built relating the dependent variable (the two vasomotor symptoms 
in terms of presence/absence) with the twenty independent variables (namely, age, 
parity, marital and professional status, income, education, presence of a recent 
psychological problem or a disease, transition from pre- to peri-menopause and from 
peri- to post-menopause, use of hormone therapy or herbal/soy products to manage 
menopause symptomatology, search for medical help to deal with menopause, alcohol 
and coffee intake, smoking, physical exercise, body mass index, stress and depression). 
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The model was evaluated with SPSS AMOS software (v. 18, IBM SPSS Inc, Chicago, 
IL). The quality of the fit of the structural model was given by chi-square statistics 
(X
2
/df), comparative fit index (CFI), goodness of fit index (GFI) and root mean square 
error of approximation (RMSEA), using the reference values indicative of good fit 
currently practiced in structural equation modelling
42,43
. A two-step approach was 
employed to evaluate the causal structural model. First, the factor‘s measurement model 
was evaluated to demonstrate an acceptable fit. Thereafter, the structural causal model, 
encompassing the two dependent and the twenty independent variables, was adjusted 
and the significance of the causal trajectories was evaluated. 
 
 
 
 
RESULTS 
 
The measurement model presented an acceptable fit (X
2
/df=5.454; CFI=.955; GFI=.946; 
RMSEA=.070; p<.001; C.I. 90%=].063;.077[) and the causal model had a good fit 
(X
2
/df=3.423; CFI=.924; GFI=.941; RMSEA=.051; p=.248; C.I. 90%=].048;.055[) . The 
structural (causal) model is shown in Figure 1.  
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As shown, the assessed variables account for 20% and 25% of the occurrence of night 
sweats and hot flushes variability, respectively. 
The structural weights and significance of each variable as a possible predictor of hot 
flushes and night sweats presence are shown in table 2. 
 
Table 2: Structural weights of independent variables (socio-demographics, health and 
menopause-related, lifestyle, stress and depression) in relation to the dependent 
variables (presence of vasomotor symptoms)  
Trajectories β(SE)p 
Hot Flashes ← Age .088(.004).030 
Night Sweats ← Age .059(.004).158 
Hot Flashes ← Marital status .111(.033)*** 
Night Sweats ← Marital status .118(.034)*** 
Hot Flashes ← N.º children -.075(.013).011 
Night Sweats ← N.º children -.081(.014).008 
Hot Flashes ← Professional status -.009(.044).776 
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Night Sweats ← Professional status -.019(.046).558 
Hot Flashes ← Educational level .007(.010).844 
Night Sweats ← Educational level .029(.010).442 
Hot Flashes ← Household annual income .003(.015).940 
Night Sweats ← Household annual income -.021(.016).575 
Hot Flashes ← Transition from pre- to peri-menopause .143(.038)*** 
Night Sweats ← Transition from pre- to peri-menopause .096(.040).011 
Hot Flashes ← Transition from peri- to post-menopause .221(.047)*** 
Night Sweats ← Transition from peri- to post-menopause .108(.049).028 
Hot Flashes ← Medical help seeking (to manage 
menopause) 
.178(.032)*** 
Night Sweats ← Medical help seeking (to manage 
menopause) 
.161(.034)*** 
Hot Flashes ← Hormone therapy -.046(.058).131 
Night Sweats ← Hormone therapy .018(.061).572 
Hot Flashes ← Herbal/soy therapy .087(.058).004 
Night Sweats ← Herbal/soy therapy .086(.061).006 
Hot Flashes ← Recent psychological problem -.031(.043).333 
Night Sweats ← Recent psychological problem -.032(.045).328 
Hot Flashes ← Recent disease .053(.038).074 
Night Sweats ← Recent disease .080(.039).010 
Hot Flashes ← Alcohol intake .049(.019).107 
Night Sweats ← Alcohol intake .120(.019)*** 
Hot Flashes ← Coffee intake .010(.017).751 
Night Sweats ← Coffee intake .023(.018).488 
Hot Flashes ← Hot beverages intake -.033(.020).298 
Night Sweats ← Hot beverages intake -.044(.021).180 
Hot Flashes ← Physical exercise -.037(.000).210 
Night Sweats ← Physical exercise -.031(.000).299 
Hot Flashes ← BMI .057(.004).069 
Night Sweats ← BMI .047(.004).148 
Hot Flashes ← Smoking -.023(.009).454 
Night Sweats ← Smoking -.021(.009).514 
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Hot Flashes ← Stress .091(.041).093 
Night Sweats ← Stress .154(.043).006 
Hot Flashes ← Depression .149(.051).006 
Night Sweats ← Depression .086(.053).121 
β=standardized estimates; SE=standard error; *** p≤.001 
 
Table 3 evidences the mean levels of vasomotor symptoms‘ severity, and of stress, 
anxiety and depression symptoms‘ frequency, as well as, the differences between the 
three menopausal statuses.    
 
Table 3 – Mean scores for vasomotor and psychological variables and differences 
between the three menopausal statuses 
Variables 
Pre- 
M(SD) 
Peri- 
M(SD) 
Post- 
M(SD) 
one-way ANOVA 
MD(SE)p 
Hot Flashes 
severity 
0.2(.566) 0.8(1.197) 1.2(1.366) Pre- Peri- -.591(.097)*** 
    Pre- Post- -1.056(.091)*** 
    Peri- Post- -.464(.090)*** 
Night Sweats 
severity 
0.3(.677) 0.8(1.204) 1.2(1.365) Pre- Peri- -.518(.098)*** 
    Pre- Post- -.869(.092)*** 
    Peri- Post- -.350(.090)*** 
Depression 1.3(.478) 1.4(.535) 1.5(.644) Pre- Peri- -.081(.047).199 
    Pre- Post- -.173(.044)*** 
    Peri- Post- -.091(.043).090 
Stress 1.6(.500) 1.7(.559) 1.8(.606) Pre- Peri- -.133(.047).012 
    Pre- Post- -.168(.044)*** 
    Peri- Post- -.035(.043).694 
Anxiety 1.2(.307) 1.4(.467) 1.4(.545) Pre- Peri- -.150(.039)*** 
    Pre- Post- -.228(.036)*** 
    Peri- Post- -.078(.035).071 
MD=mean difference; SE=standard error; ***p≤.001 
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To explore if there are significant differences between women who have and those who 
do not have vasomotor symptoms in relation to depression, anxiety and stress, the two 
groups were compared. The results are presented in the table 4. 
 
Table 4 – Comparison of women with and without hot flashes (HF) and night sweats 
(NS) regarding levels of stress, anxiety and depression 
Psychol. 
Variables 
With HF 
M(SD) 
Without HF 
M(SD) 
t-student 
t(df)p 
With NS 
M(SD) 
Without NS 
M(SD) 
t-student 
t(df)p 
Anxiety 1.6(.577) 1.2(.332) -9.249(471.816)*** 1.5(.556) 1.2(.336) -9.429(542.012)*** 
Stress 1.9(.577) 1.6(.517) -6.357(622.301)*** 1.9(.602) 1.6(.504) -6.837(686.538)*** 
Depression 1.6(.677) 1.3(.464) -6.851(528.208)*** 1.6(.665) 1.3(.469) -6.246(603.198)*** 
*** p≤.001 
 
 
DISCUSSION 
 
In this community sample, women with hot flashes and night sweats presented 
significantly higher levels of stress, anxiety and depression. Regarding the menopausal 
status, post-menopausal women presented always more severe hot flashes and night 
sweats compared with their peri-menopausal counterparts. However, these two 
menopausal statuses did not differ significantly in terms of depression, stress and 
anxiety. Therefore, given the results of the univariate analysis, the frequency of anxiety, 
depression and stress‘ symptoms is only statistically different when considering the 
presence of vasomotor symptoms (instead of taking into account the menopausal status) 
in peri- and post-menopausal women (although in the first analysis – regarding the 
absence/presence of vasomotor symptoms – pre-menopausal women are included, they 
are a small part of this sample; that is, 31 participants and 57 women in pre-menopause 
reported hot flashes and night sweats, respectively). 
Although there are strong evidences that vasomotor symptoms are one of the few 
clinical manifestations strongly associated with the hormonal fluctuation observed in 
the peri-menopause
44
, these symptoms have been reported in some studies by pre-
menopausal women
22
. In the present study this was observed: as mentioned before, 12% 
and 21% of women in pre-menopause reported hot flashes and night sweats, 
respectively.  
110 
 
It could be hypothesized that this translates a limitation on menopausal status‘ 
assessment (in this study a self-report method based on STRAW criteria
40
 was used) 
which could evidence that, although the menstrual period of these participants did not 
evidence alterations, minimal hormonal changes (not translated in manifest menstrual 
alterations) might promote these reported vasomotor symptoms. Also, it can be thought 
that socio-cultural factors (such as the identification with menopausal-peers), as well as 
the perception of age progressing towards an age interpreted as ―menopausal‖, might 
influence the interpretation of elevated body temperature (for reasons other than 
hormonal) as vasomotor symptoms. Despite these hypotheses, the assessment of 
menopausal status through age and self-assessment of menstrual history, as done on the 
present research, has been evidence as a more accurate way of determining menopausal 
status than using the presence of particular symptoms (such as vasomotor symptoms) or 
hormone levels given by laboratory tests
45
.  
The causal model encompassing socio-demographic, health, menopause-related, 
lifestyle and psychological variables (stress and depression), demonstrates that there are 
several factors that can predict the presence of vasomotor symptoms in midlife women. 
Age progression was a significant variable in relation to hot flashes‘ appearance. Also, 
being married (or in a relationship) and having less children (or no children) predicted 
the presence of both vasomotor symptoms. In other studies, being divorced was 
associated with bothersomeness of vasomotor symptoms
10
 and parous women 
evidenced a higher frequency of vasomotor symptoms
25
. 
Menopausal status (namely, being peri- and post-menopausal), as well as medical help 
sought to manage menopause, significantly predicted the occurrence of both hot flashes 
and night sweats. This is congruent with researches which evidence that the vasomotor 
symptoms result from the decrease in endogenous estrogens
6
 and are the reason which 
precipitates more frequently the medical help search to deal with menopause
5,10-12
.   
The use of herbal/soy products, contrary to what was expected, predicted the occurrence 
of both vasomotor symptoms. A review on herbal products efficacy for the treatment of 
menopausal symptoms has concluded that there is no convincing evidence and that the 
data on these products is doubtful given the poor methodology used in studies that 
document benefits of the herbal therapies and safety concerns (namely, regarding the 
use of kava)
46
. Therefore, the use of natural products for the treatment of hot flashes and 
night sweats should receive further attention and be thoroughly investigated. 
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Physical health status (specifically, the presence of a recent disease) was also significant 
in the prediction of night sweats only. This outcome supports a previous study where a 
health status qualified as excellent was linked to a decrease in night sweats, but not in 
hot flashes
13
.  
Lifestyle factors can influence significantly the degree of vasomotor symptoms‘ 
reporting
10
. In particular, daily alcohol consumption has been described as a habit that 
increases the probability of incidence and bothersomeness of night sweats
13
. In this 
study, only alcohol intake predicted one of the vasomotor symptoms. Therefore, higher 
alcohol intake was linked to the presence of night sweats. This emphasizes a conclusion 
drawn in prior researches which identify alcohol as a risk factor for vasomotor 
symptoms
13,17,24,25
. Smoking, coffee, physical exercise and BMI were not significant 
predictors of the occurrence of night sweats or hot flashes, in this sample.  
The different influences of the two psychological variables in the vasomotor symptoms, 
namely stress predicting night sweats (but no hot flashes) and depression predicting hot 
flashes (and not night sweats) might be related with the nature of the psychological 
symptoms itself. 
Individuals with higher stress levels have been identified as having lower sleep 
efficiency, higher latency on the first stage of sleep and increased arousal
47
. Since 
higher levels of stress predicted the occurrence of night sweats, this relation can be 
mediated by the sleep disturbance that results from higher levels of stress.  
Furthermore, it has been found that in a non-clinical sample of women with varying 
degrees of depressed mood, in women with higher scores of depressed mood, the 
negative affect was observed more significant during the morning; additionally, an 
improvement in depressive mood was evidenced in the evening
48
. It is hypothesized that 
this diurnal nature of the depressed mood might partially explain the connection of 
depression with hot flashes‘ occurrence, but not with night sweats. Moreover, it had 
already been highlighted that menopausal women were more likely to experience hot 
flashes if they were depressed
21
. Furthermore, this study has also demonstrated that 
women with hot flashes present a significantly higher depressive mood than their 
counterparts without hot flashes. 
The variables assessed account for 20% and 25% of the occurrence of night sweats and 
hot flashes‘ variability, respectively. Hence, variables, other than the included in this 
study, may have an impact in the emergence of vasomotor symptoms. For example, a 
causal model predicting the severity of both hot flashes and night sweats‘ severity in a 
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sample of symptomatic women (that is, who evidenced vasomotor symptoms in the 
previous month) showed that perceived control over vasomotor symptoms was the 
strongest and most significant predictor of the symptoms‘ severity; moreover, that 
causal model explained 67% and 72% of the variability of hot flashes and night sweats‘ 
severity, respectively
49
. And although vasomotor symptoms are strongly associated with 
hormonal variations
7
 there might be other non-hormonal variables that account for the 
presence of vasomotor symptoms in midlife women. 
The sample size (992 participants) was adequate for this type of statistical analysis 
given it was applied a rule of thumb of ten subjects per manifest variable, as is current 
practice in structural equation modelling
42,50
. Nevertheless, the fact that this research 
has a cross-sectional design, and that it uses a sample where a significant part of the 
participants has a college degree, limits the generalization of these results. 
 
 
CONCLUSIONS 
 
This research presents a causal model, which evidences significant predictors of 
vasomotor symptoms‘ occurrence. Socio-demographic and menopause-related variables 
are significantly linked to the presence of both hot flashes and night sweats. In this 
sample the use of herbal/soy therapies predicted the occurrence of both vasomotor 
symptoms; this outcome was unexpected given the objective of the natural products for 
menopause is, among other, symptoms‘ alleviation. Therefore, it is suggested further 
research on the subject. 
Stress and depression also predicted vasomotor symptoms: the first predicted only night 
sweats and the latter hot flashes; it is hypothesized that the differentiated prediction of 
these two psychological variables regarding both vasomotor symptoms is related with 
the nature of stress and depression‘s symptoms.   
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ABSTRACT  
Objectives: This research explores a causal model of menopausal symptoms in peri- and 
post-menopause women, having as predictors socio-demographic, health and 
menopause-related, and lifestyle variables. 
Methods: A community sample of 710 peri- and post-menopausal women (42-60 years 
old) answered to a validated inventory which assesses, in frequency and intensity,  
twelve sets of menopausal symptoms; socio-demographic (age, marital status, parity, 
education, household income, professional status), health and menopause-related 
(presence of recent disease and psychological problem, use of hormone therapy and 
herbal/soy products), and lifestyle characteristics (coffee, alcohol and hot beverages 
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intake, smoking, physical exercise and body mass index) were also evaluated. Structural 
equation modelling was used to explore the causal associations between menopausal 
symptoms and the independent variables.  
Results: Menopausal status predicted skin and facial hair changes (β=.156;p<.001), 
vasomotor (β=.122;p<.001) and sexual symptoms (β=.158;p<.001). Age was 
significantly associated with cognitive impairment (β=.087;p=.003), aches and pain 
(β=.072;p=.006), urinary (β=.115;p=.004) and also with sexual symptoms 
(β=.107;p=.021). Education and health status (specifically, psychological health status) 
were significant predictors for most of the symptoms. 
Conclusions: Several menopausal symptoms are predicted, not only by menopausal 
status, but also by socio-demographic, health and lifestyle variables. Significant 
predictors, especially lifestyle-related, should be considered in a context of a well-
adapted menopausal transition given that changes at this level might promote a 
symptoms‘ attenuation. Moreover, the aging process explains some symptoms usually 
associated with menopause; this emphasises the need for further research and discussion 
on what is specifically due to hormones decline and what is influenced by aging. 
 
Key-words: menopausal symptoms, predictors, structure equation modelling, health 
status, lifestyle 
 
 
INTRODUCTION 
 
The menopausal transition in women is one more change, added to the effects of the 
aging process, given that the hormonal changes can induce the appearance of symptoms 
which will have an impact on the quality of life
1
. However, it is still uncertain which 
symptoms are directly related to menopausal status: there is an identified set of 
symptoms that are reported in this transitional phase, but there is also a culture-specific 
influence in the experience of menopause 
2,3
. Moreover, certain occurrences during the 
menopausal period may be considered part of the aging process
4
 (Sowers, 2000).  
There are evidences that health-related characteristics like body mass index (BMI), 
smoking and physical exercise, as well as socio-demographic and economic factors, 
may influence the prevalence of menopausal symptoms
5-8
.  
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Given that health behaviours may have an impact on the occurrence of menopausal 
symptoms
9
, interventions combining pharmacology and lifestyle changes can be the 
most effective in preventing the emergence of clinical occurrences
10
. Adding to this, the 
exploration of menopause in non-clinical samples, allows clinicians and researchers to 
have a better understanding of the specificities of the menopausal transition and to 
deconstruct misconceptions due to biased sampling
11
. 
Furthermore, since the studies exploring the correlates of menopausal symptoms are 
still scarce
7
, this study has the aim of exploring, in a community sample of peri- and 
post-menopausal women, if socio-demographic, health and menopause-related, and 
lifestyle variables can predict the severity of menopausal symptoms. 
 
   
MATERIALS AND METHODS 
 
Procedure 
This cross-sectional study on menopause with Portuguese women encompasses a 
community sample, which was mainly recruited through schools and universities in the 
city of Lisbon. The inclusion criteria in this research were gender (female) and age 
(between 42 and 60 years). The American Psychological Association‘s standards on the 
ethical treatment of participants were followed. A written informed consent form was 
delivered to all participants, explaining the aims of the study, emphasizing that the 
participation in this research was voluntary and that participants could interrupt their 
collaboration at any time, without any consequences.  
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1,003 Portuguese women between the ages of 42 and 60 filled in all the 
instruments adequately (45 were excluded due to insufficient information).  
The present research includes 710 of those women, namely, participants in peri- and 
post-menopause. 
 
Subjects 
The 710 participants in peri- and post-menopause answered to a validated inventory for 
menopausal symptoms, as well as a questionnaire to identify the menopausal status and 
to explore socio-demographic, health and menopause-related, and lifestyle 
characteristics. Table 1 describes the participants regarding the assessed variables. 
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Table 1 - Distribution of the study‘s participants according to socio-demographic, health 
and menopause-related and lifestyle characteristics 
 Peri-menopause Post-menopause 
Characteristics n % n % 
n 298 42.0 412 58.0 
Age (M; SD) 
47.6 
(3.787) 
 
53.9 
(4.207) 
 
Education     
Primary school  28 9.5 62 15.4 
Middle school 68 23.1 98 24.4 
High school  91 31.0 109 27.1 
University degree or higher 107 36.4 133 33.0 
Marital status     
Married or in a relationship 218 73.2 277 67.4 
Not married or in a 
relationship 
80 26.8 134 32.6 
Parity     
0 22 7.5 42 10.4 
1 97 33.1 104 25.9 
2 136 46.4 186 46.3 
3 32 10.9 49 12.2 
>3 6 2.0 21 5.1 
Professional status     
Active 262 89.7 317 78.7 
Inactive 30 10.3 86 21.3 
Family annual income     
≤ 10.000 € 60 23.9 91 26.1 
10.001 – 20.000 € 66 26.3 85 24.4 
20.001 – 37.500 € 65 25.9 79 22.6 
37.501– 70.000 € 42 16.7 68 19.5 
≥ 70.001 € 18 7.2 26 7.4 
HT, herbal/soy therapy or     
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Nothing 
HT 13 4.5 49 13.5 
Herbal/soy therapy 16 5.5 48 13.3 
Nothing 262 90.0 265 73.2 
Recent disease     
Yes 51 18.0 95 23.8 
No 233 82.0 304 76.2 
Recent psychological problem     
Yes 43 14.8 76 18.9 
No 247 85.2 327 81.1 
Smoking behaviour     
Current smoker 87 29.7 82 20.5 
Current non-smoker 206 70.3 318 79.5 
Alcohol consumption     
Yes 157 53.0 192 47.2 
No 139 47.0 215 52.8 
Coffee consumption     
Yes 266 89.6 344 84.3 
No 31 10.4 64 15.7 
Hot beverages intake     
Daily 260 92.3 333 87.7 
Occasionally or never 22 7.8 47 12.3 
Physical activity     
Yes 127 43.1 197 48.8 
No 168 56.9 207 51.2 
Body mass index (kg/m
2
)     
≤ 24,9 157 53.0 205 50.6 
> 24,9 139 47.0 200 49.4 
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Measures 
 
The instruments included the Menopause Symptoms‘ Severity Inventory, MSSI-3812, 
which assesses menopausal symptoms in thirty-eight items, organized in twelve sets 
(depressive mood; anxiety; cognitive impairment; aches and pain; skin and facial hair 
changes; numbness; perceived loss of control; mouth, nails and hair changes; 
vasomotor, urinary and sexual symptoms). Both the frequency and intensity of the 
symptoms are measured in reference to the previous month, using a five-point Likert-
type scale, which ranges from ―never‖ to ―daily or almost every day‖ and from ―not 
intense‖ to ―extreme intensity‖, respectively. The severity of each symptom is 
calculated using the mean between the values of frequency and intensity for each of the 
symptoms.  
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria13. Peri-menopausal participants would report a variable cycle length 
(a difference of more than seven days, than usual), or had skipped two or more cycles 
and had an amenorrhea interval superior to sixty days. Post-menopausal women had at 
least a twelve-month period of amenorrhea. Besides menopausal status, the medical 
help search to manage these symptoms was explored. 
Socio-demographic characteristics (age, marital status, parity, professional status, 
educational level, family annual income), as well as health and menopause-related 
(presence of a recent disease or of a psychological problem, use of hormone therapy or 
herbal/soy products to manage menopausal symptoms), and lifestyle characteristics 
(alcohol, coffee and hot beverages intake, smoking, physical exercise and body mass 
index – BMI), were assessed. Lifestyle habits (namely, alcohol, coffee and hot 
beverages intake, smoking and physical exercise) were assessed in terms of 
presence/absence, amount and/or frequency. Hence, physical exercise, when present, 
was measured in terms of times per week, and during how many minutes, the 
participant exercised; a mean between weekly frequency and duration was used in the 
multivariated model. Coffee and hot beverages intake, when present, was assessed in a 
four-option scale, ranging from ―occasionally‖ to ―more than five per day‖. Alcohol 
intake, when observed, was measured both in terms of frequency (daily, every weekend 
or rarely) and quantity (until I feel drunk, moderately or less than a glass per occasion); 
a mean value of both translates the alcohol consumption variable, in the causal model. 
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Finally, for current smokers, smoking was quantified in a 6-point Likert-type scale that 
ranged from ―less than 10 cigarettes per month‖, until ―more than 40 cigarettes per 
day‖; this quantification integrated the structural equation model to assert the influence 
of smoking on the menopausal symptoms‘ severity. 
 
 Statistical Analysis 
Missing values were imputated for variables, where their frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. Multicollinearity 
between the independent variables was evaluated with the variance inflation factor 
(VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All variables 
presented a value below 5, indicating the absence of collinearity
14
. 
The distributions of the studied variables were explored with SPSS Statistics (v. 19, 
IBM SPSS Inc, Chicago, IL).  
To test the causal model for menopausal symptoms, a structural equation model was 
built relating the dependent variables (the twelve menopausal symptoms) with the 18 
independent variables (age, parity, marital and professional status, income, education, 
presence of a recent psychological problem or a disease, transition from peri- to post-
menopause, use of hormone therapy or herbal/soy products to manage menopause 
symptomatology, medical help search do deal with menopause, alcohol, coffee and hot 
beverages intake, smoking, physical exercise and body mass index), through AMOS 
software (v. 18, IBM SPSS Inc, Chicago, IL). The quality of adjustment of the structural 
model was given by chi-square statistics (X
2
/df), comparative fit index (CFI), goodness 
of fit index (GFI) and root mean square error of approximation (RMSEA). A two-step 
approach was used to evaluate the causal structural model. First, the factor‘s 
measurement model was evaluated to demonstrate an acceptable fit. Thereafter, the 
structural causal model, encompassing the twelve dependent and the eighteen 
independent variables, was adjusted and the significances of the causal trajectories were 
evaluated. 
 
 
RESULTS 
 
There is no multicolinearity between the independent variables. The fit of the 
measurement model was very good (X
2
/df=2.855; CFI=.915; GFI=.885; RMSEA=.051 
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].049; .054[ C.I. 90% p=.212) as it was the one of the causal model (X
2
/df=2.149; 
CFI=.908; GFI=.884; RMSEA=.040 ].038; .043[ C.I. 90% p=1.000). 
 
The following table evidences the significant structural weights (standardized estimates, 
standard error and significance level). 
 
Table 2 – Significant structural weights of the independent variables (socio-
demographic, health, menopause-related and lifestyle characteristics) regarding the 
dependent variables (menopausal symptoms) 
Trajectories β(SE)p 
Cognitive impairment ← Age .087(.005)** 
Aches and pain ← Age .072(.004)** 
Urinary symptoms ← Age .115(.006)** 
Sexual symptoms ← Age .107(.008)* 
Depressive mood ← Marital status -.060(.040)** 
Sexual symptoms ← Marital status .165(.070)*** 
Vasomotor symptoms ← Marital status .079(.051)* 
Numbness ← Professional status -.073(.072)* 
Depressive mood ← Educational level -.163(.014)*** 
Aches and pain ← Educational level -.161(.016)*** 
Vasomotor symptoms ← Educational level -.112(.014)** 
Perceived loss of control ← Educational level -.189(.011)*** 
Numbness ← Educational level -.187(.018)*** 
Mouth, nails and hair changes ← Educational level -.153(.016)*** 
Anxiety ← Educational level -.093(.015)*** 
Urinary symptoms ← Educational level -.091(.020)* 
Sexual symptoms ← Educational level  -.149 (.020)*** 
Skin and facial hair changes ← Household annual income .111(.023)** 
Vasomotor symptoms ← Parity -.116(.024)*** 
Mouth, nails and hair changes ← Parity .084(.027)* 
Vasomotor symptoms ← Menopausal status .122(.048)*** 
Skin and facial hair changes ← Menopausal status .156(.054)*** 
Sexual symptoms ← Menopausal status .158(.081)*** 
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Vasomotor symptoms ← Herbal/soy products .143(.082)*** 
Numbness ← Herbal/soy products .071(.089)* 
Sexual symptoms ← Herbal/soy products .111(.111)** 
Body shape changes ← Herbal/soy products .100(.095)** 
Vasomotor symptoms ← Recent disease .071(.057)* 
Mouth, nails and hair changes ← Recent disease  .141(.066)*** 
Depressive mood ← Recent psychological problem .357(.087)*** 
Cognitive impairment ← Recent psychological problem .346(.092)*** 
Aches and pain ← Recent psychological problem .228(.094)*** 
Vasomotor symptoms ← Recent psychological problem .124(.071)** 
Perceived loss of control ← Recent psychological problem .336(.062)*** 
Numbness ← Recent psychological problem .145(.091)*** 
Mouth, nails and hair changes ← Recent psychological 
problem 
.238(.087)*** 
Anxiety ← Recent psychological problem .331(.093)*** 
Skin and facial hair changes ← Recent psychological problem .234(.087)*** 
Urinary symptoms ← Recent psychological problem .261(.098)*** 
Sexual symptoms ← Recent psychological problem .243(.104)*** 
Body shape changes ← Recent psychological problem .203(.092)*** 
Aches and pain ← BMI .074(.006)** 
Numbness ← BMI .103(.007)** 
Urinary symptoms ← BMI .222(.008)*** 
Body shape changes ← BMI .337(.007)*** 
Perceived loss of control ← Smoking -.091(.011)* 
Numbness ← Coffee intake .067(.029)* 
Vasomotor symptoms ← Hot beverages intake   -.075(.030)* 
* p≤.05;  ** p≤.01;  *** p≤.001 
 
The following table presents the results of the squared multiple correlations, that is, the 
percentage of the variability accounted for by the socio-demographic, menopause, 
health-related and lifestyle variables in the proposed causal model for each set of 
symptoms. 
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Table 3 – Variability of menopausal symptoms explained by the independent variables 
accounted 
Menopausal Symptoms 
% of the symptoms variability accounted 
for by the independent variables 
Depressive mood 16.6 
Cognitive impairment 12.9 
Aches and pain 10.7 
Vasomotor symptoms 10.1 
Perceived loss of control 16.5 
Numbness 9.8 
Mouth, nails and hair changes 12.6 
Anxiety 12.2 
Skin and facial hair changes 9.1 
Urinary symptoms 17.2 
Sexual symptoms  19.3 
Body shape changes 16.8 
 
 
DISCUSSION 
 
Body shape changes, perceived loss of control, depressive mood, sexual and urinary 
symptoms are the menopausal symptoms which variability was explained to a greater 
extend by the socio-demographic, health, menopause-related and lifestyle characteristics 
included in this research. The most frequent predictors of menopausal symptoms were 
educational level and the presence of a psychological problem. 
The menopausal status predicted significantly skin and facial hair changes, vasomotor 
and sexual symptoms. 
Although facial hair and skin modifications are usually indentified as hormone 
therapy´s secondary effects
15
, in this group of peri- and post-menopausal women, these 
symptoms were not related with the use of that therapy but, instead, they were 
associated with the menopausal status. Hypoestrogenia as consequence of menopause is 
known for having an impact on skin; however, so does the aging process
16
. In the 
present research the changes in skin were significantly associated with the menopausal 
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status, but not with age, supporting the fact that estrogens decline have a stronger 
impact on the skin‘s conservation, than the age progression does.  
The menopause status has been identified as a robust predictor of vasomotor symptoms‘ 
occurrence in prior researches
17,18
. Moreover, and because hormone therapy is efficient 
in the decrease of these symptoms, a biological aetiology has been suggested for hot 
flashes and night sweats
19
. In this sample, the menopausal status predicted vasomotor 
symptoms, supporting a strong association between endogenous estrogens decrease and 
vasomotor symptoms. However, other non-hormonal variables, specifically marital 
status, educational level and parity, were also significantly associated with these 
symptoms.  
Sexual response has been associated to the menopause status
1,20
 and some authors 
support that only vasomotor symptoms and decrease in sexual interest are related with 
menopausal status
21
. As expected, the menopausal status significantly predicted sexual 
symptoms in this sample. However, so did age progressing, marital status, educational 
level and the presence of a psychological problem. These outcomes emphasize that, not 
only hormonal variations influence significantly the severity of vasomotor and of sexual 
symptoms in peri- and post-menopause. 
Besides sexual symptoms, there were other symptoms significantly predicted by age, 
namely, cognitive impairment, aches and pain and urinary symptoms. 
The occurrence of cognitive difficulties during peri-menopause were described 
previously; however, the authors suggest that these problems are transitory since there 
are no differences when comparing women in pre- and in post-menopause
22
. Contrary to 
this, a decline in cognitive function (namely, working memory and perceptual speed) 
was not observed across the different menopausal stages in another study
23
. Moreover, 
it has also been concluded that women attribute their memory changes, during the 
menopausal transition, to physical health status, levels of stress and aging process rather 
than to the menstrual cycle and hormone use
24
.  
Our causal model supports the two latter researches: cognitive impairment was not 
predicted by the menopausal status; instead, age progression and the presence of a 
psychological problem were strongly associated with more severe levels of cognitive 
difficulties. 
Joint pain has been referred as related with menopause
18
; however this was not the case 
in this sample, which evidences aches and pain (including joint pain) as a consequence 
of aging. 
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Age also predicted positively urinary symptoms. Lower urinary tract symptoms have 
been associated with marital status, presence of a disease, menopausal status and 
parity
25
. In this sample, besides age, only the presence of a psychological problem and 
lower educational level predicted more severe urinary symptoms. 
Surprisingly, hot beverages intake was a negative predictor of vasomotor symptoms. 
Given that it was expected for hot beverages to have a positive relation with vasomotor 
symptoms
26
, it is hypothesized that women who drank hot beverages more frequently 
would be the ones who had less severe (or absent) vasomotor symptoms; this would 
allow the maintenance of a high frequency intake of hot beverages, given that this 
would not promote a vasomotor exacerbation. Another concomitant conjecture was the 
possibility that, prior to the present investigation, women with severe vasomotor 
symptoms had learned by experience, or had been informed that a frequent ingestion of 
hot liquids triggers hot flashes and for that reason they had decreased hot beverages to a 
less frequent intake or had stopped consuming hot beverages altogether. 
The use of herbal/soy products to manage menopausal symptoms was significantly 
associated with more severe vasomotor and sexual symptoms, as well as, numbness and 
body shape modifications. Therefore, the use of these natural products was not 
significant in the attenuation of any of the menopausal symptoms and it is related with 
the exacerbation of the mentioned ones. This might translate an insufficient clinical 
supervision and a mismatching between personal needs of the symptomatic women and 
products use. Given that clinical prescription is not mandatory and pharmaceutical 
recommendations are only given if women ask for them directly, there can be an 
erroneous use of these products, based on an absence of adequate counselling.  As 
evidenced in a recent research on the decision-making process regarding the use of 
natural products for menopausal symptoms, women present several difficulties, namely, 
deciding for the adequate product, the adequate dosage and the use of this kind of 
therapy specifically for menopausal symptoms. Unrealistic expectations about the 
efficacy of the natural products, inaccurate information about them, and the interference 
of menopausal symptoms are strongly related with these difficulties
27
. 
The absence of an effect between hormone therapy and menopausal symptoms might be 
due to the fact that this is a community sample and, thus, participants might evidence 
less severe symptomatology than clinical ones, making the effect of hormone therapy 
undetectable when comparing with counterparts not using it. 
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CONCLUSION 
 
The causal model proposed in this study evidences that there are several symptoms, 
recognized as menopausal, that are predicted by the menopausal status (like skin and 
facial hair changes, vasomotor and sexual symptoms), but by socio-demographic 
characteristics as well. Others are strongly associated with the age progression, leading 
to the questioning of whether these symptoms are resultant from actual hormonal 
changes.  
This research also highlights that several socio-demographic, health-related and lifestyle 
characteristics play an important role in menopausal symptoms‘ prediction; this 
conclusion allows the promotion of strategies, specifically related with certain lifestyle 
changes, that might lead to the reduction of the menopausal symptoms‘ severity. 
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Abstract 
 
The aim of this study was to explore if spirituality could predict menopausal symptoms. 
Menopausal symptoms, spirituality, self-reported health and menopausal status, and 
socio-demographic variables were assessed in a community sample of 710 peri- and 
post-menopausal women. Structural equation modelling was used to explore a causal 
model relating menopausal symptoms to the other variables. The results evidence 
spirituality as a negative and significant predictor for the majority of menopausal 
symptoms‘ severity, independently of socio-demographic factors, health and 
menopausal statuses. Spirituality predicted depressive mood (β=-.414; p<.001), anxiety 
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(β=-.308; p<.001), cognitive impairment (β=-.287; p<.001), perceived loss of control 
(β=-.177; p<.001), aches and pain (β=-.148; p<.001), vasomotor (β=-.125; p=.005) and 
sexual symptoms (β=-.211; p<.001), and physical changes such as mouth, nails and hair 
modifications (β=-.152; p=.002), and skin and facial hair changes (β=-.184; p<.001). 
Moreover, socio-demographic variables such as marital status, education, income and 
parity were also significant predictors of various menopausal symptoms. Similarly, self-
reported physical and psychological health status, as well as menopausal status, 
predicted the menopausal symptoms‘ severity. Therefore, spirituality can have a 
positive impact on the menopausal symptoms‘ reporting. In addition, several socio-
demographic and health and menopause-related variables have demonstrated also to 
predict significantly the severity of menopausal symptoms. 
 
Key-words: menopause symptoms, spirituality, predictors, structural equation 
modelling. 
 
 
Introduction 
 
According to the World Health Organization, a good quality of life incorporates several 
dimensions, among them physical and psychological health, level of independence, and 
spirituality (or religion/personal beliefs) [1].  
During menopause, physical and psychological symptoms may emerge, being the most 
prevalent depressive mood, irritability, joint pain, tiredness, and vasomotor and sexual 
symptoms [2-6].  
It is known that both the intensity and frequency of these symptoms are affected by bio-
psycho-social factors, such as health and menopausal status, age, race, income and level 
of education [7,8]. In addition to the influence of these variables, spirituality has been 
associated with less menopausal symptoms‘ reporting in a previous research [9].  
Numerous studies with clinical samples have evidenced spirituality as being strongly 
and negatively associated with depressive mood [10-16], anxiety [10,12,17], pain [18], 
fatigue and memory disruption [10]. But the absence of association has also been 
documented [19,20].  
Therefore, the influence of spirituality is still unclear [21] and the relation between 
aging well and this dimension is lacking comprehensive research [22]. This is true in the 
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research on aging, despite the strong connection between the spirituality‘s development 
(and the importance given to personal beliefs) and age progression [23-25], and the 
evidence that the spirituality can be a well-being resource, in later life [23,26]. 
To understand the menopause experience it is crucial to consider the psychological 
aspects that might influence women‘s interpretation of this phase of life [27]. Research 
conducted on menopause has paid very little attention to the positive psychological and 
well-being outcomes associated to this period of women‘s life [27]. In addition, since 
menopause has been described as a positive phase during which women develop a 
stronger personal identity and an expanded self-awareness [28], the role of spirituality 
in this period should be considered. 
Therefore, in this study, we investigated if spirituality can predict menopause 
symptoms‘ severity, controlling for socio-demographic variables and health status, in a 
community sample of peri- (during which changes in menstrual cycle start to occur) and 
post-menopause (which starts after the final menstrual period), since menopausal 
symptoms are more prevalent during these two menopause stages [29]. 
 
 
Method 
 
Participants 
The 710 participants in peri- and post-menopause filled in the validated versions of two 
instruments, to assess menopausal symptoms and spirituality, as well as a questionnaire 
to identify menopause and health status, and to explore socio-demographic 
characteristics. Table I describes the participants. 
 
Table I - Distribution of the study‘s peri- and post-menopausal participants according to 
socio-demographic characteristics 
 Peri-menopause Post-menopause 
Characteristics n % n % 
n 298 42.0 412 58.0 
Age (M; SD) 47.6(3.787)  53.9(4.207)  
Education     
Primary school 28 9.5 62 15.4 
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Middle school 68 23.1 98 24.4 
High school 91 31.0 109 27.1 
University degree or higher 107 36.4 133 33.0 
Marital status     
Married or in a relationship 218 73.2 277 67.4 
Not married nor in a 
relationship 
80 26.8 134 32.6 
Parity     
0 22 7.5 42 10.4 
1 97 33.1 104 25.9 
2 136 46.4 186 46.3 
3 32 10.9 49 12.2 
>3 6 2.0 21 5.1 
Professional status     
Active 262 89.7 317 78.7 
Inactive 30 10.3 86 21.3 
Family‘s annual income     
≤ 10.000 € 60 23.9 91 26.1 
10.001 – 20.000 € 66 26.3 85 24.4 
20.001 – 37.500 € 65 25.9 79 22.6 
37.501– 70.000 € 42 16.7 68 19.5 
≥ 70.001 € 18 7.2 26 7.4 
Recent disease     
Yes 51 18.0 95 23.8 
No 233 82 304 76.2 
Recent psychological problem     
Yes 43 14.8 327 81.1 
No 247 85.2 76 18.9 
 
 
Procedure 
This cross-sectional study on menopause encompasses a community sample which was 
mainly recruited through schools and universities, in the city of Lisbon. The inclusion 
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criteria in this research were gender (women) and age (between 42 and 60 years). The 
American Psychological Association‘s standards on the ethical treatment of participants 
were followed. A written informed consent form was delivered to all participants, 
explaining the aims of the study, emphasizing that the participation in this research was 
voluntary and that participants could interrupt their collaboration at any time, without 
any consequences.  
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1,003 Portuguese women, in pre-, peri- and post-menopause, answered all the 
questionnaires and measuring scales adequately (45 were excluded due to lack of 
sufficient information).  
The present research includes 710 of those women, namely, participants in peri- and 
post-menopause. 
 
Measures 
Menopause Symptoms 
A validated version of the Menopause Symptoms‘ Severity Inventory, MSSI-38 [30] 
was used. This inventory includes thirty-eight items, organized in twelve sets of 
menopausal symptoms (depressive mood; anxiety; cognitive impairment; body shape 
changes; aches and pain; skin and facial hair changes; numbness; perceived loss of 
control; mouth, nails and hair changes; vasomotor, urinary and sexual symptoms). Both 
frequency and intensity of the symptoms are measured in reference to the previous 
month, using a five-point Likert-type scale which range from ―never‖ to ―daily or 
almost every day‖ and from ―not intense‖ to ―extreme intensity‖, respectively. The 
severity of each symptom is calculated afterwards using the mean values of frequency 
and intensity for each one of the symptoms. 
This instrument presented good psychometric properties, including construct and 
criterion validity, reliability and sensitivity [30].  
 
Spirituality 
Spirituality was assessed through the Portuguese version of the Spiritual Well-being 
Questionnaire [31,32]. This questionnaire is composed of 20 items, measured in a five-
point Likert-type ranging from ―very low‖ to ―very high‖, which define four dimensions 
(personal, communal, environmental and transcendental spiritual well-being). Data 
gathered showed good psychometric properties [31,32]. 
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Menopausal and Health Status 
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria [33]. Women in pre-menopause presented an absence of changes in 
their menstrual cycle. Peri-menopausal participants would report variable cycle length 
(a difference of more than seven days, than usual), or having skipped two or more 
cycles and had an amenorrhea interval superior to sixty days. Post-menopausal women 
had at least a twelve-month period of amenorrhea. 
Health status (both physical and psychological), as menopausal status, was self-
reported. The presence and the nature of a recent disease and of a psychological 
problem were asked to all participants. 
Socio-demographic characteristics (age, marital status, parity, professional status, 
educational level and family annual income) were also assessed.  
 
Statistical Analysis 
Missing values were imputated for variables, where their frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. Multicollinearity 
between the independent variables was evaluated with the variance inflation factor 
(VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All variables 
presented a value below 5, indicating the absence of collinearity [34,35]. 
The distribution of the variables studied was checked for extreme skewness and kurtosis 
with SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL).  
To test the causal model for menopausal symptoms, a structural equation model was 
built relating the twelve dependent variables (depressive mood; anxiety; cognitive 
impairment; body shape changes; aches and pain; skin and facial hair changes; 
numbness; perceived loss of control; mouth, nails and hair changes; vasomotor, urinary 
and sexual symptoms) with twenty independent variables (namely, age, marital status, 
parity, professional status, family‘s annual income, educational level, presence of a 
recent psychological problem or a disease, menopausal status and spirituality). The 
model was evaluated with SPSS AMOS software (v. 18, IBM SPSS Inc, Chicago, IL). 
The quality of the fit of the structural model was evaluated  by the chi-square statistic 
over degrees of freedom (X
2
/df), comparative fit index (CFI), goodness of fit index 
(GFI) and root mean square error of approximation (RMSEA). Reference values 
indicative of a good model fit were those values currently practiced in structural 
equation modelling [35,36]. A two-step modelling approach was employed to evaluate 
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the causal structural model. First, the factor‘s measurement model was evaluated to 
demonstrate a good fit. Thereafter, the structural causal model, encompassing the twelve 
dependent and the twenty independent variables, was adjusted and the significance of 
the causal trajectories was evaluated. 
 
 
Results 
 
There was no multicollinearity between the independent variables. The fit of the 
measurement model was very good (X
2
/df=2.475; CFI=.897; GFI=.842; RMSEA=.046 
p=1.000; C.I. 90%=].044; .048[), as was the one of the causal model (X
2
/df=2.339; 
CFI=.893; GFI=.841; RMSEA=.044; p=1.000; C.I. 90%=].042; .045[). Table II shows 
the significant structural weights.  
 
Table II – Significant structural weights of the independent variables (socio-
demographic, health and menopausal status, and spirituality) regarding the dependent 
variables (menopausal symptoms) 
Trajectories β(SE)p 
Vasomotor symptoms ← Marital status .093(.060)* 
Sexual symptoms ← Marital status .167(.087)*** 
Depressive mood ← Educational level -.111(.020)* 
Aches and pain ← Educational level -.115(.024)* 
Numbness ← Educational level -.101(.0.24)* 
Sexual symptoms ← Educational level -.107(.027)* 
Depressive mood ← Annual income -.084(.029)* 
Perceived loss of control ← Annual income -.139(.023)* 
Numbness ← Annual income -.134(.036)** 
Vasomotor symptoms ← Parity -.099(.027)* 
Mouth, nails and hair changes ← Parity .118(.033)** 
Vasomotor symptoms ← Menopausal status .141(.067)** 
Skin and facial hair changes ← Menopausal status .169(.081)** 
Sexual symptoms ← Menopausal status .198(.098)*** 
Depressive mood ← Recent psychological problem .281(.081)*** 
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Cognitive impairment ← Recent psychological problem .277(.091)*** 
Aches and pain ← Recent psychological problem .185(.095)*** 
Vasomotor symptoms← Recent psychological problem .086(.072)* 
Perceived loss of control ← Recent psychological problem .289(.061)*** 
Numbness ← Recent psychological problem .109(.093)** 
Mouth, nails and hair changes ← Recent psychological 
problem 
.197(.087)*** 
Anxiety ← Recent psychological problem .273(.091)*** 
Skin and facial hair changes ← Recent psychological problem .201(.088)*** 
Urinary ← Recent psychological problem .242(.101)*** 
Sexual symptoms ← Recent psychological problem .192(.106)*** 
Body shape ← Recent psychological problem .184(.094)*** 
Cognitive impairment ← Recent disease .122(.081)** 
Aches and pain ← Recent disease .120(.086)** 
Vasomotor symptoms ← Recent disease .130(.066)*** 
Numbness ← Recent disease .122(.085)** 
Mouth, nails and hair changes ← Recent disease .220(.080)*** 
Sexual symptoms ← Recent disease .112(.096)** 
Body shape ← Recent disease .126(.085)** 
Depressive mood ← Spirituality -.414 (.074)*** 
Cognitive impairment ← Spirituality -.287(.075)*** 
Aches and pain ← Spirituality -.148(.075)*** 
Vasomotor symptoms ← Spirituality -.125(.057)** 
Perceived loss of control ← Spirituality -.177(.047)*** 
Mouth, nails and hair changes ← Spirituality -.152(.069)** 
Anxiety ← Spirituality -.308(.077)*** 
Skin and facial hair changes ← Spirituality -.184(.070)*** 
Sexual symptoms ← Spirituality -.211(.085)*** 
β=standardized estimates; SE=standard error; p=significance level 
* p<.05; ** p<.01; *** p<.001 
 
Squared multiple correlations evidenced that 25.7% of depressive mood, 14.5% of 
anxiety and 1.5% of perceived loss of control, was explained by the socio-demographic 
variables, health and menopause status, and spirituality. 
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Similarly, 18.2%, 7.5% and again 7.5% of the variability of sexual, vasomotor and 
urinary symptoms‘ severity were explained by the variables assessed. 
Finally, 13.5% of cognitive impairment, 9.0% of aches and pain, 9.0% of numbness, 
8.4% of mouth, nails and hair changes, 8.2% of skin and facial hair changes, and 1.7% 
of body shape‘s variability were explained by the spirituality, socio-demographic 
variables, perceived health and menopause status. 
 
 
Discussion 
 
Depressive mood, anxiety and sexual symptoms have been identified as negative 
psychological experiences during the climacteric period. However, it has been 
emphasised that these are not exclusively associated with hormonal changes, but also 
with socio-demographic variables and negative psychosocial events [37]. These 
observations are confirmed in the present study, as the educational level, marital status, 
household‘s annual income, parity, as well as menopausal status and health status 
(having a recent disease and a psychological problem), are significant predictors of the 
menopausal symptoms‘ severity. 
Menopause status (namely, the transition from peri- to post-menopause) has been 
identified as a robust predictor of vasomotor symptoms‘ occurrence, as well as of sexual 
problems in prior researches [28,38-40]. In this sample, menopausal status predicted not 
only the sexual symptoms and skin and facial hair changes, but also vasomotor 
symptoms, hence supporting a strong association between endogenous estrogens 
decrease and vasomotor symptomatology. However, socio-demographic variables, 
specifically marital status and parity, were also significantly associated with these 
symptoms: married women (or participants in a relationship) and women with less (or 
without) children, presented a higher severity of vasomotor symptoms than their 
counterparts not married (nor in a relationship) and with more children.  
Moreover, being married or in a relationship predicted significantly a higher severity of 
sexual symptoms. This might express that married women and participants with a 
partner are more sexuality active (having a higher prevalence of symptoms in the 
context of their active sexual life), than their counterparts with another marital status (as 
divorced, separated, widowed or single); also, it cannot be excluded that this higher 
prevalence of sexual symptoms might also be associated with the partners‘ sexual or 
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health problems. In a previous study with menopausal women and partners, data 
regarding the latter evidenced the presence of erectile dysfunction (23.8%), premature 
ejaculation (21.2%) and alcohol abuse (43.5%); adding to this, male sexual dysfunction 
increased the risk of more exacerbated menopause symptoms in women [41]. Other 
authors have documented that the partners‘ health problems were associated with lower 
regularity of sexual intercourse and satisfaction [42]. 
Low income has been related to depressive symptoms elsewhere regarding women in 
climacteric period [43]. In this sample of peri- and post-menopausal women, 
participants with higher family‘s annual income had less severe depressive symptoms 
than participants with lower household income. Equally, a perceived loss of control was 
also negatively predicted by income. 
A higher level of education has been strongly associated with lower prevalence of 
depression [44]. This tendency is supported in the present research, since the 
educational level is a significant and negative predictor of depressive mood (that is, 
women with more schooling years have a less severe depressive mood than participants 
with less schooling years), as well as for numbness, aches and pain, and sexual 
symptoms (similarly, women with higher educational levels present less severe 
symptoms). Likewise, menopausal women in another study with lower educational level 
manifested higher physical and psychological scores than participants with more 
schooling years [41]. 
It has been evidenced that high scores in physical and mental health components are 
associated with more sexual symptoms around menopause [42]. This conclusion is 
reinforced by our results: women with a self-reported disease evidence a higher severity 
of menopausal symptoms than participants without the presence of a recent disease. The 
same tendency was observed regarding a perceived psychological problem, which was 
also a positive and significant predictor for all menopausal symptoms‘ severity. 
Similarly, it has been concluded that a good perceived health status decreases the risk 
for severe menopausal symptoms [41] and, depending on the self-assessed health status, 
women will present differences in the prevalence of menopausal symptoms [45]. 
Although spirituality has been associated with better health outcomes [46-48] as well as 
health-related behaviours [49], evidence about the connection between spirituality and 
health outcomes is still under debate [50]. Our results showed that spirituality was a 
negative and significant predictor of menopausal symptoms‘ severity, namely, of 
depressive mood, cognitive impairment, aches and pain, perceived loss of control, 
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mouth, nails and hair changes, anxiety, skin and facial hair changes, vasomotor and 
sexual symptoms (the only symptoms which did not show a significant association with 
spirituality were numbness, urinary symptoms and body shape changes). Hence, women 
with higher levels of spirituality present lower severity of the mentioned menopausal 
symptoms, comparing with their counterparts who have lower levels or an absence of 
spirituality.  
Therefore, spirituality predicted lower levels of very similar symptoms in peri- and 
post-menopausal women, as those observed previously for different and mainly clinical 
populations, specifically pain [18], anxiety [10,12,17], depressive mood [10-16], fatigue 
and memory problems [10]. It is possible that there are other variables mediating the 
strong predictive effect of spirituality on the severity of symptoms. Indeed, Williams 
and Sternthal [51] mentioned that the positive effect of spirituality in health can be 
mediated by health practices and social relationships.  
Regarding the menopause experience, it has been concluded elsewhere that, as women 
move towards the menopausal transition, they become less positive regarding the 
evaluation of their role(s) in life, when compared with women in pre-menopause [27]. 
This might be associated with the fact that the most important and consistently 
mentioned role was being a mother [27]. In a developmental perspective, it is assumed 
that this role will be subjected to transformations as children grow up and became 
independent. Furthermore, this developmental task, which is observed as women go 
through midlife (and, concomitantly, through the menopausal transition), might be 
associated with the negative assessments of women‘s role(s) in life. Given that 
spirituality encompasses the determination and pursuing of existential goals (like inner 
potential, meaning, feeling whole and connected with others), and it is based on values 
regarding the self, others, nature and life, also reflecting the awareness of a transcendent 
dimension [52], it might function as protective experience in this stage of a women‘s 
life. 
It has been evidenced that characteristics such as age, education, socio-economic and 
health status should be considered when exploring the associations between health 
outcomes and spirituality, since they can be confounding variables. In addition, 
multivariate methods are recommended in estimating the magnitude of these 
associations and often fail to be used [50].  Our study intended to overcome this gap in 
the spirituality‘s research by using structural equation modelling and attaining a 
multivariate causal model, hence strengthening the conclusions drawn. However, 
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regarding spirituality, the hypothesis that less severe symptoms predict higher levels of 
spirituality cannot be disregarded. Thus, it would be important to explore further 
relations involving spirituality in future studies.  
Research focusing on this variable is also important given the benefits that it appears to 
have on health and on symptoms‘ reporting. In the present study, higher scores of 
spirituality have predicted a lower severity of menopausal symptoms, but other 
researchers have supported the benefits of this component to health. A higher 
spirituality was associated with lower levels of smoking, higher self-esteem and 
satisfaction with social support [53], and with psychosocial adjustment [54]. 
Additionally, spirituality has also been evidenced as buffering the effects of negative 
life events during middle-age [55], and as a moderator between the negative effect of 
aging-related frailty and psychological well-being [56]. Moreover, spirituality provides 
a sense of wholeness, particularly important in the presence of health complications 
[57].  
Gender differences have been noticed in relation to this variable. The existent, but 
scarce, literature on the subject identifies women as presenting stronger association with 
spirituality. Religious involvement has predicted significantly lower mortality rates at 
follow-up [58,59] and this association was stronger in women [59,60]. Similarly, in a 
normative sample of college students, it was found that female participants presented 
higher levels of spirituality when compared with their male counterparts [61]. A 
possible explanation is a greater socialisation for emotional expression and the need for 
support given women‘s typical caregiving role [24]. However, further research is 
needed to confirm these results in other samples, in an aging population, comparing 
genders. 
 
 
 Conclusions 
  
This study evidences spirituality as a predictor of lower severity of menopausal 
symptoms during peri- and post-menopause. This result, obtained through structural 
equation modelling, is independent of socio-demographic characteristics and perceived 
health and menopausal status. 
Therefore, spirituality can be a protective characteristic regarding the development and 
report of several symptoms. Given these results and since the existent literature is still 
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scarce, further research is recommended, especially in the aging population which is 
more prone to evidence physical frailty or a disease diagnosis. 
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Current knowledge on this subject: 
- There are some evidences about an association between spirituality‘s development and 
age progression. 
- The impact of spirituality on health variables, specifically on menopausal symptoms is 
still poorly understood. 
154 
 
 
What this study adds: 
- Spirituality is a significant predictor of menopausal symptoms‘ severity. 
- Independently of socio-demographic, and health and menopausal status, women with 
higher levels of spirituality report less severe menopausal symptoms of both physical 
and psychological nature. 
- Besides spirituality, socio-demographic, health and menopause-related variables 
predict significantly certain menopausal symptoms. 
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ABSTRACT  
 
Objective: Hormonal changes during menopausal transition are linked to physical and 
psychological symptoms‘ emergence. The aim of this research is to explore if life events 
predict menopausal symptoms is a sample of peri- and post-menopausal women, 
controlling for confounding variables. Methods: This cross-sectional research 
encompasses a community sample of 992 women who answered to socio-demographic, 
health, menopause-related and lifestyle questionnaires; menopausal symptoms and life 
events were assessed with validated instruments. Structural equation modelling was 
used to build a causal model having as dependent variables twelve sets of menopausal 
symptoms. Results: Menopausal status predicted only three symptoms, namely, 
skin/facial hair changes (β=.136;p=.020), sexual (β=.157;p=.004) and, marginally, 
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vasomotor symptoms (β=.094;p=.054). Life events predicted depressive mood (β=-
.391;p=.002), anxiety (β=-.271;p=.003), cognitive impairment (β=-.295;p=.003), body 
shape changes (β=-.136;p=.031), aches/pain (β=-.212;p=.007), skin/facial hair changes 
(β=-.171;p=.021), numbness (β=-.169;p=.015), perceived loss of control (β=-
.234;p=.008), mouth, nails and hair changes (β=-.290;p=.004), vasomotor (β=-
.113;p=.044) and sexual symptoms (β=-.208;p=.009). Moreover, menopausal herbal/soy 
products‘ use was associated with higher symptoms‘ severity. When compared with 
pre-menopausal women, peri- and post-menopausal participants presented a higher 
severity for the majority of symptoms. Conclusions: Although women in peri- and post-
menopausal manifested higher symptoms‘ severity, only three of the menopausal 
symptoms assessed were predicted by menopausal status. Since the vast majority of 
menopausal symptoms‘ severity was significantly influenced by life events, it is 
concluded that the symptomatology exacerbation, in peri- and post-menopausal women, 
might be due to life conditions and events, rather than hormonal changes. Therefore, 
these should be accounted for in menopause-related clinical and research settings.  
 
 
INTRODUCTION 
 
The severity of menopausal symptoms, which have their highest prevalence in late peri-
menopause and early post-menopause[1], is known to be influenced by bio-psycho-
social factors[2,3,4]. 
The symptoms reported during climacteric period have been associated with the 
reduction of estrogens[5]. However, the symptoms‘ onset is also affected by well-being, 
professional status, smoking and education[6]; lifestyle can also entail an influence in 
psychological symptoms of menopause, namely depressive mood and anxiety[7]. 
Vasomotor and sexual symptoms have been identified as the clinical manifestations 
more strongly associated with the menopausal status[6,8-10]; psychological and somatic 
symptoms (other than sexual and vasomotor) related with the menopause process are 
more likely to be associated with psychosocial factors[10].  
Therefore, some studies have identified negative life events as a strong predictor of 
some menopausal symptoms[2,8]. 
The empty nest experience, everyday-life stress, health problems (partner‘s or own), 
death of a loved one, offspring‘s adolescence, financial difficulties, diseased parents, 
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reformulation of family roles, professional changes, modifications in the interpersonal 
relationships and in the lifestyle are some of the experiences that midlife (and 
menopausal) women might face and which can be responsible for the exacerbation of 
some psychological symptoms during this period[7,11,12].  
Thus, the aim of this study is to explore if menopausal symptoms, both physical and 
psychological, are predicted by life events, controlling for confounding variables such 
as socio-demographic factors, health and menopause-related variables, and lifestyle, in a 
sample of peri- and post-menopausal women. It is also our objective to compare 
different menopausal statuses (namely, pre-, peri- and post-menopause) regarding the 
severity of menopausal symptoms, in a community sample. 
 
 
METHODS 
Participants 
A community sample of 992 women in pre-, peri- and post-menopause was included in 
the present study. Table 1 describes the participants, aged between 42 and 60 years.  
 
Table 1 - Distribution of the study‘s participants according to socio-demographic, health 
and menopause-related characteristics and lifestyle 
 Pre- Peri- Post- 
Characteristics n % n % n % 
n 282 28.5 298 30.0 412 41.5 
Age (M; SD) 45.7(3.230)  47.6(3.787)  53.9(4.207)  
Marital status       
Married or in a 
relationship 
202 71.9 218 73.2 277 67.4 
Not married or in 
a relationship 
79 28.1 80 26.8 134 32.6 
Education       
Primary school  19 6.9 28 9.5 62 15.4 
Middle school 51 18.5 68 23.1 98 24.4 
High school  79 28.6 91 31.0 109 27.1 
University degree 127 46.0 107 36.4 133 33.0 
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Professional status       
Active 259 92.5 262 89.7 317 78.7 
Inactive 21 7.5 30 10.3 86 21.3 
Parity       
0 21 7.5 22 7.5 42 10.4 
1 83 30.0 97 33.1 104 25.9 
2 123 44.4 136 46.4 186 46.3 
>2 50 18.1 38 12.9 70 17.3 
Income       
≤ 10.000€ 47 19.5 60 23.9 91 26.1 
10.001€-20.000€ 66 27.4 66 26.3 85 24.4 
20.001€-37.500€ 63 26.1 65 25.9 79 22.6 
37.501€-70.000€ 44 18.3 42 16.7 68 19.5 
≥ 70.001€ 21 8.7 18 7.2 26 7.4 
Medical help search 
(to manage 
menopause) 
      
Yes 35 13.5 136 46.7 257 71.6 
No 224 86.5 155 53.3 102 28.4 
Hormone therapy, 
herbal/soy therapy 
or nothing 
      
Hormone ther. 4 1.5 13 4.5 49 13.5 
Herbal/soy ther. 0 0 16 5.5 48 13.3 
Nothing 273 98.5 262 90.0 265 73.2 
Recent disease       
Yes 35 12.4 51 18.0 95 23.8 
No 245 86.9 233 82.0 304 76.2 
Recent 
psychological 
problem 
      
Yes 33 12.0 43 14.8 76 18.9 
No 243 88.0 247 85.2 327 81.1 
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Body mass index 
(kg/m
2
) 
      
≤ 24,9 166 59.1 157 53.0 205 50.6 
> 24,9 115 40.9 139 47.0 200 49.4 
Physical exercise       
Yes 118 42.1 127 43.1 197 48.8 
No 162 57.9 168 56.9 207 51.2 
Coffee       
Daily 229 81.8 243 82.4 301 74.3 
Never or 
occasionally 
51 18.2 52 17.6 104 25.7 
Alcohol       
Yes 137 49.1 157 53.0 192 47.2 
No 142 50.9 139 47.0 215 52.8 
Smoking       
Current smoker 73 25.9 87 29.7 82 20.5 
Current non-
smoker 
204 73.6 206 70.3 318 79.5 
 
 
Procedure 
This cross-sectional study encompasses a community sample which was mainly 
recruited through schools and universities in the city of Lisbon. The inclusion criteria in 
this research were gender (female), literacy and age (between 42 and 60 years). The 
American Psychological Association‘s standards on the ethical treatment of participants 
were followed. A written informed consent form was delivered to all participants, 
explaining the aims of the study, emphasizing that the participation in this research was 
voluntary and that participants could interrupt their collaboration at any time, without 
any consequences.  
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1.003 Portuguese women answered to all the instruments adequately (45 were 
excluded due to lack of sufficient information). In this study 992 participants were 
included since 11 women gave insufficient information to determine menopausal status. 
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Measures 
Menopause Symptoms 
A validated version of the Menopause Symptoms‘ Severity Inventory, MSSI-38[13] 
was used. This inventory includes thirty-eight items, organized in twelve sets of 
menopausal symptoms (depressive mood; anxiety; cognitive impairment; body shape 
changes; aches and pain; skin and facial hair changes; numbness; perceived loss of 
control; mouth, nails and hair changes; vasomotor, urinary and sexual symptoms). Both 
frequency and intensity of symptoms were measured in reference to the previous month, 
using a 5-point Likert-type scale which ranges from ―never‖ (0) to ―daily or almost 
every day‖ (4) and from ―not intense‖ (0) to ―extreme intensity‖ (4), respectively. The 
severity of each symptom is calculated afterwards, using the mean between the values 
of frequency and intensity for each item. 
 
Life Events 
The Life Experiences Survey[14] evaluates the impact of a variety of events in the 
participants‘ life, during the previous month. This inventory includes 47 events that can 
be measured in a 7-point Likert-type scale, ranging from ―very negative‖ (-3) to ―very 
positive‖ (3). There is also the possibility to answer ―does not apply‖ for each event. 
Only events which were mentioned by at least 10% of the sample were included in the 
causal model. 
 
Menopausal and Health–related variables  
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria[15]. Women in pre-menopause presented an absence of changes in 
their menstrual cycle. Peri-menopausal participants would report variable cycle length 
(a difference of more than seven days, than usual) or had skipped two or more cycles 
and had an amenorrhea interval superior to sixty days. Post-menopausal women had at 
least a twelve-month period of amenorrhea. 
Besides menopausal status, the use of hormone therapy, herbal/soy products or nothing 
to manage menopause symptoms was also asserted. In addition, search for medical help 
to manage these symptoms was also controlled. 
Health status (both physical and psychological), as menopausal status, was self-
reported. The presence of a recent disease and of a psychological problem was asked to 
the participants. 
161 
 
Lifestyle 
Alcohol and coffee intake, smoking, physical exercise and body mass index (BMI) were 
assessed.  
Lifestyle habits were explored in terms of presence/absence, amount and/or frequency. 
Hence, physical exercise was measured in terms of times per week, and during how 
many minutes, the participant exercised; a mean value of weekly frequency and 
duration was used in the multivariated model. Coffee intake, when present, was 
assessed in a four-option scale, ranging from ―occasionally‖ to ―more than five per 
day‖. Alcohol intake, when observed, was measured both in terms of frequency 
(―daily‖, ―every weekend‖ or ―rarely‖) and quantity (―until I feel drunk‖, ―moderately‖ 
or ―less than a glass per occasion‖); a mean value of both translates the alcohol 
consumption variable, in the causal model. Finally, for current smokers, smoking was 
quantified in a 6-point Likert-type scale that ranged from ―less than 10 cigarettes per 
month‖, until ―more than 40 cigarettes per day‖; this quantification integrated the 
structural equation model to assert the influence of smoking on the menopausal 
symptoms‘ severity. 
 
Socio-demographic characteristics 
Socio-demographic factors such as age, marital status, parity, professional status, 
educational level and family annual income were explored.  
 
Statistical Analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. 
The distribution of the variables studied was explored with SPSS Statistics (v. 19, IBM 
SPSS Inc, Chicago, IL).  
To explore if there were significant differences regarding the severity of menopausal 
symptoms, the participants in the three menopausal stages (pre-, peri- and post-
menopausal) were compared with a one-way ANOVA, followed by a Tukey‘s test, to 
identify if differences were observed between menopausal statuses. 
Multicollinearity between the independent variables was explored with the variance 
inflation factor (VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables presented a value below 5, indicating the absence of collinearity[16]. 
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To test the causal model for menopausal symptoms in peri- and post-menopausal 
participants, a structural equation model was built, relating the dependent variables 
(twelve sets of symptoms) with the eighteen independent variables (namely, age, parity, 
marital and professional status, income, education, presence of a recent psychological 
problem or a disease, transition from peri- to post-menopause, use of hormone therapy 
or herbal/soy products to manage menopause symptomatology, medical help search to 
deal with menopause, alcohol and coffee intake, smoking, physical exercise, body mass 
index and life events). The model was evaluated with SPSS AMOS software (v. 18, 
IBM SPSS Inc, Chicago, IL). The quality of the fit of the structural model was given by 
chi-square statistics (χ2/df), comparative fit index (CFI), goodness of fit index (GFI) 
and root mean square error of approximation (RMSEA), and the reference values 
currently practiced in structural equation modelling[17] were used. A two-step approach 
was employed to evaluate the causal structural model. First, the factor‘s measurement 
model was evaluated to demonstrate an acceptable fit. Thereafter, the structural causal 
model, encompassing the dependent and independent variables, was adjusted and the 
significance of the causal trajectories was evaluated. 
 
 
RESULTS 
 
Women in the three different menopausal statuses were compared regarding the twelve 
sets of menopausal symptoms. Mean scores (which can range from 0 to 4) and standard 
deviations, of each symptom in each menopausal status, are also given. The results are 
shown in table 2. 
 
Table 2 – Menopausal symptoms: comparison between pre-, peri and post-menopausal 
participants 
Menopausal 
symptoms 
Pre- 
M(SD) 
Peri- 
M(SD) 
Post- 
M(SD) 
ANOVA one-way 
 MD(SE)p 
Depressive mood .771(.894) .958(.909) 1.032(.952) Pre- Peri- -.187(.077).042 
    Pre- Post- -.262(.073).001 
    Peri- Post- -.075(.072).551 
Cognitive .832(.833) 1.129(.952) 1.230(.962) Pre- Peri- -.297(.078)*** 
163 
 
impairment 
    Pre- Post- -.397(.073)*** 
    Peri- Post- -.101(.072).340 
Aches and pain .966(.818) 1.227(.873) 1.396(.934) Pre- Peri- -.262(.074).001 
    Pre- Post- -.430(.069)*** 
    Peri- Post- -.168(.068).037 
Vasomotor 
symptoms 
.263(.534) .730(.979) 1.102(1.186) Pre- Peri- -.467(.083)*** 
    Pre- Post- -.839(.077)*** 
    Peri- Post- -.373(.076)*** 
Numbness .574(.881) .791(1.012) .954(1.058) Pre- Peri- -.217(.084).028 
    Pre- Post- -.380(.079)*** 
    Peri- Post- -.163(.078).092 
Mouth, nails and 
hair changes 
.461(.660) .647(.846) .710(.833) Pre- Peri- -.186(.068).016 
    Pre- Post- -.249(.063)*** 
    Peri- Post- -.063(.062).575 
Anxiety 1.095(.842) 1.379(.895) 1.399(.926) Pre- Peri- -.284(.075)*** 
    Pre- Post- -.304(.070)*** 
    Peri- Post- -.020(.069).954 
Skin and facial 
hair changes 
.364(.699) .452(.758) .666(.831) Pre- Peri- -.087(.066).380 
    Pre- Post- -.302(.062)*** 
    Peri- Post- -.214(.061).001 
Urinary 
symptoms 
.513(.751) .626(.876) .857(1.021) Pre- Peri- -.114(.077).302 
    Pre- Post- -.345(.072)*** 
    Peri- Post- -.231(.071).003 
Sexual symptoms .528(.794) .892(1.018) 1.380(1.208) Pre- Peri- -.364(.089)*** 
    Pre- Post- -.853(.083)*** 
    Peri- Post- -.488(.082)*** 
Body shape 
changes 
.789(.874) 1.118(1.042) 1.135(1.094) Pre- Peri- -.330(.086)*** 
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    Pre- Post- -.346(.081)*** 
    Peri- Post- -.016(.080).977 
Perceived loss of 
control 
.215(.432) .364(.624) .450(.695) Pre- Peri- -.149(.051).011 
    Pre- Post- -.236(.048)*** 
    Peri- Post- -.087(.047).160 
MD=Mean difference; SE=Standard error; ***p≤.001 
 
To assert if life events could be a significant predictor of menopausal status, in a sample 
of peri- and post-menopausal women (with a total dimension of 710 participants), a 
causal model encompassing the eighteen independent variables (age, parity, marital and 
professional status, household income, education, presence of a recent psychological 
problem or a disease, transition from peri- to post-menopause, use of hormone therapy 
or herbal/soy products to manage menopause symptomatology, medical help search do 
deal with menopause, alcohol and coffee intake, smoking, physical exercise, body mass 
index and life events) was built. 
Both the measurement (χ2/df=2.153; CFI=.871; GFI=.852; RMSEA=.041; p=1.000; C.I. 
90%=].039; .042[) and the structural model (χ2/df=1.967; CFI=.860; GFI=.848; 
RMSEA=.037; p=1.000; C.I. 90%=].036; .039[) evidenced a good fit. 
Given the high number of trajectories, only significant ones are presented in the table 3. 
 
Table 3 – Significant structural weights: causal model relating the independent variables 
(socio-demographic, health and menopause-related factors, lifestyle and life events) 
with the dependent variable (menopausal symptoms) 
Significant trajectories  β(SE)p 
Vasomotor symptoms ← Marital status .088(.059).029 
Sexual symptoms ← Marital status .160(.087)*** 
Depressive mood ← Educational level -.116(.020).010 
Aches and pain ← Educational level -.099(.024).041 
Mouth, nails and hair changes ← Educational level -.116(.022).032 
Sexual symptoms ← Educational level  -.123(.027).021 
Depressive mood ← Household annual income -.101(.030).019 
Perceived loss of control ← Household annual income -.147(.023).007 
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Numbness ←Household annual income -.126(.036).010 
Depressive mood ← Parity .075(.029).035 
Vasomotor symptoms ← Parity -.089(.027).020 
Mouth, nails and hair changes ← Parity .147(.031)*** 
Anxiety ← Parity .083(.034).023 
Cognitive impairment ← Recent disease .116(.081).003 
Aches and pain ← Recent disease .109(.084).005 
Vasomotor symptoms ← Recent disease .122(.065).002 
Numbness ← Recent disease .112(.084).006 
Mouth, nails and hair changes ← Recent disease .217(.076)*** 
Skin and facial hair changes ← Recent disease .100(.080).032 
Sexual symptoms ← Recent disease .109(.095).011 
Body shape changes ← Recent disease .095(.083).023 
Depressive mood ← Recent psychological problem .284(.081)*** 
Cognitive impairment ← Recent psychological problem .273(.090)*** 
Aches and pain ← Recent psychological problem .172(.093)*** 
Vasomotor symptoms ← Recent psychological problem .084(.070).031 
Perceived loss of control ← Recent psychological problem .281(.061)*** 
Numbness ← Recent psychological problem .095(.092).020 
Mouth, nails and hair changes ← Recent psychological problem .175(.083)*** 
Anxiety ← Recent psychological problem .273(.091)*** 
Skin and facial hair changes ← Recent psychological problem .197(.088)*** 
Urinary symptoms ← Recent psychological problem .241(.101)*** 
Sexual symptoms ← Recent psychological problem .196(.104)*** 
Body shape changes ← Recent psychological problem .165(.092)*** 
Skin and facial hair changes ← Menopausal status .136(.083).020 
Sexual symptoms ← Menopausal status  .157(.098).004 
Vasomotor symptoms ← Menopausal status .094(.066).054 
Depressive mood ←Medical help search (to manage menopause) .074(.061).046 
Aches and pain ← Medical help search (to manage menopause) .146(.073)*** 
Vasomotor symptoms ← Medical help search (to manage 
menopause) 
.175(.056)*** 
Numbness ← Medical help search (to manage menopause) .110(.073).009 
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Mouth, nails and hair changes ← Medical help search (to 
manage menopause) 
.140(.065).002 
Anxiety ← Medical help search (to manage menopause) .121(.071).002 
Sexual symptoms ← Medical help search (to manage 
menopause) 
.111(.082).012 
Body shape changes ← Medical help search (to manage 
menopause) 
.145(.072)*** 
Vasomotor symptoms ← herbal/soy products .131(.091)*** 
Sexual symptoms ← herbal/soy products .114(.133).008 
Body shape changes ← herbal/soy products .107(.117).010 
Aches and pain ← BMI .109(.008).008 
Numbness ← BMI .124(.008).004 
Urinary symptoms ← BMI .259(.009)*** 
Body shape changes ← BMI .388(.009)*** 
Cognitive impairment ← Smoking -.094(.021).023 
Perceived loss of control ← Smoking -.105(.014).026 
Numbness ← Coffee .095(.039).022 
Cognitive impairment ← Alcohol .092(.043).021 
Depressive mood ← Life events -.391(.578).002 
Cognitive impairment ← Life events -.295(.479).003 
Aches and pain ← Life events -.212(.394).007 
Vasomotor symptoms ← Life events -.113(.216).044 
Perceived loss of control ← Life events -.234(.244).008 
Numbness ← Life events -.169(.333).015 
Mouth, nails and hair changes ← Life events -.290(.408).004 
Anxiety ← Life events -.271(.478).003 
Skin and facial hair changes ← Life events -.171(.297).021 
Sexual symptoms ← Life events -.208(.410).009 
Body shape changes ← Life events -.136(.294).031 
β=standardized estimates; SE=standardized error; *** p≤.001 
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DISCUSSION 
 
Menopausal symptoms are expected to be exacerbated in peri-menopause and to 
decrease in post-menopause[2], and the only symptoms that post-menopausal women 
seem to have more exacerbated than peri-menopausal women are vasomotor ones[3]. 
However, it has also been observed that women in post-menopause present higher rates 
of menopausal symptoms than their counterparts in peri-menopause[18]. Our results 
support the latter conclusion, since post-menopausal women presented higher mean 
scores for all symptoms, although only aches and pain, vasomotor, sexual and urinary 
symptoms, and skin and facial hair changes were significantly higher in post-
menopause (compared with their peri-menopause counterparts).  
The literature has also highlighted that psychological symptoms are frequent in pre-
menopausal women and associated with vasomotor symptoms[3]. Nonetheless, peri-
menopause has also been identified in another study as the menopausal stage were 
psychological symptoms are more prevalent[10]. In this research, all symptoms, both 
psychological and somatic, were significantly elevated in peri- and post-menopausal 
women when compared with their pre-menopausal counterparts; the only exception was 
skin and facial hair changes, and urinary symptoms that did not vary significantly 
between participants in pre-menopause and in the menopausal transition. Still 
concerning psychological symptoms, when compared with post-menopausal 
participants, women in peri-menopause did not differ significantly, specifically in terms 
of perceived loss of control, anxiety and depressive mood‘s severity. 
Moreover, the severity of menopausal symptoms in this community sample was low: in 
a scale ranging from 0 to 4, the symptoms varied between a mean score of .215 
(SD=.432; perceived loss of control in pre-menopausal participants) and 1.399 
(SD=.926; anxiety in post-menopausal). 
In this study, higher education and income were significant predictors of lower severity 
of menopausal symptoms. These two characteristics have been emphasized, in the past, 
as influencing the way women experience symptoms and manage the search for medical 
care: women with higher socio-economic status and more schooling have more access 
to health care systems and use more often hormone therapy for menopausal 
symptoms[9]. In addition, it can be hypothesized that these factors provide, to midlife 
women, not only more medical help, but also more support mechanisms and strategies, 
which may allow them to manage their menopausal symptoms (and their lives) 
168 
 
differently than their counterparts with lower educational level and economical status. 
This might partially explain how women with more schooling years and a higher 
household income presented a lower severity of depressive mood, aches and pain, 
changes related with the mouth, nails and hair, sexual symptoms, numbness and 
perceived loss of control. 
Marital status has been previously identified as a predictor of sexual symptoms during 
the menopausal transition[19,20]. The results of the present study emphasized this: 
married women (or with a partner) had more severe sexual symptoms than their 
counterparts who were not married or in a relationship. Besides sexual difficulties, 
marital status as well as parity, were significantly linked to vasomotor symptoms; 
hence, women with more children and who were not married (or in a relationship) 
reported less severe vasomotor symptoms. 
The health status, both physical and psychological, can be also significantly related with 
the symptomatology occurring during the menopause process, namely with sexual 
symptoms[19]. In this study, besides sexual symptoms, self-reported physical and 
psychological status significantly predicted the vast majority of menopausal symptoms.   
The peri-menopausal status has been identified as a risk factor for somatic and 
vasomotor symptoms[2]. The transition from peri- to post-menopause was significantly 
associated with sexual and skin and facial hair changes (vasomotor symptoms were 
predicted by menopausal status but only in a marginally significant way), in the present 
study. This emphasizes the conclusions drawn elsewhere: hypoestrogenism subsequent 
to menopause can lead to changes in the skin[21] and there is a significant connection 
between the menopausal stage and sexual symptoms[10]. 
Furthermore, the search medical help to manage menopause, significantly predicted 
both physical and psychological symptoms: women who had used health care for 
menopause management presented higher severity of symptoms independently of socio-
demographic, lifestyle, health and menopausal status and life events. Previous results 
have demonstrated that there is an association between seeking for medical help and the 
frequency of menopausal symptoms, which was influenced by socio-demographic 
characteristics[9]. 
The use of herbal/soy products to manage menopausal symptoms was significantly 
associated with more severe vasomotor and sexual symptoms, as well as body shape 
modifications. Therefore, the use of these natural products did not attenuate the 
climacteric symptoms, but rather predicted their exacerbation. This might translate an 
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insufficient clinical control and a mismatching between personal needs of the 
symptomatic women and products‘ use. In addition, it has been evidenced that herbal 
therapies for menopausal symptoms might be ineffective[22,23], and some might not 
meet the necessary safety conditions[24]. Further research on the impact of herbal/soy 
therapies is necessary to confirm them as an eligible treatment of menopause-related 
symptomatology.  
A higher BMI was also a significant predictor for several physical symptoms; hence 
women with a more elevated body weight would present more severe complaints in 
terms of aches and pain, numbness, urinary symptoms and body shape changes. It has 
been evidenced elsewhere that the menopausal status does not have an impact in self-
rated health; however, modifications in BMI can predict a change in the perceived 
health status[25]. This data is relevant as an increase in weight can be reported around 
the menopause transition[26], and weight gain prevention should be targeted in order to 
prevent its impact not only in the body shape perception, but also in the perceived 
health status and specific physical symptoms that are, as demonstrated by our results, 
worsened with higher body weight. 
Smoking seems to be associated to less severe cognitive impairment and perceived loss 
of control since it is a significant and negative predictor. Prior outcomes have identified 
a moderate alcohol intake (when accompanied with physical exercise and absence of 
smoking behavior) as beneficial to menopausal women‘s well-being[27]. In this 
research, alcohol intake positively predicted cognitive difficulties: participants who 
drank more alcohol manifested more severe cognitive impairment than those who drank 
less (or no) alcohol.  
A decline in the sexual life during the menopausal transition and post-menopause has 
been associated with a stressful life[20]. In addition, in a previous study, everyday 
stressful experiences had a negative impact in middle-aged women[27] and negative life 
events were presented as a risk factor for menopausal symptoms[2]. Specifically, 
negative vital events (as well as family dysfunction) incremented the risk for 
psychological symptoms: depression, anxiety and stress[3]. However, menopausal 
women might attribute certain symptoms (namely, a worsening in the sexual response) 
not only to life events, but also to physical and emotional changes subsequent to 
menopause[28]. 
The connection between life events and menopausal symptoms is supported in this 
research which shows that, independently from socio-demographic, menopausal and 
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health-related variables and lifestyle, live events significantly predicted all menopausal 
symptoms, except for the urinary ones. This supports the literature which evidences that 
life events can be related with the exacerbation of psychological menopausal 
symptoms[7,11,12] and goes further demonstrating that some physical symptoms might 
be significantly predicted by life events. Hence, women who evaluated their recent life 
events in a more positive way manifested less severe menopausal symptoms.  
Although the measurement of menopausal symptoms has been receiving some attention, 
their significance for every life is still weakly developed[1]. Given the predictive power 
of life events concerning menopausal symptoms‘ severity, it is important to 
contextualize women in their lives when assessing menopausal symptoms and the 
impairment perceived to be caused by them. As our results show, in a causal model 
accounting for the socio-demographic, health and menopause-related variables, lifestyle 
and life events, menopausal status can predict the severity of certain symptoms. 
However, the exacerbation of the majority of symptoms was predicted by events that 
integrate women‘s lives. This outcome emphasizes the need to amplify the way 
clinicians and researchers perceive menopause and its related clinical manifestations, 
since they can be associated not with menopausal status but rather with events which 
occur in middle-aged women‘s lives. 
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Abstract 
 
Objective: Weight gain during midlife is frequent in women. This study explores the 
variation of weight around the time of menopause transition (loss, maintenance or gain), 
and identifies the predictors of this weight variation and, specifically, of weight gain. It 
is also investigated in which phase of life the overweight started. 
Methods: This study is a cross-sectional research encompassing a community sample of 
497 women in peri- and post-menopause who provided information about weight before 
menopause transition and current weight. Structural equation modelling was used to 
investigate the causal models of weight variation and weight gain. The studied variables 
included age, marital status, parity, professional status, education, income, self-reported 
physical and psychological health status, use of hormone therapy, menopausal status, 
alcohol and coffee intake, smoking, physical exercise, body shape concerns, depression, 
stress and life events.  
Results: The vast majority of women (69%) gained weight from pre-menopause to 
current menopausal status (peri- or post-menopause) and 37% of overweight or obese 
participants identified menopause as the period when overweight began. The significant 
predictors of weight gain were educational level (β=-.146; p=.017), physical exercise 
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(β=-.111; p=.021), having a recent psychological problem (β=.191; p<.001), transition 
from peri- to post-menopause (β=.147; p=.013) and body shape concerns (β=.313; 
p<.001). 
Conclusions: Given the difficulty of the weight loss process and the negative impact of 
overweight/obesity on health, prevention of weight gain in pre-menopause is 
recommended and risk groups should be targeted considering the characteristics which 
account for a significant prediction of weight increase. 
 
Key-words: weight variation; weight gain; menopause; predictors; structured equation 
modelling 
 
 
Introduction 
 
Nowadays, 1.1 billion adults are overweight or obese, and excessive body weight is 
considered the sixth most important factor in the origin of the overall burden of disease 
worldwide (Haslam & James, 2005). In developed countries in particular, from 2 to 7% 
of total health care costs are due to obesity (Hossain, Kawar, & Nahas, 2007). 
Women usually report a weight gain during midlife (Campbell & Samaras, 2000; 
Dubnov, Brzezinski, & Berry, 2003; Heymsfield et al., 1994). During the menopausal 
process there are changes in body fat distribution, with a loss of lean body mass and an 
increase in total body fat and visceral fat (Heymsfield et al., 1994; Morita et al., 2006; 
Sternfeld, Bhat, Wang, Sharp, & Quesenberry, 2005). However, it is suggested that this 
weight increase during the menopausal transition is more strongly associated with the 
aging process than with hormonal changes (Simkin-Silverman & Wing, 2000).  Despite 
this substantiation, other research evidenced that menopause has a significant and 
independent effect on the increase of the body‘s fat mass in peri-menopausal women 
(Ho, Wu, Chan, & Sham, 2010). 
Independently of its predictors, obesity has been identified as a risk for certain cancers, 
type II diabetes, hypertension, coronary heart disease and stroke (Kruger, Ham, & 
Prohaska, 2009). Furthermore, weight gain was significantly associated with increased 
risk for breast and endometrial cancer, especially in those who never used hormonal 
therapy (Chang et al., 2007; Harvie et al., 2005; Huang et al., 1997). Moreover, weight 
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gain during menopause can have a negative impact on cardiovascular health (Simkin-
Silverman, Wing, Boraz, & Kuller, 2003).  
Since obesity‘s prevalence has been increasing and its treatment is difficult (Cooper et 
al., 2010), the prevention of weight gain during this period of women‘s life is an import 
health target (Simkin-Silverman et al., 2003).  
Socio-demographic factors and lifestyle have been evidenced as contributors to weight 
gain (Campbell & Samaras, 2000; Crawford, Casey, Avis, & Mckinlay, 2000; 
Lahmann, Lissner, Gullberg, & Berglund, 2000; Nagata, Takatsuka, Kawakami, & 
Shimizu, 2002; Simkin-Silverman & Wing, 2000). 
The data regarding menopausal status and hormone therapy use is not unanimous. 
Several studies show no association between these two and weight gain (Campbell & 
Samaras, 2000; Crawford et al., 2000; Davies, Heaney, Recker, Barger-Lux, & Lappe, 
2001; Simkin-Silverman & Wing, 2000). On the other hand, there is evidence that the 
menopausal status has an impact on some metabolic and behavioural responses 
associated with weight loss (Riesco et al., 2008). Furthermore, early post-menopause 
has been associated with an increase of intra-abdominal fat (Toth, Tchernof, Site, & 
Poehlman, 2006). 
The influence of depression and stress in weight gain is not certain. In past research 
depression did not increase the risk for future obesity although the reverse was factual: 
obese people had an increased risk for depression (Roberts, Deleger, Strawbridge, & 
Kaplan, 2003). However, depression has been associated with higher body weight 
elsewhere (Linde et al., 2004; Pagoto et al., 2007). 
Stress has been evidenced as a predictor of weight gain, especially in young women 
(Serlachius, Hamer, & Wardle, 2007); in contrast, this psychological variable was not 
related with body weight in another research (Kim, Bursac, Dilillo, White, & West, 
2009). 
The literature also documents that certain life events could lead to weight gain (Roberts, 
Troop, Connan, Treasure, & Campbell, 2007); conversely, it has also been reported that 
that life experiences cannot predict body weight (Strickland, Giger, Nelson, & Davis, 
2007). 
Body shape concerns are frequently studied in both the context of adolescence (Davies 
& Furnham, 1986; Field et al., 2005) or in eating disorders (Beato, Cano, & Belmonte, 
2003; Hadigan & Walsh, 1991). Additionally, prior body dissatisfaction has been 
identified as a robust predictor of weight gain rate in the years following pre-
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adolescence (Anglé, Keskinen, Lapinleimu, Helenius, Raittinen, Röneemaa, & Simell, 
2005). These types of concerns, however, have not been investigated in menopausal 
women. Given the modification in body weight that is usually reported in the phase, it is 
pertinent to explore how body shape concerns impact on the weight modification, 
during the menopause process. 
Therefore, the present research explores if socio-demographic, health, menopause, 
lifestyle, and psychological variables (such as depression, stress and body shape 
concerns), as well as life events, are predictors of weight variation and, specifically, of 
weight gain in a sample of peri- and post-menopausal women. 
 
 
Methods 
Participants 
A community sample of 1,003 women, aged between 42 and 60 years, participated in a 
larger study on menopause. In this particular research, 497 participants who were in 
peri- and post-menopause, and that gave information on their current weight and weight 
before the menstrual cycle variations started (that, weight in the pre-menopause phase), 
were included. 
Characterization of participants is presented in table 1. 
 
Table 1 – Characterization of peri- and post-menopausal participants 
 Peri- Post- 
Characteristics n % n % 
n 166 33.4 331 66.6 
Age (M±SD) 48.4±3.645  54.0±4.147  
Marital status     
Married or in a relationship 125 75.3 224 67.9 
Not married or in a 
relationship 
41 24.7 106 32.1 
Parity     
0 10 6.2 29 9 
1 58 35.8 83 25.6 
2 73 45.1 157 48.5 
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> 2 21 13 54 16.7 
Educational level     
Primary school 16 9.8 46 14.2 
Middle school 37 22.6 79 24.4 
High school  45 27.4 81 25.0 
University degree 66 40.2 118 36.4 
Professional status     
Active 143 87.7 256 78.5 
Inactive 20 12.3 70 21.5 
Household annual income     
≤ 10.000 € 34 23.6 66 23.2 
10.001 – 20.000 € 33 22.9 72 25.3 
20.001 – 37.500 € 38 26.4 64 22.5 
37.501– 70.000 € 26 18.1 59 20.7 
≥ 70.001 € 13 9.0 24 8.4 
Hormone therapy     
Yes 12 7.5 44 15.1 
No 154 92.5 287 84.9 
Recent disease     
Yes 34 21.5 78 24.3 
No 124 78.5 243 75.7 
Recent psychological problem     
Yes 28 17.3 57 17.5 
No 134 82.7 268 82.5 
Coffee intake     
Yes  148 89.2 275 83.6 
No 18 10.8 54 16.4 
Alcohol intake     
Yes  90 54.2 156 47.4 
No 76 45.8 173 52.6 
Current smoker     
Yes  57 34.5 70 21.7 
No 108 65.5 253 78.3 
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Physical exercise     
Yes  68 41.5 164 50.2 
No 96 58.5 163 49.8 
Body mass index (kg/m
2
)     
> 24,9 76 45.8 162 49.4 
≤ 24,9 90 54.2 166 50.6 
 
Measures 
The instruments included the Portuguese adaptation of the Depression, Anxiety and 
Stress Scales (Lovibond & Lovibond, 1995; Pais-Ribeiro, Horando, & Leal, 2004), the 
Body Shape Questionnaire (Cooper, Taylor, Cooper, & Fairburn, 1987), the Life Events 
Survey (Sarason, Johnson, & Siegel, 1978; Silva, Pais-Ribeiro, Cardoso, & Ramos, 
2003), as well as a questionnaire to identify the menopausal status according to the 
Stages of Reproductive Aging Workshop criteria (Soules et al., 2001) and to explore 
socio-demographic variables, perceived physical and psychological health status, weight 
variation, menopause-related and lifestyle characteristics.  
The Depression, Anxiety and Stress Scales (Lovibond & Lovibond, 1995; Pais-Ribeiro, 
Horando, & Leal, 2004) include 21-items organized in three factors (depression, anxiety 
and stress), with answers being given in a 4-points Lykert-type scale (ranging from ―did 
not apply to me‖ to ―it applied to me most of the time‖. Data gathered with this measure 
has shown good psychometric properties (Lovibond & Lovibond, 1995; Pais-Ribeiro, 
Horando, & Leal, 2004).  
The Body Shape Questionnaire (Cooper, Taylor, Cooper, & Fairburn, 1987) assesses 
the concerns about the body form in 34-items. Responses were given in a 6-point 
Likert-type scale with scores ranging from ―never‖ to ―always‖. A confirmatory factor 
analysis was done and, because the item 26 (―Have you vomit in order to feel thinner?‖) 
had the highest modification index (66.421), its residual evidenced covariance with 
several other residuals and presented the lowest correlation with the construct (.301), 
thus it was excluded. The data gathered with this 33-item version manifested good 
psychometric characteristics. 
The Life Experiences Survey (Sarason, Johnson, & Siegel, 1978; Silva, Pais-Ribeiro, 
Cardoso, & Ramos, 2003) evaluates the impact of a variety of events in the participants‘ 
life, during the previous month. This inventory includes 47 events that can be measured 
in a 7-point Likert-type scale, ranging from ―very negative‖ to ―very positive‖. There is 
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also the possibility to answer ―does not apply‖ for each event. Only events which were 
mentioned by at least 10% of the sample were included in the causal model. 
Regarding menopausal status, peri-menopausal women would report variable cycle‘s 
length (more than seven days different than usual), or had skipped two or more cycles 
and had an amenorrhea interval superior to sixty days. Post-menopausal women were 
confirmed for having at least a twelve-month period of amenorrhea. 
Weight variation was assessed through self-reported current weight and weight before 
the variability in the menstrual cycle had begun. The difference between current and 
past weight (prior to the menstrual alterations) informed us whether the participant had 
lost, maintained or gained weight during menopausal transition.  
Socio-demographic characteristics (age, marital status, parity, professional status, 
educational level, household annual income), as well as self-reported physical and 
psychological health status (recent diseases and psychological problems) and lifestyle 
characteristics (alcohol and coffee intake, smoking and physical exercise) were also 
assessed.  
Lifestyle habits (namely, alcohol, coffee, smoking and physical exercise) were asserted 
in terms of presence/absence, amount and/or frequency. Hence, physical exercise was 
measured in terms of times per week, and during how many minutes, the participant 
exercised; a mean between weekly frequency and duration was used in the multivariated 
models. Coffee intake, when present, was assessed in a four-option scale, ranging from 
occasionally to more than five per day. Alcohol intake, when observed, was measured 
both in terms of frequency (daily, every weekend or rarely) and quantity (until I feel 
drunk, moderately or less than a glass per occasion); a mean value of both translates the 
alcohol consumption variable, in the causal models. Finally, for current smokers, 
smoking was quantified in a 6-point Likert-type scale that ranged from less than 10 
cigarettes per month, until more than 40 cigarettes per day; this quantification integrated 
the structural equation models to assert the influence of smoking on the weight variation 
and gain. 
Finally, to investigate if an excessive increase in weight had begun during menopause 
transition, women were also asked when the overweight had started. 
 
Procedure 
The American Psychological Association‘s standards on ethical treatment of 
participants were followed. A written informed consent was delivered to all participants 
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explaining the aims of the study, emphasizing that the participation in this research was 
voluntary and that participants could interrupt their collaboration at any time without 
any consequences. A copy of the informed consent was given to every participant, 
where the contacts of the responsible researcher were included so that women could 
contact her if any question emerged.  
After having given their informed consent and agreed to participate in the research, a 
community sample of 1,003 Portuguese women, not searching for help to lose weight, 
and between 42 and 60 years of age, filled in all the instruments adequately. This 
sample was manly recruited through schools and universities in the city of Lisbon. The 
inclusion criteria in this research were gender (women), literacy (at least primary 
school) and age (between 42 and 60). Of a total of 1,003 participants, 497 peri- and 
post-menopausal women gave information about actual weight and weight prior to 
changes in menstrual cycle. 
 
Statistical Analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. To explore the 
sample distribution of the variables studied SPSS Statistics (v. 19.0, SPSS Inc., 
Chicago, IL) was used. 
Multicollinearity between the independent variables was evaluated with the variance 
inflation factor (VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables should present a VIF‘s value below 5 in order to prove the absence of 
multicollinearity (Maroco, 2010; Weisberg, 1985). 
To explore if weight variation (loss, maintenance or gain) was independent of the 
menopausal status, a chi-square test (for independence) was used. 
To test the causal models for body weight variation and weight gain during menopause 
transition, structural equation modelling was used through AMOS software (v. 18, IBM 
SPSS Inc, Chicago, IL). The goodness of fit of the structural model was given by chi-
square statistics (χ 2/df), comparative fit index (CFI), goodness of fit index (GFI) and 
root mean square error of approximation (RMSEA). Reference values indicative of good 
model fit were those values currently practiced in structural equation modelling (Byrne, 
2001; Maroco, 2010). A two-step modelling approach was employed to evaluate the 
causal structural model. First, the factor‘s measurement model was evaluated to 
demonstrate a good fit. Thereafter, the structural causal model, encompassing the 
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dependent variable (weight variation or weight gain) and the independent variables 
(socio-demographic, health and menopause-related, lifestyle and psychological 
variables, and life events), was adjusted and the significances of the causal trajectories 
were evaluated. 
 
 
Results 
 
The majority of peri- and post-menopausal women gained weight from pre-menopause 
to current menopausal status, as evidenced in table 2. 
 
Table 2 - Weight variation: comparison between current weight and weight prior to 
menstrual changes had started 
 Peri-menopausal Post-menopausal 
Weight n % M±SD N % M±SD 
Lost 20 12 -4.7±4.807 44 13 -6.5±6.296 
Maintained 48 29 0±0 43 13 0±0 
Gained 98 59 5.2±3.863 244 74 7.5±6.185 
 
The chi-square test (for independence) showed that the weight variation (loss, 
maintenance and gain) was not independent of menopausal status (χ2(2)=18.907; 
p<.001). 
Participants were also asked when the excessive weight began. Results from women 
with a body mass index above 25 kg/m
2
 are presented in table 3. 
 
Table 3 - Beginning of excessive body weight in overweight and obese women  
 Overweight Obesity 
Start of excessive weight in participants 
with current BMI ≥ 25 kg/m2 
n % n % 
Childhood 8 5.7 6 9.2 
Adolescence 5 3.5 5 7.7 
Beginning of adulthood 38 27.0 17 26.2 
Pregnancy 6 4.3 8 12.3 
183 
 
Thirties  8 5.7 4 6.1 
Forties  5 3.5 --- --- 
Menopause 64 45.4 23 35.4 
Medical problem 5 3.5 1 1.5 
Smoking cessation 1 0.7 --- --- 
Other 1 0.7 1 1.5 
 
The multicollinearity analysis showed that anxiety presented a VIF‘s value above 5, 
hence demonstrating collinearity between anxiety and other predictor variables in the 
model (Maroco, 2010; Weisberg, 1985). For that reason anxiety was excluded from the 
causal models. 
 
Weight variation 
The measurement model (X
2
/df=2.722; CFI=.821; GFI=.877; RMSEA=.059; p<.001; 
C.I. 90%=].055; .063[) and the structural model (X
2
/df=2.105; CFI=.820; GFI=.877; 
RMSEA=.047; p=.920; C.I. 90%=].044; .050[) evidenced a good fit. The variables 
accounted for explained 18.3% of the variability of the body weight variation (that is, 
loss, maintenance and gain) in peri- and post-menopausal women. Table 4 presents the 
structural weights regarding variables integrated in the causal model. 
 
Table 4 - Predictors of weight variation (loss, maintenance and gain) between current 
weight (at peri- or post-menopause) and pre-menopause weight 
Structural weights β(SE)p 
Weight variation ← Age .054(.077).310 
Weight variation ← Marital status -.026(.671).558 
Weight variation ← Professional status .025(.816).590 
Weight variation ← Educational level -.063(.204).231 
Weight variation ← Annual income -.090(.310).088 
Weight variation ← Parity .079(.280).071 
Weight variation ← Smoking -.061(.184).175 
Weight variation ← Alcohol -.009(.380).845 
Weight variation ← Coffee -.030(.331).484 
Weight variation ← Physical exercise -.052(.003).216 
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Weight variation ← Recent disease .021(.705).629 
Weight variation ← Recent psychological 
problem 
.074(.864).115 
Weight variation ← Hormone therapy .034(.928).423 
Weight variation ← Transition from peri- to 
post-menopause 
.105(.762).043 
Weight variation ← Depression .050(1.004).564 
Weight variation ← Stress -.143(.776).063 
Weight variation ← Body shape concerns .361(.322)*** 
Weight variation ← Life events .089(.396).121 
*** p<.001 
 
Weight gain 
In order to explore which variables predicted weight gain, a causal model was explored 
encompassing only the 342 women who had gained weight from pre-menopause to their 
current menopausal status (peri- or post-menopause). Both measurement (X
2
/df=2.451; 
CFI=.795; GFI=.845; RMSEA=.065; p<.001; C.I. 90%=].060; .071[) and structural 
models (X
2
/df=1.872; CFI=.803; GFI=.847; RMSEA=.051; p=.406; C.I. 90%=].046; 
.055[) presented a good fit. 
Several predictors emerged as statistically significant from this analysis, as shown in 
table 5. 
 
Table 5 - Predictors of weight gain from pre-menopause to the current menopausal 
status (peri- or post-menopause) 
Structural weights β(SE)p 
Weight gain ← Age .041(.072).504 
Weight gain ← Marital status -.075(.649).147 
Weight gain ← Professional status -.029(.779).580 
Weight gain ← Educational level -.146(.195).017 
Weight gain ← Annual income -.099(.290).106 
Weight gain ← Parity .066(.268).208 
Weight gain ← Smoking -.071(.187).162 
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Weight gain ← Alcohol -.061(.360).214 
Weight gain ← Coffee -.012(.328).808 
Weight gain ← Physical exercise -.111(.003).021 
Weight gain ← Recent disease .057(.673).248 
Weight gain ← Recent psychological problem .191(.794)*** 
Weight gain ← Hormone therapy -.043(.811).385 
Weight gain ← Transition from peri- to post-
menopause 
.147(.749).013 
Weight gain ← Depression -.090(.899).367 
Weight gain ← Stress -.040(.697).202 
Weight gain ← Body shape concerns .313(.293)*** 
Weight gain ← Life events .080(.427).283 
*** p < .001 
 
The significant predictors account for 25.7% of variability in weight gain in this sample 
of peri- and post-menopausal women who had an increment on body weight from the 
absence of menstrual cycle changes until the present date. 
 
 
Discussion 
 
Although 31% of participants lost or maintained their weight from pre-menopause to 
their current menopausal status (peri- or post-menopause) most women reported a 
weight gain. These results are congruent with previous research (Campbell & Samaras, 
2000; Dubnov et al., 2003; Heymsfield et al., 1994). Moreover, a great majority of 
women that are overweight and obese, evidenced menopause as the life period were 
excessive weight began. Besides obese and overweight women, 91 women with normal 
weight (that is, with a BMI between 18.5 and 24.9 kg/m
2
) perceived themselves as 
having excessive weight (specifically, they identified in the questionnaire when their 
excessive weight had began). This data might reveal a degree of dissatisfaction with 
current weight in these participants in peri- and post-menopause, leading to this 
overestimation of body weight; this outcome, which has been evidenced before (Cooper 
& Fairburn, 1983), is likely to be associated with an interpersonal-cultural pressure and 
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the desire of thinness, which can predict body image dissatisfaction (Matz, Foster, 
Faith, & Wadden, 2004).  
The weight variation (loss, maintenance or gain) was significantly predicted by 
menopausal status and body shape concerns. Therefore, women whose weight 
difference was higher and positive (that is, had gained weight instead of maintained or 
lost) were more likely to be in post-menopause. Similarly, women with more frequent 
body shape concerns had a higher and positive weight difference (in terms of weight 
gained), when compared with participants with less frequent body shape concerns. 
The educational level had been previously proven to have a negative association with 
BMI, including in a study with a multinational sample of women (Lahmann et al., 2000; 
McLaren, 2007; Molarius et al., 2000). In this research, the education appears as a 
negative predictor of weight gain, reinforcing prior conclusions: women who had a 
lower schooling level presented a higher weight gain than their counterparts with a 
higher schooling level.  
As expected, physical exercise also predicted significantly and negatively weight gain, 
since women who presented a higher frequency and intensity of physical activity had a 
lower increase in body weight than participants with lower levels of physical exercise. 
This conclusion is supported by previous studies (Campbell & Samaras, 2000; 
Crawford et al., 2000; Simkin-Silverman & Wing, 2000) and highlights the importance 
of implementing physical exercise at pre-menopause so that the weight increase, during 
the menopause transition and post-menopause, is minimized. 
Although depression and stress did not predict weight increment, having a recent 
psychological problem was significantly associated with weight gain. This means that 
some types of psychological distress, other than depression, stress or the presence of 
stressful life events (which, again, did not predict weight gain), might contribute to a 
weight increase during menopausal transition and post-menopause; for example anxiety, 
that was not possible to include in the structural model, has been related with higher 
BMI in women (Anderson, Cohen, Naumova, & Must, 2006).  
Moreover, the association between psychological distress and weight cycling has been 
evidenced before (Petroni et al., 2007). In this research, it is observed that the vast 
majority of obese and overweight women identify the beginning of excessive weight at 
the time of menopause, hence reducing the chances of having a history of extended 
weight cycling, and partially supporting the absence of a significant association between 
weight gain and two kinds of psychological distress (namely, depression and stress). 
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Body shape concerns were also a significant and positive predictor of weight gain. 
Women who presented more frequent concerns with their body shape had a higher 
weight gain than women less frequently worried with their body figure. This can be 
influenced by expectations about weight and body changes around menopause that 
might create in women a concern with body figure. This expectation can promote an 
attentional bias towards shape and weight-related changes which in turn can lead to 
body dissatisfaction (Smith & Rieger, 2006). And, as stated before, body dissatisfaction 
at a young age can predict a subsequent weight increase rate (Anglé et al., 2005). This 
study emphasizes this outcome, that is, body shape concerns predicted significantly 
weight gain in a different developmental phase: midlife. Moreover, body dissatisfaction 
has been considered strongly associated with binge and emotional eating, abnormal 
attitudes towards body and weight, and low self-esteem (Johnson & Wardle, 2005). This 
might also explain part of how body shape concerns are a predictor of weight gain. 
Furthermore, and although some studies evidence that the menopause transition is not 
related with weight gain (Campbell & Samaras, 2000; Crawford et al., 2000; Davies et 
al., 2001; Simkin-Silverman & Wing, 2000), this research demonstrates the opposite. In 
this sample of peri- and post-menopausal women, the transition from peri- to post-
menopause significantly predicted weight increase, independently of socio-demographic 
characteristics, health status, hormone use, lifestyle factors, psychological variables and 
life events. This outcome accentuates the conclusion drawn elsewhere (Riesco et al., 
2008), which evidences that menopausal status has an impact on some metabolic and 
behavioural responses, given that pre-menopausal women manifest more positive 
improvements at these levels, when compared with post-menopausal women, after a 
weight loss program. Additionally, early post-menopause has been associated with an 
increase of intra-abdominal fat, which is independent of age and total adiposity (Toth et 
al., 2006), and that can contribute to some extent to the weight gain observed. 
Weight gain prevention is usually conducted in another normative life phase, 
particularly, by the time of pregnancy since the post-partum weight retention can be of 
around 13 kg (Giroux, Lander, Charleswoth, & Mottola, 2009). Given the results of the 
present study, the same prevention in pre-menopausal women is recommended since it 
was observed an increment of weight in the menopausal transition. This prevention 
should take into account the risk group for weight gain, namely, women in menopausal 
transition, with more frequent body shape concerns, with lower educational level, who 
do not practise physical exercise and present psychological distress. 
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ABSTRACT 
 
Cognitive-behavioural therapy (CBT) has proven to be effective in weight reduction. 
This research explores if a brief, individual, 8-session CBT can promote weight loss in 
midlife women, as compared with a control group (waiting list). Anthropometric 
(weight and abdominal perimeter), psychological (health-related and sexual quality-of-
life, stress, anxiety and depression) and behavioural measures (binge eating disorder, 
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restrained, external and emotional eating) were assessed at the baseline (T1), post-
treatment (T2) and at the 4-month follow up (T3), in a group of 17 participants. At the 
post-intervention, participants with individual CBT had higher health-related quality of 
life and restrained eating; stress levels and emotional eating had decreased. At T3, 
women who underwent CBT had a significantly lower weight, abdominal perimeter, 
external eating and higher restrained eating. During these three assessments there were 
no significant differences in the waiting list participants. Moreover, binge eating 
disorder was significantly lower in CBT participants at T2 and T3 when compared with 
baseline. An effective, though small, weight loss was achieved. Changes in eating 
behaviour were also successful and maintained. However, there is the need to improve 
the efficacy of the intervention in order to promote a greater weight reduction. 
 
Key-words: cognitive-behavioural therapy, weight loss, control group, follow up, 
midlife, women 
 
 
INTRODUCTION 
 
It has been more than a decade since the World Health Organization (WHO) 
identified obesity has an epidemic, recognizing it as an actual public health threat 
(WHO, 1998). Currently, 30-80% of adults in the countries of the WHO‘s European 
Region are overweight and obesity was recently growing rapidly towards 150 million 
among adult population in 2010 (WHO, 2007). In the United States current data points 
to a prevalence of 33.6% for overweight and 34.3% for obesity among adults (Centres 
for the Disease Control and Prevention, 2010). 
Obesity is a risk factor for cardiovascular disease, metabolic syndrome, 
dyslipidaemia, type II diabetes and premature death (Hu et al., 2001; van Gaal, Mertens, 
& de Block, 2006; Xydakis et al., 2004). In addition, metabolic and muscular-skeletal 
benefits, as well as brain function improvement, may be attained through weight loss 
and physical fitness (Franco et al., 2009; Xydakis et al., 2004).  
Cognitive-behavioural therapy (CBT) has proven to be effective in weight 
reduction (Cooper et al., 2010; Kalodner & DeLucia, 1991; Mefferd, Nichols, Pakiz, & 
Rock, 2007; Munsh et al., 2007). However, it is not easy to achieve and maintain this 
weight lost (Cooper et al., 2010; DiLillo, Siegfried, & West, 2003). 
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There are some psychological symptoms that can be associated to excessive 
weight and obesity. Anxiety, depression (Anderson, Cohen, Naumova, & Must, 2006; 
Cilli et al., 2003; Luppino et al., 2010) and stress have been strongly related with higher 
body mass index (BMI) and weight gain, especially in women (Block, He, Zaslavsky, 
Ding, & Ayanian, 2009; Serlachius, Hamer, & Wardle, 2007; Smith, Baum, & Wing, 
2005). However, this association is not unanimous since in another study anxiety and 
depression symptoms were not associated with the severity of overweight (Castellini et 
al., 2008). Furthermore, and independently of the depressive mood, increased stress can 
predict binge eating (Yacono-Freeman & Gil, 2004). The presence of binge eating 
disorder (BED), as proposed by DSM-IV-TR (APA, 2000), increases the likelihood of 
higher BMI comparing with individuals without BED (Grucza, Przybeck, & Cloninger, 
2007).  
Research with BED has evidenced that CBT can be effective in the reduction or 
cessation of binge eating (Eldredge et al., 1997; Wilson & Fairburn, 2007), being that 
its decrease will promote a weight reduction (Agras, Telch, Arnow, Eldredge, & 
Marnell, 1997). 
A consequence of weight loss can be the improvement of sexual (Kolotkin et al., 
2008) and health-related quality of life (QoL) (Blissmer et al., 2006; Kolotkin, Crosby, 
Williams, Hartley, & Nicol, 2001). However, this conclusion is not unanimous 
(Maciejewski, Patrick, & Williamson, 2005). 
The objective of this study was to explore the efficacy of an 8-week individual 
CBT in weight and binge eating reduction and to investigate if these changes will 
promote differences in depression, anxiety, stress, QoL and eating behaviours in 
middle-aged women.  
 
 
METHODS 
 
Participants 
After giving their informed consent and agreeing to participate in the research, a 
community sample of 1,003 participants, with ages between 42 and 60 years old, 
participated in a study about menopause with Portuguese midlife women. Participants 
with a body mass index (BMI) above 24.9 kg/m
2
 were given the opportunity to 
participate in an intervention for weight loss. Eighteen women integrated and completed 
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the 8-week cognitive-behavioural therapy or were on a waiting list for an equivalent 
amount of time. One participant of the individual CBT was excluded from the final 
statistical analysis because of the presence of axis II psychopathology (APA, 2000). The 
mean age of the 17 participants was 51 (M=51.0; SD=5.820) and mean BMI was 29 
(M=29.3; SD=2.183). Table 1 describes the participants at baseline. 
 
Table 1 – Participants‘ characterization 
Variables n % 
Marital status   
Married or in a relationship 12 70.6 
Not married or in a relationship 5 29.4 
Professional status   
Active 14 82.4 
Inactive 3 17.6 
Educational level   
Primary school 3 17.7 
Middle school 3 17.6 
High School 4 23.5 
University 7 41.2 
Family annual income   
Less than 10.000 euro 4 23.5 
10.001 – 20.000 euro 4 23.5 
20.001 – 37.500 euro 5 29.4 
37.501 – 70.000 euro 3 17.6 
More than 70.001 euro 1 5.9 
Menopausal status   
Pre-menopause  5 29.4 
Peri-menopause  6 35.3 
Post-menopause 6 35.3 
Physical exercise   
Yes 9 52.9 
No 8 47.1 
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Measures 
The socio-demographic characteristics, menopausal status, BMI and physical 
exercise were evaluated in a first moment through self-reported measures. 
The menopausal status was defined according to Soules et al. (2001). Pre-
menopausal women did not manifest any changes in their menstrual cycle, peri-
menopausal reported variations in it and post-menopausal women were confirmed for 
having at least a 12-month period of amenorrhea. 
Weight and abdominal perimeter were measured by a trained health 
psychologist, always using the same scale, acquired for this project; the remaining 
variables were assessed by self-reported measures. 
Binge eating disorder was explored using the DSM-IV-TR (2000) criteria as 
evidenced in ―Criteria for Further Study‖. 
The instruments included the Portuguese adaptation of the Depression, Anxiety 
and Stress Scales (DASS) to assess stress, anxiety and depression symptoms (Lovibond 
& Lovibond, 1995); the Utian Quality of Life Scale, to explore sexual and health-related 
quality of life in menopausal women (Utian, Janata, Kingsberg, Schluter, & Hamilton, 
2002); and the Dutch Eating Behaviour Questionnaire (van Strien, Frijters, Bergers, & 
Defares, 1986) to measure restrained, emotional and external eating behaviour.  
 
Procedure 
Socio-demographic data was collected in a cross-sectional study with a 
community sample of 1,003 women with ages between 42 and 60. Women who had 
participated in this study voluntary enrolled in an intervention for weight loss. From 
those who were enrolled, the ones with a BMI above 24.9 kg/m
2
 where contacted by 
telephone, and distributed to one of two conditions (CBT or waiting list) randomly, and 
prior to the contact, with the support of a computer-generated randomization scheme.  
From the forty-three women enrolled, thirty-four had a BMI above the 
mentioned cutline and were contacted. From those, thirteen women were unreachable or 
unavailable to participate.  
Eleven participants were attributed to the individual CBT and 10 to a waiting list 
(WL) which lasted twenty-six weeks, the same time that the intervention group from T1 
until T3. During the intervention two participants in CBT and one in WL dropped out.  
After these twenty-six weeks, the nine women on the waiting list started the 
individual intervention and went from T1 until T3. Two participants of the experimental 
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group did not complete the follow-up assessment and one participant of the same group 
was not taken into consideration in the statistical analysis because she was diagnosed 
with an axis II mental disorder.  
Menopausal status, anthropometric measures and psychological variables were 
evaluated one week before the intervention (or control condition) began, one week after 
it ended and four months after the second assessment. Baseline (T1), post-test (T2) and 
follow-up were conducted by a psychologist different from the one who delivered the 
intervention. The anthropometric measurements were always made in the same weight 
scale. 
To prevent experimenter‘s bias, the psychologist, responsible for the 
assessments, was told that these were done in the context of a study on menopause, 
without giving any further information on the different groups or specific objectives. 
The participants were told, at the time of the recruitment that, any questions about the 
intervention should be addressed to the psychologist who was responsible for the 
treatment, and a phone contact was provided for that effect.  
 
Intervention 
The cognitive-behavioural intervention was structured by two psychologists and 
psychotherapists, after a literature review and based on previous interventions. It was 
planned as presented in Table 2. The intervention was individual, conducted in an 
adequate setting, and with a weekly frequency. 
 
Table 2 – Contents of each session 
Sessions Contents 
1
st
  Relationship with the food and the body 
 Eating routines 
 
Psycho-education about the consequences of excessive weight and 
obesity 
 Motivation increment 
2
nd
  
Analysis of situations when there was an excessive ingestion of food 
happens 
 
Exploration of thoughts, emotions and behaviours subsequent to 
excessive food ingestion 
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Evaluation of perceived control before and during excessive food 
ingestion 
3
rd
  ABC model 
 Lifestyle characteristics facilitating excessive eating 
 Triggers‘ identification 
4
th
  
Triggers‘ identification and exploration of obstacles to triggers‘ 
management  
 Cognitive restructuration 
 Behavioural techniques  
 Physical exercise promotion 
5
th
  
Evaluating successful and unsuccessful implementation of behavioural 
techniques   
 Exploration of new behavioural techniques 
 Development of mindfulness 
 
Development of attention towards triggers and consequent behaviour 
(successful versus unsuccessful management)   
 Motivation increment 
6
th
 
Assessment of successful and unsuccessful management of excessive 
food ingestion 
 Difficulties‘ anticipation  
 Assessment of cognitive and behavioural techniques   
7
th
  Lifestyle: integrating changes 
 Redefining daily well-being 
8
th
  Maintenance of adaptive changes made 
 Relapse prevention 
 
 
Statistical Analysis 
Data was first analysed to check for outliers and distribution forms. No missing 
value imputation was made. 
To explore if at baseline the two groups were homogeneous, a t-Student test was 
used to compare both conditions, on the anthropometric, psychological and behavioural 
variables. 
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Comparisons between groups on the repeated measures were done using mixed 
repeated measures ANOVA. Post hoc LSD test for mean differences was used to 
compare the three assessments (T1, T2 and T3) for the anthropometric, psychological 
and behavioural measures, in each group (CBT and waiting list). 
Additionally, to explore if binge eating disorder had suffered changes in the three 
assessments, the Cochrane-Q test was used.   
Finally, to investigate if the amount of weight loss in the experimental group 
was related with educational level and family income, a Spearman correlation was used. 
 
  
RESULTS 
 
To assert if the participants who did CBT differed from the ones who were 
attributed to the waiting list, the two groups were compared regarding to 
anthropometric, psychological and behavioural variables. 
 
Table 3 – Comparison of participants placed in intervention (CBT) with participants in 
waiting list (WL) at baseline assessment (T1) 
Variables 
t-Student 
t(df)p 
Weight (kg) -.476(24).639 
Abdominal perimeter (cm) -.810(24).426 
BMI (kg/m
2
) -.996(24).329 
Health QoL .734(24).470 
Sexual QoL -.854(24).401 
Depression -.153(24).880 
Anxiety  .011(24).992 
Stress .502(24).620 
Restrained eating -.788(24).438 
Emotional eating .069(24).946 
External eating .702(24).489 
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To explore if the variables changed during the three assessments, within the 
same condition, CBT and waiting list groups were analysed separately, after the 
confirmation of sphericity for all variables/groups with the Mauchly test. 
Results of the control group are presented in table 4.  
 
Table 4 – Waiting list: comparison between T1, T2 and T3 assessment for all variables 
Variables 
T1 
n=9 
M(SD) 
T2 
n=9 
M(SD) 
T3 
n=9 
M(SD) 
I J 
Mean Difference 
I-J(SE)p 
 
η2p 
Weight (kg) 78.1(7.169) 78.1(6.294) 78.9(5.704) T1 T2 .022(.561).969 
.270      T3 -.822(.765).314 
    T2 T3 -.844(.492).125 
Abdominal 
perimeter(cm) 
98.5(6.961) 99.5(7.000) 99.0(5.831) T1 T2 -.989(1.508).530 
.069 
     T3 -.478(.695).511 
    T2 T3 .511(1.289).702 
BMI (kg/m
2
) 31.8(2.401) 31.8(2.201) 32.2(2.230) T1 T2 -.011(.234).963 
.267      T3 -.372(.332).295 
    T2 T3 -.361(.212).127 
Health QoL 2.5(.623) 2.7(.645) 2.8(.627) T1 T2 -.175(.138).243 
.406      T3 -.286(.124).052 
    T2 T3 -.111(.109).336 
Sexual QoL 3.3(.676) 3.1(.954) 3.1(.909) T1 T2 .222(.229).360 
.167      T3 .222(.176).242 
    T2 T3 .000(.157)1.000 
Depression 1.7(.776) 1.6(.555) 1.7(.833) T1 T2 .079(.107).479 
.065      T3 .016(.230).947 
    T2 T3 -.063(.235).794 
Anxiety 1.6(.580) 1.5(.589) 1.4(.351) T1 T2 .063(.093).512 
.226      T3 .206(.137).170 
    T2 T3 .143(.141).340 
Stress 1.9(.463) 1.8(.853) 1.9(.780) T1 T2 .079(.160).633 
.032 
     T3 -.016(.198).938 
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    T2 T3 -.095(.245).780 
Restrained 
Eat 
3.0(.722) 2.8(.747) 2.7(733) T1 T2 .178(.262).517 
.149 
     T3 .278(.262).320 
    T2 T3 .100(.130).464 
Emotional 
Eat 
2.7(.844) 3.0(.978) 2.8(.921) T1 T2 -.222(.121).103 
.299 
     T3 -.093(.146).545 
    T2 T3 .130(.161).443 
External Eat 2.8(.402) 2.8(.631) 2.9(.740) T1 T2 -.033(.125).796 
.121      T3 -.167(.166).344 
    T2 T3 -.133(.147).391 
 
Changes in the experimental group from baseline to follow-up are presented in 
table 5.   
 
Table 5 – CBT group: comparison between T1, T2 and T3 assessment for all variables 
Variables 
T1 
n=17 
M(SD) 
T2 
n=17 
M(SD) 
T3 
n=15 
M(SD) 
I J 
Mean Difference 
I-J(SE)p 
 
η2p 
Weight (kg) 76.9(5.434) 76.4(5.100) 74.5(4.390) T1 T2 .493(1.093).659 
.536      T3 2.233(.621).003 
    T2 T3 1.740(.915).078 
Abdominal 
perimeter(cm) 
96.5(5.852) 96.1(5.472) 95.0(5.954) T1 T2 -.187(.897).838 
.288 
     T3 1.620(1,122).171 
    T2 T3 1.807(.759).032  
BMI (kg/m
2
) 30.9(2.297) 30.7(2.581) 29.9(2.085) T1 T2 .177(.455).703 
.521      T3 .891(.251).003 
    T2 T3 .713(.392).091 
Health QoL 2.7(.633) 3.0(.498) 2.9(.644) T1 T2 -.343(.152).041 
.289      T3 -.210(.138).151 
    T2 T3 .133(.166).435 
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Sexual QoL 3.0(.989) 3.1(1.017) 3.2(.516) T1 T2 -.178(.102).104 
.183      T3 -.133(.203).521 
    T2 T3 .044(.172).800 
Depression 1.6(.676) 1.3(.326) 1.5(.552) T1 T2 .286(.156).088 
.233      T3 .143(.160).388 
    T2 T3 -.143(.101).177 
Anxiety 1.6(.677) 1.4(.411) 1.5(.493) T1 T2 .137(.098).185 
.158      T3 .051(.120).678 
    T2 T3 -.086(.085).328 
Stress  2.0(.633) 1.6(.342) 1.9(.605) T1 T2 .343(.136).024 
.375      T3 .095(.137).499 
    T2 T3 -.248(.108).038 
Restrained Eat 2.8(.691) 3.3(.619) 3.3(.616) T1 T2 -.540(.164).005 
.547      T3 -513(.134).002 
    T2 T3 .027(.146).858 
Emotional Eat 2.8(.728) 2.4(.674) 2.6(.737) T1 T2 .411(.175).034 
.287      T3 .298(.155).076 
    T2 T3 -.113(.128).391 
External Eat 2.9(.547) 2.7(.433) 2.7(.425) T1 T2 .233(.110).052 
.454      T3 .293(.086).004 
    T2 T3 .060(.079).461 
 
 
In relation to binge eating disorder (BED), there were significant differences in 
the intervention group, comparing T1 both with T2 and with T3 (Q(2)=2.315; p=.021). 
Before the intervention (T1) there were 6 participants (from a total of 17) with BED; at 
T2 and T3 only one participant met the criteria for this disorder. 
In the waiting list condition there were no significant differences regarding BED 
prevalence (Q(2)=.000; p=1.000) since there were the exact same number of 
participants with BED in T1, T2 and T3 (4 women with binge eating disorder and 5 
without). 
Additionally, within the experimental group, it was observed that the association 
between family income and amount of weight lost was not significant (rp=.232; p=.406). 
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Yet, there was a very strong, positive and significant correlation between the 
educational level and the amount of weight lost (rp=.722; p=.001). 
 
 
DISCUSSION 
 
Achieving weight reduction and maintaining the weight loss after the end of an 
intervention is not easy (Cooper et al., 2010; DiLillo et al., 2003). In the present 
research, the mean weight loss evidenced at follow-up (T3), by the participants who had 
undergone CBT, was 2.4kg or 3.1% of the baseline weight. In opposition, between 
baseline and follow-up, the control group had a mean 1.2% increase of their initial 
weight (that is, a mean increment of 0.8kg). 
Although this reduction was below the 5% loss pointed as a successful weight 
loss in other studies (e.g., Teixeira et al., 2004), it was statistically significant.  
Immediately after the intervention, a significantly decrease in emotional and increase in 
restrained eating was observed in the participants who did CBT. At follow-up the 
emotional eating was not significantly different, but the decrease in restrained behaviour 
observed in T2 was maintained. Moreover, four months after the CBT had finished, 
external eating was significantly lower when compared with baseline. Additionally, 
BED also decreased significantly in women who did the CBT (this reduction was 
observed immediately after the intervention and maintained at follow up), comparing 
with the control group, in which the participants who met the criteria for BED at T1 
continued meeting these at follow-up (T3).  
Even though eating behaviours changed significantly within an eight-week 
individual CBT (demonstrated in the T2 assessment), it did not reflect an objective 
weight reduction immediately after the intervention, given that there were no significant 
changes between the baseline (T1) and the second assessment (T2). This is congruent 
with prior research which demonstrates that, despite the decrease in binge eating 
behaviour, weight loss might not be achieved (Grilo & Masheb, 2005). It has been 
concluded elsewhere, regarding cognitive-behavioural and behavioural interventions, 
that the first is more effective in reducing binge eating while the second promotes a 
greater weight loss reduction by the end of the intervention (Munsh et al., 2007), an 
evidence that supports the results of the present research. 
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Cognitive restraint has been associated with a significantly lower energy and fat 
intake, higher carbohydrate and fibre use and been also strongly associated to a higher 
weight reduction at a 18-month follow-up (Keränen, Strengell, Savolainen, & Laitinen, 
2011). This conclusion supports the observation that, four months after the intervention, 
a significant weight loss accompanied by an increase in restrained eating and a decline 
in external ingestion, occurred when compared with the baseline assessment. This data 
is also in agreement with another study which pointed out that, after a two-year follow-
up, participants who managed to maintain their weight, also demonstrated the 
maintenance of the changes in eating behaviours (Pekkarinen, Takala, & Mustajoki, 
1996).  
Cognitive factors and the establishment of clear objectives, components that 
were approached in this brief CBT, have been evidenced as important when addressing 
a treatment of this kind, as they can contribute to weight regain (Cooper & Fairburn, 
2001).  
Stress levels decreased significantly from the baseline (T1) to the post-
intervention assessment (T2). Given that during the third and fourth sessions, we 
addressed the triggers of excessive food ingestion, and considering that these triggers 
are frequently stressful events (Loth, van den Berg, Eisenberg, & Neumark-Sztainer, 
2008), the identification and exploration of strategies to manage these triggers could 
have some influence in the observed stress decline. However, stress levels were 
significantly higher at the time of follow-up in the intervention group, when compared 
with the prior assessment (T2). As shown before, there is evidence that cortisol 
reactivity, in response to stress, stimulates a caloric food intake (Dallman et al., 2004; 
Epel, Lapidus, McEwen, & Brownell, 2001). Thus, it is hypothesized that a significant 
increase in stress might have prevented further weight loss. We do not exclude that the 
follow-up assessment (T3) could have been a stressful event itself for the participants 
who have perceived a weight lost lower than expected. Knowing that this would be the 
last contact with this research (which can have been perceived has a source of support in 
a weight loss intended process), it could have contributed to an increase in stress levels 
at T3.  
The therapy format (group versus individual) has been subject of debate. There 
are no significant differences in terms of the intervention‘s efficacy when comparing 
group with individual interventions (Adams, Grady, Wolk, & Mukaida, 1986; Jeffery et 
al., 1983). However, in a recent research with a large sample, weight reduction (as well 
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as decrease in blood pressure, glucose and cholesterol) was higher in a group 
intervention, when compared with an individual one (Jovanović et al., 2009). 
Consequently, it is suggested that a group format could enhance the efficacy of this 
CBT. Furthermore, and because contents regarding physical exercise and nutrition were 
promoted according to general guidelines (WHO, 2006), it would be important, in 
future research, to include individualized nutritional and physical exercise plans as a 
complement to this intervention, given their efficacy in weight reduction (Wu, Gao, 
Chen, & van Dam, 2009). 
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Abstract  
 
Objective: The aim of this study was to build a causal model to explore the predictors 
of BMI in normal weight, overweight and obese middle-aged women.  
Methods: A community sample of women aged between 42 and 60 years answered a 
questionnaire to determine socio-demographic information (age, parity, professional and 
marital status, education and household income), lifestyle (physical exercise, coffee and 
alcohol intake, and smoking) and self-reported weight, height and menopausal status. 
Several instruments were used to assert psychological variables, namely depression, 
anxiety, stress and body shape concerns. Structural equation modelling was used to 
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build a causal model, encompassing all variables mentioned, to compare the three 
categories of BMI (i.e., normal weight, overweight and obese participants).  
Results: The models comparing the three categories of BMI presented a good fit and 
the invariance analysis regarding the structural model assured group comparison. 
Education was a significant predictor of BMI for normal weight (β=-.083; p=.023), 
overweight (β=-.085; p=.023) and obese (β=-.086; p=.023) women. Depression also 
predicted BMI for normal weight (β=-.230; p<.001), overweight (β=-.236; p<.001) and 
obese (β=-.237; p<.001) participants. Stress predict body weight only in normal weight 
subjects (β=.289; p<.001). Finally, for normal weight (β=.247; p<.001), overweight 
(β=.254; p<.001) and obese (β=.254; p<.001) participants, body shape concerns 
predicted BMI. 
Conclusions: Our results demonstrate that depression is a significant and negative 
predictor of BMI (women with higher levels of depressive symptoms evidenced a lower 
BMI) and stress only predicting BMI in normal weight participants (women with higher 
scores in stress presented a higher BMI). Body shape concerns and education were both 
predictors for all categories of BMI, demonstrating that women with higher education 
and less frequent concerns with body shape presented a lower BMI. 
 
Keywords: middle-age; BMI; predictors; normal weight; overweight; obesity 
 
 
Introduction 
 
High body mass index (BMI), namely overweight and obesity, has been evidenced as 
compromising quality of life, particularly when health related
1
. In addition, overweight, 
especially obesity, have a significant impact on the onset of functional impairment, 
including impairment in daily living activities, lower body mobility and strength
2
. 
The increment of the risk of developing several diseases has also been emphasized, 
namely, coronary heart disease
3
, diabetes, hypertension
4
 and several cancers
5
 have been 
associated with an increased BMI. 
Given the actual high (and growing) prevalence of obesity and excessive weight in 
European countries and the United States
6,7
, it is important to assert the underlying 
factors in order to allow an effective management of these conditions
5
. 
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There is evidence that women usually report a weight gain during midlife
8-10
. Age, 
namely being over 40, is associated with obesity/overweight
11
. Moreover, a low 
educational level
11,12
, unemployment
12
 and being married
11
 have also been associated 
with higher BMI. It has also been observed that in women with a high socio-economic 
status the relationship between depression and obesity is stronger than in women with 
low socio-economic status
13
. 
Lifestyle habits are other determinant in overweight and obesity. It is proven that having 
a sedentary lifestyle facilitates the occurrence of both
11
, as it does being an ex-smoker 
or a non-smoker, who have higher BMI compared with current smokers
14
. However, 
this conclusion is not consistent: daily cigarette consumption has also been associated 
with higher BMI in some studies
12
, or evidenced as not having any relation with BMI in 
others
15
. Alcohol consumption has also been associated with a lower likelihood of being 
obese, in women over 50 years of age
16
.  
Stress can be related to weight gain, especially in women in the first year of 
university
17
. Furthermore, having a child with a life-threatening disease
18
 and workload 
increment
19,20
 will function as severe stressors and lead to weight increase in women. 
Similarly, it is observed that both salivary cortisol secretion and BMI increase with the 
proximity of a stressful event are connected, and the first can significantly predict the 
latter
21
. Furthermore, strains in family interactions, perceived limitations in life and 
financial difficulties have also been related with weight gain in women who already 
have a high BMI
19
.  
Nevertheless this association has not been consistently confirmed
22
. Perceived stress did 
not predict the weight category in a group of peri-menopausal African American 
women
23
, nor was it related with body weight in another research
24
. 
It has been emphasized that a BMI between 20 and 25 is linked with optimal mental 
health and lower health services usage
25
. Therefore, psychological distress has been 
identified as higher among underweight, overweight and obese women, compared with 
their counterparts with normal BMI, independently of lifestyle factors
26
. 
The literature evidences that obesity, and a higher BMI, are strongly associated with 
depression
13,27-31
. An increased BMI is also related to the onset of depression in female 
participants: an early onset can be associated with higher BMI
32
. Nonetheless, other 
variables might account for this connection. BMI has been associated with depression 
levels, but this positive relation seems to be mediated by low dichotomous thinking; in 
women who presented high levels of this cognitive bias this association was absent
33
.  
218 
 
Despite the evidences of a strong connection between depression and a high BMI, this 
conclusion is not unanimous. A meta-analysis conducted in the field did not suggest a 
significant association between obesity and depression
34
 and, among female 
adolescents, an absence of relation between obesity and depression was also 
confirmed
35
. 
Again, in a study with obese and non-obese participants, obesity was not associated to 
depression. However, in people who had ever experienced a major depression episode, 
weight gain was more likely to occur during this depressive period in obese participants 
given their higher probability to over-eat during the episode
36
. In another research, 
depression did not increase the risk for future obesity although the reverse was factual: 
obese people had an increased risk for depression
37
.  
Anxiety disorders have also been related with a higher BMI in women
32
. Additionally, 
sub-clinical anxiety was significantly higher in obese patients than in normoponderal 
subjects
38
 and middle-aged women with high weight anxiety have been found to be 
more likely to engage in dieting behavior
39
. 
Contrary to previous researches, anxiety was not associated with BMI in a multiethnic 
group of women
31
. Moreover, anxiety was not associated with weight cycling, neither in 
normal-weight nor in overweight women
40
 and, in a research with adolescents, anxiety 
levels did not differ between obese and normal weight subjects
41
.  
Prior body dissatisfaction has also been identified elsewhere as a predictor of body 
weight increase rate in the years following pre-adolescence
42
. Body shape concerns are 
frequently studied with an adolescent population
43,44
 or in the context of eating 
disorders
45,46
. However, little is known about these concerns in the midlife population. 
Given that around menopause changes in body fat distribution will be observed, with an 
increase in total body fat and visceral fat
10,47,48
, these types of concerns are pertinent to 
explore in order to identify if they play an important role as BMI predictors. 
Therefore, the objective of this study is to investigate a causal model of BMI in normal 
weight, overweight and obese middle-aged women to explore if different predictors are 
evidenced in the different weight categories.  
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Methods 
 
Participants 
Participants were a community sample of 986 women, aged between 42 and 60 years. 
The mean BMI of normal weight participants was 22.3 kg/m
2
 (SD=1.685), of 
overweight women was 27.1 kg/m
2
 (SD=1.475) and obese participants had a mean BMI 
of 33.7 kg/m
2
 (SD=3.041). 
Table 1 describes the 986 participants by body weight class. 
 
Table 1 - Distribution of the study participants according to BMI 
 Normal weight Overweight Obese 
Characteristics n % n % n % 
n 527 53,4 334 33.9 125 12.7 
Age (M; SD) 49.0(5.153)  50.4(5.308)  50.6(5.114)  
Marital status       
Married or in a 
relationship 
357 68.0 247 74 91 72.8 
Not married or in 
a relationship 
168 32.0 87 26.0 34 27.2 
Parity       
0 48 9.3 25 7.7 11 8.8 
1 148 28.6 95 29.3 40 32.0 
2 225 43.4 162 50.0 56 44.8 
3 71 13.7 30 9.3 15 12.0 
>3 26 5.1 12 3.7 3 2.4 
Education       
Primary school  36 7.0 48 14.6 27 21.8 
Middle school 89 17.3 86 26.1 44 35.5 
High school  140 27.3 104 31.1 32 25.8 
University degree 
or higher 
248 48.4 91 27.7 21 16.9 
Professional status       
Active 452 87.9 280 84.6 102 82.9 
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Inactive 62 12.1 51 15.4 21 17.1 
Family annual 
income 
      
≤ 10.000 € 85 19.4 78 26.9 32 30.5 
10.001 – 20.000 € 96 21.9 80 27.6 41 39.0 
20.001 – 37.500 € 107 24.4 74 25.5 23 21.9 
37.501– 70.000 € 102 23.3 46 15.9 5 4.8 
≥ 70.001 € 48 11.0 12 4.1 4 3.8 
Menopausal status       
Pre-menopause 162 31.3 90 27.0 27 21.8 
Peri-menopause 152 29.3 97 29.1 42 33.9 
Post-menopause 204 39.4 146 43.8 55 44.4 
Physical exercise       
Yes 269 51.6 138 41.8 33 26.4 
No 252 48.4 192 58.2 92 73.6 
Smoking behaviour       
Current smoker 158 30.7 70 21.3 15 87.8 
Current non-
smoker 
357 69.3 258 78.7 108 12.2 
Alcohol intake       
Yes 284 54.4 154 46.4 51 40.8 
No 238 45.6 178 53.6 74 59.2 
Coffee intake       
Yes 454 86.8 292 87.4 104 83.2 
No 69 13.2 42 12.6 21 16.8 
 
 
Procedure 
This cross-sectional study encompasses a community sample of 1,003 women who were 
mainly recruited through schools and universities in the city of Lisbon. The inclusion 
criteria in the research were gender (women), literacy and age (between 42 and 60 
years).  
The American Psychological Association‘s standards on the ethical treatment of 
participants were followed. A written informed consent form was delivered to all 
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participants, explaining the aims of the study, emphasizing that the participation in this 
research was voluntary and that participants could interrupt their collaboration at any 
time, without any consequences. Each participant kept a copy of the informed consent 
form, where the contacts of the responsible researcher were included (so that women 
could contact her if any question emerged). 
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1,003 Portuguese women, between 42 and 60 years of age, filled in all the 
instruments adequately (45 were excluded due to lack of sufficient information).  
Of these 1,003 women, 17 were excluded from the present study: 7 participants 
presented underweight (that is, BMI lower than 18.5 kg/m
2
) and 10 did not give enough 
information to calculate the BMI. The present research includes 986 female participants, 
presenting three different BMI categories: normal weight, overweight and obesity. 
 
Measures 
To assess socio-demographic, lifestyle, menopausal status, BMI and psychological 
variables (depression, anxiety, stress and body shape concerns) a questionnaire and two 
instruments, which presented good psychometric properties, were used.  
 
Depression, Anxiety and Stress 
These variables were assessed through the Portuguese version of the Depression, 
Anxiety and Stress Scales
49,50
; each subscale includes 7 items, with answers being given 
in a 4-point Lykert-type scale (ranging from ―did not apply to me‖ to ―it applied to me 
most of the time‖).  
 
Body Shape Concerns 
The Body Shape Questionnaire
51
 assesses the concerns about the body appearance in 34 
items. Responses were given in a 6-point Likert-type scale with scores ranging from 
―never‖ to ―always‖. Item 26 (―Have you vomited in order to feel thinner?‖) was 
excluded from this Portuguese version of the instrument, because it presented levels of 
kurtosis (ku=79) and skewness (sk=8) above those recommended for structural equation 
modelling (ku=7; sk=3)
52
. Moreover, this item had the lowest standardized estimate 
(
2
=.091). In 
addition, it presented very high modification indexes (around 60) and its residual was 
correlated with several other residuals from other items. This evidenced that this item 
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explained very little of the measured construct, and shared with several other items the 
little variance that it explained. Therefore, it was not included.   
 
Menopausal status 
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria53. Pre-menopausal women were identified for not having any 
changes in their menstrual cycle. Peri-menopausal participants would report a variable 
cycle length (a difference of more than seven days than usual) or had skipped two or 
more cycles and had an amenorrhea interval superior to sixty days. Post-menopausal 
women had, at least, a twelve-month period of amenorrhea. 
  
Socio-demographic variables, lifestyle and BMI 
Socio-demographic (age, marital status, parity, professional status, educational level, 
family‘s annual income) and lifestyle characteristics (alcohol and coffee intake, 
smoking and physical exercise) were assessed.  
Lifestyle characteristics were assessed in terms of presence/absence, amount and/or 
frequency. Hence, physical exercise was measured in terms of times per week, and 
during how many minutes the participant exercised; a mean between weekly frequency 
and duration was used in the structural equation model. Coffee intake, when present, 
was assessed in a four-option scale, ranging from occasionally to more than five per 
day. Alcohol intake, when observed, was measured both in terms of frequency (―daily‖, 
―every weekend‖ or ―rarely‖) and quantity (―until I feel drunk‖, ―moderately‖ or ―less 
than a glass per occasion‖); a mean value of both translates the alcohol consumption 
variable, in the causal model. Finally, for current smokers, smoking was quantified in a 
6-point Likert-type scale that ranged from less than 10 cigarettes per month, until more 
than 40 cigarettes per day; this quantification integrated the structural equation model to 
assert the influence of smoking on BMI. 
BMI was calculated through self-reported weight and height. 
 
Statistical analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. 
Group differences between women with normal weight, overweight, and obese, 
regarding anxiety, depression, stress and body shape concerns, were evaluated with the 
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one-way ANOVA (followed by post-hoc Tukey‘s test) implemented in SPSS Statistics 
(v. 19, IBM SPSS Inc, Chicago, IL).  
Multicollinearity between the independent variables was explored with the variance 
inflation factor (VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables must present a value below 5 in order to indicate the absence of collinearity
54
.  
To test the causal BMI model, a structural equation model was built relating this 
dependent variable with sixteen independent variables (namely, age, marital status, 
parity, professional status, family‘s annual income, educational level, transition from 
pre- to peri- and from peri- to post-menopause, alcohol and coffee, smoking, physical 
exercise, depression, stress, anxiety and body shape concerns). The model was 
evaluated with SPSS AMOS software (v. 18, IBM SPSS Inc, Chicago, IL). The quality 
of the fit of the structural equation model was given by chi-square statistics (X
2
/df), 
comparative fit index (CFI), goodness of fit index (GFI) and root mean square error of 
approximation (RMSEA), and the reference values currently used to suggest a good 
model fit in structural equation modelling
55
 were used. 
A 3-step approach was employed to evaluate the causal structural model. First, the 
factors‘ measurement model was evaluated to demonstrate an acceptable fit. Thereafter, 
the structural causal model, encompassing the dependent and the independent variables, 
was adjusted and the significance of the causal trajectories was evaluated. Finally, 
invariance analysis was done comparing the three groups (women with normal weight, 
with overweight and with obesity) and, if invariance of the model was evidenced, the 
three groups would be compared regarding the significant predictors of actual BMI. 
 
 
Results 
 
The three BMI categories were compared regarding the four psychological variables: 
stress, depression, anxiety, and body shape concerns. The results are presented in table 
2. 
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Table 2 – Comparative analysis between the three groups regarding the psychological 
variables  
Psychological 
variables 
Normal 
weight 
Overweight Obese One-way ANOVA 
M(SD) M(SD) M(SD) Groups compared MD(SE)p 
Anxiety 1.3(.438) 1.4(.489) 1.4(.471) Norm_W Over_W -.102(.032).005 
    Norm_W Obes -.135(.046).010 
    Over_w Obes -.033(.049).773 
Depression 1.4(.522) 1.5(.598) 1.5(.577) Norm_W Over_W -.102(.039).026 
    Norm_W Obes -.107(.056).135 
    Over_w Obes -.006(.059).995 
Stress 1.7(.549) 1.7(.570) 1.8(.582) Norm_W Over_W -.024(.039).819 
    Norm_W Obes -.085(.056).283 
    Over_w Obes -.061(.059).554 
Body shape 
concerns 
1.7(.634) 2.2(.847) 2.5(.983) Norm_W Over_W -.477(.057)*** 
    Norm_W Obes -.834(.084)*** 
    Over_w Obes -.357(.089)*** 
MD: mean difference; SD: standard deviation; SE: standard error; *** p≤.001 
 
Multicollinearity analysis 
VIF values were above 5 for anxiety evidencing collinearity with other independent 
variables in the model. For that reason anxiety was excluded from the causal model. 
 
Fit of the model 
Both measurement (X
2
/df=2.419; CFI=.992; GFI=.986; RMSEA=.038; p=.948; C.I. 
90%=].026; .050[) and structural model evidenced a good fit (X
2
/df=3.251; CFI=.965; 
GFI=.971; RMSEA=.048; p=.741; C.I. 90%=].042; .053[). 
 
Invariance analysis 
The unconstrained measurement model did not have a significantly better fit than the 
model with constrained factorial weights (X
2
(3)=5.906; p=.116) hence confirming the 
invariance of the measurement model. Therefore, there are no significant differences in 
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the factorial measurement weights between the three groups (normal weighted, 
overweighed and obese participants) and the groups can be compared regarding socio-
demographic, menopausal status, lifestyle and psychological variables. 
 
Causal Model 
A causal model for BMI was built, integrating fifteen independent variables and 
comparing three different categories of BMI. The results are evidenced in table 3. 
 
Table 3 – Structural weights of the dependent variable regarding all independent 
variables considered in the causal model 
Structural weights 
Normal weight 
β(SE)p 
Overweight 
β(SE)p 
Obese 
β(SE)p 
BMI ← Age .081(.015).056 .083(.015).056 .083(.015).056 
BMI ← Marital status .052(.134).112 .053(.134).112 .053(.134).112 
BMI ← Professional status -.027(.175).406 -.027(.175).406 -.027(.175).406 
BMI ← Educational level -.083(.041).023 -.085(.041).023 -.086(.041).023 
BMI ← Annual income -.067(.062).072 -.069(.062).072 -.069(.062).072 
BMI ← Parity -.033(.059).294 -.033(.059).294 -.033(.059).294 
BMI ← Smoking -.029(.037).360 -.030(.037).360 -.030(.037).360 
BMI ← Alcohol -.042(.075).183 -.043(.075).183 -.043(.075).183 
BMI ← Coffee .004(.067).899 .004(.067).899 .004(.067).899 
BMI ← Physical exercise .030(.112).343 .031(.112).343 .031(.112).343 
BMI ← Transition from pre- 
to peri-menopause 
-.025(.150).490 -.026(.150).490 -.026(.150).490 
BMI ← Transition from peri- 
to post-menopause 
.009(.181).844 .010(.181).844 .010(.181).844 
BMI ← Depression -.230(.143)*** -.236(.143)*** -.237(.143)*** 
BMI ← Stress .289(.043)*** .107(.226).093 .077(.348).437 
BMI ← Body shape concerns .247(.061)*** .254(.061)*** .254(.061)*** 
β: standardized estimate; SE: standard error; ***p≤.001 
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Discussion 
 
Univariate and comparative analysis showed significant differences between midlife 
women with normal weight, overweight and obesity regarding several psychological 
variables. 
As evidenced elsewhere, normoponderal participants have significantly lower scores of 
non-clinical anxiety and depression when compared with obese individuals
38
. The 
univariate analysis supports this for anxiety, which was significantly lower in women 
with normal weight when compared both with overweight and obese participants. 
However, depression levels did not differ between normal weight and obese 
participants; the significant differences were only between women with a healthy 
weight and overweight, being the latter who evidenced higher levels of depressive 
symptoms. 
In the comparative analysis, stress did not differ among the three groups. On the 
contrary, body shape concerns where significantly different between the three BMI 
categories (normal weight, overweight and obesity) and women with a higher BMI 
category presented more frequent concerns with their body shape when compared with 
participants with a lower BMI category.  
When socio-demographic, lifestyle and menopausal status are controlled in the 
multivariate analysis it is observed that depression is a significant predictor of BMI, in 
all three groups (healthy weight, overweight and obesity). However, depressive mood is 
a negative predictor, that is, for each BMI group women with more frequent depressive 
symptoms presented lower BMI than their counterparts (included in the same BMI 
category) with higher body weight. This outcome is fairly new since either a positive or 
no association between BMI (and overweight/obesity) and depression have been 
evidenced before 
13,27-31,34,36,56
.  
However, it has been previously documented that decreased emotional well-being was 
significantly associated with poor appetite
57
 and it is also known that the diagnosis 
symptoms for depression can include weight and appetite changes, namely, gain or 
loss
58
. In addition, for men who quit smoking, an improved mood predicted weight gain 
at follow up, comparing with counterparts with depression, which gain significantly less 
weight
59
. Also, the weight loss literature emphasized the strong association between 
depression and physiological changes when a plateau of weight reduction is achieved: 
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after losing 11% of initial weight, depression symptoms increased significantly
60
. 
Moreover, it has been shown elsewhere that the remission of depressive symptoms is 
associated with weight gain, and this was not a pharmacological effect but rather a 
result of recovery
61
. This might indicate that, when depressed, people can have an 
inferior weight than when they are not depressed; this could explain the negative 
correlation between BMI and depressive mood. Therefore, the literature has already 
presented few evidences indicating that depressive symptoms can be a negative, rather 
than a positive predictor of body weight.  
Regardless of the depressive mood, increased stress can predict binge eating
62
 and 
consequently body weight increase. In the present research, stress is a positive and 
significant predictor of BMI, but only in women with normal weight. Hence, 
participants (with a healthy BMI) with higher levels of stress manifested a higher BMI 
than women feeling less stress. This is in agreement with previous studies
17-21
. 
However, stress has also been mentioned as not related with body weight
24
 and a prior 
study on weight cycling revealed that stress had no significant association with BMI in 
overweight women
40
. The causal model, which allows the control of confounding 
variables, shows stress as significantly predicting BMI, but only in normal weight 
participants. This might evidence that in women who do not have major problems with 
body weight (that is, are neither overweight nor obese), stress influences weight; 
whereas in participants who have difficulties related with weight management (that is, 
are overweight or obese) body weight is influenced by factors other than stress. Thus, 
factors such as behavioural weight control, self-defeating thoughts or frustration for not 
meeting thinness social standards might influence the BMI in overweight and obese 
women. 
Body shape concerns were also a significant predictor of BMI: participants with more 
frequent body shape concerns evidenced higher BMI than their counterparts with less 
frequent concerns about their body form. Body dissatisfaction has already been 
identified as predicting the weight gain rate after adolescence
42
. These results 
demonstrate that, in midlife, concerns with the body (which might evidence 
dissatisfaction with its form) predict a higher body weight. 
Education has been mentioned as a significant and negative predictor of BMI
11,12,63,64
. 
Our results support the conclusions from previous studies that educational level is a 
negative predictor of BMI, not only in overweight and obese participants, but also in 
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normal weight participants. Regarding other socio-demographic variables, age and 
income were marginally significant predictors of BMI for the three categories. 
Although physical activity has been consistently associated with weight variability
65
 the 
relation between BMI and physical exercise is inexistent in this study. Although almost 
half of normal weight and overweight participants, and 26% of obese women of this 
sample, do practise physical activity, the absence of a connection might be related with 
a low frequency and duration of physical activity done by these participants. 
Additionally, although around menopause women report a weight increase
9
, 
menopausal status was not a significant predictor of BMI.  
It is important to consider that in self-report assessments women can underreport their 
weight and height, independently of depression levels or BMI status
66
, which might be a 
limitation. 
The sample sizes for the three sub-groups (527 participants with normal weight, 334 
with overweight and 125 with obesity) were adequate for this type of statistical analysis, 
accordingly with the common rule of thumb of five subjects per manifest variable, 
which is current practice in structural equation modelling
52
. Given the absence of 
multicollinearity, good psychometric properties of the instruments used, and the good fit 
of both measurement and causal models, these outcomes are statistically valid and 
reliable. Nevertheless, the fact that this research has a cross-sectional design limits the 
generalization of these results.  
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health and menopause-related factors, lifestyle, life events, menopausal symptoms, 
body shape concerns, stress and spirituality 
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Abstract 
 
Background: Midlife women can face several significant changes during middle-age 
related with menopause, health deterioration and life events, which can have an impact 
on their well-being. The aim of this research was to build a causal model to identify 
variables which can predict subjective well-being in midlife. 
Methods: A community sample of 1,003 women aged between 42 and 60 years filled in 
questionnaires which asserted socio-demographic, health and menopause-related, and 
lifestyle characteristics. Additionally, participants answered the Body Shape 
Questionnaire (Cooper et al, 1987), the Depression, Anxiety and Stress Scales 
(Lovibond & Lovibond, 1995), the Spiritual Well-being Scale (Gomez & Fisher, 2003), 
the Life Events Survey (Sarason et al., 1978), the Menopause Symptoms‘ Severity 
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Inventory (Pimenta et al., 2011) and the Subjective Well-being Scale (Albuquerque & 
Tróccoli, 2004). Structural equation modelling was used to generate a causal model to 
explore which variables predicted well-being in midlife, controlling for possible 
confounding variables. 
Results: Stress (β=-.247;p=.023), spirituality (β=.252;p<.001), life events 
(β=.166;p=.023), depressive mood (β=-.493;p=.019), having a recent psychological 
problem (β=-.117;p=.047) and coffee intake (β=.104;p=.033) were the statistically 
significant predictors of subjective well-being. These variables account for 92% of the 
well-being. 
Conclusions: Although menopause has been identified as having a negative impact on 
well-being, this impact was not confirmed. Moreover, since life events and stress were 
significant predictors, hardiness development in middle-aged should be focused. In this 
context, spirituality is also a personal resource to promote well-being. 
 
 
Introduction 
 
In addition to physiological health, it is important to understand what determines well-
being during the aging process and how the various factors are associated with women‘s 
psychological and physical optimal functioning [1]. The pertinence of this line of 
research is incremented by the fact that, around the year 2050, the percentage of people 
with more than 60 years old will grow from 10% to 21% [2]. The literature has 
evidenced that general psychosomatic complaints can have a negative impact on well-
being in middle-aged women [3]. 
Also, lowered well-being is related with the presence of certain cytokines (namely, 
interleukin-6, implicated in age-related diseases such as osteoporosis, some forms of 
cancer, Alzheimer‘s, among others) proving that there is an association between 
psychological factors and inflammatory process, characteristic of later life [4]. 
Moreover, in a Japanese research with middle-age and elderly men and women, who 
were assessed in 1993 and again in 2000, low subjective well-being was related with 
mortality (independent of the causes, gender, age, education, health-related variables 
and living alone) [5]. 
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However, other variables such as socio-demographic, lifestyle, health and menopause-
related, menopause symptoms, spirituality, stress, body shape concerns and life events 
can have an impact on well-being. 
Socio-demographic characteristics 
Higher educational level [5,6], higher income [7,8,9], parental status [10,11], being 
married [3,5,6,8] and professionally active [12] are associated with better health and 
well-being. 
However, this is not unanimous: single middle-aged women have presented some 
personality characteristics enhanced,  which were associated with higher well-being, 
than their married counterparts [13]; childlessness has also been related to midlife well-
being (not directly, but through the influence of current marital, health and socio-
economic status) [14]. 
 
Lifestyle  
Healthier lifestyles have been associated with enhanced well-being [1,15]. Dieting and 
smoking behaviour [3], physical activity [16], and alcohol (when consumed moderately 
and by women who exercise and do not smoke) [17], had a significant impact in well-
being during the climacteric period. 
 
Health and menopausal status, hormone therapy and medical help search 
Variables related with health status can significantly influence well-being in midlife [3].  
Regarding menopausal status, the results are not consensual. Although very few studies 
have explored well-being during menopausal years, evidences are that the menopausal 
status does not influence well-being [3]. However, in a more recent research, and along 
the same menopause stage, it has been concluded that, as women go from early to late 
peri-menopause, negative mood decreases, positive mood is maintained and well-being 
improves significantly [18]; additionally, in post-menopausal women, age progression 
was significantly associated with a decrease in negative affect and an increase in 
positive affect [19]. 
Despite this, a negative impact has also been reported: menopause can worsen well-
being [20].  
In another longitudinal research, neither being in menopause transition nor hormonal 
levels (such as estrone glucuronide and follicle-stimulating hormone), predicted the 
participants‘ well-being [21]. 
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Hormone therapy has also been described as having a positive impact on well-being, 
incrementing it, especially in surgical postmenopausal women [22]. Though, in different 
study (using dehydroepiandrosterone against a placebo), no significant differences were 
observed between women using hormone therapy and those using a placebo in terms of 
well-being [23]. 
Well-being has also been related with the search for medical help, to manage 
menopause [24] 
 
Menopausal symptoms 
Hot flashes have been identified as exacerbating negative mood [19] and their severity 
is associated with decreased well-being [25]. Nonetheless, in a different research, 
neither the presence nor the severity of hot flashes predicted well-being [21]. Similarly, 
in another study, there were no significant differences in well-being between women 
who were in late peri-menopause (and manifested the highest prevalence of vasomotor 
symptoms) and their counterparts without vasomotor symptomatology [26]. However, 
except for this menopausal status (that is, peri-menopause), women in pre- and in post-
menopause, and who had vasomotor symptoms, presented a lower well-being when 
compared with participants without these symptoms [26].  
Is has been concluded elsewhere that well-being can predict sexuality [27]; on the other 
hand, sexual problems might occur during menopause transition and these can impair 
well-being [28].  
Depression can also be linked to the decline of the ovarian function [29] and depressive 
symptoms have been strongly associated with decreased well-being in middle-aged and 
older adults [30]. Cognitive difficulties have also been reported during the menopausal 
transition [31]. In addition, fatigue, which can also be identified during menopause, has 
been evidenced as a significant predictor of well-being [27]. 
Nonetheless, the relief of menopausal symptoms around menopause is not the only 
factor that is strongly associated to the improvement of well-being [28]. 
 
Life events 
During midlife, women often have their children leaving home and their marriage 
ending by divorce or widowhood [32] and might also have the need to assume the 
caregiving role of aged parents [33]. The empty nest experience has been evidence as 
not having an impact, by itself, on the midlife women‘s well-being; however, in 
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interaction with other variables (such as professional status) it might interfere with it 
[12]. Being professionally active and a caregiver might be two conflicting roles and this 
conflict can have a negative impact on well-being [34].  
Furthermore, the autobiographical reasoning about self-growth is related with well-
being. Hence, both positive processing (that is, the tendency to interpret events 
positively) and differentiated processing of negative life events (that is, the extent to 
which past events are perceived as self-growth promoters) predict well-being [35]. 
Literature has evidenced as well that well-being can change significantly with life 
events and daily hassles in middle-aged women [17,18,21].  
 
Spirituality 
Little is still known about the contribution that spirituality can have to well-being and 
health [36]. Yet, personal resources have been mentioned as a significant predictor of 
well-being during the menopausal transition and post-menopause, determining the 
variability of women‘s well-being more significantly than other menopause-related 
variables [21]. In this context, some studies support that spirituality can be a well-being 
resource in later life [37,38]. 
   
Body shape concerns 
During midlife and menopausal transition women frequently report an increase in body 
weight [39-41], and weight increase has been shown to have a negative impact on well-
being [42].  
In addition, dissatisfaction with body weight is related with self-esteem in older women 
[43]. Also, age has been found to moderate the association between regular body 
monitoring and body dissatisfaction, and this association was higher in middle-aged 
women (compared with older women) [44]. Nonetheless, in another research, body 
weight dissatisfaction did not vary across the life span in a female sample [45]. 
 
Stress 
Stress was found to be significantly related with subjective well-being in midlife 
[3,46,47] and stress associated to the professional role can lead to a lower life 
satisfaction in midlife men and less happiness in women [8]. 
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Given the multiplicity of variables that can impact the well-being during middle-age, 
the aim of this study is to, through a structural causal model of subjective well-being for 
middle-aged women, evaluate which of the variables mentioned previously, can explain 
subjective well-being, after controlling for confounding variables. 
 
Method 
 
Participants 
One thousand and three women agreed to participate in this study and answered to all 
questionnaires and instruments adequately. This community sample encompasses 
women aged between 42 and 60 years and 71% were married, as evidenced in table 1.  
 
Table 1 - Distribution of the study‘s participants according to socio-demographic, health 
and menopause-related characteristics, and lifestyle 
Characteristics 
Participants 
n % 
N 1,003  
Age M (SD) 49.7 (5.241) --- 
Marital status   
Married or in a relationship 706 70.5 
Not married or in a relationship 295 29.5 
Parity   
0 85 8.6 
1 290 29.5 
2 450 45.8 
≥ 3 158 16.0 
Education   
Primary school  112 11.4 
Middle school 222 22.6 
High school  280 28.5 
University degree 395 37.5 
Professional status   
Active 849 86.2 
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Inactive 136 13.8 
Household annual income   
≤ 10,000€ 199 23.5 
10,001€ - 20,000€ 220 26.0 
20,001€ - 37,500€ 208 24.6 
37,501€ - 70,000€ 154 18.2 
≥ 70,001€ 65 7.7 
Recent disease   
Yes 184 18.9 
No 789 81.1 
Psychological problem   
Yes 153 15.6 
No 827 84.4 
Menopausal status   
Pre-menopause 282 28.4 
Peri-menopause 298 30.0 
Post-menopause 412 41.5 
Medical help sought to manage 
menopause 
  
Yes 431 47.2 
No 483 52.8 
Hormone therapy, herbal/soy therapy 
or nothing 
  
Hormone therapy 67 7.2 
Herbal/soy therapy 64 6.8 
Nothing 803 85.8 
Smoking   
Current smoker 247 25.2 
Current non-smoker 733 74.8 
Alcohol   
Yes 493 49.6 
No 500 50.4 
Coffee   
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Yes 862 86.5 
No 134 13.5 
Physical exercise   
Yes 447 45.2 
No 543 54.8 
Body mass index (kg/m
2
)   
Underweight (BMI<18.5) 7 0.7 
Normal weight (18.5≥ BMI≤24.9) 527 53.1 
Overweight (24.9>BMI≤29.9) 334 33.6 
Obesity (BMI>29.9) 125 12.6 
 
 
Procedure 
This cross-sectional study encompasses a community sample which was mainly 
recruited through schools and universities in the city of Lisbon. The inclusion criteria in 
this research were gender (women), literacy and age (between 42 and 60 years). The 
American Psychological Association‘s standards on the ethical treatment of participants 
were followed. A written informed consent form was delivered to all participants, 
explaining the aims of the study, emphasizing that the participation in this research was 
voluntary and that participants could interrupt their collaboration at any time, without 
any consequences.  
After receiving the informed consent and agreeing to participate in the research, a 
sample of 1,003 Portuguese women answered to all the instruments adequately (45 were 
excluded due to lack of sufficient information).  
 
Measures 
Due to the complexity and size of the theoretical model proposed and given the high 
number of independent variables (thirty-four), each instrument was used in a shortened 
version, that is, each construct (specifically, each subscale) was assessed only by the 
three items with the highest structural weights. 
All instruments produced data with good psychometric properties (sensitivity, factorial 
validity and reliability) in this sample. 
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Subjective Well-being 
The Subjective Well-being Scale has 62 items and encompasses an emotional (positive 
and negative affect) and a cognitive component (life satisfaction), measured in a 5-point 
Lykert-type scale, ranging from ―nothing‖ to ―extremely‖ in the emotional components, 
and from ―I completely disagree‖ to ― I completely agree‖ in the cognitive component 
[48]. 
 
Menopause Symptoms 
A validated version of the Menopause Symptoms‘ Severity Inventory, MSSI-38 [49] 
was used. This inventory includes thirty-eight items, organized in twelve sets of 
menopausal symptoms (depressive mood; anxiety; cognitive impairment; body shape 
changes; aches and pain; skin and facial hair changes; numbness; perceived loss of 
control; mouth, nails and hair changes; vasomotor, urinary and sexual symptoms). Both 
frequency and intensity of symptoms were measured in reference to the previous month, 
using a 5-point Likert-type scale which ranges from ―never‖ to ―daily or almost every 
day‖ and from ―not intense‖ to ―extreme intensity‖, respectively. The severity of each 
symptom is calculated afterwards, using the mean between the values of frequency and 
intensity for each item. 
 
Stress 
This variable was assessed through the Portuguese version of the Depression, Anxiety 
and Stress Scales [50,51]; the stress subscale includes 7 items, with answers being given 
in a 4-point Lykert-type scale (ranging from ―did not apply to me‖ to ―it applied to me 
most of the time‖).  
 
Body Shape Concerns 
The Body Shape Questionnaire [52] assesses the concerns about the body appearance in 
34 items. Responses were given in a 6-point Likert-type scale with scores ranging from 
―never‖ to ―always‖.  
 
Life Events 
The Life Experiences Survey [53,54] evaluates the impact of a variety of events in the 
participants‘ life, during the previous month. This inventory includes 47 events that can 
be measured in a 7-point Likert-type scale, ranging from ―very negative‖ to ―very 
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positive‖. There is also the possibility to answer ―does not apply‖ for each event. Only 
events which were mentioned by at least 10% of the sample were included in the causal 
model. 
 
Spirituality 
Spirituality was assessed through the Portuguese version of the Spiritual Well-being 
Questionnaire [55,56] which allows the measurement of four dimensions, namely 
personal, communal, environmental and transcendental well-being, evaluated in a 5-
point Likert-type scale, ranging from ―very low‖ to ―very high‖. 
 
Menopausal and Health–related variables  
The menopausal status was defined according to the Stages of Reproductive Aging 
Workshop‘s criteria [57]. Women in pre-menopause presented an absence of changes in 
their menstrual cycle. Peri-menopausal participants would report variable cycle length 
(a difference of more than seven days, than usual) or had skipped two or more cycles 
and had an amenorrhea interval superior to sixty days. Post-menopausal women had at 
least a twelve-month period of amenorrhea. 
Besides menopausal status, the use of hormone therapy, herbal/soy products or nothing 
to manage menopause symptoms was also asserted. In addition, the search for medical 
help to manage these symptoms was also controlled. 
Health status (both physical and psychological), as well as menopausal status, was self-
reported. The participants were asked about the presence of a recent disease and of a 
psychological problem. 
 
Lifestyle 
Alcohol and coffee intake, smoking, physical exercise and body mass index (BMI) were 
assessed.  
Lifestyle habits were explored in terms of presence/absence, amount and/or frequency. 
Hence, physical exercise was measured in terms of times per week and during how 
many minutes the participant exercised; a mean value of weekly frequency and duration 
was used in the multivariated model. Coffee intake, when present, was assessed in a 
four-option scale, ranging from ―occasionally‖ to ―more than five per day‖. Alcohol 
intake, when observed, was measured both in terms of frequency (―daily‖, ―every 
weekend‖ or ―rarely‖) and quantity (―until I feel drunk‖, ―moderately‖ or ―less than a 
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glass per occasion‖); a mean value of both translates the alcohol consumption variable, 
in the causal model. Finally, for current smokers, smoking was quantified in a 6-point 
Likert-type scale that ranged from ―less than 10 cigarettes per month‖ to ―more than 40 
cigarettes per day‖; this quantification integrated the structural equation model to assert 
the influence of smoking on the subjective well-being. 
 
Socio-demographic characteristics 
Socio-demographic variables, such as age, marital status, parity, professional status, 
educational level and family annual income, were also explored.  
 
Statistical Analysis 
Missing values were imputated for variables, where its frequency was lower than 10% 
of the sample. This was done using the mean interpolation method. 
Multicollinearity between the independent variables was explored with the variance 
inflation factor (VIF) given by SPSS Statistics (v. 19, IBM SPSS Inc, Chicago, IL). All 
variables presented a value below 5, indicating the absence of collinearity [58,59]. 
The distribution of the variables studied was explored with SPSS Statistics (v. 19, IBM 
SPSS Inc, Chicago, IL).  
To test the causal model for subjective well-being, a structural equation model was built 
relating the dependent variable (well-being) with the thirty-four independent variables 
(namely, age, parity, marital and professional status, income, education, presence of a 
recent psychological problem or a disease, transition from pre- to peri-menopause and 
from peri- to post-menopause, use of hormone therapy or herbal/soy products to manage 
menopause symptomatology, medical help search do deal with menopause, alcohol and 
coffee intake, smoking, physical exercise, BMI, stress, body shape concerns, the twelve 
types of menopausal symptoms, life events and spirituality). The model was evaluated 
with SPSS AMOS software (v. 18, IBM SPSS Inc, Chicago, IL). The quality of the fit 
of the structural model was given by chi-square statistics (X
2
/df), comparative fit index 
(CFI), goodness of fit index (GFI) and root mean square error of approximation 
(RMSEA), and the reference values currently practiced in structural equation modelling 
were used [59,60]. A two-step approach was employed to evaluate the causal structural 
model. First, the factor‘s measurement model was evaluated to demonstrate an 
acceptable fit. Thereafter, the structural causal model, encompassing the dependent and 
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the thirty-four independent variables, was adjusted and the significance of the causal 
trajectories was evaluated. 
 
Results 
 
The fit of both the measurement (X
2
/df=2.503; CFI=.863; GFI=.842; RMSEA=.039; 
p=1.000; C.I. 90%=].038; .040[) and the causal models were good (X
2
/df=2.255; 
CFI=.859; GFI=.841; RMSEA=.035; p=1.000; C.I. 90%=].035; .036[). 
The causal model encompassing the 34 independent variables is presented in Figure 1. 
 
Figure 1 - Subjective Well-being: its relation with socio-demographics, health and 
menopause-related variables, lifestyle, life events, body shape concerns, stress, 
spirituality and menopausal symptoms 
 
 
Stress (β=-.247; p=.023), spirituality (β=.252; p<.001), life events (β=.166; p=.023), 
depressive mood (β=-.493; p=.019), having a recent psychological problem (β=-.117; 
p=.047) and coffee intake (β=.104; p=.033), were the significant predictors of subjective 
well-being. Parity was only a marginally significant predictor (β=.088; p=.091). The 
249 
 
variables included in the causal model explain 92% of the variability of subjective well-
being. 
 
Discussion 
 
In this study with middle-aged women, depressive mood presented a strong and 
negative association with well-being. Moreover, literature supports this conclusion: 
subjects with depression or depressive mood tend to manifest significantly lower levels 
of well-being [30,61,62]. Another indicator of mental health, which predicted 
significantly and negatively well-being, was the presence of a recent psychological 
problem. Therefore, women with a self-reported psychological problem (of diverse 
nature) or with higher levels of depressive mood would report significantly lower levels 
of well-being than their counterparts with lower depressive mood and absence of a 
psychological problem.  
Regarding spirituality, the present study supports the conclusions of previous ones 
[37,38] demonstrating that spirituality can be a significant predictor and a resource of 
well-being in midlife. Recent research emphasizes the increasing attention that is being 
given to spirituality, both in health-care (through the integration of courses on 
spirituality in medicine, by medical schools) [63] and in self-care context, given its 
potential to promote personal development and well-being in illness and health [36]. 
Both life events (other than becoming peri- and post-menopausal, which did not predict 
well-being levels) and stress, affected significantly the variability of women‘s well-
being during midlife. Therefore, participants who evaluated their recent life events more 
positively and presented lower levels of stress, manifested higher levels of well-being. 
This is concordant with previous studies [3,17,18,21,46,47].  
In a previous study about middle-aged women‘s self-care actions, one-fourth of the 
sample mentioned self-care behaviours were associated with developmental changes 
that happen in midlife [64]. And it has been concluded elsewhere that behaviours 
leading to good health promotion, in midlife women, were related with hardiness (that 
is, the psychological ability to cope with stress) [65]. Given that both stress and life 
events (assessed not only by the presence of the event but also by the impact it had) 
were significant predictors of well-being, the development of hardiness, as well as 
spirituality, seem to be important resources to maintain well-being during middle-age. 
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Of all lifestyle variables, coffee intake was the only one significantly predicting well-
being. Caffeine has a stimulant effect on the central nervous system, and consumption 
patterns reveal the motives why people take it: at the beginning of the day caffeine 
facilitates waking up and during the day it helps to neutralize tiredness [66]. The 
benefits of caffeine intake are an increment of energy, attention, alertness, cognitive 
performance and elevation of mood [67]. A moderate consumption (defined as less than 
six cups per day) has been related to less depressive symptoms, lower suicide risk and 
decreased cognitive failure [67]. Moreover, in a previous study testing the effects of a 
combination of caffeine, taurine and glucuronolactone, used is some energy drinks, it 
was found that this combination had a positive impact against a group taking a placebo, 
improving significantly well-being, vitality and social extrovertedness; the authors 
suggest that caffeine might be the mediator of these effects [68]. It cannot be 
disregarded that this effect is also exacerbated by expectations: it has been proven, in a 
double-blind design, that people who believe they are drinking caffeine (but, in fact, 
consuming a placebo) show increases in subjective alertness; however, there were no 
significant changes in well-being and reaction time [69]. Therefore, our results show 
that people who take more coffee present (due to physiological, expectation effect or 
both) a higher well-being than those who drink less (or none) coffee. 
It has been proven before that, rather than the endocrine changes, it is the health status, 
psychosocial variables and lifestyle that determine well-being in women undergoing 
midlife [3]. The causal model of well-being presented in this study confirms this 
conclusion: self-reported psychological health status, depressive mood, spirituality, life 
events, stress, and coffee intake significantly predict well-being. 
Although peri- and post-menopause have been identified as having a significant impact 
on women‘s well-being and quality of life [70-72], in this study this developmental 
change did not predict well-being. This might be due to the fact that, being this a 
community sample, the symptoms‘ severity is not exacerbated. Moreover, it has been 
evidenced that menopause can be associated to positive experiences (like relief due to 
menses‘ and pre-menstrual syndrome‘s cessation) [70] which might counteract the 
negative ones. 
Although the variables studied account for almost the total variability (92%) of well-
being in this sample of middle-aged women, the hypothesis that other factors, not 
approached is this study, might have also influenced well-being of these women cannot 
be excluded. For example, a longitudinal study, which assessed participants when they 
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were adolescents and again 25 years later, concluded that family experiences during the 
adolescence predicted the well-being in adulthood [73]. In addition, a close relationship 
with the mother at the age of 16 was a significant predictor of life satisfaction of women 
at the age of 42 [74]. 
The sample size (1,003 participants) was adequate for this type of statistical analysis 
given that a rule of thumb of ten subjects per manifest variable was applied, as is current 
practice in structural equation modelling [59,75]. Nevertheless, the fact that this 
research has a cross-sectional design, and uses a sample where more than one third of 
the women have a college degree, limits the generalization of these results. Also, in the 
model, we have only considered direct effects of the predictor variables in subjective 
well-being. It is however possible that some predictors can interact (e.g. education and 
marital status) and possible mediation and moderation effects of the predictors may well 
need to be address in future researchs. 
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GENERAL CONCLUSION 
 
 
1. Menopause and Menopausal Symptoms 
 
The qualitative study has revealed that, is this sample of Portuguese women, 
participants identified much more negative consequences than positive ones regarding 
menopause (93 versus 63 responses). The model built shows that menopause is 
represented as a negative occurrence, a positive or a neutral experience, or as a life 
cycle transition. The perceived positive consequences are structured in two factors 
which are cessation of menses or absence of positive consequences on one hand, and 
positive psychological changes on the other hand. The negative consequences of 
menopause are of psychological/sexual nature, physical nature, vasomotor symptoms or 
weight gain and perception of loss, as demonstrated by the proposed four-factor model. 
From all the negative consequences, perceived by women as a direct effect of 
menopause, only vasomotor and sexual symptoms were proven to be subsequent to the 
menopausal status in three different causal models, tested later in the study‘s 
development. Weight gain was not considered to be an effect of the menopausal status 
in these three models (and when measured for the previous month), but when analysing 
women‘s weight change in a larger period of time (from pre-menopause until current 
menopausal status), hormonal changes appeared to play an important role in weight 
gain.    
This research supports a predominantly negative vision of menopause, although, as 
literature evidences and this study supports, women also perceive positive outcomes.  
The inventory built to assess menopausal symptoms, was initially based on the 
information provided by the peri- and post-menopausal interviewees (specifically, 
regarding the elicited contents of perceived negative consequences), derived from pre-
existing menopausal symptoms‘ scales and supported on the opinion of specialists 
(namely, two gynecologists and one clinical psychologist with experience on women‘s 
issues). The result was a measure with good psychometric characteristics, which 
assessed twelve sets of symptoms, both psychological and physical. It was demonstrated 
that measuring the symptoms‘ frequency or intensity are two statistically different 
things; moreover, researchers assessing the frequency might obtain higher mean scores 
than those measuring symptoms in terms of intensity. 
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Regarding vasomotor symptoms‘ severity, in symptomatic women, this research 
adds fairly new outcomes: coffee can be a negative predictor (rather than a positive, as 
evidenced in previous researches), as well as perceived control, which was the strongest 
predictor accounted for in this model (even stronger than hormone therapy use).  
This confirms that physiological symptoms, such as hot flashes and night sweats, 
can be influenced (regarding their severity) by non-hormonal variables, such as a 
lifestyle variables and perceived control. This conclusion is of particular importance for 
women who do not use hormonal therapies; the increased perception of control (given it 
is a predictor of less accentuated vasomotor symptoms), can be a useful strategy to 
manage the exacerbation of vasomotor symptoms in these women, given that the use of 
hormone therapies increases the risk for breast cancer (especially, considering women 
with a higher vulnerability to oncologic disease and long-term use of hormone therapy) 
(Corrao et al., 2008). Therefore, and congruently with Liao and Hunter (1998), the 
modification of certain habits and negative beliefs (in this case, the absence of control) 
will lead to an improvement of the climacteric experience.  
After establishing that perceived control can predict the severity of vasomotor 
symptoms, in symptomatic women, stress and depression symptoms were also 
confirmed as significant predictors of vasomotor symptoms‘ occurrence: women with 
more frequent stress and depression-related symptoms were more likely to evidence hot 
flashes and night sweats, independently of socio-demographic, health and menopause-
related, and lifestyle factors. 
In this causal model of vasomotor symptoms‘ occurrence, several variables 
predicted the emergence of hot flashes: older women, married (or in a relationship), 
with less children, using natural products to manage menopausal symptoms, and with 
more frequent depressive symptoms were more likely to manifest them. Regarding 
night sweats, again participants married (or in a relationship), with less children, with a 
recent disease, using herbal/soy products (specific for climacteric symptoms) and with 
more frequent stress symptoms presented night sweats.   
The fact that, on the one hand, stress (which is associated with sleep disturbance) 
predicted night sweats‘ (but not hot flashes) occurrence and, on the other hand, 
depression (which is worse during the diurnal period of the day), is associated with hot 
flashes (but not with night sweats), shows a differentiated impact of the two 
psychological variables. This difference regarding stress and depression‘s influence on 
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night sweats and hot flashes can be due to the very nature of the two psychological 
symptoms. Therefore, it can be thought that another way to cope with vasomotor 
symptoms (in this case their emergence) is through the management of stress and 
depressive symptoms. 
Additionally, this research showed that from twelve sets of symptoms, typically 
identified in literature as menopausal symptoms, only three were predicted by the 
menopausal status. Thus (and independently from socio-demographic, health status and 
lifestyle factors), skin and facial hair changes, vasomotor and sexual symptoms were 
predicted by the transition from peri- to post-menopause, evidencing that these are the 
single conditions associated with the hormonal changes. The same causal model 
identified age as a significant predictor of cognitive impairment, aches and pain, urinary 
and sexual symptoms. Therefore, age can foretell more symptoms than the menopausal 
status itself, and age progression seemed to explain conditions that have been attributed 
to the menopausal status.  
Two of the symptoms reflected in the menopausal stage have been gathering 
concordance regarding their identification as the only symptoms which are, in fact, 
related with peri- and post-menopausal status (that is, vasomotor and sexual symptoms). 
The other symptom (skin and facial hair changes) was already mentioned as a possible 
side effect of hormonal therapy (Munarriz et al., 2002); nonetheless, previous 
researchers have identified skin alterations as subsequent to hormonal changes (but also 
age) (Raine-Fenning, Brincat, & Muscat-Baron, 2003).  
The remaining, supposedly menopausal, symptoms were predicted by marital 
status, educational level, parity, income, health status, body mass index, among others. 
And, although skin/facial hair changes, vasomotor and sexual symptoms are 
significantly linked to the menopausal status, they are also influenced by socio-
demographic characteristics, and by physical and psychological health statuses. 
These conclusions support the bio-psycho-social conceptualization of menopause: 
although some symptoms emerged subsequently to changes in the menopausal status, 
the vast majority of the symptoms assessed are not predicted by this imminently 
hormonal variable (stage of menopause). Thus, these outcomes establish the 
consequences of menopause not as a medical condition (as it has been seen given the 
(over)medicalization of this natural process), but instead as a set of physical and 
psychological conditions which are due to age progression, life conditions and health-
related variables. 
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This causal model, as well as two other models, has confirmed an unexpected 
association: women who use natural products to manage menopausal symptoms, have 
reported them with higher severity when compared with women who do not use 
herbal/soy therapy. This result evidences that this products might not have the expected 
therapeutical effect. Since studies (specially, randomized controlled trials) about the 
efficacy of the herbal/soy therapies are still scarce, it is suggested that further research is 
developed with these products in order to clarify their usefulness in the menopausal 
symptoms‘ management. 
The causal models testing the predictive power of both personal and contextual 
variables (namely, spirituality and life events) have proven that both can predict 
menopausal symptoms (in fact, they were associated with the vast majority of 
symptoms assessed), independently of socio-demographic, health and menopause-
related and lifestyle factors. This, once again, supports the hypothesis that the 
climacteric symptoms that are commonly identified in literature may not be in fact 
clinical conditions derived from hormonal changes, but rather physical and 
psychological manifestations associated with life conditions and internal resources, 
again confirming the inadequacy of a generalized medicalization to menopause.  
Three exceptions can be observed, namely vasomotor and sexual symptoms, and 
skin/facial hair changes, which have proven to be consistently predicted by the 
menopausal status, in the three causal models (that is, the previous one – that tested only 
the influence of socio-demographic, health and menopause-related factors, and lifestyle 
– and the two models exploring the predictive power of spirituality and life events). 
While the literature has evidenced depressive mood and anxiety as being associated 
with climacteric‘s hormonal changes, this was not supported by this research:  
menopausal status did not predict the two psychological symptoms. This research 
evidenced that the participants in post- and peri-menopause manifested more severe 
depressive mood and anxiety, when compared with their pre-menopausal counterparts. 
These symptoms were related with life conditions (such as socio-demographic, health-
related variables and lifestyle) and events, and with personal characteristics (namely, 
spirituality). It can be also thought that negative representations of menopause might be 
associated with these two symptoms (literature has supported that negative attitudes 
regarding menopause might be associated with a more negative climacteric experience). 
This is hypothesized since the results of the qualitative study highlight that women can 
manifest a negative representation of menopause, and their perceived negative 
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consequences (including anxiety and depressed mood) were much more frequent than 
positive ones. 
 
 
2. Body Weight 
 
Regarding weight changes, it is concluded that the majority of women in this study 
gained weight from the pre- to peri- or to the post-menopause. Besides socio-
demographic and health-related variables (that is, lower education, less intense and 
frequent physical exercise, and presence of a psychological problem), also body shape 
concerns and menopausal status determined the weight increase.  
It is important to emphasize that, menopausal status did not predict body shape 
changes (that is, weight gain and feeling bloated) when assessed by the Menopausal 
Symptoms‘ Severity Inventory (MSSI-38); this might be explained by the fact that this 
instrument asserts these body alterations only regarding the previous month. When 
weight gain is evaluated comparing weight in pre-menopause with body weight in the 
current menopausal status (peri- or post-menopause), the hormonal changes seemed to 
play a significant part in weight gain. Also, more frequent body shape concerns 
predicted an increase in weight.  
This body weight increase had already been identified as a negative consequence 
perceived by women as associated to menopause, as evidenced by several interviews 
with peri- and post-menopausal women.  
These results support that women with more concerns about their body shape, with 
less frequent and intense physical exercise routines, less educated, with a psychological 
problem and close to the menopausal transition, are the most vulnerable to manifest 
later, in the menopausal transition or post-menopause, a weight increase and, therefore, 
should be to targeted to weight gain prevention. 
The literature has evidenced that cognitive-behavioural therapies are effective in 
weight loss. This was partially supported by the present research: a brief (eight sessions) 
and individual cognitive-behavioural intervention allowed a small group of participants 
(seventeen) to significantly lose weight (comparing weight prior to the intervention and 
the weight at the 4-month follow-up), but the loss was below the 5% of body weight, 
established as a successful weight lost. We suggested that the intervention might need to 
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be longer and a group format might have benefits for this particular health-related 
objective. 
Other conclusion of the present study is that three different body mass index (BMI) 
categories, specifically, normal weight, overweight and obesity, are all predicted by 
body shape concerns and education level (that is, more frequent concerns and less 
schooling years are associated with higher BMI inside each category). Moreover, and 
contrary to what literature shows, in this sample of middle-aged women, more frequent 
depression symptoms predicted a lower BMI, for the three categories. Although this 
outcome is not the most frequent in the literature (in fact, most studies associate an 
increased weight with more severe depression symptoms), a limited number of 
researchers have documented that this relation might be observed. Moreover, stress 
levels were also associated with weight but only in participants with a healthy weight. 
Thus, increased stress and depression symptoms do not appear to be associated with 
a higher body weight in both overweight and obese middle-aged women. 
 
 
3. Well-being during Midlife 
 
Finally, the variability of subjective well-being in this sample of midlife women is 
almost totally explained (92%) by the variables accounted for. Therefore, the purposed 
causal model identifies life events (more positively evaluated), higher spirituality, less 
frequent stress symptoms, lower severity of depressive mood, the absence of a self-
reported psychological problem and higher coffee intake as the variables that are 
associated with higher well-being.  
This research evidences that neither menopausal status nor a recent disease impact 
on well-being. This might be explained by the adaptation mechanism, that is, 
unhappiness might emerge when people experience changes perceived as negative for 
the first time, but soon they adapt to it and stop evidencing such a negative mood 
(Diener, 2000). Furthermore, health-related changes‘ acceptance can be one of the 
factors more strongly associated with well-being (Migliorini & Tonge, 2009).    
On the other hand, we can hypothesize that cultural constructions of certain 
changes, namely, menopause, are also associated with positive representations (as 
evidenced in the qualitative research), and these (although in lower number when 
compared with the negative representations) may counteract the impact of a 
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disagreeable representation or negative expectation and, consequently, not have a 
significant impact on well-being at midlife. 
 
 
4. Limitations and Future Research  
 
This study has several limitations and leaves room to future research. A recent 
study has shown that, although women lose weight with cognitive-behavioural 
interventions, longer follow-ups (namely, three years) have demonstrated that it is very 
difficult for people to maintain the new lower weight on the long run: most women 
regain it (Cooper et al., 2010). Hence, the 4-month follow-up used to assess the success 
of the weight loss after the cognitive-behavioural intervention gives little information. It 
is recommended that future studies in the field use longer follow-ups. 
Also, the fact that one third of the sample has a college degree limits the 
generalization of the results, since education can be an important predictive variable.  
Furthermore, marital status tends to be a rather narrow variable since it does not 
provide information on the quality of the relationship. And, as it is known that quality of 
the marriage is associated with life satisfaction (Hohaus & Berah, 1996), and that an 
emotionally supportive relationship with a partner also contributes to the middle-aged 
women‘s well-being in midlife (Martire, Stephens, & Townsend, 1998), it is suggested 
that in future studies that the quality of, or satisfaction with, the relationship is included. 
Since the partner‘s sexual dysfunction and health problems can be correlated with 
menopausal women‘s sexual symptoms (Chedraui, Aguirre, Hidalgo, & Fayad, 2007; 
Sarti et al., 2010), in future studies data regarding the partner should be collected to 
assert if this condition also explains part of women‘s sexual symptoms.  
Regarding the life events assessed, not having included menopause as a life event 
could be pointed as a limitation. However, although technically menopause corresponds 
to the last menstrual period (and therefore, it is an event limited in time), most women 
perceive menopause as a phase of life and, therefore, its inclusion as a life occurrence 
could be misinterpret and evaluated with a bias. Moreover, the transitions from pre- to 
peri-menopause and again from peri- to post-menopause were assessed as events (in 
terms of presence or absence) in the context of the menopausal status‘ determination.  
Another limitation was the fact of not asserting if women were in a sexually active 
relation; this might confound results concerning MSSI-38 sexual symptoms‘ subscale 
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and in Utian Quality of Life Scale (namely, in relation to the sexual quality of life), 
since it is not known if participants who answered to the items negatively did it because 
they had a negative sexual quality of life (or, in the case of MSSI-38, an absence of 
negative sexual experiences) or because they were not sexually active. 
Moreover, the instruments assessing symptoms‘ reporting can be linked to the 
vulnerability of measuring symptoms through checklists, namely the elicitation effect 
since these instruments will facilitate more positive answers, than open-ended questions 
would (Dennerstein, Dudley, Hopper, Guthrie, & Burger, 2000). Therefore, although 
this community sample does not present a high severity of symptoms (namely, 
regarding menopausal symptoms), it is hypothesised that, due to the mentioned 
limitation, this reporting is in reality, lower than the identified in this study.  
 
This work intends to be a useful contribution to the understanding of menopause (in 
terms of representation and assessment), adding information about the factual 
menopausal symptoms and proving that most symptoms identified as ―menopausal‖ are 
not predict by menopausal status and are influenced by personal characteristics, life 
conditions, health status, lifestyle and life events. Additionally, in was our objective to 
explore the weight gain phenomenon during menopause, ways to promote weigh loss 
(through a brief intervention) and body mass categories‘ predictors, allowing also new 
insights about what determines well-being in Portuguese middle-aged women.  
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APPENDIX A 
 
Cross-sectional study’s questionnaires and instruments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ESTUDO DE DOUTORAMENTO: A MULHER E A MENOPAUSA 
 
Consentimento Informado 
 
 
 
 
 
Se aceita participar, por favor rubrique esta página e a seguinte e, de seguida, retire para si a primeira página 
(são ambas iguais e a primeira página é para si). 
 
Data: ____/____/____ 
 
____________________ 
(Rubrica da participante) 
 
 
 
 
 
O presente estudo de doutoramento, efectuado na especialidade de Psicologia da Saúde e com a 
orientação da Prof. Doutora Isabel Leal (ISPA – Instituto Superior de Psicologia Aplicada), é financiado 
pela Fundação para a Ciência e Tecnologia (referência SFRH/BD/32359/2006). 
 
Esta investigação estuda a fase da vida da mulher durante a qual ocorre a menopausa. 
 
Numa primeira etapa o objectivo deste estudo é explorar a forma como as mulheres portuguesas, com 
idades compreendidas entre os 42 e os 60 anos, vivem esta fase da sua vida e que aspectos contribuem 
para o seu bem-estar durante o período de menopausa. Neste momento, convido-a a participar nesta fase 
da investigação através do preenchimento das questões que encontrará nas páginas seguintes. 
 
Esta investigação tem igualmente o objectivo de explorar, numa segunda fase, formas de diminuir 
determinados sintomas da menopausa (concretamente, os afrontamentos) e ajudar a gerir o peso de forma 
saudável (focando o comportamento alimentar e a relação com o corpo), tendo como finalidade a 
diminuição de peso, caso a participante tenha excesso de peso.  
Não se irá recorrer a medicação e a exploração de formas para diminuir os afrontamentos e o (excesso 
de) peso será feita através de uma intervenção psicológica breve que não envolve riscos. Algumas 
pessoas poderão ser convidadas a participar na segunda fase (que se iniciará brevemente), convite esse 
que poderão rejeitar, se assim o quiserem, sem que isso tenha quaisquer consequências. Se quiser 
participar na segunda fase, deverá preencher também a última folha. 
 
A sua participação é de elevada importância para que possamos conhecer de uma forma mais objectiva e 
abrangente como é que as mulheres portuguesas vivem o período de menopausa. 
 
Sublinha-se que todos os dados são totalmente confidenciais.  
 
Muito obrigada pela sua participação! 
 
A investigadora responsável, 
 
Filipa Pimenta 
Instituto Superior de Psicologia Aplicada 
Rua Jardim do tabaco, 34 
1149-041 Lisboa 
Tel.:218 811 700 
Tlm: 96.341.22.24 
e-mail: filipa_pimenta@ispa.pt  
ESTUDO DE DOUTORAMENTO: A MULHER E A MENOPAUSA 
 
 
Consentimento Informado 
 
 
 
Se aceita participar, por favor rubrique e coloque a data. 
Data: ____/____/____ 
_____________________ 
(Rubrica da participante) 
 
 
 
 
 
 
O presente estudo de doutoramento, efectuado na especialidade de Psicologia da Saúde e com a 
orientação da Prof. Doutora Isabel Leal (ISPA – Instituto Superior de Psicologia Aplicada), é financiado 
pela Fundação para a Ciência e Tecnologia (referência SFRH/BD/32359/2006). 
 
Esta investigação estuda a fase da vida da mulher durante a qual ocorre a menopausa. 
 
Numa primeira etapa o objectivo deste estudo é explorar a forma como as mulheres portuguesas, com 
idades compreendidas entre os 42 e os 60 anos, vivem esta fase da sua vida e que aspectos contribuem 
para o seu bem-estar durante o período de menopausa. Neste momento, convido-a a participar nesta fase 
da investigação através do preenchimento das questões que encontrará nas páginas seguintes. 
 
Esta investigação tem igualmente o objectivo de explorar, numa segunda fase, formas de diminuir 
determinados sintomas da menopausa (concretamente, os afrontamentos) e ajudar a gerir o peso de forma 
saudável (focando o comportamento alimentar e a relação com o corpo), tendo como finalidade a 
diminuição de peso, caso a participante tenha excesso de peso.  
Não se irá recorrer a medicação e a exploração de formas para diminuir os afrontamentos e o (excesso 
de) peso será feita através de uma intervenção psicológica breve que não envolve riscos. Algumas 
pessoas poderão ser convidadas a participar na segunda fase (que se iniciará brevemente), convite esse 
que poderão rejeitar, se assim o quiserem, sem que isso tenha quaisquer consequências. Se quiser 
participar na segunda fase, deverá preencher também a última folha. 
 
A sua participação é de elevada importância para que possamos conhecer de uma forma mais objectiva e 
abrangente como é que as mulheres portuguesas vivem o período de menopausa. 
 
Sublinha-se que todos os dados são totalmente confidenciais.  
 
Muito obrigada pela sua participação! 
 
A investigadora responsável, 
 
Filipa Pimenta 
Instituto Superior de Psicologia Aplicada 
Rua Jardim do tabaco, 34 
1149-041 Lisboa 
Tel.:218 811 700 
Tlm: 96.341.22.24 
e-mail: filipa_pimenta@ispa.pt 
Refira, por favor, de que forma recebeu este questionário: 
1. Recebi no Hospital S. Francisco Xavier___ 
2. Recebi de outra forma (Por favor, especifique qual ____________________________________  
 
 
QUESTIONÁRIO SÓCIO-DEMOGRÁFICO 
a) Idade: _____ 
b) Data de Nascimento: ____/_____/_____ (dia/mês/ano) 
c) Raça: Caucasiana (branca)___     Negra___     Asiática___     Outra___ 
d) Estado civil: Casada___ Divorciada___ Separada___  Solteira___ União de Facto___ Viúva___ 
e) N.º de filhos que tem: _______           
f) Situação profissional: Activa___ Reformada___ Desempregada___ Outra______________ 
i. Que profissão exerce/exerceu? __________________________________________________ 
g) Habilitações literárias: 4ª classe ou menos___   Antigo 5º ano___   Antigo 7º ano___   Bacharelato___   
Licenciatura___   Outro ______________________________________ 
h) Rendimento total anual bruto do agregado familiar: Até 10.000€___   De 10.001 a 20.000€ ___  
De 20.001 a 37.500€___   De 37.501 a 70.000€___   Superior a 70.000€ ___ 
 
QUESTIONÁRIO DE SAÚDE 
A - Menopausa: 
1.  Nos últimos 12 meses teve ciclos menstruais mais curtos ou mais longos, isto é, com uma variação de 7 ou 
mais dias do que o habitual (por exemplo, ter o período de 24 em 24 dias em vez de 31 em 31 dias)?  
Sim__   Não__ 
2.  Nos últimos 12 meses teve menstruações irregulares, isto é, passaram 2 meses (ou mais meses) sem que o 
período lhe aparecesse e permaneceu sem ter o período durante 60 ou mais dias? Sim__ Não__ 
3.  Já esteve 12 meses (ou mais tempo) sem ter menstruação? Sim___   Não___ 
4.  Procurou ajuda médica (isto é, consultar um médico ginecologista ou um médico de clínica geral) para 
gerir os sintomas da menopausa? Sim___   Não___ 
5.  Está a tomar alguma medicação, produtos naturais ou de outro género, para os sintomas da menopausa?   
Sim ___   Não ___  Se sim, qual(quais)?____________________________________________________ 
6.  (Caso não tenha a menstruação há mais de 12 meses) Teve uma menopausa natural, isto é, sem ser 
consequência de intervenção médico-cirúrgica? Sim___   Não___   Ainda não estive 12 meses sem 
menstruação___ 
7.  (Caso não tenha a menstruação há mais de 12 meses) Que idade tinha quando teve a sua última 
menstruação?_____ anos 
 
B - Saúde geral: 
8. Teve recentemente alguma(s) doença(s)? Sim___   Não___ 
i. Se sim, qual(quais)?_______________________________________________________________ 
9. Foi sujeita a alguma intervenção cirúrgica? Sim___   Não ___ 
i. Se sim, que tipo de intervenção?__________________________________________________ 
ii. Se sim, há quanto tempo fez a intervenção?____________________________________________ 
10. Teve recentemente algum problema psicológico? Sim___   Não___ 
i. Se sim, que tipo de problema?_______________________________________________________ 
ii. Está a ser acompanhada por um psicológico? Sim___   Não___ 
11. Qual o seu peso actual? _______ kg 
12. E a sua altura? _______ m 
13. Caso tenha excesso de peso, desde quando começou a ter peso a mais? Desde criança___   Desde a 
adolescência___   Desde o início da idade adulta___   Desde a menopausa___   Outro_______________ 
 
C - Consumo de tabaco, bebidas quentes, álcool e café 
14. É fumadora?   Sim, sou fumadora___    Não, sou ex-fumadora___    Não, nunca fumei___ 
i. (Caso seja fumadora) Fuma todos os dias? Sim___   Não___ 
ii. (Caso seja fumadora) Que quantidade de cigarros fuma? Mais de 40 cigarros por dia___   Entre 40 e 
20 cigarros por dia___   Entre 20 e 10 cigarros por dia___   Menos de 10 cigarros por dia___ Menos de 
10 cigarros por semana___   Menos de 10 cigarros por mês___ 
15. Com que frequência toma bebidas quentes (leite, café, chá, etc.)? Mais de 5 vezes por dia___   Entre 5 e 
3 vezes por dia___   Entre 3 vezes e 1 vez por dia___    Tomo bebidas quentes ocasionalmente___  Nunca 
tomo bebidas quentes___ 
16. Consome bebidas alcoólicas? Sim___   Não___ 
i. Se sim, com que regularidade: diariamente___   todos os fins-de-semana___   raramente___ 
ii. Se sim, em que quantidades: até ficar embriagada___   moderadamente___   um copo ou menos por 
cada ocasião___ 
17. Costuma tomar café? Sim___   Não___ 
i. Se sim, quantos cafés costuma tomar? Mais de 5 cafés por dia___   Entre 5 e 3 cafés por dia___   Entre 
3 e 1 café por dia___   Tomo café ocasionalmente___   
 
D – Exercício físico e peso: 
18. Pratica algum tipo de exercício físico (ir ao ginásio, caminhadas, etc.)? Sim___   Não___ 
i. Se sim, quantas vezes por semana? __________________________ 
ii. Se sim, durante quanto tempo exercita? _______________________ 
19. Quanto pesa neste momento?____kg.          
20. Quanto pesava antes de começar a ter alterações no seu ciclo menstrual (isto é, quando começou a ter 
ciclos menstruais mais curtos e a ser irregular)?____ kg   Ainda não detectei alterações no meu ciclo 
menstrual____ 
 
De seguida irá encontrar alguns questionários que a convidam a explorar vários aspectos da sua vida. Por 
favor preencha todas as questões. Não existem respostas certas nem erradas.  
Os meus agradecimentos pela sua atenção e sinceridade! 
Escala de Bem-estar Subjectivo 
 
Gostaria de saber como se tem sentido ultimamente. Encontra de seguida algumas palavras que descrevem 
diferentes sentimentos e emoções. Leia cada item e escreva seguidamente, no espaço ao lado de cada 
palavra, o número que melhor expressa sua resposta de acordo com a seguinte escala: 
 
1 
Nada 
2 
Um pouco 
3 
Moderadamente 
4 
Bastante 
5 
Extremamente 
 
Ultimamente tenho-me sentido:  
 
 
1. Aflita ___ 17. Transtornada ___ 33. Abatida ___ 
2. Alarmada ___ 18. Animada ___ 34. Amedrontada ___ 
3. Amável ___ 19. Determinada ___ 35. Aborrecida ___ 
4. Activa ___ 20. Chateada ___ 36. Agressiva ___ 
5. Angustiada ___ 21. Decidida ___  37. Estimulada ___ 
6. Agradável ___ 22. Segura ___ 38. Incomodada ___ 
7. Alegre ___ 23. Assustada ___ 39. Bem ___ 
8. Apreensiva ___ 24. Dinâmica ___ 40. Nervosa ___ 
9. Preocupada ___ 25. Empenhada ___  41. Empolgada ___ 
10. Capaz ___ 26. Produtiva ___ 42. Vigorosa ___ 
11. Contente ___  27. Impaciente ___ 43. Inspirada ___ 
12. Irritada ___ 28. Receosa ___ 44. Tensa ___ 
13. Deprimida ___ 29. Entusiasmada ___ 45. Triste ___  
14. Interessada ___ 30. Desanimada ___ 46. Agitada ___ 
15. Entediada ___ 
16. Atenta:_____ 
31. Ansiosa ___ 
32. Indecisa:___ 
47. Envergonhada ___ 
 
 
Por favor indique de seguida, para cada uma das seguintes afirmações, o número que melhor 
expressa a sua opinião sobre a sua vida actual. 
 
1 2 3 4 5 
Discordo 
Completamente 
Discordo Não sei Concordo 
Concordo 
Completamente 
   
 
48. Estou satisfeita com a minha vida  1     2     3     4     5 
49. Tenho aproveitado as oportunidades da vida 1     2     3     4     5 
50. Avalio a minha vida de forma positiva 1     2     3     4     5 
51. A minha vida está longe do meu ideal de vida em quase todos os aspectos 1     2     3     4     5 
52. Se eu pudesse mudaria o meu passado  1     2     3     4     5 
53. Tenho conseguido tudo o que esperava da vida 1     2     3     4     5 
54. A minha vida está de acordo com o que desejo para mim 1     2     3     4     5 
55. Gosto da minha vida 1     2     3     4     5 
56. A minha vida é má 1     2     3     4     5 
57. Estou insatisfeita com a minha vida 1     2     3     4     5 
58. A minha vida poderia estar melhor 1     2     3     4     5 
59. Tenho mais momentos de tristeza do que de alegria na minha vida  1     2     3     4     5 
60. A minha vida não tem interesse 1     2     3     4     5 
61. As minhas condições de vida são muito boas  1     2     3     4     5 
 Escalas de Ansiedade, Stress e Depressão 
  
Por favor leia cada uma das afirmações abaixo e assinale 1, 2, 3 ou 4 para indicar quanto cada afirmação 
se aplicou a si durante a semana passada, tendo em conta as seguintes opções de resposta:  
 
Não se aplicou nada a 
mim 
Aplicou-se a mim 
algumas vezes 
Aplicou-se a mim 
muitas vezes 
Aplicou-se a mim a 
maior parte das vezes 
1 2 3 4 
 
 
 
Questionário de Sintomas do Climatério 
 
Indique, por favor, com que FREQUÊNCIA e INTENSIDADE experimentou as seguintes situações 
no MÊS PASSADO, tendo em conta as seguintes hipóteses de resposta para a frequência (isto é, 
quantas vezes) e a intensidade (ou seja, o quão forte foi) de cada situação: 
 
Frequência: 
Nunca 
Sim, menos de 
uma vez por 
semana 
Sim, uma ou 
duas vezes por 
semana 
Sim, várias 
vezes por 
semana 
Sim, diariamente 
ou quase todos os 
dias 
1 2 3 4 5 
 
 
Intensidade: 
Nada intensa 
Intensidade 
mínima 
Intensidade 
moderada 
Intensidade 
elevada 
Intensidade 
extrema 
1 2 3 4 5 
62. Considero-me uma pessoa feliz 1     2     3     4     5 
1 - Tive dificuldade em me acalmar 1 2 3 4 
2 - Senti a minha boca seca 1 2 3 4 
3 - Não consegui sentir nenhum sentimento positivo 1 2 3 4 
4 - Senti dificuldade em respirar 1 2 3 4 
5 - Tive dificuldade em tomar iniciativa para fazer coisas 1 2 3 4 
6 - Tive tendência a reagir em demasia em determinadas situações 1 2 3 4 
7 - Senti tremores (por ex., nas mãos) 1 2 3 4 
8 - Senti que estava a utilizar muita energia nervosa 1 2 3 4 
9 - Preocupei-me com situações em que podia entrar em pânico e fazer figura 
ridícula 
1 2 3 4 
10 - Senti que não tinha nada a esperar do futuro 1 2 3 4 
11 - Dei por mim a ficar agitada 1 2 3 4 
12 - Senti dificuldade em relaxar 1 2 3 4 
13 - Senti-me desanimada e melancólica 1 2 3 4 
14 - Fui intolerante em relação a qualquer coisa que me impedisse de 
terminar aquilo que estava a fazer 
1 2 3 4 
15 - Senti-me quase a entrar em pânico 1 2 3 4 
16 - Não fui capaz de ter entusiasmo por nada 1 2 3 4 
17 - Senti que não tinha muito valor como pessoa 1 2 3 4 
18 - Senti que por vezes estava sensível 1 2 3 4 
19 - Senti alterações no meu coração sem fazer exercício físico 1 2 3 4 
20 - Senti-me assustada sem ter tido uma boa razão para isso 1 2 3 4 
21 - Senti que a vida não tinha sentido 1 2 3 4 
 Sintomas 
Frequência 
(isto é, quantas vezes?) 
Intensidade 
(ou seja, o quão forte 
foi?) 
1 – Batimento cardíaco acelerado ou forte  1  2  3  4  5   1   2   3   4  5 
2 – Sentir-se tensa ou nervosa  1  2  3  4  5   1   2   3   4  5 
3 – Dificuldade em dormir  1  2  3  4  5   1   2   3   4  5 
4 – Sentir-se facilmente excitada (isto é, agitada, 
exaltada ou sobressaltada) 
 1  2  3  4  5   1   2   3   4  5 
5 – Ataques de pânico  1  2  3  4  5   1   2   3   4  5 
6 – Dificuldade em concentrar-se  1  2  3  4  5   1   2   3   4  5 
7 – Sentir-se cansada ou com falta de energia  1  2  3  4  5   1   2   3   4  5 
8 – Perda de interesse pela maior parte das coisas  1  2  3  4  5   1   2   3   4  5 
9 – Ataques de choro  1  2  3  4  5   1   2   3   4  5 
10 – Irritabilidade  1  2  3  4  5   1   2   3   4  5 
11 – Mudanças de humor  1  2  3  4  5   1   2   3   4  5 
12 – Estar descontente com a sua minha vida pessoal  1  2  3  4  5   1   2   3   4  5 
13 – Sentir-se ansiosa ou nervosa  1  2  3  4  5   1   2   3   4  5 
14 – Sentir perda ou falta de memória  1  2  3  4  5   1   2   3   4  5 
15 – Diminuição geral da capacidade de 
desempenho (isto é, fazer menos coisas do que 
costumava fazer) 
 1  2  3  4  5   1   2   3   4  5 
16 – Sentir-se deprimida, em baixo ou triste  1  2  3  4  5   1   2   3   4  5 
17 – Sentir-se impaciente com outras pessoas  1  2  3  4  5   1   2   3   4  5 
18 - Querer estar sozinha  1  2  3  4  5   1   2   3   4  5 
19 – Sentir-se tonta ou desmaiar  1  2  3  4  5   1   2   3   4  5 
20 – Pressão e sensação de tensão na cabeça ou no 
corpo 
 1  2  3  4  5   1   2   3   4  5 
21 – Dormência ou formigueiro nalgumas partes 
do corpo 
 1  2  3  4  5   1   2   3   4  5 
22 – Dores de cabeça  1  2  3  4  5   1   2   3   4  5 
23 – Dores nos músculos e articulações  1  2  3  4  5   1   2   3   4  5 
24 – Perda de sensibilidade nas mãos ou pés  1  2  3  4  5   1   2   3   4  5 
25 – Dificuldade em respirar ou sentir falta de ar  1  2  3  4  5   1   2   3   4  5 
26 – Flatulência (gases) ou dores provocadas por 
gases 
 1  2  3  4  5   1   2   3   4  5 
27 – Dores na parte detrás do pescoço ou da cabeça  1  2  3  4  5   1   2   3   4  5 
28 – Diminuição da força física  1  2  3  4  5   1   2   3   4  5 
29 – Pele seca  1  2  3  4  5   1   2   3   4  5 
30 – Aumento de peso  1  2  3  4  5   1   2   3   4  5 
31 – Aumento de pêlos faciais  1  2  3  4  5   1   2   3   4  5 
32 – Mudanças na aparência, textura ou tonalidade 
da sua pele 
 1  2  3  4  5   1   2   3   4  5 
33 – Sentir-se inchada  1  2  3  4  5   1   2   3   4  5 
34 – Dores na parte lombar das costas (parte 
inferior das costas) 
 1  2  3  4  5   1   2   3   4  5 
35 – Perdas de urina quando se ri ou tosse  1  2  3  4  5   1   2   3   4  5 
36 – Sensibilidade dos seios  1  2  3  4  5   1   2   3   4  5 
37 – Afrontamentos  1  2  3  4  5   1   2   3   4  5 
38 – Suores nocturnos  1  2  3  4  5   1   2   3   4  5 
39 – Sudação excessiva  1  2  3  4  5   1   2   3   4  5 
40 – Perda de interesse sexual  1  2  3  4  5   1   2   3   4  5 
41 – Dificuldade em urinar  1  2  3  4  5   1   2   3   4  5 
42 – Vontade excessiva de urinar  1  2  3  4  5   1   2   3   4  5 
43 – Secura vaginal (sensação de secura, ardor e 
problemas durante o acto sexual) 
 1  2  3  4  5   1   2   3   4  5 
44 – Problemas no cabelo (por ex., insuficiência ou 
excesso de cabelo) 
 1  2  3  4  5   1   2   3   4  5 
45 – Alterações nas unhas (mudanças na cor, na 
espessura, no aspecto da unha, etc.) 
 1  2  3  4  5   1   2   3   4  5 
46 – Problemas na boca e nos dentes (dor e ardor 
nas gengivas, alteração do paladar, aumento da 
sensibilidade ao quente e ao frio, boa seca, etc.) 
 1  2  3  4  5   1   2   3   4  5 
47 – Hemorragias vaginais muito fortes e/ou 
irregulares 
 1  2  3  4  5   1   2   3   4  5 
 
Escala de Qualidade de Vida 
 
Por favor indique o seu grau de concordância com as seguintes afirmações, avaliando em que medida 
elas se aplicam a si em relação ao passado mês. Certifique-se que responde a todas as afirmações, 
marcando com um círculo a sua opção, tendo em conta a seguinte escala de cinco pontos: 
 
Não é 
verdadeiro no 
meu caso 
 
Parcialmente 
verdadeiro no 
meu caso 
 
Largamente 
verdadeiro no 
meu caso 
1 2 3 4 5 
 
 
1 - Sou capaz de controlar as coisas que, na minha vida, são 
importantes para mim. 
1 2 3 4 5 
2 - Sinto-me desafiada pelo meu trabalho. 1 2 3 4 5 
3 - Acredito que o meu trabalho beneficia a sociedade. 1 2 3 4 5 
4 - Não estou satisfeita com a minha vida sexual. 1 2 3 4 5 
5 - Estou satisfeita com a minha vida amorosa. 1 2 3 4 5 
6 - Tenho recebido muito reconhecimento pessoal na minha 
comunidade ou no meu emprego. 
1 2 3 4 5 
7 - Sinto-me insatisfeita com a minha aparência. 1 2 3 4 5 
8 - A minha alimentação não é equilibrada. 1 2 3 4 5 
9 - Sinto que controlo o meu comportamento alimentar. 1 2 3 4 5 
10 - Habitualmente, faço exercício físico três ou mais vezes 
por semana. 
1 2 3 4 5 
11 - O meu humor está geralmente deprimido. 1 2 3 4 5 
12 – Sinto ansiedade frequentemente. 1 2 3 4 5 
13 - A maior parte das coisas que me acontecem estão fora 
do meu controlo. 
1 2 3 4 5 
14 - Estou satisfeita com a frequência com que tenho 
relações sexuais com um(a) parceiro(a). 
1 2 3 4 5 
15 - Actualmente, sinto desconforto físico ou dor durante a 
actividade sexual. 
1 2 3 4 5 
16 - Acredito que não tenho controlo sobre a minha saúde 
física. 
1 2 3 4 5 
17 - Sinto-me orgulhosa das metas que alcancei em termos 
profissionais. 
1 2 3 4 5 
18 - Considero a minha vida estimulante. 1 2 3 4 5 
19 - Continuo a traçar para mim novos objectivos pessoais. 1 2 3 4 5 
20 - Tenho a expectativa de que irão acontecer na minha 
vida coisas boas. 
1 2 3 4 5 
21 - Sinto-me bem fisicamente. 1 2 3 4 5 
22 - Sinto-me em forma fisicamente. 1 2 3 4 5 
23 - Continuo a traçar para mim novos objectivos 
profissionais. 
1 2 3 4 5 
 
 
Questionário de Bem-estar Espiritual 
 
A espiritualidade pode descrever-se como algo que reside no íntimo do ser humano. 
A saúde espiritual pode ser vista como um indicador do quão bem nos sentimos connosco próprios e com os 
aspectos que valorizamos no mundo que nos rodeia. 
 
Para cada uma das afirmações seguintes, assinale com uma cruz o número que melhor indique em que medida 
sente que cada afirmação reflecte a sua experiência pessoal nos últimos 6 meses. 
 
Responda utilizando a seguinte escala: 
 1 = Muito pouco         2 = Pouco   3 = Moderadamente        4 = Muito         5 = Totalmente 
 
Se lhe parecer mais adequado, pode substituir a palavra “Deus” por “Força Cósmica” ou outra expressão 
idêntica, cujo significado seja mais relevante para si. 
Não perca muito tempo em cada afirmação. A primeira resposta é provavelmente a mais adequada para si. 
 
Em que medida você se sente a desenvolver: 
M
u
it
o
 
p
o
u
c
o
 
P
o
u
c
o
 
M
o
d
e
r
a
d
a
/ 
M
u
it
o
 
T
o
ta
lm
e
n
te
 
1. um sentimento de amor pelos outros 1 2 3 4 5 
2. uma relação pessoal com o Divino ou Deus 1 2 3 4 5 
3. generosidade em relação aos outros 1 2 3 4 5 
4. uma ligação com a natureza 1 2 3 4 5 
5. um sentimento de identidade pessoal 1 2 3 4 5 
6. admiração e respeito pela Criação  1 2 3 4 5 
7. espanto e admiração perante uma paisagem deslumbrante 1 2 3 4 5 
8. a confiança entre as pessoas 1 2 3 4 5 
9.  conhecimento sobre si mesma 1 2 3 4 5 
10. um sentimento de união com a natureza 1 2 3 4 5 
11. o sentimento de união com Deus ou o Universo 1 2 3 4 5 
12. uma relação de harmonia com o ambiente 1 2 3 4 5 
13. um sentimento de paz com Deus 1 2 3 4 5 
14. alegria na vida 1 2 3 4 5 
15. uma vida de meditação e/ou oração 1 2 3 4 5 
16. paz interior 1 2 3 4 5 
17. respeito pelas outras pessoas 1 2 3 4 5 
18. um sentido para a vida 1 2 3 4 5 
19. um sentimento de bondade para com os outros 1 2 3 4 5 
20. a sensação de “magia” na natureza 1 2 3 4 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Questionário de Experiências de Vida 
 
A seguir vai encontrar uma lista de acontecimentos que, por vezes, trazem algumas mudanças à vida de quem 
passa por eles. Se os acontecimentos que se seguem ocorreram consigo durante o último ano, por favor responda se 
tiveram consequências positivas (boas) ou negativas (más) na sua vida.  
Faça um X na resposta que parece ser mais próxima daquilo que pensa. Se no último ano não passou pelo 
acontecimento indicado, faça uma cruz na última coluna da direita (“Não se aplica”). 
 
Acontecimento de 
vida 
Muito 
negativo 
Mais ou 
menos 
negativo 
Um 
pouco 
negativo 
Não teve 
consequências 
nenhumas 
Um 
pouco 
positivo 
Mais ou 
menos 
positivo 
Muito 
positivo 
Não 
se 
aplica 
1. Casamento         
2. Problemas com a 
justiça 
        
3. Morte do 
marido/companheiro(a) 
        
4. Alteração dos hábitos 
de sono (dormir muito 
mais ou muito menos) 
        
5. Morte de uma pessoa 
de família: 
        
a) Mãe         
b) Pai         
c) Irmão         
d) Irmã         
g) Outro 
(quem?_____________) 
        
6. Grandes mudanças 
nos hábitos alimentares 
(comer muito mais ou 
comer muito menos) 
        
7. Recusa de 
empréstimo ou hipoteca 
        
8. Morte de um amigo(a) 
próximo(a) 
        
9. Grande sucesso na 
vida pessoal 
        
10. Transgressões 
menores da lei (por 
exemplo, perturbação da 
paz) 
        
12. Gravidez         
13. Mudança na situação 
profissional (por 
exemplo, 
responsabilidades 
diferentes no trabalho, 
grandes mudanças nas 
condições de trabalho, 
mudança nas horas de 
trabalho, etc.) 
        
14. Emprego novo 
 
        
  
Acontecimento de 
vida 
Muito 
negativo 
Mais ou 
menos 
negativo 
Um 
pouco 
negativo 
Não teve 
consequências 
nenhumas 
Um 
pouco 
positivo 
Mais ou 
menos 
positivo 
Muito 
positivo 
Não 
se 
aplica 
15. Problema de saúde 
ou acidente grave de 
uma pessoa de família: 
        
a) Pai         
b) Mãe         
c) Irmã         
d) Irmão         
g) Marido/ 
companheiro(a) 
        
h) Outro 
(quem?____________) 
        
16. Dificuldades sexuais         
17. Problemas com o 
patrão (por exemplo, 
estar em risco de perder 
o emprego, ter sido 
suspensa, etc.) 
        
18. Problemas com a 
família do 
marido/companheiro(a) 
        
19. Grande mudança no 
seu nível económico 
(para melhor ou para 
pior) 
        
20. Grande mudança na 
proximidade dos 
membros da família 
(aumento ou diminuição 
da proximidade) 
        
21. Entrada de um novo 
membro para a família 
(através do nascimento, 
da adopção, de um 
familiar que foi viver 
para sua casa, etc.) 
        
22. Mudança de casa         
23. Separação ou 
divórcio do 
marido/companheiro(a) 
devido a conflito 
        
24. Grande mudança nas 
suas actividades 
religiosas (aumento ou 
diminuição da 
frequência) 
        
 
25. Reconciliação (fazer 
as pazes) com o 
marido/companheiro(a) 
 
        
  
Acontecimento de 
vida 
Muito 
negativo 
Mais ou 
menos 
negativo 
Um 
pouco 
negativo 
Não teve 
consequências 
nenhumas 
Um 
pouco 
positivo 
Mais ou 
menos 
positivo 
Muito 
positivo 
Não 
se 
aplica 
26. Grande mudança no 
número de discussões 
com o 
marido/companheiro(a) 
(muitas mais ou muitas 
menos) 
        
28. Mudança no 
emprego do marido 
(perda de emprego, 
começar a trabalhar num 
novo emprego, reforma, 
etc.) 
        
29. Grande mudança na 
quantidade e forma 
como ocupa os seus 
tempos livres 
        
30. Pedir um 
empréstimo muito 
elevado (para comprar 
casa, montar negócio, 
etc.) 
        
31. Pedir emprestado 
algum dinheiro (para 
comprar um frigorífico, 
uma televisão, etc.) 
        
32. Ser despedida do 
emprego 
        
34. Ter um aborto         
35. Estar gravemente 
doente ou ter um 
acidente grave 
        
36. Grande mudança 
nas actividades sociais 
(por exemplo, ir mais 
ou menos a festas, ao 
cinema, visitar amigos 
ou familiares, etc.) 
        
37. Grandes mudanças 
nas condições de vida 
da sua família (por 
exemplo, construção de 
uma casa nova, 
remodelação da casa, 
deterioração da casa, 
etc.) 
        
38. Divórcio         
40. Reforma do 
trabalho 
 
 
        
  
Acontecimento de 
vida 
Muito 
negativo 
Mais ou 
menos 
negativo 
Um 
pouco 
negativo 
Não teve 
consequências 
nenhumas 
Um 
pouco 
positivo 
Mais ou 
menos 
positivo 
Muito 
positivo 
Não 
se 
aplica 
41. Saída de casa de 
um(a) filho(a) (porque 
casou, foi estudar para 
longe de casa, foi viver 
sozinho(a), etc.) 
        
42. Deixar de estudar 
porque chegou ao fim de 
um ciclo de estudos 
        
43. Separação do 
marido/companheiro(a) 
devido a trabalho, 
viagem, etc. 
        
44. Noivado         
45. Terminar a relação 
com namorado(a) 
        
46. Sair de casa pela 
primeira vez 
        
47. Reconciliação 
(fazer as pazes) com o 
namorado(a) 
        
Outras experiências 
recentes que tiveram 
impacto na sua vida 
(escreva em baixo qual 
e faça uma cruz na 
resposta que acha estar 
mais próxima do que 
pensa) 
        
48. 
 
 
        
49. 
 
 
        
50. 
 
 
 
        
  
Questionário de Imagem Corporal 
 
Por fim, gostaríamos de saber como se tem sentido em relação à sua aparência ao longo do ÚLTIMO 
MÊS. Por favor leia cada uma das questões e assinale a opção que melhor se aplica ao seu caso, tendo em 
conta a seguinte escala: 
 
Nunca Raramente Às vezes Frequentemente 
Muito 
frequentemente 
Sempre 
1 2 3 4 5 6 
 
Durante as ÚLTIMAS QUATRO SEMANAS: 
 
1 - sentir-se aborrecida fê-la preocupar-se com a forma do seu corpo? 1 2 3 4 5 6 
2 - tem estado tão preocupada com a forma do seu corpo que começou a 
sentir que devia fazer dieta? 
1 2 3 4 5 6 
3 - tem pensado que as suas coxas, ancas ou nádegas são demasiado 
grandes para o resto do seu corpo? 
1 2 3 4 5 6 
4 – tem sentido medo de ficar gorda (ou mais gorda)? 1 2 3 4 5 6 
5 - preocupou-se com o facto do seu corpo não ser suficientemente 
firme? 
1 2 3 4 5 6 
6 - sentir-se cheia (por exemplo, depois de ingerir uma refeição grande) 
fê-la sentir-se gorda? 
1 2 3 4 5 6 
7 - sentiu-se tão mal com a forma do seu corpo a ponto de chorar? 1 2 3 4 5 6 
8 - evitou correr devido à hipótese do seu corpo poder estremecer? 1 2 3 4 5 6 
9 - estar com mulheres magras fê-la sentir-se desconfortável com a 
forma do seu corpo? 
1 2 3 4 5 6 
10 - preocupou-se com o facto das suas coxas se espalharem quando 
está sentada? 
1 2 3 4 5 6 
11 - comer, mesmo que seja uma quantidade pequena de comida, fê-la 
sentir-se gorda? 
1 2 3 4 5 6 
12 - reparou nas formas do corpo de outras mulheres e sentiu-se em 
desvantagem quando as comparou com a forma do seu corpo? 
1 2 3 4 5 6 
13 - pensar na forma do seu corpo interferiu com a sua capacidade de se 
concentrar (por exemplo, enquanto está a ver televisão, a ler, a ouvir 
conversas)? 
1 2 3 4 5 6 
14 - estar nua, por exemplo, durante o banho, fê-la sentir-se gorda? 1 2 3 4 5 6 
15 - tem evitado usar roupas que a façam reparar na forma do seu 
corpo? 
1 2 3 4 5 6 
16 - imaginou cortar do seu corpo partes de gordura? 1 2 3 4 5 6 
17 - comer doces, bolos ou outros alimentos ricos em calorias fê-la 
sentir-se gorda? 
1 2 3 4 5 6 
18 - deixou de ir a eventos sociais (por exemplo, festas) por sentir-se 
mal em relação à forma do seu corpo? 
1 2 3 4 5 6 
19 - sentiu-se excessivamente grande ou arredondada?  1 2 3 4 5 6 
20 - sentiu vergonha do seu corpo? 1 2 3 4 5 6 
21 – a preocupação com a forma do seu corpo fê-la fazer dieta? 1 2 3 4 5 6 
22 - sentiu-se mais feliz com a forma do seu corpo quando o seu 
estômago estava vazio (por exemplo, de manhã)? 
1 2 3 4 5 6 
23 - pensou que tem a forma de corpo que tem actualmente por falta de 
auto-controlo? 
1 2 3 4 5 6 
24 - tem-se preocupado com o facto de outras pessoas estarem a ver 
dobras de gordura na zona da sua cintura ou do seu estômago? 
1 2 3 4 5 6 
  
25 - pensou que não é justo que outras mulheres sejam mais magras que 
você? 
1 2 3 4 5 6 
26 - vomitou para se sentir mais magra? 1 2 3 4 5 6 
27 - preocupou-se por estar a ocupar demasiado espaço (por exemplo, 
enquanto está sentada num sofá ou no banco do autocarro), quando na 
companhia de outras pessoas? 
1 2 3 4 5 6 
28 - preocupou-se pelo facto do seu corpo apresentar covas ou 
ondulações? 
1 2 3 4 5 6 
29 - ver o seu reflexo (por exemplo, no espelho ou na montra de uma 
loja) fê-la sentir-se mal com a forma do seu corpo? 
1 2 3 4 5 6 
30 - beliscou partes do seu corpo para ver a quantidade de gordura? 1 2 3 4 5 6 
31 - evitou situações nas quais as pessoas pudessem ver o seu corpo (por 
exemplo, vestiários)? 
1 2 3 4 5 6 
32 - tomou laxantes para se sentir mais magra? 1 2 3 4 5 6 
33 - sentiu-se particularmente desconfortável com a forma do seu corpo, 
quando na companhia de outras pessoas? 
1 2 3 4 5 6 
34 - a preocupação com a forma do seu corpo fê-la sentir que devia 
fazer exercício? 
1 2 3 4 5 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
2ª Fase da Investigação de Doutoramento sobre Menopausa: Intervenção Psicológica para 
Afrontamentos e Peso 
 
Brevemente irá iniciar-se uma outra fase desta investigação de doutoramento. 
Durante essa fase irão seleccionar-se algumas participantes às quais se irá facultar gratuitamente (isto é, 
sem qualquer custo para a participante) uma intervenção psicológica breve com a psicóloga responsável pelo 
estudo e psicoterapeuta em formação, Filipa Pimenta. 
A intervenção terá cerca de 8 sessões (uma por semana, 60 minutos cada) e terá dois objectivos: 
a) atenuar os afrontamentos (isto é, calores súbitos e incómodos típicos da menopausa, durante os quais 
pode ocorrer um avermelhar da pele e sudação)  
b) ajudar a gerir o seu peso (focando concretamente o seu comportamento alimentar e a sua relação com o 
corpo), tendo como objectivo a diminuição de peso, caso a voluntária tenha excesso de peso.  
 
Assim, pretende-se que as participantes sejam senhoras: 
- com idades compreendidas entre os 42 e os 60 anos;  
- que tenham afrontamentos e que não estejam a fazer qualquer tratamento para os afrontamentos; 
- que tenham excesso de peso. 
  
Estas sessões (cerca de 8 sessões, 60 minutos cada) irão decorrer num consultório de psicologia situado no 
Edifício Imaviz em Lisboa, na Avenida Fontes Pereira de Melo, n.º 35 – 11 B. 
O horário será combinado posteriormente, tendo em conta a sua disponibilidade e a da psicóloga. 
 
Se estiver interessada, por favor deixe de seguida o seu contacto para beneficiar dessas sessões. Sublinho 
que deixar o contacto não implica qualquer compromisso em, quando for contactada por mim, aceitar 
participar. A participação será sempre voluntária, podendo desistir a qualquer momento.  
 
Nome: ________________________________________________________________________________ 
Telefone/ Telemóvel: __________________________      
E-mail: ____________________________________ 
Estou interessada em usufruir da intervenção psicológica que tem como objectivo: 
  ___ Apenas a diminuição dos afrontamentos 
  ___ Apenas a gestão do peso 
⁮   ___ A diminuição dos afrontamentos e a gestão do peso 
   
 
Melhores cumprimentos, 
 
Filipa Pimenta 
Instituto Superior de Psicologia Aplicada 
Rua Jardim do tabaco, 34 
1149-041 Lisboa 
Tel.:218 811 700 
Tlm: 96.341.22.24 
e-mail: filipa_pimenta@ispa.pt 
 
 
 
 
 
 
 
 
 
  
Se sente afrontamentos, MESMO QUE SEJAM POUCO FREQUENTES E POUCO INTENSOS, por favor 
responda também ao questionário desta página. 
Se não sente quaisquer afrontamentos, a sua participação acaba aqui. Muito obrigada pela colaboração! 
 
 
 
Questionário PHFC 
 
 
Indique, por favor, o seu grau de concordância ou discordância com cada uma das quinze afirmações 
seguintes, assinalando o número apropriado para cada afirmação de acordo com a seguinte escala: 
 
 
 
 
 
 
 
 
Muito obrigada pela sua participação! 
 
 
1 2 3 4 
Discordo fortemente Discordo Concordo Concordo fortemente 
1 – Os afrontamentos estão a controlar a minha vida 1 2 3 4 
2 – É largamente da minha responsabilidade gerir os meus 
afrontamentos 
1 2 3 4 
3 – Consigo reduzir o meu mal-estar durante os afrontamentos se 
permanecer calma e relaxada 
1 2 3 4 
4 – Com muita frequência sinto um afrontamento que aparece de forma 
repentina 
1 2 3 4 
5 – Se eu fizer todas as coisas certas, posso gerir com sucesso os 
afrontamentos 
1 2 3 4 
6 – Consigo fazer muita coisa para lidar com os meus afrontamentos  1 2 3 4 
7 –No que toca à gestão dos meus afrontamentos, sinto que apenas 
consigo fazer o que o meu médico me diz  
1 2 3 4 
8 – Quando consigo gerir bem a minha vida pessoal, os meus 
afrontamentos não são tão intensos 
1 2 3 4 
9 – Tenho uma capacidade considerável para controlar os meus 
afrontamentos 
1 2 3 4 
10 – Eu dependo da ajuda de outras pessoas para lidar com os 
afrontamentos  
1 2 3 4 
11 – Normalmente, consigo saber em que dias os meus afrontamentos 
vão ser intensos 
1 2 3 4 
12 – Independentemente do que faça ou por muito que tente, não 
consigo aliviar os meus afrontamentos 
1 2 3 4 
13 - Consigo lidar de uma forma eficaz com os meus afrontamentos  1 2 3 4 
14 – Sinto que os meus afrontamentos são influenciados por factores 
que ultrapassam o meu controlo  
1 2 3 4 
15 – Quero aprender o máximo possível sobre os afrontamentos e a 
menopausa  
1 2 3 4 
  
APPENDIX B 
 
Longitudinal study’s questionnaires and instruments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ESTUDO DE DOUTORAMENTO: A MULHER E A MENOPAUSA 
 
 
De seguida irá encontrar alguns questionários. Por favor responda a TODAS as questões. 
Não existem respostas certas nem erradas. 
 
 
21.  Nos últimos 12 meses teve ciclos menstruais mais curtos, isto é, com menos 7 ou mais dias do que o 
habitual (por exemplo, ter o período de 24 em 24 dias em vez de 31 em 31 dias)? Sim__   Não__ 
22.  Nos últimos 12 meses teve menstruações irregulares, isto é, passaram 2 meses (ou mais meses) sem que o 
período lhe aparecesse e permaneceu sem ter o período durante 60 ou mais dias? Sim__   Não__ 
23.  Já esteve 12 meses (ou mais tempo) sem ter menstruação? Sim___   Não___ 
24.  Está a tomar alguma medicação, produtos naturais ou de outro género, para os sintomas da menopausa? 
Sim___   Não___ 
25.  Está a fazer algum tratamento para perder peso?  
i) Sim___   Não___ 
ii) Se sim, que tipo de tratamento? _____________________________________________________ 
 
 
Escala de Qualidade de Vida 
 
Por favor indique o seu grau de concordância com as seguintes afirmações, avaliando em que medida elas 
se aplicam a si em relação ao passado mês. Certifique-se que responde a todas as afirmações, marcando 
com um círculo a sua opção, tendo em conta a seguinte escala de cinco pontos: 
 
Não é 
verdadeiro no 
meu caso 
 
Parcialmente 
verdadeiro no 
meu caso 
 
Largamente 
verdadeiro no 
meu caso 
1 2 3 4 5 
 
 
1 - Sou capaz de controlar as coisas que, na minha vida, são 
importantes para mim. 
1 2 3 4 5 
2 - Sinto-me desafiada pelo meu trabalho. 1 2 3 4 5 
3 - Acredito que o meu trabalho beneficia a sociedade. 1 2 3 4 5 
4 - Não estou satisfeita com a minha vida sexual. 1 2 3 4 5 
5 - Estou satisfeita com a minha vida amorosa. 1 2 3 4 5 
6 - Tenho recebido muito reconhecimento pessoal na minha 
comunidade ou no meu emprego. 
1 2 3 4 5 
7 - Sinto-me insatisfeita com a minha aparência. 1 2 3 4 5 
8 - A minha alimentação não é equilibrada. 1 2 3 4 5 
9 - Sinto que controlo o meu comportamento alimentar. 1 2 3 4 5 
10 - Habitualmente, faço exercício físico três ou mais vezes 
por semana. 
1 2 3 4 5 
11 - O meu humor está geralmente deprimido. 1 2 3 4 5 
12 – Sinto ansiedade frequentemente. 1 2 3 4 5 
13 - A maior parte das coisas que me acontecem estão fora 1 2 3 4 5 
  
do meu controlo. 
14 - Estou satisfeita com a frequência com que tenho 
relações sexuais com um(a) parceiro(a). 
1 2 3 4 5 
15 - Actualmente, sinto desconforto físico ou dor durante a 
actividade sexual. 
1 2 3 4 5 
16 - Acredito que não tenho controlo sobre a minha saúde 
física. 
1 2 3 4 5 
17 - Sinto-me orgulhosa das metas que alcancei em termos 
profissionais. 
1 2 3 4 5 
18 - Considero a minha vida estimulante. 1 2 3 4 5 
19 - Continuo a traçar para mim novos objectivos pessoais. 1 2 3 4 5 
20 - Tenho a expectativa de que irão acontecer na minha 
vida coisas boas. 
1 2 3 4 5 
21 - Sinto-me bem fisicamente. 1 2 3 4 5 
22 - Sinto-me em forma fisicamente. 1 2 3 4 5 
23 - Continuo a traçar para mim novos objectivos 
profissionais. 
1 2 3 4 5 
 
 
 
Escalas de Ansiedade, Stress e Depressão 
  
Por favor leia cada uma das afirmações abaixo e assinale 1, 2, 3 ou 4 para indicar quanto cada afirmação se 
aplicou a si durante a semana passada, tendo em conta as seguintes opções de resposta:  
 
Não se aplicou nada a 
mim 
Aplicou-se a mim 
algumas vezes 
Aplicou-se a mim 
muitas vezes 
Aplicou-se a mim a 
maior parte das vezes 
1 2 3 4 
 
 
1 - Tive dificuldade em me acalmar 1 2 3 4 
2 - Senti a minha boca seca 1 2 3 4 
3 - Não consegui sentir nenhum sentimento positivo 1 2 3 4 
4 - Senti dificuldade em respirar 1 2 3 4 
5 - Tive dificuldade em tomar iniciativa para fazer coisas 1 2 3 4 
6 - Tive tendência a reagir em demasia em determinadas situações 1 2 3 4 
7 - Senti tremores (por ex., nas mãos) 1 2 3 4 
8 - Senti que estava a utilizar muita energia nervosa 1 2 3 4 
9 - Preocupei-me com situações em que podia entrar em pânico e fazer figura ridícula 1 2 3 4 
10 - Senti que não tinha nada a esperar do futuro 1 2 3 4 
11 - Dei por mim a ficar agitada 1 2 3 4 
12 - Senti dificuldade em relaxar 1 2 3 4 
13 - Senti-me desanimada e melancólica 1 2 3 4 
14 - Fui intolerante em relação a qualquer coisa que me impedisse de terminar aquilo 
que estava a fazer 
1 2 3 4 
15 - Senti-me quase a entrar em pânico 1 2 3 4 
16 - Não fui capaz de ter entusiasmo por nada 1 2 3 4 
17 - Senti que não tinha muito valor como pessoa 1 2 3 4 
18 - Senti que por vezes estava sensível 1 2 3 4 
19 - Senti alterações no meu coração sem fazer exercício físico 1 2 3 4 
20 - Senti-me assustada sem ter tido uma boa razão para isso 1 2 3 4 
21 - Senti que a vida não tinha sentido 1 2 3 4 
  
 
6. Acontece dar por si a comer grandes quantidades de comida (superiores à que a 
maioria das pessoas poderia consumir no mesmo espaço de tempo e sob 
circunstâncias semelhantes), num curto espaço de tempo e com a sensação de 
perda de controlo sobre a comida que ingere durante esse período (por ex., 
sensação de que não pode parar de comer ou controlar o que come ou quando está a 
comer)? 
a. Sim___   Não___ 
b. Se sim, indique quantas vezes por dia_____   OU   quantas vezes por 
semana_____ 
 
7. Durante estes períodos em que come grandes quantidades de comida, verifica 
que: 
a. A ingestão é muito mais rápida que o habitual? Sim___   Não___ 
b. Come até se sentir desagradavelmente cheia? Sim___   Não___ 
c. Consome grandes quantidades de comida apesar de não sentir fome? 
Sim___   Não___ 
d. Come sozinha por sentir embaraço? Sim___   Não___ 
e. Sente-se desgostosa consigo própria, deprimida ou grande culpabilidade 
depois de ingerir estas grandes quantidades de comida? Sim___   Não___ 
 
 
Questionário Holandês de Comportamento Alimentar 
 
Responda, por favor, ao questionário que se segue tendo em conta aquilo que faz 
habitualmente com respeito à sua alimentação. As respostas, quaisquer que sejam, são 
sempre adequadas uma vez que traduzem um modo pessoal de agir. 
Responda nos quadrados respectivos tendo em conta o seu caso particular. Note que em 
algumas situações dispõe de uma outra opção se a pergunta não for adequada ao seu 
caso. 
 
 
1. Tem desejo de comer quando se sente irritado? 
frequentemente 
 
 
2. Se a comida lhe sabe bem, come mais do que o habitual? 
frequentemente 
 
3. Sente desejo de comer quando não tem nada que fazer? 
frequentemente 
 
 
4. Quando o seu peso aumenta come menos do que o habitual? 
frequentemente 
 
  
 
5. Tem desejo de comer quando se sente deprimido ou desanimado? 
frequentemente 
 
 
6. Se a comida cheira bem ou tem bom aspecto, come mais do que o habitual? 
frequentemente 
 
7. Com que frequência recusa comida ou bebidas, por estar preocupado com o seu peso? 
    
frequentemente 
 
8. Tem desejo de comer quando se sente sozinho? 
frequentemente 
 
 
9. Se vê ou cheira algo delicioso, sente desejo de o comer? 
frequentemente 
 
10. Sente desejo de comer quando alguém o deixa “em baixo”? 
Muito 
frequentemente 
 
 
11. Durante as refeições tenta comer menos do que gostaria de comer? 
frequentemente 
 
12. Se tem alguma coisa deliciosa para comer come-a de imediato? 
frequentemente 
 
13. Tem desejo de comer quando se sente zangado? 
frequentemente 
 zangado 
 
14. Controla minuciosamente o que come? 
frequentemente 
 
15. Quando passa por uma padaria apetece-lhe comprar algo delicioso? 
frequentemente 
 
 
  
16. Sente desejo de comer quando alguma coisa desagradável está prestes a acontecer? 
frequentemente 
 
17. Come propositadamente alimentos que fazem emagrecer? 
frequentemente 
 
18. Se vê alguém a comer sente também desejo de comer? 
frequentemente 
 
19. Quando come demasiado procura comer menos no dia seguinte? 
frequentemente 
 
 
20. Tem desejo de comer quando se sente ansioso, preocupado ou tenso? 
     
frequentemente 
 
 
21. Consegue resistir a comer alimentos deliciosos? 
frequentemente 
 
22. Come menos propositadamente para não aumentar o seu peso? 
frequentemente 
 
23. Sente desejo de comer quando as coisas lhe correm mal ou não lhe correm de 
feição? 
frequentemente 
 
24. Quando passa por uma confeitaria ou snack-bar, sente desejo de comprar alguma 
coisa deliciosa? 
frequentemente 
 
25. Tem desejo de comer quando se sente impaciente? 
frequentemente 
 
 
26. Com que frequência tenta não comer entre as refeições porque está a controlar o seu 
peso? 
 
frequentemente 
 
  
27. Come mais do que o habitual quando vê alguém a comer? 
frequentemente 
 
28. Tem desejo de comer quando se sente aborrecido? 
frequentemente 
 
 
29. Com que frequência tenta não comer, durante a tarde, porque está a controlar o seu 
peso? 
frequentemente 
 
30. Tem desejo de comer quando se sente amedrontado? 
frequentemente 
 
 
31.Toma em consideração o seu peso quando escolhe o que vai comer? 
frequentemente 
 
32. Tem desejo de comer quando se sente desapontado ou desiludido? 
    
frequentemente 
Nunca me sinto desapontado ou desiludido 
 
33. Quando está a preparar uma refeição apetece-lhe comer (petiscar) alguma coisa? 
frequentemente 
 
Se sente afrontamentos, por favor continue a responder às perguntas que se seguem. 
Se não sente quaisquer afrontamentos, o preenchimento do seu questionário acaba aqui. 
Por favor entregue-o à psicóloga. Muito obrigada. 
 
 
Intensidade e Frequência dos Afrontamentos 
 
Peço-lhe agora que indique, por favor, com que FREQUÊNCIA e INTENSIDADE 
sentiu AFRONTAMENTOS (isto é, calores súbitos e incómodos típicos da menopausa, 
durante os quais pode ocorrer um avermelhar da pele e sudação) e SUORES 
NOCTURNOS (isto é, suar de forma intensa durante a noite) no MÊS PASSADO.  
Faça uma cruz na opção que melhor se adequa ao seu caso em relação à frequência (isto 
é, quantas vezes) e à intensidade (ou seja, o quão forte foi) dos seus afrontamentos e 
dos suores nocturnos, de acordo com as seguintes escalas: 
     
 
 
 
  
Frequência:          Intensidade: 
1 = Nunca        1 = Nada 
2 = Sim, menos de uma vez por semana    2 = Intensidade mínima 
3 = Sim, uma ou duas vezes por semana    3= Intensidade moderada 
4 = Sim, várias vezes por semana     4 = Intensidade elevada 
5 = Sim, diariamente ou quase todos os dias   5 = Intensidade extrema 
 
 Frequência Intensidade 
1 – Afrontamentos  1  2  3  4  5   1   2   3   4  5 
2 – Suores nocturnos  1  2  3  4  5   1   2   3   4  5 
 
 
Questionário PHFC 
 
Indique por favor o ser grau de concordância ou discordância com cada uma das quinze 
afirmações da escala seguinte, assinalando o número apropriado para cada afirmação: 
 
 
1 2 3 4 
Discordo fortemente Discordo Concordo Concordo fortemente 
 
 
1 – Os afrontamentos estão a controlar a minha vida 1 2 3 4 
2 – É largamente da minha responsabilidade gerir os meus 
afrontamentos 
1 2 3 4 
3 – Consigo reduzir o meu mal-estar durante os afrontamentos se 
permanecer calma e relaxada 
1 2 3 4 
4 – Com muita frequência sinto um afrontamento que aparece de forma 
repentina 
1 2 3 4 
5 – Se eu fizer todas as coisas certas, posso gerir com sucesso os 
afrontamentos 
1 2 3 4 
6 – Consigo fazer muita coisa para lidar com os meus afrontamentos  1 2 3 4 
7 –No que toca à gestão dos meus afrontamentos, sinto que apenas 
consigo fazer o que o meu médico me diz  
1 2 3 4 
8 – Quando consigo gerir bem a minha vida pessoal, os meus 
afrontamentos não são tão intensos 
1 2 3 4 
9 – Tenho uma capacidade considerável para controlar os meus 
afrontamentos 
1 2 3 4 
10 – Eu dependo da ajuda de outras pessoas para lidar com os 
afrontamentos  
1 2 3 4 
11 – Normalmente, consigo saber em que dias os meus afrontamentos 
vão ser intensos 
1 2 3 4 
12 – Independentemente do que faça ou por muito que tente, não 
consigo aliviar os meus afrontamentos 
1 2 3 4 
13 - Consigo lidar de uma forma eficaz com os meus afrontamentos  1 2 3 4 
14 – Sinto que os meus afrontamentos são influenciados por factores 
que ultrapassam o meu controlo  
1 2 3 4 
15 – Quero aprender o máximo possível sobre os afrontamentos e a 
menopausa  
1 2 3 4 
  
APPENDIX C 
 
Analysis of the Instruments’ Psychometric Properties 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ANALYSIS OF INSTRUMENTS’ PSYCHOMETRIC PROPERTIES 
 
 
 
 
The construct validity of all scales was asserted by confirmatory factor analysis, 
convergent and discriminant validity. 
The goodness of fit of the measurement model was given by chi-square statistics (χ 
2
/df), comparative fit index (CFI), goodness of fit index (GFI) and root mean square 
error of approximation (RMSEA). Reference values indicative of good model fit were 
those values currently practiced in structural equation modelling (Byrne, 2001; Maroco, 
2010a). 
The convergent validity of the instruments was analysed through the average 
variance extracted (AVE). An adequate value should be higher than .45. The 
discriminant validity was explored comparing the inter-factors’ squared correlation with 
the AVE of each individual factor. To demonstrate the factors’ discriminant validity, the 
squared correlation between factors should be smaller than the individual (Maroco, 
2010a). 
Criterion validity was explored through concurrent-oriented validity of scales, using 
Pearson’s correlation with similar constructs. 
In addition, to demonstrate the stability of the original structure of the instruments 
and assert external validity of the measurement model, initial confirmatory factor 
analysis was made in 60% of the sample, randomly selected, and the factor weights and 
correlations stability were confirmed in the remaining 40% of the sample (Maroco, 
2010a). 
Sensitivity was explored through the analysis of minimum and maximum values, 
skewness and kurtosis. Values are expected to range through the overall Lykert-type 
scales (from the minimum to the maximum scores) and skewness and kurtosis are 
expected to have absolute values below 3 and 7 respectively (Kline, 2005; Maroco, 
2010a).  Finally, reliability was studied applying the Cronbach’s alpha.  Alpha scores 
should be above .70 (Maroco, 2010b). 
 
 
 
  
Subjective Well-being Scale  
(Albuquerque & Tróccoli, 2004) 
 
 
Construct Validity 
Confirmatory factor analysis 
Item 47 was excluded given it presented a low standardized estimate (λ=.394; 
p<.001) and evidenced a value of squared multiple correlations below the recommended 
.250 (r
2
=.155). Moreover, the modification index (MI≈14) was above the recommended 
value of 11 (Maroco, 2010a) and the residual of this item was correlated with several 
other residuals of different items. 
The subjective well-being measurement model without item 47 presented a good fit 
(X
2
/df=3.793; CFI=.846; GFI=.798; RMSEA=.053; p<.001; C.I. 90%=].051; .054[). 
 
Convergent validity 
All subscales present good AVE scores (i.e., equal or above .450). 
   
Table 1 – Subjective well-being scale: convergent validity  
Subjective well-being subscales AVE 
Positive Affect .479 
Negative Affect .510 
Life Satisfaction .455 
 
Discriminant validity  
Of the three paired-factors possible comparisons, all presented discriminant 
validity.  
 
Table 2 – Subjective well-being scale: discriminant valitity  
Association between different factors 
Squared 
correlations 
Negative Affect – Positive Affect .260 
Positive Affect – Life Satisfaction .314 
Life Satisfaction – Negative Affect .397 
  
Criterion validity 
Negative affect subscale was positively and highly related with Depression Anxiety 
and Stress Scales’ (DASS) depression factor (r=.653; p<.001). 
In addition, both positive affect (r=.592; p<.001) and life satisfaction (r=.594; 
p<.001) were positively and strongly correlated with personal spiritual well-being. 
 
External Validity 
The model presents a good adjustment (X
2
/df=2.494; CFI=.871; GFI=.753; 
RMSEA=.039; p=1.000; C.I. 90%=].038; .040[) in both groups (60% and 40% of the 
total sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(58)=70.844; p=.120), hence 
confirming external validity of the measurement model. Therefore, there are no 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) confirming the stability of the subjective well-being’s 
assessment. 
 
Reliability 
The internal consistency of three subscales and of the overall scale was also 
explored. All subscales presented a very good Cronbach’s alpha, as shown in table 3. 
  
Table 3 – Subjective well-being scale: reliability  
Scale Cronbach’s Alpha 
Positive affect  .951 
Negative affect  .963 
Life satisfaction  .923 
Subjective well-being (overall scale) .828 
  
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values of the 61 items. All items presented answers ranging from 
1 to 5 and all values of kurtosis and skewness were below 7 and 3, respectively, as 
evidenced in table 4. 
 
  
Table 4 – Subjective well-being scale: values regarding minimum and maximum scores, 
skewness and kurtosis   
 
Items Minimum Maximum Skewness Kurtosis 
1 1 5 1.918 3.791 
2 1 5 2.069 4.511 
3 1 5 -.238 .386 
4 1 5 -.653 .634 
5 1 5 .939 .189 
6 1 5 -.172 .245 
7 1 5 -.259 .098 
8 1 5 .610 -.276 
9 1 5 .459 -.641 
10 1 5 -.599 .570 
11 1 5 -.316 .175 
12 1 5 .616 -.465 
13 1 5 1.025 .179 
14 1 5 -.469 .101 
15 1 5 .856 -.080 
16 1 5 -.310 -.114 
17 1 5 1.736 2.591 
18 1 5 -.270 .029 
19 1 5 -.490 -.004 
20 1 5 .739 .027 
21 1 5 -.513 .169 
22 1 5 -.335 -.108 
23 1 5 1.513 2.043 
24 1 5 -.466 .126 
25 1 5 -.538 .256 
26 1 5 -.577 .394 
27 1 5 .568 -.469 
28 1 5 .835 .111 
29 1 5 -.245 -.056 
  
30 1 5 1.049 .562 
31 1 5 .710 -.309 
32 1 5 .934 .188 
33 1 5 1.168 .731 
34 1 5 1.663 2.360 
35 1 5 1.052 .568 
36 1 5 1.449 1.719 
37 1 5 -.154 -.525 
38 1 5 1.159 .961 
39 1 5 -.392 .184 
40 1 5 .639 -.415 
41 1 5 .119 -.772 
42 1 5 -.195 -.387 
43 1 5 -.179 -.400 
44 1 5 .763 -.260 
45 1 5 1.049 .307 
46 1 5 .821 -.085 
48 1 5 -.808 .005 
49 1 5 -.685 .081 
50 1 5 -1.117 1.463 
51 1 5 -.573 -.676 
52 1 5 -.355 -1.000 
53 1 5 .004 -1.025 
54 1 5 -.216 -1.041 
55 1 5 -.924 .485 
56 1 5 -1.649 2.452 
57 1 5 -.784 -.549 
58 1 5 .741 -.081 
59 1 5 -.870 -.225 
60 1 5 -1.350 1.461 
61 1 5 -.389 -.927 
62 1 5 -.776 .239 
 
  
Shortened version with three items for each subscale of subjective well-being scale 
The items with the highest structural weights were items 24, 25 and 29 for the 
positive affect; 13, 30 and 45 for the negative affect and 48, 55 and 62 regarding life 
satisfaction.  
 
Confirmatory factor analysis 
The subjective well-being measurement model with only the nine items mentioned 
above, presented an acceptable fit (X
2
/df=4.388; CFI=.983; GFI=.977; RMSEA=.058; 
p<.001; C.I. 90%=].047; .070[). 
 
Convergent validity 
All subscales measured with the three items presented good AVE scores (namely, 
above .450), as seen in table 5. 
 
Table 5 – Subjective well-being – shortened version: convergent validity 
Subjective well-being AVE 
Positive affect .640 
Negative affect .691 
Life satisfaction .696 
 
Reliability 
Although Cronbach’s alpha values were very good for all subscales, the overall 
scale showed a very low internal consistency, as presented in table 6. 
 
Table 6 – Subjective well-being – shortened version: reliability 
Subjective well-being Cronbach’s Alpha 
Positive affect .835 
Negative affect .869 
Life satisfaction .871 
Overall scale .271 
 
 
 
  
Depression, Anxiety and Stress Scales 
(Lovibond & Lovibond, 1995; Pais-Ribeiro, Horando, & Leal, 2004) 
 
Construct Validity 
Confirmatory factor analysis 
The Depression, Anxiety and Stress Scales (DASS) evidenced a measurement 
model with an acceptable fit (X
2
/df=4.210; CFI=.947; GFI=.934; RMSEA=.057; p<.001; 
C.I. 90%=].052; .061[). 
 
Convergent validity 
Depression and stress subscales presented good AVE scores (i.e., equal or above 
.450). However, anxiety evidenced a low AVE value, as evidenced in the table 7. 
   
Table 7 – Depression, Anxiety and Stress Scales: convergent validity 
DASS subscales AVE 
Depression .568 
Anxiety .403 
Stress .486 
 
Discriminant validity  
Of the three paired-factors possible comparisons, none presented discriminant 
validity.  
 
Table 8 – Depression, Anxiety and Stress Scales: discriminant validity 
Association between different factors Squared correlations 
Stress – Anxiety .689 
Anxiety – Depression .624 
Depression – Stress .568 
 
Criterion validity 
DASS’ depression subscale was positively and highly related with depressive mood 
subscale from the Menopausal Symptoms’ Severity Inventory, MSSI-38 (r=.737; 
p<.001). 
  
Similarly, DASS’ anxiety subscale was positively and strongly connected with the 
anxiety subscale from the MSSI-38 (r=.607; p<.001). 
There was also a moderate and positive association between the factor of perceived 
loss of control (MSSI-38) and the stress subscale (DASS) (r=.479; p<.001). 
 
External Validity 
The model presents a good fit (X
2
/df=3.171; CFI=.919; GFI=.889; RMSEA=.047; 
p=.976; C.I. 90%=].044; .049[) in both groups (60% and 40% of the total sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(18)=21.165; p=.271), hence 
confirming the external validity of the measurement model. Therefore, there are no 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) confirming the stability of the depression, anxiety and stress 
constructs, as measure with DASS. 
 
Reliability 
The internal consistency of three subscales was also explored. All subscales 
presented a very good Cronbach’s alpha, as shown in table 9. 
  
Table 9 – Depression, Anxiety and Stress Scales: reliability 
Subscales Cronbach’s Alpha 
Stress .867 
Anxiety .819 
Depression .898 
  
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values of the 21 items. All items presented answers ranging from 
1 to 4 and the majority of items manifested values of kurtosis and skewness below 7 and 
3, respectively, as recommended.  The only exceptions were items 9 and 15 regarding 
kurtosis, both from anxiety subscale. 
 
 
  
Table 10 – Depression, Anxiety and Stress Subscales: values regarding minimum and 
maximum scores, skewness and kurtosis   
Items  Minimum Maximum Skewness Kurtosis 
1 1 4 1.207 1.262 
2 1 4 1.537 1.877 
3 1 4 1.857 3.112 
4 1 4 2.486 6.445 
5 1 4 1.527 2.319 
6 1 4 .901 .675 
7 1 4 2.520 6.293 
8 1 4 1.027 .686 
9 1 4 2.727 7.807 
10 1 4 2.383 5.480 
11 1 4 1.047 .833 
12 1 4 .940 .455 
13 1 4 1.123 .721 
14 1 4 1.473 1.954 
15 1 4 2.936 8.966 
16 1 4 2.076 4.211 
17 1 4 2.195 4.381 
18 1 4 .621 .316 
19 1 4 1.425 1.374 
20 1 4 2.073 4.293 
21 1 4 2.440 5.474 
 
Shortened version with three items for the stress subscale 
The items with the highest structural weights were items 8, 11 and 12 for the stress 
subscale. 
 
Confirmatory factor analysis 
The stress measurement model with only the three items mentioned above, was 
saturated and therefore its fit (X
2
/df=.000; CFI=1.000; GFI=1.000) should not be 
evaluated. 
  
Convergent validity 
The subscale measured with the three items showed a good AVE score (namely, . 
629). 
 
Reliability 
Cronbach’s alpha value for the shortened version of the stress subscale was good 
(.834). 
 
 
 
Utian Quality of Life Scale 
(Utian, Janata, Kingsberg, Schluchter, & Hamilton, 2002) 
 
Construct Validity 
Confirmatory factor analysis 
The residual of item 20 manifested covariances with other factors (and with 
modification indices extremely above the admissible value, that is, equal or below 11) 
(Maroco, 2010a), namely, occupational factor (MI=152.972) and health subscale 
(MI=17.333). The item itself, although belonging to the emotional subscale, was 
reflected in the factor health-related quality of life (QoL) (MI=38.273), occupational 
QoL (MI=99.409) and thirteen other items of the QoL scale with modification indices 
equally high. For these reasons, item 20 was excluded.   
The Utian QoL Scale without item 20 evidenced a measurement model with an 
acceptable fit (X
2
/df=4.899; CFI=.887; GFI=.913; RMSEA=.062; p<.001; C.I. 
90%=].059; .066[). 
 
Convergent validity 
All subscales presented an AVE scores below the admissible (i.e., equal or above 
.450) to be considered to have convergent validity, as evidenced in the table 11. 
   
 
 
 
 
  
Table 11 – Utian QoL Scale: convergent validity 
Utian QoL Scale AVE 
Occupational .444 
Health .288 
Emotional .336 
Sexual .375 
 
Discriminant validity  
Of the six paired-factors possible comparisons, four presented discriminant validity. 
As shown in table 12 there was no discriminant validity between occupational and 
health, and between health and emotional subscales.   
 
Table 12 – Utian QoL Scale: discriminant validity 
Association between different factors 
Squared 
correlations 
Occupational – Health .397 
Health – Emotional .303 
Emotional – Sexual .194 
Sexual – Occupational .123 
Sexual – Health .096 
Emotional – Occupational .260 
 
Criterion validity 
The depressive mood subscale from the Menopausal Symptoms’ Severity Inventory 
(MSSI-38) presented a strong and negative relation with the emotional QoL subscale 
(rp=-.669; p<.001), as did the anxiety subscale from MSSI-38 (rp=-.662; p<.001). 
Similarly, the MSSI-38’s sexual symptoms factor was negatively and significantly 
(although weakly) related with the sexual QoL subscale (rp=-.236; p<.001). 
Cognitive impairment (MSSI-38) was also negatively (though the relation was 
weak) and significantly associated with occupational QoL (rp=-.341; p<.001)  
Aches and pain (rp=-.384; p<.001) and body shape changes (rp=-.393; p<.001) 
MSSI-38’s subscales were both associated with health-related QoL, although the 
associations were only close to moderate. 
  
Although QoL and well-being are two constructs theoretically close, the association 
between these two in the present study, although positive and significant, was weak 
(rp=.209; p<.001); this might be due partially to the fact that the measure used to assess 
QoL is specific to menopause, narrowing the construct. 
 
External Validity 
The model presents a good fit (X
2
/df=2.800; CFI=.882; GFI=.892; RMSEA=.042; 
p=1.000; C.I. 90%=].040; .045[) in both groups (60% versus 40% of the total sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(18)=27.194; p=.075), hence 
confirming the external validity of the measurement model. Therefore, there are no 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) confirming the stability of the quality of life construct 
assessed with Utian QoL Scale. 
 
Reliability 
The internal consistency of four subscales and overall scale were also explored. 
Subscales presented an acceptable Cronbach’s alpha as shown in table 13. 
  
Table 13 - Utian QoL Scale: reliability 
Scale Cronbach’s Alpha 
Occupational  .864 
Emotional .680 
Health  .693 
Sexual .617 
QoL overall scale .857 
  
 
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values the 22 items. All items presented answers ranging from 1 
to 5 and values of kurtosis and skewness were below 7 and 3, respectively, as 
recommended.   
  
 
Table 14 – Utian QoL Scale: values regarding minimum and maximum scores, 
skewness and kurtosis    
Items  Minimum Maximum Skewness Kurtosis 
1 1 5 -.327 -.408 
2 1 5 -.168 -.877 
3 1 5 -.465 -.727 
4 1 5 -.425 -1.134 
5 1 5 -.370 -1.149 
6 1 5 -.100 -.831 
7 1 5 -.401 -.824 
8 1 5 -.472 -.686 
9 1 5 .015 -.826 
10 1 5 .983 -.488 
11 1 5 -.906 -.154 
12 1 5 -.715 -.351 
13 1 5 -.947 .076 
14 1 5 -.021 -1.161 
15 1 5 -1.520 1.308 
16 1 5 -.629 -.529 
17 1 5 -.327 -.805 
18 1 5 -.161 -.538 
19 1 5 -.469 -.506 
21 1 5 -.273 -.431 
22 1 5 -.023 -.705 
23 1 5 -.328 -.997 
 
 
 
 
 
 
 
  
 
Spiritual Well-being Scale 
(Gomez & Fisher, 2003; Gouveia, Marques, & Pais-Ribeiro, 2009) 
 
Construct Validity 
Confirmatory factor analysis 
The Spiritual Well-being Scale evidenced a measurement model with an acceptable 
fit (X
2
/df=5.364; CFI=.938; GFI=.916; RMSEA=.066; p<.001; C.I. 90%=].062; .070[). 
 
Convergent validity 
All subscales presented good AVE scores (i.e., equal or above .450), as evidenced 
in the table 15. 
   
Table 15 – Spiritual Well-being Scale: convergent validity 
Spiritual Well-being Scale AVE 
Personal .521 
Communal .453 
Environmental .588 
Transcendental .641 
 
Discriminant validity  
Of the six paired-factors possible comparisons, only one (personal-communal) did 
not present discriminant validity.  
 
Table 16 – Spiritual Well-being Scale: discriminant validity 
Association between different factors 
Squared 
correlations 
Personal - Communal  .533 
Communal – Environmental .36 
Environmental – Transcendental .36 
Transcendental – Personal .240 
Transcendental – Communal .25 
Personal – Environmental .397 
  
 
Criterion validity 
Both the depressive mood (r=-.486; p<.001) and anxiety’s (r=-.429; p<.001) 
subscales from the Menopausal Symptoms’ Severity Inventory (MSSI-38) presented a 
moderated and negative relation with the personal dimension of spiritual well-being. 
Additionally, personal spiritual well-being manifested a moderate and positive 
association with positive affect (r=.592; p<.001) and life satisfaction (r=.594; p<.001), 
and a negative one with the negative affect factor (r=-.450; p<.001), from the Subjective 
Well-being Scale. 
 
External Validity 
The model presents a very good fit (X
2
/df=2.461; CFI=.939; GFI=.891; 
RMSEA=.043; p=1.000; C.I. 90%=].039; .046[) in both groups (60% and 40% of the 
total sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(16)=.000; p=1.000), hence confirming 
the external validity of the measurement model. Therefore, there are no significant 
differences in the factorial measurement weights between both groups (60% of the 
sample versus 40%) confirming the stability of the spiritual well-being construct, 
assessed with this instrument. 
 
Reliability 
The internal consistency of four subscales was also explored. The subscales 
presented a good Cronbach’s alpha as shown in table 17. 
  
Table 17 - Spiritual Well-being Scale: reliability 
Scale Cronbach’s Alpha 
Personal subscale .842 
Communal subscale .874 
Environmental subscale  .879 
Transcendental subscale .894 
Spiritual well-being (overall scale) .866 
  
  
 
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values for the 20 items. All items presented answers ranging 
from 1 to 5 and values of kurtosis and skewness were below 7 and 3, respectively, as 
recommended.   
 
Table 18 – Spiritual Well-being: values regarding minimum and maximum scores, 
skewness and kurtosis   
Items  Minimum Maximum Skewness Kurtosis 
1 1 5 -.377 .387 
2 1 5 -.155 -.645 
3 1 5 -.303 .389 
4 1 5 -.354 -.176 
5 1 5 -.267 -.005 
6 1 5 -.828 .289 
7 1 5 -1.044 .942 
8 1 5 -.191 .052 
9 1 5 -.465 .474 
10 1 5 -.429 -.198 
11 1 5 -.360 -.632 
12 1 5 -.374 -.020 
13 1 5 -.476 -.486 
14 1 5 -.368 -.166 
15 1 5 .205 -.618 
16 1 5 -.267 .031 
17 1 5 -.898 1.550 
18 1 5 -.549 .190 
19 1 5 -.271 -.149 
20 1 5 -.448 -.284 
 
 
 
  
 
Shortened version with three items for each subscale 
The items with the highest structural weights were items 5, 9 and 14 for the 
personal subscale; 3, 17 and 19 for the communal spiritual well-being; 2, 11 and 13 for 
the transcendental subscale; and items 10, 12 and 20 for the environmental subscale.  
 
Confirmatory factor analysis 
The spiritual well-being measurement model with only the twelve items mentioned 
above, presented an acceptable fit (X
2
/df=5.452; CFI=.966; GFI=.958; RMSEA=.067; 
p<.001; C.I. 90%=].059; .075[). 
 
Convergent validity 
All subscales measured with the three items presented good AVE scores (namely, 
above .450), as seen in table 19. 
 
Table 19 – Spiritual well-being – shortened version: convergent validity 
Spiritual well-being AVE 
Personal .475 
Communal .559 
Environmental .674 
Transcendental .766 
 
Reliability 
Cronbach’s alpha values were good for all subscales, as presented in table 20. 
 
Table 20 – Spiritual well-being – shortened version: reliability 
Spiritual well-being Cronbach’s Alpha 
Personal .724 
Communal .779 
Environmental .857 
Transcendental .907 
Overall scale .884 
 
  
Body Shape Questionnaire 
(Cooper, Taylor, Cooper, & Fairburn, 1987) 
 
Construct Validity 
Confirmatory factor analysis 
A confirmatory factor analysis was done. Item 26 had the highest modification 
index (MI=66.421), its residual evidenced covariance with several other residuals and it 
presented the lowest correlation with the construct (.301). Furthermore, this item had a 
kurtosis higher than 7 (|ku|=78.359) and a skewness superior to 3 (|sk|=8.201) and, thus, 
was excluded.  
The Body Shape Questionnaire evidenced a measurement model with an acceptable 
fit (X
2
/df=7.390; CFI=.869; GFI=.767; RMSEA=.080; p<.001; C.I. 90%=].077; .082[). 
 
Convergent validity 
The scale presented an acceptable AVE score, i.e., equal or above .450 (AVE= 
0.484).  
 
Criterion validity 
The body shape changes subscale (MSSI-38) evidenced a significant and positive 
association with body shape concerns, as measured by the Body Shape Questionnaire 
(r=.561; p<.001).  
 
External Validity 
The model presents an acceptable fit (X
2
/df=4.392; CFI=.853; GFI=.733; 
RMSEA=.058; p<.001; C.I. 90%=].056; .060[) in both groups (60% and 40% of the total 
sample). 
However, the unconstrained measurement model has a significantly better fit than 
the model with constrained factorial weights (X
2
(32)=82.437; p<.001). Therefore, the 
external validity of the measurement model was not confirmed. Hence, there are 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) and the stability of the body shape concerns’ construct, as 
measured by the Body Shape Questionnaire, was not confirmed. This instrument 
presents factorial validity in the present sample, however, it is not possible to assure its 
validity in a different sample. 
  
Reliability 
The internal consistency of the Body Shape Questionnaire (without item 26), given 
by the Cronbach’s alpha was very good (.967). 
   
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values for the 20 items. All items presented answers ranging 
from 1 to 6; for the majority of the items, values of kurtosis and skewness were below 7 
and 3, respectively, as recommended.  However, items 7, 8, 13, 18, 27 and 32 presented 
values of kurtosis and/or skewness above the reference values. 
 
Table 21 – Body Shape Questionnaire: values regarding minimum and maximum 
scores, skewness and kurtosis   
Items Minimum Maximum Skewness Kurtosis 
1 1 6 .613 -.031 
2 1 6 .570 -.425 
3 1 6 1.172 .583 
4 1 6 .398 -.719 
5 1 6 .466 -.411 
6 1 6 .559 -.435 
7 1 6 2.887 8.921 
8 1 6 3.192 11.633 
9 1 6 1.852 3.238 
10 1 6 2.128 4.507 
11 1 6 2.028 4.173 
12 1 6 .995 .571 
13 1 6 2.516 7.260 
14 1 6 1.249 1.020 
15 1 6 .861 .027 
16 1 6 1.232 .571 
17 1 6 .972 .362 
18 1 6 3.386 13.045 
19 1 6 1.704 2.346 
  
20 1 6 1.911 3.450 
21 1 6 .842 .105 
22 1 6 1.164 -.656 
23 1 6 .965 .202 
24 1 6 1.085 .603 
25 1 6 2.209 4.821 
27 1 6 3.963 18.377 
28 1 6 1.364 1.552 
29 1 6 1.197 .923 
30 1 6 1.450 1.919 
31 1 6 1.753 2.479 
32 1 6 2.707 7.691 
33 1 6 1.717 2.930 
34 1 6 .416 -.722 
 
Shortened version with three items for the body shape questionnaire 
The items with the highest structural weights were the 14, 29 and 33. 
 
Confirmatory factor analysis 
The body shape questionnaire measurement model, with the three items mentioned 
above, was saturated; hence its fit (X
2
/df=.000; CFI=1.000; GFI=1.000) should not be 
considered. 
 
Convergent validity 
The subscale measured with the three items showed a good AVE score (namely, 
.715). 
 
Reliability 
Cronbach’s alpha value for the shortened version of the body shape questionnaire 
was very good (.878). 
 
 
 
  
Perceived Control over Hot Flushes Index 
(Reynolds, 1997) 
 
Construct Validity 
Confirmatory factor analysis 
The item 15 was not significantly correlated with the construct, presenting a 
negative standardized estimate (λ=-.105; p=.134) and only 1.1% of its variance was 
explained by the construct. Moreover, the modification index (MI=33.785) evidenced 
this item as the strongest negative influence on the quality of fit of the measurement 
model. Therefore, this item was excluded. 
The instrument without item 15 evidenced a measurement model with a good fit 
(X
2
/df=2.786; CFI=.891; GFI=.910; RMSEA=.077; p<.001; C.I. 90%=].065; .090[). 
 
Convergent validity 
The two subscales presented weak AVE’s scores (i.e., lower than .450) as 
evidenced in table 22. 
 
Table 22 – Perceived Control over Hot Flushes Index: convergent validity 
Scale AVE 
Control .401 
Lack of control .285 
 
Discriminant validity  
The two subscales presented discriminant validity, as evidenced in table 23.  
 
Table 23 – Perceived Control over Hot Flushes Index: discriminant validity 
Association between different factors Squared 
correlations 
Control - Lack of control  .102 
 
 
 
 
  
Criterion validity 
The perceived loss of control (r=-.156; p=.012) and vasomotor symptoms (r=-.209; 
p=.001) subscales, from the MSSI-38, evidenced a significant, although very weak, 
correlation with the perceived control over hot flushes’ dimension. The same was 
observed for lack of control again in relation with perceived loss of control (r=.162; 
p=.010) and vasomotor symptoms’ factor (r=.483; p<.001), presenting the latter a 
moderate correlation. 
 
External Validity 
The model presents an acceptable adjustment (X
2
/df=1.640; CFI=.864; GFI=.856; 
RMSEA=.052; p=.395; C.I. 90%=].041; .062[) in both groups (60% and 40% of the total 
sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(12)=12.488; p=.407), hence 
confirming the external validity of the measurement model. Therefore, there are no 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) confirming the stability of the perceived control over hot 
flashes index. 
  
Reliability 
The internal consistency of the Perceived Control over Hot Flashes Index (without 
item 15), given by the Cronbach’s alpha was good, as evidenced in table 24. 
 
 Table 24 - Perceived Control over Hot Flushes Index: reliability 
Scale Cronbach’s Alpha 
Control subscale .851 
Lack of control subscale .703 
Overall scale  .782 
  
 
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values for the 14 items. All items presented answers ranging 
  
from 1 to 4 and evidenced values of kurtosis and skewness below 7 and 3, respectively, 
as recommended.   
 
Table 25 – Perceived Control over Hot Flushes Index: values regarding minimum and 
maximum scores, skewness and kurtosis   
Items  Maximum Minimum Skewness Kurtosis 
1 1 4 -.787 .307 
2 1 4 .043 -.844 
3 1 4 -.370 -.206 
4 1 4 .308 -.674 
5 1 4 -.058 -.726 
6 1 4 -.313 -.461 
7 1 4 -.105 -.681 
8 1 4 .068 -.490 
9 1 4 -.098 -.592 
10 1 4 -.821 .156 
11 1 4 .919 .458 
12 1 4 -.290 -.539 
13 1 4 -.561 -.261 
14 1 4 .407 -.498 
 
 
 
Life Events Survey 
(Sarason, Johnson, & Siegel, 1978; Silva, Pais-Ribeiro, Cardoso, & Ramos, 2003) 
 
Quality of the fit of the measurement model 
Only the events identified as present in the last year by at least 10% of the 
participants were included in the analysis. Therefore, items 2, 3, 7, 10, 12, 23, 25, 30, 
31, 32, 34, 35, 38, 40, 42, 43, 44, 45, 46 and 47 were excluded. Items 11, 27 and 33 
were not included in the instrument given they were addressed to men and all 
participants of this study were female. 
  
The measurement model with the remain items presented an acceptable fit 
(X
2
/df=4.770; CFI=.645; GFI=.904; RMSEA=.061; p<.001; C.I. 90%=].058; .065[) 
 
External Validity 
The model presents an acceptable adjustment (X
2
/df=3.089; CFI=.594; GFI=.871; 
RMSEA=.046; p=.997; C.I. 90%=].043; .048[) in both groups (60% and 40% of the total 
sample). 
The unconstrained measurement model does not have a significantly better fit than 
the model with constrained factorial weights (X
2
(22)=23.044; p=.399), hence 
confirming the external validity of the measurement model. Therefore, there are no 
significant differences in the factorial measurement weights between both groups (60% 
of the sample versus 40%) confirming the stability of the life events assessment, as 
measured with these items. 
  
Reliability 
The internal consistency of the Life Events Scale, as used in this sample (that is, 
including only the situations identified by at least 10% of the participants), and given by 
the Cronbach’s alpha, was acceptable (.721). 
 
Sensitivity 
To address sensitivity, the range of the Likert-type scale was explored as well as the 
skewness and kurtosis values for the 20 items. All items presented answers ranging 
from 1 to 4 and the majority evidenced values of kurtosis and skewness below 7 and 3, 
respectively, as recommended.  However, items 14, 17, 22, 24, 28 and 39 manifested 
values of kurtosis and/or skewness above the reference values recommended as optimal 
scores.  
 
Table 26 – Life Events Survey: values regarding minimum and maximum scores, 
skewness and kurtosis   
Items Minimum Maximum Skewness Kurtosis 
1 -3 3 .664 1.048 
4 -3 3 -.146 1.195 
5 -3 3 -1.449 1.068 
  
6 -3 3 .259 2.362 
8 -3 3 -2.410 6.475 
9 -3 3 .688 .707 
13 -3 3 .220 1.839 
14 -3 3 2.357 11.813 
15 -3 3 -1.264 .651 
16 -3 3 -1.116 5.633 
17 -3 3 -3.071 15.492 
18 -3 3 -1.812 6.998 
19 -3 3 -.124 2.008 
20 -3 3 .364 3.642 
21 -3 3 1.623 3.224 
22 -3 3 1.503 9.366 
24 -3 3 1.354 9.744 
26 -3 3 .232 4.265 
28 -3 3 -.057 9.125 
29 -3 3 .498 1.775 
36 -3 3 .377 1.885 
37 -3 3 1.194 5.406 
39 -3 3 -18.033 36.168 
41 -3 3 .570 6.313 
 
 
Menopause Symptoms’ Severity Inventory (MSSI-38) 
(Pimenta, Leal, Maroco, & Ramos, in press) 
 
Shortened version with three items for each subscale 
The only subscales which were shortened were depressive mood, anxiety and aches 
and pain, since the other nine subscales already had three or two items.  
The items with the highest structural weights were 2, 4 and 10 for the anxiety 
subscale; 9, 12 and 18 for the depressive mood; and 23, 27 and 34 for aches and pain’s 
subscale.  
 
  
Confirmatory factor analysis 
The MSSI-38’s measurement model with the shortened subscales presented a good 
fit (X
2
/df=2.380; CFI=.943; GFI=.927; RMSEA=.044; p<.001; C.I. 90%=].040; .048[). 
 
Convergent validity 
The subscales measured with the three items presented good AVE scores (namely, 
above .450), as seen in table 27. 
 
Table 27 – Depressive mood, anxiety and aches/pain subscales (MSSI-38) – shortened 
version: convergent validity 
Subscales AVE 
Depressive mood .482 
Anxiety .641  
Aches and pain .540 
 
Reliability 
Cronbach’s alpha values were good for the three subscales, as presented in table 28. 
 
Table 28 – Depressive mood, anxiety and aches/pain subscales (MSSI-38) – shortened 
version: reliability 
Subscales Cronbach’s Alpha 
Depressive mood .741 
Anxiety .840 
Aches and pain .794 
 
 
 
 
 
 
 
 
 
  
Dutch Eating Behaviour Questionnaire 
(van Strien, Frijters, Bergers, & Defares, 1986; Viana & Singe, 2003) 
 
 
Reliability 
The internal consistency of the three subscales is good, as evidenced in table 29. 
 
Table 29 - Dutch Eating Behaviour Questionnaire: reliability 
Scale Cronbach’s alpha 
Emotional eating .945 
External eating .780 
Restrained eating  .914 
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APPENDIX D 
 
Interviews’ Contents and Emergent Categories from Content Analysis (Paper 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Análise de conteúdo 
 
 
 
 
Parti
cipa
nte 
a) Prof., Hab. lit. e 
Est. civil 
b) Idade Actual: 
Idade menopausa 
c) Terapia 
hormonal, produto 
natural ou nada  
O que é para si a menopausa? 
(Represent.) 
 
Se existir(em) alguma(a), que 
consequência(s) positiva(s) associa à 
menopausa? 
(C+) 
 
Se existir(em) alguma(a), que 
consequência(s) negativa(s) associa à 
menopausa? 
 (C-) 
1 a) Reformada, 
Ensino médio, 
Casada 
b) 59:54 
c) Produto natural 
(PN)  
- uma forma de crescimento. Cresci/o 
- pela ordem da vida, o período aparece 
e depois desaparece. Term_Menst_ 
Menst 
- Deixei de me preocupar com 
contracepção Termin_Menst_Contracp 
- Mais calma Alt_Psic_Calma 
 
- os afrontamentos são um pequeno 
incómodo Sint_Vas 
- preocupação com osteoporose 
Preoc_Doença_Osteo 
2 a) Reformada, 
Ensino Secundário, 
Casada 
b) 59:50 
c) Terapia hormonal 
(TH)  
- é uma fase natural que faz parte do 
ciclo da vida. Fase_CV_NN 
- é uma fase que nós aceitamos 
Fase_CV_Aceitação 
- é a consequência da passagem dos 
anos. Env_Idade 
- nada, foi muito soft Nenhuma - nada, além da osteoporose 
Preoc_Doença_Osteo 
 
3 a) Funcionária 
administrativa, 
Ensino médio, 
Solteira 
b) 64:48 
c) Nada 
- para mim não significa nada porque 
não lhe dei nenhuma importância. 
Desval 
No meu caso não senti que fosse o 
virar de 1 página dado que não lhe dei 
importância. Desval 
Nenhuma Nenhuma - tensão arterial descontrolada 
Preoc_Doença_TA 
  
4 a) Reformada, 
Ensino médio, 
Viúva. 
b) 63:51 
c) TH  
- Um descanso (pelo término da 
menstruação). Term_Menst_Menst 
- Limpeza Term_Menst_Hig 
 
- liberdade para planear férias de praia  
(ausência de menstruação) 
Termin_Menst_Férias 
- tirando os afrontamentos, não senti nada 
de negativo Sint_Vas 
 
5 a) Reformada, 
Ensino Secundário, 
Casada. 
b) 58:52 
c) TH  
- Não aceitei a menopausa, foi um 
alívio conseguir superá-la 
Fase_Neg_Exp_Neg 
- O terminar da menstruação: isso foi um 
alívio Term_Menst_Menst  
- o terminar do mal-estar por altura do 
período foi muito bom pois deixei de ter 
dores de cabeça que acompanhavam 
sempre o período Termin_Menst_SPM  
- deixar de ter menstruação foi bom porque 
não é uma coisa prática 
Term_Menst_Menst 
 
- Angústia e tristeza logo aos 48/49 anos 
Alt_Psic_Humor 
- Agravamento da osteopenia (já perto da 
osteoporose) Preoc_Doença_Osteo 
- Medo de não ficar bem em termos de 
saúde, concretamente, em relação às dores 
nas articulações devido à presença de 
osteopenia Preoc_Doença_Osteo 
- Senti que a vida terminava ali, 
Alt_Psic_Desesperança  
- senti que já não tinha nada para dar 
Alt_Psic_desvalorização  
- estava a ficar velha Env 
- Engordei muito com a medicação 
Aum_Peso  
6 a) Funcionária 
administrativa, 
Ensino médio, 
Divorciada 
b) 60:43 
c) Nada 
- é uma coisa normal; Fase_CV_NN 
- é uma fase natural Fase_CV_NN 
- é o terminar de um ciclo e o começo 
de outro ciclo que também é 
maravilhoso Fase_Pos_ Exp_Pos 
- é uma nova vida que pelo término da 
menstruação traz uma libertação 
(sexual) Fase_Pos_Ganho e um 
condicionamento pois já não se pode 
ter filhos Fase_Neg_Perda  
- Término da menstruação 
Termin_Menst_Menst  
- higiene Term_Menst_Hig 
- Se tivesse parceiro, sentir-me-ia mais 
liberta em termos sexuais 
Term_Menst_Liberdd_Sxl 
- A menopausa precoce vai afectar os ossos 
mais precocemente Preoc_doença_Osteo  
mas com cuidados - alimentação 
equilibrada e suplementos naturais - 
diminui-se os riscos 
  
7 a) Desempregada, 
Ensino Secundário, 
Divorciada 
b) 58:52 
c) TH  
 
--- - deixar de ter a menstruação: já não tenho 
de me chatear com tampões 
Termin_Menst_Tampões 
- já não me preocupo com o controlo da 
natalidade Termin_Menst_Contracp 
- Senti muita angústia e ansiedade na altura 
da menopausa Alt_Psic_Ansiedd 
- A menopausa veio agravar uma 
vulnerabilidade que já existia por 
acontecimentos familiares stressantes 
anteriores Alt_Psic_Vulnerabilidd 
- Flacidez da carne (pescoço) 
Alt_Fís_Flacidez 
8 a) Arquitecta, 
Licenciatura, Casada 
b) 53: (ainda não 
teve menopausa) 
c) Nada 
- esta fase é uma maravilha 
Fase_Pos_Exp_Pos 
- é uma 2ª adolescência: irreverência, 
digo o que penso e sinto-me livre 
Fase_Pos_Exp_Pos 
- eu não penso na menopausa: não 
existe, isto é, não tem importância 
Desval 
- busco saber mais daquilo que me 
interessa  Alt_Psic_Invest 
 
Nenhuma 
9 a) Professora, 
Licenciatura, União 
de facto 
b) 59:49 
c) Nada 
-é um problema que temos que 
ultrapassar Fase_Neg_Exp_Neg  
- temos que passar por esta etapa, mas 
não é uma transição fácil 
Fase_Neg_Exp_Neg 
- perda de 1 capacidade 
Fase_Neg_Perda 
- é a chegada à velhice Env_Id 
Nenhuma - Foi mau, tive a sensação de chegar ao fim, 
Alt_Psic_Desesperança  
- senti-me a perder a capacidade de ser 
mulher Perda_Mulher  
- perde-se algo que não é recuperável; a 
incapacidade para ter filhos foi para mim 
chocante. Perda_Capac_reprod 
- Houve uma diminuição do desejo sexual, 
Alt_Sx_Desejo mas não me aborreci com 
isto. 
 
10 a) Médica, 
Licenciatura, 
Divorciada 
- é uma coisa natural Fase_ CV_NN 
- é mais um ciclo da vida 
Fase_CV_Outra_Fase 
- deixei de me preocupar com os pensos 
Termin_Menst_Tampões;  
- maior higiene Term_Menst_Hig  
As perdas não têm a ver com a menopausa 
Nenhuma 
  
b) 55 (ainda não teve 
menopausa) 
c) Nada 
- é o fim da fábrica 
Term_Menst_Reprod 
- é o final da procriação 
Term_Menst_Reprod 
- é o aparecimento de alterações no 
corpo (ex., articulações) 
Conseq_Fís_Neg 
- degenerescência Fase_Neg_Perda  
- a fase de envelhecimento Env_Idade 
 - é também  uma involução 
Fase_Neg_Perda 
- os ovários deixam de funcionar 
Term_Menst_Ovár_Estrog 
- a evolução da idade e do físico 
Env_Idade 
- deixa de haver um impedimento ao acto 
sexual Term_Menst_Liberdd_Sxl 
 
11 a) Funcionária 
administrativa, 
Ensino secundário, 
Casada;  
b) 59:50 
c) PN 
- é uma coisa natural Fase_CV_NN 
- a paragem dos ovários 
Term_Menst_Ovár_Estrog 
 
- foi um alívio em termos da menstruação  
Termin_Menst_Menst 
Nenhuma 
12 a) Gestora, 
Licenciatura, Casada 
b) 53 (ainda não teve 
menopausa)  
c) Nada 
- não tenho pensado muito nisso 
Desval 
- é algo que faz parte da natureza 
Fase_CV_NN 
- é um processo natural Fase_CV_NN  
- Ausência do período 
Termin_Menst_Menst  
- estou livre de engravidar o que é um 
alívio Termin_Menst_Contracp 
- Diminuição do apetite sexual, 
Alt_Sx_Desejo que é natural, mas pode ser 
preocupante se o parceiro estiver sempre 
disposto para sexo e a mulher não 
- pode-se ficar com a saúde física mais 
debilitada Preoc_Doença_SOE 
  
13 a) Tradutora, 
Bacharelato, Casada 
- é uma grande seca 
Fase_Neg_Exp_Neg 
- há muitas que posso agora fazer 
Alt_Psic_Invest 
- começamos a sentir que o físico está a 
ceder Alt_Fís_Mudança_Corpo e arrasta a 
  
b) 54:45 
c) Nada 
- é quando nos apercebemos que a 
idade está a passar Env_Id 
- altura em que se olha para trás para 
ver as minhas pegadas. Até à 
menopausa não há tempo para pensar; 
nesta altura há mais tempo e as coisas 
ganham um ritmo e um significado 
diferente que pode ser bom 
Fase_Pos_Ganho 
- A vida é um continuum e a 
menopausa é mais um apeadeiro 
Fase_CV_Outra_Fase 
- é uma etapa compensadora: há uma 
procura de algo mais profundo e 
permanente Fase_Pos_Exp_Pos 
- Fase muito boa Fase_Pos_Exp_Pos 
excepto o condicionamento físico 
Conseq_Fís_Neg 
- Tranquilidade Alt_Psic_Calma 
- Tenho mais certezas 
Alt_Psic_Confiança_Certezas  
- já tenho experiência que me leva a dizer 
“isto sim, isto não” e com esta idade já não 
faço fretes; digo sim e não sem remorsos e 
lamentos Alt_Psic_Assertividd 
- Tenho mais confiança 
Alt_Psic_Confiança_Certezas 
 
parte psicológica Alt_Psic_SOE 
- em termo físicos já não somos capazes de 
fazer o que queremos 
Alt_Fís_Dificuldd_Fís  
- perdas de memória Alt_Psic_Memória  
- dificuldades físicas (já me custa subir 
escadas) Alt_Fís_Dificuldd_Fís 
14 a) Reformada, 
Ensino secundário, 
Divorciada 
b) 60:49 
c) Nada 
- é uma experiência positiva 
Fase_Pos_Exp_Pos 
 
Só vejo consequências positivas; o período 
por exemplo era um condicionamento em 
relação às férias Termin_Menst_Férias 
- A perspectiva positiva a partir de agora 
pesa mais Alt_Psic_Valoriz_Exp_Pos 
- A pessoa fique mais livre e começa a ver 
outros interesses Alt_Psic_Invest 
 
Nenhuma 
15 a) Bancária, Ensino 
secundário, Casada 
b) 57:45 
c) TH  
- a continuação do sentimento de ser 
mulher Manut_Mulher  
- alívio por deixar de ter o período por 
causa da praia e piscina 
- Foi um alívio deixar de ter o período  
Termin_Menst_Menst  
- deixei de me preocupar com 
contracepção Termin_Menst_Contracp 
- aumento de kg, Aum_Peso  
- há uma mudança no corpo, 
Alt_Fís_Mudança_Corpo  
- secura vaginal Alt_Sxl_Sec_Vaginal 
  
Term_Menst_Praia e por causa da 
higiene Term_Menst_Hig  
- No meu caso foi um pouco cedo de 
mais, mas também acho que já não 
queria mais filhos Fase_Neg_Perda 
- A menopausa é uma fase como 
qualquer outra Fase_CV_Outra_Fase 
- é um marco, isto é, natural, na nossa 
vida, tal como o aparecimento da 
menstruação também o é 
Fase_CV_NN 
- o desaparecer da menstruação 
também é importante 
Term_Menst_Menst  
- metade da vida já passou Env_Idd,  
- fase de decadência 
Fase_Neg_Exp_Neg,  
- deixamos de ser reprodutivas 
Term_menst_reprod 
- Poupança de dinheiro com pensos 
Termin_Menst_Tampões 
- Higiene Term_Menst_Hig 
16 a) Professora, 
Licenciatura, 
Solteira 
b) 57:52 
c) PN 
- a menopausa é um sinal que nós não 
queremos muito encarar 
Fase_Neg_Exp_Neg  
- início de uma nova fase de 
envelhecimento Env_Idd 
- menopausa são a secura vaginal, 
rugas, perdas de memória, osteoporose 
Conseq_Fís_Neg 
- Menopausa é um sinónimo de  
envelhecimento Env_Id 
- sinto uma maior paz Alt_Psic_Calma 
- amadurecimento Alt_Psic_Amadur 
- sinto que estou menos preocupada 
Alt_Psic_Despreoc  
- vou aceitando mais as coisas (as pessoas 
à minha volta, da minha idade, começam a 
morrer, mas vou aceitando); há uma maior 
capacidade de aceitação 
Alt_Psic_Aceitaç_Toler 
- nesta fase faço massagens, viagens, 
espectáculos; deixei de adiar as coisas 
- senti algum angústia devido a grandes 
hemorragias Alt_psic_Ansiedd 
- falhas de memória, Alt_Psic_memória  
- canso-me um bocadinho mais 
Alt_Fís_Dim_Energia 
 
  
lúdicas Alt_Psic_Invest 
 
17 a) Farmacêutica, 
Licenciatura, 
Solteira 
b) 45:40 
c) Nada 
- ausência do ciclo de menstruação 
Term_Menst_Menst 
- o início de uma outra fase da mulher 
Fase_CV_Outra_Fase 
- faz parte de um crescimento Cresci/o 
e do envelhecimento Env_Id 
Nada Nenhuma - sintomas da menopausa (afrontamentos) 
Sint_Vas 
- preocupação com  consequências a longo 
prazo, isto é, osteoporose 
Preoc_Doença_Osteo 
e doenças cardio-vasculares 
Preoc_Doença_DCV 
- ter afrontamentos, sentir a cabeça suada: 
na altura sentia vergonha 
Sint_Vas_Vergonha 
- também houve um mal-estar psicológico, 
Alt_Psic_SOE  
- senti mais irritabilidade, falta de paciência 
Alt_Psic_Irritab_Impaciên que tiveram 
um impacto médio 
- em relação à sexualidade, dado haver 
algumas alterações sexuais Alt_Sx_SOE há 
que fazer um maior investimento  
 
18 a) Professora, 
Licenciatura, Casada 
b) 47:42 
c) Nada 
--- - Deixar de ter o período 
Termin_menst_menst 
- uma indisposição horrorosa, calores muito 
grandes Sint_Vas acordava de noite toda 
suada: tinha vergonha pois parecia que 
tinha feito chichi na cama 
Sint_Vas_Vergonha 
- a mulher sente-se…, não é bem rejeitada, 
é mais acabrunhada porque as outras 
pessoas vêem-na a abanar-se 
Sint_Vas_Vergonha 
  
- tive que deixar de beber álcool em 
situações sociais; quando saía só bebia 
água. Perda_Rotinas 
- Teve impacto porque passei a sair menos 
e a isolar-me mais nesta fase 
Perda_rotinas 
- na presença dos outros sinto-me 
inferiorizada Alt_Psic_Desvalorização 
 
19 a) Professora, 
Licenciatura, Casada 
b) 57:50 
c) Nada 
- envelhecimento do corpo Env_Id 
- a partir daqui a sociedade põe a 
mulher de lado Fase_Neg_Exp_Neg 
- é outra fase da vida 
Fase_CV_Outra_Fase 
- é um período de desconforto (tem-se 
os afrontamentos e os suores 
nocturnos), mas que se consegue gerir 
Conseq_Fís_Neg 
 
- passei a ser mais permissiva e tolerante 
Alt_Psic_Aceit_Toler 
 
- Em termos físicos vejo os braços flácidos; 
Alt_Fís_Flacidez  
- o envelhecimento do corpo Env  
- aumento do peso, Aum_Peso  
- há uma mudança no corpo (aparecem os 
pneus) Alt_Fís_Mudança_Corpo  
- sinto uma maior flacidez 
Alt_Fís_Flacidez 
- sintomas da menopausa: desconforto 
devido aos afrontamentos, aos suores 
nocturnos Sint_Vas 
 
20 a) Chefe de secção, 
Ensino secundário, 
Casada 
b) 52:51 
c) Nada 
- é uma coisa normal Fase_CV_NN 
- é um estado de idade Env_Id 
- não deixo de ser mulher 
Manut_Mulher 
- paragem da menstruação 
Term_Menst_Menst 
- é normal, natural Fase_CV_NN 
Nada Nenhuma - aumento do peso Aum_Peso do colesterol 
Preoc_Doença_Colest e da tensão arterial 
Preoc_Doença_TA 
 
21 a) Funcionária 
administrativa, 
- bem chata e desagradável só por 
causa dos afrontamentos 
- deixar de ter o período foi bom 
Termin_Menst_menst 
Afrontamentos Sint_Vasomotor 
  
Ensino médio, União 
de facto 
b) 44: (ainda não 
teve menopausa) 
c) Nada 
Conseq_Fís_Neg 
- a mulher não deixa de ser mulher, 
nem deixa de captar o interesse só por 
causa da menopausa Manut_Mulher 
  
- já não há o condicionamentos do período  
a nível sexual, é uma libertação 
Term_Menst_Liberdd_Sxl 
22 a) Funcionária 
administrativa, 
Ensino médio 
Solteira 
b) 54:50 
c) Nada 
- uma coisa natural Fase_CV_NN 
 
Deixei de andar com tampões e pensos 
Termin_Menst_Tampões 
Nada Nenhuma 
23 a) Reformada, 
Ensino médio, 
Casada   
b)58:48 
c) Nada  
- nunca pensei na menopausa nem 
nunca liguei Desval 
 
- o fim do período é um alívio porque uma 
pessoa deixa de se preocupar com a 
prevenção da gravidez 
Termin_Menst_Contracp  
- não ter menstruação é por si mesmo um 
alívio Termin_Menst_Menst 
Nenhuma 
24 a) Professora, 
Licenciatura, união 
de facto 
b) 57: 49 
c) TH  
- fase da vida como outra fase 
Fase_CV_Outra_Fase 
- não é o fim, é uma nova fase 
Fase_CV_Outra_Fase 
- é o início de um novo estado de vida: 
já não sou tão nova como era Env_Id 
- uma fase diferente em que se está 
disposta para outras coisas: netos, nova 
relação, vivência sexual muito boa. 
Fase_Pos_Exp_Pos 
- é mais uma etapa, sem sensação de 
perda Fase_CV_Outra_Fase 
- deixar de ser menstruada foi uma  
libertação porque acabou a contracepção 
Termin_Menst_Contracp 
- grande libertação das dores menstruais e 
das hemorragias Termin_Menst_Menst 
- É desagradável suar mas gere-se bem 
Sint_Vasomotor 
25 a) Escriturária, - quando os órgãos reprodutores - não me preocupar com o controlo da Nada Nenhuma 
  
Ensino secundário, 
Solteira 
b) 39:34 
c) Nada 
deixam de funcionar 
Term_Menst_Ová_Estrog 
- envelhecimento Env_Idd 
natalidade Termin_Menst_Contracp 
 
 
 
26 a) Reformada, 
Bacharelato, Casada  
b) 53:43 
c) Nada 
- é mais um período da vida 
Fase_CV_Outra_Fase  
- é o ponto mais alto em termos 
intelectuais Fase_Pos_Exp_Pos 
- o começo do declínio físico (perda de 
massa óssea, memória, elasticidade e 
desejo sexual) Conseq_Fís_Neg 
- para mim a menopausa é um apelo a 
gozar a vida Fase_Pos_Exp_Pos  
- diz-me que estou a envelhecer 
Env_Id 
 
- foi um alívio ver-me livre da 
menstruação, já estava farta. 
Term_menst_Menst 
- psicologicamente, continuo a ser uma 
nova estudante com vontade de aprender 
novas coisas Alt_Psic_Invest  
- maior sensibilidade 
Alt_Psic_Sensibilidd 
 
- por causa do que se ouve sobre a 
osteoporose, vigio de perto a minha saúde 
Preoc_Doença_Osteo 
- a irritabilidade 
Alt_Psic_Irrita_Paciência e a mudança de 
humor Alt_Psic_Humor  
- os afrontamentos, apesar de terem sido 
muito poucos Sint_Vas 
 
27 a) Funcionária 
administrativa, 
Ensino secundário, 
Viúva 
b) 59:55 
c) Nada 
- fase neutra Fase_CV_Neutra 
- noção de que estamos a envelhecer e 
na curva final Env_Id 
- fase normal da vida, tal como 
gravidez Fase_CV_NN 
- foi óptimo, um alívio em relação ao 
período Termin_Menst_Menst 
 
- Pele muito seca (pés) Alt_Fís_Pele_Seca 
- Queda de cabelo Alt_Fís_Queda_Cabelo 
 
28 a) Funcionária 
administrativa, 
Bacharelato, 
Divorciada  
b)55: (ainda não teve 
menopausa) 
c) Nada 
- não me vem à cabeça nada de 
especial Desval 
- tem a ver com o processo natural 
Fase_ CV_NN 
- ligo a menopausa ao envelhecimento 
Env_Id 
- não é uma doença, é uma 
característica das mulheres da minha 
Nenhuma - sinto que já não sou jovem, Env  
- fisicamente já não faço as coisas que 
fazia. Alt_Fís_Dificuldd_Fís 
- é uma chatice a perda do desejo sexual, 
Alt_Sx_Desejo  
- pele mais flácida Alt_Fís_Flacidez e está 
tudo a descair 
 
  
idade Env_Idd 
- tenho uma postura neutra, nem 
positiva, nem negativa. Fase_ 
CV_Neutra 
- É uma coisa que tem que ser. Temos 
que aprender a viver com esta 
característica (menopausa) 
Fase_CV_Aceitação 
 
29 a) Professora, 
Licenciada, Casada 
b) 50: (ainda não 
teve menopausa) 
c) Nada 
- deixamos de poder ter filhos 
Term_Menst_Reprod 
- faz parte do continuum da vida  que 
temos de aceitar Fase_CV_Aceitação 
 
Não ter o período Termin_Menst_Menst - receio de ter osteoporose, 
Preoc_Doença_Osteo  
- ganho de peso  Aum_Peso  
- redução do desejo sexual Alt_Sx_Desejo 
 
30 a) Bancária, Ensino 
secundário, Casada  
b) 59:48 
c) TH  
- para mim, na altura, foi como uma 
coisa que me tiraram Fase_Neg_Perda  
- tive uma sensação de perda 
(concretamente em termos sexuais, 
excitação, desejo) Fase_Neg_Perda 
- A ideia de “período” é sinónimo de 
vida; a menopausa é o oposto, 
Fase_Neg_Perda   
- é a entrada na fase descendente da 
vida da mulher Fase_Neg_Exp_Neg  
- há uma modificação a partir da 
menopausa e começa-se a perder 
Fase_Neg_Perda 
 - A partir da menopausa há qualquer 
coisa que morre na mulher: a 
esperança! Fase_Neg_Perda 
Nada nenhuma - fisicamente: nada de significativo, 
engordei um bocadinho Aum_Peso 
- menos energia Alt_Fís_Dim_energia 
- psicologicamente: nenhuma consequência 
- afectou muito o desejo sexual (diminui): 
Alt_Sx_Desejo criei expectativas mais 
exigentes da minha parte, ie, como desejo 
menos estou à espera de receber mais.  
- A diminuição de desejo sexual provocou 
um afastamento do meu marido 
Alt_Sx_Afastamento (pensava “isto não é 
justo para a mulher”), criou uma irritação 
em mim Alt_Psic_irritab_impaciênc  
- a diminuição do desejo sexual implicou 
depois o afastamento. 
Alt_Sx_Afastamento 
  
Menor capacidade para acreditar, para 
a esperar. Fase_Neg_Perda  
- sempre pensei que teria outro filho, 
mas com a chegada da menopausa isso 
tornou-se impossível Fase_Neg_Perda 
 
- senti-me a perder um pouco a essência de 
ser mulher Perda_Mulher. Aparecem 
medos, insegurança e culpabilização por 
não conseguir a performance sexual 
Alt_Sx_Culpa_Inseg e ter desejo. Mas 
depois as coisas entraram noutra rotina e 
compensa-se de outra forma. 
 
31 a) TOC, Bacharelato, 
Casada  
b) 60:52 
c) Nada 
- é o fim do período,  
Term_Menst_Menst 
- redução do estrogénio 
Term_menst_Ová_Estrog 
 
Término da menstruação: deixou de 
interferir com as férias! 
Termin_Menst_Férias 
- Acalmei-me (era muito impulsiva); 
Alt_Psic_Calma 
- Tranquilidade, Alt_Psic_Calma 
- paz comigo mesma Alt_Psic_Calma 
 
Nada Nenhuma 
32 a) Bancária, 
Licenciatura, 
Divorciada 
b) 57:51 
c) PN 
- há algo que nos foge, algo que tem a 
ver com o ser mulher. 
Fase_Neg_Perda 
Nenhuma Só o receio de perder saúde 
Preoc_Doença_SOE 
- a partir daqui começa-se a perder coisas e 
pode surgir o receio não ser desejada pelo 
meu companheiro, Alt_Sx_Culpa_Inseg – 
- tenho medo de perder o poder de sedução 
Perda_aspecto_sedutor 
- maior dificuldade em andar 
Alt_Fís_Dificuldd_Fís, diminuição de 
energia física Alt_Fís_Dim_Energia tive 
que abrir mão de alguns hábitos 
Perda_rotinas  
- já não posso ser mãe 
Perda_Capac_Reprod  
  
33 a) Médica, 
Licenciatura, Casada 
b) 52: 48 
c) TH  
- a menopausa é uma fase natural da 
evolução da mulher Fase_CV_NN 
Nenhuma - aumento de peso Aum_Peso 
- diminuição da paciência 
Alt_Psi_Irritab_Impaciênc 
 
34 a) Costureira, Ensino 
básico, Casada  
b) 56:51 
c) PN 
- é outra fase da vida 
Fase_CV_Outra_Fase 
- uma mudança na vida: de fresca e 
nova passa-se para madura e a 
caminhar para velha Env_Id 
- é a perda de uma fase produtiva (isto 
é, já não se pode ter filhos) 
Fase_Neg_Perda  
- tem-se menos vitalidade, 
Conseq_Fís_Neg tem-se menos 
actividade e que já não conseguimos 
voltar para trás Fase_Neg_Perda 
 
- alívio por deixar de ter o período 
Termin_Menst_Menst 
- diminuição da vitalidade e actividade 
Alt_Fís_Dim_Energia  
- diminuição do desejo sexual 
Alt_Sx_Desejo 
 
35 a) Comercial, Ensino 
básico, Viúva  
b) 52:--- 
c) Nada 
- é uma fase natural Fase_CV_NN - libertar-me da preocupação de engravidar 
Termin_Menst_contracp 
- aumento do peso Aum_Peso 
- modificação do corpo 
Alt_Fís_Mudança_Corpo 
36 a) Contabilista, 
Licenciatura, Casada 
b) 60:55 
c) Nada 
- foi um aborrecimento: os 
afrontamentos, o mal-estar 
Conseq_Fís_Neg 
- é uma nova fase da vida 
Fase_CV_Outra_Fase 
- deixei de andar com pensos 
Termin_Menst_Tampões 
- deixei de ser menstruada 
Termin_Menst_Menst 
- não poder engravidar mais 
Perda_Capac_Reprod 
- receio de estar mais vulnerável a doenças 
Preoc_Doença_SOE 
- diminuição do desejo sexual 
Alt_sx_desejo 
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CATEGORIAS PARA A REPRESENTAÇÃO DE MENOPAUSA 
 
 
1 – Crescimento (Cresci/o) - processo ou fase de crescimento 
 
2 - Término da Menstruação (Term_Menst) 
a) término da experiência fisiológica externa que é a menstruação 
(Term_Menst_Menst) 
b) aumento de higiene ou limpeza (Term_Menst_Hig) 
c) paragem dos ovários/ diminuição de estrogénios (experiência fisiológica 
interna, isto é, paragem ou diminuição refere-se objectivamente à gónada ou à 
hormona) (Term_Menst_Ovár_Estrog) 
d) liberdade para ir à praia/piscina (Term_Menst_Praia) 
e) Término da capacidade reprodutiva (Term_Menst_Reprod) [este término 
refere-se ao termo da capacidade de ter filhos e não: ao termo do especificado 
nas alíneas a) e c) ou ainda à perda da menstruação ou a outra perda subjectiva 
ou objectiva (incluindo a perda da capacidade de ter filhos)] 
 
3 - Fase Normal/Neutra do Ciclo de vida (Fase_CV) 
 a) fase normal ou natural da vida (Fase_CV_NN) 
 b) fase que se aceita ou que tem de ser aceite (Fase_CV_Aceitação)   
 c) uma outra ou uma nova fase da vida (Fase_CV_Outra_Fase) 
 d) fase neutra (Fase_CV_Neutra) 
  
4 - Manutenção da Feminilidade (Manut_Mulher) 
 
5 - Envelhecimento/Progressão da idade (Env_Idade) – Menopausa como 
consequência do envelhecimento ou consequência da progressão da idade 
 
6 – Desvalorização (Desval) - Desvalorização da menopausa como uma 
fase diferente ou com o potencial de ter um impacto significativo na vida da 
mulher (por ex., não me vem à cabeça nada de especial, não tem 
importância, não liguei) 
 
7 - Consequências físicas negativas (Conseq_Fís_Neg) – Representação baseada nas 
consequências físicas negativas (que não sejam genericamente descritas como 
envelhecimento ou consequência da idade ou referidas como perdas) ou sintomas que 
resultam da menopausa (tal como afrontamentos ou osteoporose). Deverão ser 
enunciadas como alterações, presentes na altura da menopausa, mas ausentes antes 
desta. 
  
8 - Fase Positiva (Fase_Pos) 
a) experiência positiva, enunciação de adjectivação positiva e descrição de 
acontecimentos ou estados positivos sem os referenciar como ganhos objectivos 
derivados da menopausa (Fase_Pos_Exp_Pos) 
b) Ganho, isto é, descrição de algo que passa a existir a partir da menopausa, que 
é valorizado e que não existia antes (Fase_Pos_Ganho) 
13 
 
 
 
9 - Fase negativa (Fase_Neg) 
a) experiência negativa com referência a adjectivação negativa sem referência a 
perdas objectivas (Fase_Neg_Exp_Neg) 
b) Perda de algo (incluir aqui a perda da capacidade de ter filhos, quando o 
término desta faculdade é visto como uma perda) (Fase_Neg_Perda) 
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CATEGORIAS PARA CONSEQUÊNCIAS POSITIVAS DA MENOPAUSA 
 
 
1 – Ausência de consequências positivas (Nenhuma) 
   
2 – Término da Menstruação (Termin_Menst) 
 a) término da menstruação (Termin_Menst_Menst) 
 b) higiene (Termin_Menst_Hig) 
 c) término do uso de contracepção (Termin_Menst_Contracp) 
 d) término do síndrome pré-menstrual (Termin_Menst_SPM) 
 e) maior liberdade sexual (Termin_Menst_Liberdd_Sx)  
 f) término do uso de tampões/pensos (Termin_Menst_Tampões) 
 g) liberdade para planear férias (Termin_Menst_Férias)  
  
3 – Alterações psicológicas (Alt_Psic) 
 a) maior calma (ou sinónimo) (Alt_Psic_Calma) 
b) maior despreocupação (Alt_Psic_Despreoc) 
c) maior confiança/certezas (Alt_Psic_Confiança_Certezas)   
d) maior assertividade (Alt_Psic_Assertividd) 
c) maior capacidade de aceitação ou tolerância (Alt_Psic_Aceit_Toler) 
d) amadurecimento (Alt_Psic_Amadur) 
e) desejo de investir em coisas que gosta/em coisas novas (Alt_Psic_Invest)  
f) dar mais valor às experiências positivas (Alt_Psic_Valoriz_Exp_Pos) 
g) maior sensibilidade (Alt_Psic_Sensibilidd) 
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CATEGORIAS PARA CONSEQUÊNCIAS NEGATIVAS DA MENOPAUSA 
 
1- Ausência de consequências negativas (Nenhuma) 
 
2- Presença Sintomas Vasomotores  
a. Sintomas vasomotores (Sint_Vas) 
b. Vergonha ligada à manifestação dos sintomas vasomotores 
(Sint_Vas_Vergonha) 
 
3- Alterações na vida sexual (Alt_Sx) 
a. diminuição do desejo sexual (Alt_Sx_desejo) 
b. secura vaginal (Alt_Sx_Sec_Vaginal) 
c. sem outra especificação (Alt_Sx_SOE) 
d. alteração da relação com o marido (afastamento entre ambos) 
(Alt_Sx_Afastamento) 
e. culpa ou insegurança relacionadas com a performance sexual da própria 
mulher (Alt_Sx_Culpa_Inseg) 
 
4- Preocupação com surgimento ou agravamento de doença (Preoc_Doença) 
a. Osteoporose/osteopenia (Preoc_Doença_Osteo) 
b. Tensão arterial (Preoc_Doença_TA) 
c. Doença cardio-vascular (Preoc_Doença_DCV) 
d. Colesterol (Preoc_Doença_Aum_Colest) 
e. Sem outra especificação (Preoc_Doença_SOE) 
 
5- Aumento de peso (Aum_Peso) 
 
6- Alterações psicológicas (Alt_Psic) 
a. Humor deprimido ou alterações de humor (tristeza/angústia/alterações de 
humor) (Alt_Psic_Humor) 
b. Desesperança em relação ao futuro (Alt_Psic_desesperança) 
c. Sentimentos de desvalorização ou de inferioridade 
(Alt_Psic_desvalorização) 
d. Irritabilidade ou falta de paciência (Alt_Psic_irritab_Impaciênc) 
e. Ansiedade (Alt_Psic_Ansiedd) 
f. Agravamento de vulnerabilidade já existente devido a acontecimentos de 
vida stressantes (Alt_Psic_vulnerabilidd) 
g. Dificuldades de memória (Alt_Psic_Memória) 
h. Alterações psicológicas sem outra especificação (Alt_Psic_SOE) 
 
7- Alterações Físicas 
a. Flacidez de partes do corpo (Alt_Fís_Flacidez) 
b. Percepção de mudança corporal (Alt_Fís_Mudança_Corpo) 
c. Dificuldade física em fazer determinadas coisas (Alt_Fís_Dificuldd_fís) 
d. Pele seca (Alt_Fís_Pele_Seca) 
e. Queda de cabelo (Alt_Fís_Queda_Cabelo) 
f. Cansaço ou diminuição de energia (Alt_Fís_Dim_Energia) 
 
8- Percepção de Perda 
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a. Perda relacionada com a feminilidade/natureza de mulher 
(Perda_mulher) 
b. Perda da capacidade de ter filhos (Perda_capac_reprod) 
c. Deixar de fazer algumas coisas que gostava de fazer ou isolamento social 
(Perda_rotinas) 
d. Receio de perder um aspecto físico sedutor (Perda_aspecto_sedutor) 
 
9- Envelhecimento (Env) 
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De: onbehalfof+nickpanay+msn.com@manuscriptcentral.com em nome  
de nickpanay@msn.com 
Enviado: quarta-feira, 4 de Maio de 2011 11:07 
Para: Filipa Fernandes Pimenta 
Assunto: Climacteric - Decision on Manuscript ID DCLI-2011-0021.R1 
 
04.05.11 
 
Dear Ms Pimenta: 
 
Ref: Menopause Symptoms’ Severity Inventory (MSSI-38): Assessing  
symptoms’ frequency and intensity 
 
I have now carefully considered your revised paper and have recommended  
publication in Climacteric.  We are pleased to accept your paper in its  
current form which will now be forwarded to the publisher for copy  
editing and typesetting. 
 
You will receive proofs for checking, and instructions for transfer of  
copyright in due course. 
 
The publisher also requests that proofs are checked and returned within  
48 hours of receipt. 
 
Thank you for your contribution to Climacteric and we look forward to  
receiving further submissions from you. 
 
 
Sincerely, 
Nick Panay 
Editor in Chief (Europe) 
Climacteric 
nickpanay@msn.com Nick.Panay@imperial.nhs.uk 
 
---------------------------------------------------- 
There are now over 150 Informa Healthcare journals available on our free  
table of contents alerting service! To register for this free service for  
Climacteric visit:  
http://informahealthcare.com/page/services/alertingservices 
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e: ees.mat.0.10ef9c.0057da5e@eesmail.elsevier.com em nome de  
Maturitas [mat@elsevier.com] 
Enviado: quinta-feira, 5 de Maio de 2011 08:22 
Para: Filipa Fernandes Pimenta 
Assunto: Ms. No. MAT-D-11-00062R1 
 
Ref.:  Ms. No. MAT-D-11-00062R1 
Perceived control, lifestyle, health, socio-demographic factors and  
menopause: impact over hot flashes and night sweats Maturitas 
 
Dear MS Pimenta, 
 
The revised manuscript you submitted for publication in MATURITAS has now  
been evaluated. After due consideration I am pleased to inform you that  
the manuscript has now been accepted for publication in Maturitas. 
 
The abstract of your manuscript, and the full article, respectively, will  
appear in PubMed (MEDLINE) and in the MATURITAS Articles-in-Press section  
ScienceDirect within 1-4 weeks of receipt of your author corrections.  
Publication of your article in print in an issue will occur at a later  
date.  
 
We would like to congratulate you on your successful submission and hope  
that you will continue considering publishing your work in MATURITAS. 
 
With kind regards, 
 
Virginia O'Brien 
Journal Manager 
Maturitas 
 
Comments from the Editors and Reviewers: 
 
Reviewer #1: The authors have addressed my previous questions and  
comments and the paper is now suitable for publication - I would still  
recommend editing for language though.The authors have made detailed  
changes and have been responsive to feedback. 
 
 
